date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2018-01-21 13:01:31.879,604.4,605.0,593.1,603.95,933216.0,Pharma weekly wrap: Pharma stocks extend losses ahead of Q3 results,"Most stocks including Sun Pharma (-2.24 percent), Cipla (-1.79 percent), Aurobindo Pharma (-3.98 percent) and Cadila Healthcare (-2.1 percent) saw declines",negative,negative,-0.0744540039708689,neutral,3.3443983402489588,positive
2018-01-29 13:56:40.402,613.0,613.1,603.4,605.85,595299.0,"Cipla, Strides Shasun unit get USFDA approval for HIV drug","Cipla and Strides Shasun unit receive final approval from USFDA for tenofovir disoproxil fumarate tablets, used for the treatment of HIV-1 infections in adults",positive,positive,-1.1663947797716112,negative,-2.664473684210534,negative
2018-02-07 13:00:47.020,584.0,616.95,582.1,616.0,8336955.0,"Cipla Q3 profit seen up 13%; generic Renvela, Pulmicort, Dacogen may drive US biz",Operating profit is expected to increase 16.7 percent year-on-year to Rs 791 crore and margin may expand 70 basis points to 19.3 percent in Q3.,positive,positive,5.47945205479452,positive,5.109243697478988,positive
2018-02-07 18:01:43.682,584.0,616.95,582.1,616.0,8336955.0,Cipla Q3 profit rises about 7% to Rs401 crore,"Cipla net profit rose to Rs401 crore in the third quarter ended 31 December, from Rs375 crore a year earlier",positive,positive,5.47945205479452,positive,5.109243697478988,positive
2018-02-08 18:00:27.897,595.0,625.95,597.8,625.4,2369661.0,Cipla takes dual route to beat US market blues,Cipla will use its research budget (expensed in the profit and loss account) for its generic products and use acquisitions to take forward its ambitions in the specialty product space,neutral,positive,5.109243697478988,positive,-1.3267657106538528,negative
2018-02-08 18:00:55.587,595.0,625.95,597.8,625.4,2369661.0,"Pharma shares in focus; Cipla, Sun Pharma surge over 5%","At 02:59 PM; Nifty Pharma index, the largest gainer among sectoral indices, was up 3.6% as compared to 1.01% rise in the benchmark Nifty 50 index",positive,positive,5.109243697478988,positive,-1.3267657106538528,negative
2018-02-14 13:00:41.867,613.25,621.45,603.0,608.05,1390456.0,"Indian pharma firms renew focus; Dr Reddy's, Cipla eye $100-bn China market","DRL looking to introduce anti-cancer drugs, while Cipla, Wockhardt planning to launch core therapies",neutral,neutral,-0.847941296371797,neutral,-0.3108130214297362,neutral
2018-02-27 18:00:25.704,590.0,596.55,587.35,591.0,2246106.0,"Pricing woes force Cipla, Glenmark, Lupin to go slow on US drug pipeline",Indian pharmaceutical companies focusing on selective product launches in US market. Companies focus on complex products as tough competition in generic impact markets.,neutral,neutral,0.1694915254237288,neutral,-1.9279339956221475,negative
2018-02-28 13:00:19.513,593.9,593.9,580.7,582.45,1331686.0,Cipla ties up with Roche to sell two key drugs in India,Cipla and Roche Pharma India signs an agreement under which Cipla will promote and distribute tocilizumab and Syndyma,positive,positive,-1.9279339956221475,negative,-0.2748668613640307,neutral
2018-03-01 13:01:18.495,593.9,593.9,580.7,582.45,1331686.0,Cipla's U-turn: Happily ever after?,"In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roche to promote Actemra and Syndyma.",neutral,positive,-1.9279339956221475,negative,-0.2748668613640307,neutral
2018-03-20 13:00:50.239,558.5,567.45,546.4,551.0,3085632.0,Cipla shares fall after US FDA found deficiencies at Goa unit,"Shares of pharmaceutical company Cipla Ltd declined as much as 6.6 per cent to Rs 522.90, the lowest since June 6. US FDA has found deficiencies in Cipla's batch production and control records after i",negative,negative,-1.342882721575649,negative,-2.7567567567567486,negative
2018-03-21 13:02:05.842,555.0,555.0,538.15,539.7,1504482.0,Cipla gets USFDA observations for its Goa plant,Cipla says at this stage it does not foresee any impact on the other products being manufactured or filed from the Goa plant,neutral,neutral,-2.7567567567567486,negative,-0.0745434215430445,neutral
2018-03-26 18:01:11.029,543.75,549.0,542.0,545.0,2201606.0,Cipla rises 1% on launching authorized generic of Aloxi in US market,"Cipla USA, Inc. has launched an authorized generic version of Aloxi in the United States under applicable agreements with Helsinn Healthcare SA, in response to the at-risk launch by Teva.",positive,positive,0.2298850574712643,neutral,0.3768382352941092,neutral
2018-03-27 13:00:18.899,544.0,548.8,534.0,546.05,2666673.0,Cipla stock: Healthy momentum in sales indicates strong earnings visibility,Cipla's relatively late entry into the US market is proving a blessing,positive,negative,0.3768382352941092,neutral,5.599707682470079,positive
2018-04-12 13:00:31.763,557.55,561.15,552.55,554.95,1017607.0,Sundyota ties up with Italian firm to launch probiotic products in India,Plans to set up formulations facility near Ahmedabad; in marketing tie-up with Cipla,positive,positive,-0.4663258900546873,neutral,5.786095289756803,positive
2018-04-16 18:01:54.649,585.55,588.35,575.7,580.0,2681369.0,Cipla gains 5% after USFDA inspection with no data integrity or repeat observations,The US Food and Drug Administration has recently completed its inspection of Cipla's Indore facility.,positive,positive,-0.9478268294765528,negative,0.695876288659786,neutral
2018-04-17 13:02:00.589,582.0,597.0,582.0,586.05,3851511.0,USFDA conducts inspection at Cipla's Indore facility,,neutral,neutral,0.695876288659786,neutral,-0.0427899015832263,neutral
2018-04-17 13:02:59.028,582.0,597.0,582.0,586.05,3851511.0,Cipla Q4 PAT seen up 57.7% YoY to Rs. 322 cr: Edelweiss,"Net Sales are expected to increase by 6.2 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs. 3,805.3 crore, according to Edelweiss.",positive,positive,0.695876288659786,neutral,-0.0427899015832263,neutral
2018-04-25 13:01:16.900,591.0,602.9,590.55,598.9,1501823.0,"Cipla poised to maintain high growth, earnings may grow by over 20%",Growth is expected to be strong in the March 2017-18 quarter (Q4) as well and in the current financial year,positive,positive,1.3367174280879826,positive,-0.1661129568106312,neutral
2018-05-02 13:01:54.736,613.0,613.1,597.0,611.9,997948.0,"Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin",Drug major Cipla has received final approval from the US health regulator for generic equivalents of  Vazculep and Aromasin,neutral,positive,-0.1794453507340983,neutral,-2.417905570985144,negative
2018-05-09 23:01:04.876,594.0,594.6,572.5,574.1,2157321.0,Cipla enters into exclusive pact with US-based MannKind to sell inhaled insulin in India,"Under the agreement, Cipla is responsible for obtaining regulatory approvals to distribute Afrezza in India, including approval from the Drug Controller General of India (DCGI), while MannKind will manufacture and supply the drug",positive,positive,-3.3501683501683464,negative,-0.3985789792912147,neutral
2018-05-11 10:02:59.500,577.05,580.75,565.1,574.75,920337.0,"Stay cautious, Nifty likely to struggle around 10,780 levels; Short Cipla","“Failing to breakout 10,780 may push the Nifty into consolidation,” said Jaydeb Dey, Technical Analyst at Stewart & Mackertich Wealth Management",neutral,neutral,-0.3985789792912147,neutral,0.6608695652173834,neutral
2018-05-14 18:01:47.451,579.8,593.0,573.1,575.0,2049242.0,"Nifty Pharma breaks 6-day losing streak; Dr. Reddy's Labs, Cipla climb 1%","The Nifty Pharma index settled 0.19 per cent up at 8,462.",positive,positive,-0.8278716798896093,neutral,-3.269565217391297,negative
2018-05-18 18:02:26.858,555.0,556.0,530.0,531.45,1706289.0,Stempeutics partners with Cipla for its stem cell drug,"Founded in 2006 by Manipal Education and Medical Group (MEMG), Stempeutics later entered into an alliance with Cipla in 2009. It is an advanced clinical stage biotech firm.",neutral,positive,-4.243243243243235,negative,-2.4734317690209684,negative
2018-05-21 23:00:35.181,524.8,531.1,507.2,525.0,3074747.0,"SBI, HPCL, IOC, Cipla, Dr Reddy’s, Bosch results"," Close to 60 companies including Andhra Bank, Allcargo, Bata India, Batliboi, Ballarpur, Bemco Hydraulics, Bosch, Bharat Forge, Capital Trust, CARE, Cipla, Dr Reddy’s Laboratories, GE Power, Future Co",neutral,neutral,0.0381097560975696,neutral,3.689320388349514,positive
2018-05-22 10:01:41.336,524.8,531.1,507.2,525.0,3074747.0,"Stocks To Watch: Cipla, Dr. Reddy’s, HPCL, IOC",Stocks to watch out for in Tuesday’s trade.,neutral,neutral,0.0381097560975696,neutral,3.689320388349514,positive
2018-05-23 10:00:46.962,515.0,564.9,515.0,534.0,7379641.0,Cipla Q4 FY18 results no reason to reverse stock underperformance,The US generics pain is unlikely to subside anytime soon despite optimistic commentary from Cipla due to the growing number of USFDA approvals,negative,positive,3.689320388349514,positive,-0.2889095992544183,neutral
2018-05-28 10:00:21.145,534.0,548.3,534.0,540.8,1452767.0,"Hold  Cipla, target Rs  580:   Reliance Securities",Hold  Cipla Ltd.  at a price target of Rs  580 .,neutral,positive,1.273408239700366,positive,-1.5674271934706077,negative
2018-05-30 10:01:17.495,529.1,529.1,519.55,525.4,2154176.0,Pharmaceutical companies offering freebies may come under GST lens,"The tax heads of firms such as Novartis India, Sun Pharma, Cipla, Lupin have been summoned for meetings with tax officials, they said.",neutral,neutral,-0.6993006993007079,neutral,-1.106696935300799,negative
2018-05-31 18:01:21.481,526.95,530.75,521.05,524.8,1624680.0,Accumulate Cipla; target of Rs 585: Dolat Capital,"Dolat Capital recommended accumulate rating on Cipla with a target price of Rs 585 in its research report dated May 22, 2018.
",neutral,positive,-0.4080083499383415,neutral,-1.4502369668246402,negative
2018-06-04 10:01:32.016,527.5,529.0,517.15,519.85,1245733.0,"From Cipla to Glenmark, pharma companies' double-digit growth in doubt",Govt's proposed changes in pricing policy could play spoilsport,positive,neutral,-1.4502369668246402,negative,4.18989044781858,positive
2018-06-05 10:02:17.280,520.3,544.75,517.7,542.1,3395819.0,"Now, Indian pharmaceutical majors also face the African challenge",Cipla and Aurobindo among major companies whose March quarter sales in the institutional segment fell close to 50%,neutral,neutral,4.18989044781858,positive,-0.6917542888765911,neutral
2018-06-08 13:00:37.657,541.8,562.0,538.75,557.0,4811342.0,Pharma shares in focus as Nifty Pharma index rises 2%,"Sun Pharma, Cadila Healthcare, Dr Reddy's Laboratories, Cipla, Glenmark Pharma and Lupin from the Nifty Pharma index were up in the range of 2% to 3% on the NSE.",positive,positive,2.805463270579558,positive,0.2678571428571428,neutral
2018-06-08 18:01:16.695,541.8,562.0,538.75,557.0,4811342.0,Cipla partners with Eli Lilly to market diabetes drug,"Cipla has partnered with Eli Lilly to market and distribute Lilly’s insulin glargine injection, Basaglar, in India.Eli Lilly and Company (India) Pvt Ltd is a 100 per cent subsidiary of the US-based fi",neutral,neutral,2.805463270579558,positive,0.2678571428571428,neutral
2018-06-14 13:00:16.456,590.0,614.55,589.8,610.05,7121087.0,Cipla gets USFDA nod for generic Isuprel injection,"The company has received final approval from the United States Food and Drug Administration (USFDA) for its product which is a generic version of Hospira Inc's Isuprel injection, Cipla said in a statement.",neutral,positive,3.398305084745755,positive,-0.9558823529411802,negative
2018-06-14 13:02:28.320,590.0,614.55,589.8,610.05,7121087.0,Cipla gains 2% on USFDA approval for generic Isuprel,"The company has received final approval for its abbreviated new drug application (ANDA) for Isoproterenol hydrochloride injection USP, 0.2mg/mL, single - use sterile Ampoule from the United States Food and Drug Administration (USFDA).",positive,positive,3.398305084745755,positive,-0.9558823529411802,negative
2018-06-15 18:01:29.493,590.0,614.55,589.8,610.05,7121087.0,"Pharma stocks in green; Alembic Pharma, Cipla surge over 3%","Among the 50 stocks in Nifty index, 20 were trading in the green, while 30 were in the red.",positive,neutral,3.398305084745755,positive,-0.9558823529411802,negative
2018-06-19 23:00:55.760,613.0,622.75,600.35,603.7,9103616.0,Cipla gets USFDA nod for generic HIV drug,"Cipla today said it has received approval from the US health regulator to market Efavirenz tablets, used to treat HIV-1 infections in adults. The Mumbai-based firm has received final nod from the Unit",neutral,positive,-1.5171288743882472,negative,-0.7884362680683238,neutral
2018-06-20 10:01:16.772,613.0,622.75,600.35,603.7,9103616.0,"Cipla, IIFL Holdings and Oberoi Realty among top stocks to track today",Here is a list of top stocks that are likely to be in focus in today's trading session -,neutral,neutral,-1.5171288743882472,negative,-0.7884362680683238,neutral
2018-06-20 13:01:02.066,608.8,609.7,602.0,604.0,3038582.0,Cipla climbs 3% on USFDA approval to HIV drug,The stock rose 3.27 per cent to hit a high of Rs 622 on BSE.,positive,positive,-0.7884362680683238,neutral,1.7963576158940435,positive
2018-06-21 18:01:00.591,604.0,618.05,595.25,614.85,3241496.0,Cipla gets USFDA nod for generic Testosterone Cypionate injection,Cipla has received final nod from USFDA for generic Testosterone Cypionate injection used for replacement therapy in males for deficiency or absence of endogenous testosterone,neutral,neutral,1.7963576158940435,positive,-0.9998374248089704,negative
2018-07-03 18:00:30.387,644.95,648.0,623.8,628.0,5022952.0,"Pharma shares in focus; Aurobindo, Cipla, Divis Labs up 4%","At 02:43 pm; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.3% as compared to 0.46% rise in the Nifty 50 index.",positive,positive,-2.628110706256306,negative,-1.044303797468358,negative
2018-07-12 10:00:40.567,629.4,636.7,622.7,634.0,2175192.0,Cipla acquires 100% stake in South African pharmaceutical company Mirren,The transaction is subject to the approval by the Competition Commission of South Africa,neutral,neutral,0.7308547823323837,neutral,-1.1041009463722398,negative
2018-07-12 13:01:20.058,634.0,634.0,624.2,627.0,1472198.0,Cipla's subsidiary to buy South Africa's Mirren for 450 mn South African Rand,"Cipla said the acquisition of Mirren, which specialises in over the counter (OTC) pharmaceutical products, will strengthen its market position and help it to accelerate growth within OTC space. ",neutral,positive,-1.1041009463722398,negative,-1.7953606609469264,negative
2018-07-12 18:02:05.481,634.0,634.0,624.2,627.0,1472198.0,Cipla subsidiary to buy South Africa’s Mirren for Rs 228 crore,Cipla said the acquisition of Mirren will strengthen its market position and help it to accelerate growth within the over-the-counter  (OTC) space,neutral,positive,-1.1041009463722398,negative,-1.7953606609469264,negative
2018-07-18 13:01:03.392,629.8,632.1,606.15,613.15,1422421.0,"Cipla plans acquisitions to enter new therapies, boost Africa business",The company is looking at inorganic growth opportunities to offset delays in product approvals,positive,positive,-2.6436964115592216,negative,1.7725018294170218,positive
2018-07-23 10:01:44.352,623.15,637.3,617.25,634.0,1551239.0,"Sun Pharma, Cipla, Bajaj Finance, Nestle to get astrological support this week: Satish Gupta","Sun Pharma, Cipla, Ajanta Pharma, Bajaj Finance, Shriram Transport and Nestle will get astrological support, says Satish Gupta of astrostocktips.",neutral,positive,1.741153815293272,positive,-1.3092515182585485,negative
2018-07-24 13:02:17.287,629.0,631.0,613.45,621.15,1411265.0,"D-street Buzz: 120 stocks hits 52-week low; L&T Infotech up 5%, Vedanta gains 2%","Kotak Mahindra Bank, HUL, TCS, NTPC, Yes Bank, Cipla, Bajaj Finance and Bajaj Finserv are the top losers on the indices.",positive,negative,-1.2480127186009575,negative,1.3651050080775518,positive
2018-08-02 18:00:27.522,640.95,647.6,639.0,640.0,1529153.0,Pharma shares in focus; Nifty Pharma index hits 6-month high,"Divi's Lab, Aurobindo Pharma, Lupin, Dr Reddy's Lab, Sun Pharma, Glenmark Pharma and Cipla from the Nifty pharma index were up in the range of 1% to 3% on the NSE.",neutral,positive,-0.1482174896637874,neutral,-1.3755795981452823,negative
2018-08-02 18:02:29.413,640.95,647.6,639.0,640.0,1529153.0,"Cipla’s Uganda arm plans IPO, listing",Ugandan drugmaker Cipla Quality Chemical Industries Ltd said on Thursday it plans an initial public offering and a listing on the East African country’s stock exchange.The company said each of its sha,neutral,neutral,-0.1482174896637874,neutral,-1.3755795981452823,negative
2018-08-07 13:01:22.059,629.0,645.45,623.6,644.1,4115826.0,Cipla gets USFDA nod for joint pain relief gel,"Drug major Cipla today said it has received final approval from the United States Food and Drug Administration (USFDA) for Diclofenac Sodium Topical Gel, indicated for relief from pain caused by osteo",neutral,positive,2.4006359300476987,positive,-4.26810477657936,negative
2018-08-07 23:00:14.751,629.0,645.45,623.6,644.1,4115826.0,"Cipla, Indian Bank, HCC, Lupin, 8K Miles results","Over 175 companies including 8K Miles, 20 Microns, AB Capital, Asahi Songwon, Balrampur Chini, BEML, BPCL, Blue Star, Cipla, City Union Bank, EID Parry, Emami Infra, Forbes, Future Consumer, Goodyear,",neutral,neutral,2.4006359300476987,positive,-4.26810477657936,negative
2018-08-08 18:02:31.314,649.0,662.5,616.7,621.3,9976307.0,"Cipla Q1 profit rises 10% to ₹451 crore, tops estimates",Cipla’s net profit rose 10.4% from a year earlier to ₹451 crore in the first quarter ended 30 June,positive,positive,-4.26810477657936,negative,-0.616049283942719,neutral
2018-08-09 10:00:22.176,649.0,662.5,616.7,621.3,9976307.0,Cipla Q1 results: Costs and US recovery vital for FY19 health,Cipla’s success in getting new approvals does lend confidence to its view that US sales will ramp up,neutral,positive,-4.26810477657936,negative,-0.616049283942719,neutral
2018-08-10 23:01:37.178,624.95,628.5,614.5,621.1,3161073.0,Cipla arm secures marketing rights for cancer drug in US,"Cipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.",neutral,neutral,-0.616049283942719,neutral,1.028938906752408,positive
2018-08-12 23:02:43.194,622.0,631.55,619.2,628.4,2368711.0,"Stocks To Watch: Coal India, Indian Oil, HDFC Bank, NBCC, Cipla","HDFC Bank will be in focus after Parekh Sukthankar, Deputy MD and Founding Member resigned.",neutral,neutral,1.028938906752408,positive,2.6784295024638407,positive
2018-08-13 10:00:29.766,622.0,631.55,619.2,628.4,2368711.0,"Stocks in the news: Tata Steel, Glenmark, Union Bank, Sun TV, Godfrey Phillips",Cipla | NBCC | Ashok Leyland | Coal India | Hinduja Global Solutions | Welspun Corp and Reliance Communications are stocks which are in the news today.,neutral,neutral,1.028938906752408,positive,2.6784295024638407,positive
2018-08-23 13:00:13.792,658.0,658.0,645.0,651.9,1900589.0,"Nifty Pharma index hits 52-week high; Cipla, Sun Pharma touch 52-week highs","Nifty Pharma index hit a 52-week high of 10,142, rising 2%, in early morning deal, surpassing its previous high of 10,063 recorded on November 3, 2017 in intra-day trade on the NSE.",positive,positive,-0.9270516717325264,negative,0.9035222052067348,positive
2018-08-23 23:00:43.011,658.0,658.0,645.0,651.9,1900589.0,"From Glenmark to Cipla, Indian firms see rise in drug recalls in US","The reasons behind recall could vary from contamination (cross-batch, air-borne, dosage mix up, container, impurities) to wrong labelling, discolouration of tablets, non-standard quality",positive,neutral,-0.9270516717325264,negative,0.9035222052067348,positive
2018-08-28 13:00:50.610,650.0,653.65,640.0,641.65,1887894.0,"D-Street Buzz: Metals shine with Hindalco up 2%, RIL leads; Infosys hits new 52-week high","45 stocks are trading at new 52-week high including names like Axis Bank, Bajaj Finance, Cipla, Jubilant Food, Infosys, Mahindra & Mahindra, Reliance Industries, Tech Mahindra and VIP Industries among others.",positive,neutral,-1.284615384615388,negative,0.7054263565891402,neutral
2018-08-28 13:02:26.656,650.0,653.65,640.0,641.65,1887894.0,"D-Street Buzz: Pharma, IT stocks gain with Cipla up 2%; Tech Mahindra hits new 52-week high, RIL at fresh record high","The breadth of the market favoured declines, with 727 stocks advancing, 877 declining and 456 remaining unchanged. On BSE, 927 stocks advanced, 919 declined and 110 remained unchanged.",positive,positive,-1.284615384615388,negative,0.7054263565891402,neutral
2018-09-12 10:00:31.661,654.9,662.0,643.25,653.75,3301817.0,"Sun Pharma, Cipla, M&M and Reliance Capital among top stocks to watch",Sun Pharma said the US health regulator USFDA was conducting an inspection of its Mohali facility in Punjab.,neutral,neutral,-0.1755993281416975,neutral,0.0075301204819208,neutral
2018-09-17 23:02:15.335,665.0,673.0,660.6,663.3,1813479.0,Ugandan unit of Cipla raises $41 million in IPO: Broker,"John Porter, chief business officer at brokerage Renaissance Capital, told Reuters interest came from local and international investors.",neutral,neutral,-0.2556390977443677,neutral,-0.7485029940119761,neutral
2018-09-18 23:02:00.485,668.0,678.45,645.75,663.0,3042788.0,"In new world order, output counts, not attendance","Companies like Mahindra, Tata Motors, Cipla and Godrej are giving more flexibility and freedom to the employees.",neutral,positive,-0.7485029940119761,neutral,-1.1976047904191618,negative
2018-09-21 13:00:52.475,668.0,671.55,638.4,660.0,2275962.0,Cipla stock gains nearly 2% on USFDA approval for anti-nausea drug,"Cipla has received approval from US Food and Drug Administration for Palonosetron Hydrocholride injectable, which is available in strength of 0.25 mg/5ml.",positive,positive,-1.1976047904191618,negative,-2.7643504531721987,negative
2018-09-24 10:02:02.110,662.0,668.95,640.8,643.7,2765070.0,"DHFL, Usha Martin, Cipla and Inox Leisure among stocks in the news",Here's a look at the top stocks that may hog the limelight in today's session.,neutral,neutral,-2.7643504531721987,negative,2.694099378881991,positive
2018-10-01 10:02:42.129,653.05,659.0,643.5,657.0,1308933.0,We are determined to make fearless living a habit: Cipla's Umang Vohra,'We are looking to provide end-to-end solutions in the area of disease management for Patients',neutral,neutral,0.6048541459306402,neutral,0.7076923076923112,neutral
2018-10-05 13:02:13.269,635.3,649.55,631.0,640.0,1805911.0,"Ajanta Pharma, Wockhardt, Strides Pharma, Divis Labs, Cipla to get astrological support: Satish Gupta","Pharma stocks like Ajanta Pharma, Wockhardt, Strides Pharma, Divis Labs and Cipla will get astrological support, says Satish Gupta  of astrostocktips.",neutral,positive,0.7398079647410744,neutral,-0.0078542255733691,neutral
2018-10-10 10:00:43.922,639.35,651.0,633.3,639.65,1880677.0,"Cipla plans expansion, aims to launch at least one product in US every year","In India, the company is by far the leader in the respiratory drugs segment, having a turnover of over Rs 18.93 billion",positive,neutral,0.0469226558223124,neutral,-1.8486055776892465,negative
2018-10-12 18:00:26.973,620.0,627.2,612.6,624.75,2084850.0,Cipla Q2 PAT may dip 12.7% YoY to Rs. 368.9 cr: ICICI Direct,"Net Sales are expected to decrease by 1 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 4,042.4 crore, according to ICICI Direct.",neutral,negative,0.7661290322580645,neutral,3.9566613162118736,positive
2018-10-16 23:01:37.371,644.9,646.0,637.0,640.2,1280542.0,Cipla Q2 PAT seen up 3% YoY to Rs. 450.4 cr: Sharekhan,"Net Sales are expected to increase by 7.8 percent Y-o-Y (up 11.7 percent Q-o-Q) to Rs. 4,401.4 crore, according to Sharekhan.",positive,positive,-0.7287951620406159,neutral,-1.0620021864750828,negative
2018-10-17 18:02:17.693,644.9,646.0,637.0,640.2,1280542.0,Cipla Q2 PAT may dip 6.7% YoY to Rs. 390 cr: HDFC Securities,"Net Sales are expected to increase by 8.8 percent Y-o-Y (up 12.7 percent Q-o-Q) to Rs. 4,440 crore, according to HDFC Securities.",neutral,positive,-0.7287951620406159,neutral,-1.0620021864750828,negative
2018-10-23 18:01:11.014,625.5,635.0,615.6,621.8,987144.0,Cipla’s arm completes acquisition of South Africa’s Mirren,Drug major Cipla Tuesday said its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd.Cipla Medpro South Africa (Pty) Ltd has completed the acquisition of 100 per ce,positive,positive,-0.5915267785771455,neutral,-1.535849971708027,negative
2018-10-24 23:03:01.550,618.55,624.0,605.15,609.05,5735797.0,Cipla’s arm completes acquisition of South Africa’s Mirren,Drug major Cipla said on Tuesday its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd. Cipla Medpro South Africa (Pty) Ltd. has completed the acquisition of 100%,positive,positive,-1.535849971708027,negative,-1.255745239658583,negative
2018-11-05 10:00:50.658,607.4,617.5,557.1,562.5,12937991.0,"Stocks in the news: Future Retail, Cipla, GAIL, ONGC and PNB Housing",Heres a list of stocks which may hog limelight in todays session.,neutral,neutral,-7.392163319064863,negative,-4.513513513513505,negative
2018-11-05 13:00:36.516,555.0,555.0,527.35,529.95,16939859.0,"Cipla, GAIL, Power Grid, SBI Q2 results today; what to look for",Brokerage firm Sharekhan expects domestic loan growth of SBI to improve.,neutral,positive,-4.513513513513505,negative,-0.4944029850746226,neutral
2018-11-05 18:01:00.006,555.0,555.0,527.35,529.95,16939859.0,Cipla warns of headwinds in second half after second-quarter profit miss,"Cipla’s Q2 profit falls to Rs 377 crore in the quarter ended September 30, lower than Rs 423 crore a year ago, and analysts average expectation of Rs 456 crore",negative,negative,-4.513513513513505,negative,-0.4944029850746226,neutral
2018-11-05 18:01:13.251,555.0,555.0,527.35,529.95,16939859.0,"D-Street Buzz: Pharma, media stocks fall with Cipla & Sun TV down 7%; PSU banks gain","The breadth of the market favoured the declines with 801 stocks advancing and 926 declining while 347 remained unchanged. On the BSE, 1184 stocks advanced, 1356 declined and 158 remained unchanged.",negative,positive,-4.513513513513505,negative,-0.4944029850746226,neutral
2018-11-06 10:00:16.125,555.0,555.0,527.35,529.95,16939859.0,Cipla takes a cautious approach towards tender business to protect margins,"Tender business, which accounts for around 20% of consolidated sales, came under pressure because of intense competition and aggressive pricing",neutral,negative,-4.513513513513505,negative,-0.4944029850746226,neutral
2018-11-06 10:00:28.991,555.0,555.0,527.35,529.95,16939859.0,Cipla stock falls 7% on weak Q2 results; pressure on tender biz to continue,"Company cautious on prospects, given supply disruptions & commodity inflation, among others",negative,neutral,-4.513513513513505,negative,-0.4944029850746226,neutral
2018-11-06 18:00:27.347,536.0,536.0,532.1,533.35,697947.0,Continue to see GST impact of restocking in India sales: Cipla,"Umang Vohra, Cipla's Managing Director, said some of the tender businesses are growing 40 percent lower than last year.",neutral,negative,-0.4944029850746226,neutral,-1.6059757236227867,negative
2018-11-07 10:29:27.519,536.0,536.0,532.1,533.35,697947.0,Cipla: A perfect storm in one quarter,"Cipla said it lost some revenues to supply-related issues, costing it revenues close to ₹100 crore in the quarter",neutral,negative,-0.4944029850746226,neutral,-1.6059757236227867,negative
2018-11-09 13:02:00.860,535.5,535.8,524.0,526.9,6122906.0,"D-Street Buzz: Metal stocks down led by JSW Steel, Tata Steel; Bharti Airtel slips 5%","Bharti Airtel, Wipro, Tata Steel, Infosys, TCS, Cipla and JSW Steel are the top losers on the indices.",negative,negative,-1.6059757236227867,negative,0.1509433962264065,neutral
2018-11-11 18:02:08.527,530.0,541.9,529.05,530.8,7668415.0,Reality Check - Cipla,"Cipla needs a booster shot The stock of pharma major Cipla has declined nearly 18 per cent over the last month. The fall in the share price has been steep, after it registered a poor show (year-on-yea",neutral,negative,0.1509433962264065,neutral,-1.2172284644194755,negative
2018-11-12 10:01:58.383,530.0,541.9,529.05,530.8,7668415.0,"Lupin to Cipla, pharma firms on course to shed 'underperformer' tag in FY19","Easing of pricing pressures, launch of limited competition drugs in the US, weak rupee are key triggers",neutral,negative,0.1509433962264065,neutral,-1.2172284644194755,negative
2018-11-12 13:02:35.009,534.0,534.0,526.5,527.5,2405418.0,Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients,The approved products is a generic therapeutic equivalent version of Roche's Valcyte.,neutral,neutral,-1.2172284644194755,negative,-1.8281191104410188,negative
2018-11-13 13:00:30.070,530.6,532.6,517.0,520.9,2740256.0,Cipla's subsidiary to acquire US-based Avenue Therapeutics for $ 215 million,"At the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the aggregate.",neutral,neutral,-1.8281191104410188,negative,-0.0191607587660514,neutral
2018-11-14 18:02:28.085,521.9,525.0,514.45,521.8,2658244.0,Avenue Therapeutics buy will allow Cipla to enter specialty hospital business in US:  Kedar Upadhye,"
We are happy with the acceleration of the US pipeline, says Ciplas Global CFO.",neutral,positive,-0.0191607587660514,neutral,1.7826336975273058,positive
2018-11-15 18:00:58.635,521.7,534.0,521.1,531.0,3481955.0,Centrum cuts target price for Cipla,Cipla's revenues during Q2FY19 declined 2% YoY while the margin was down by 220 bps.,negative,negative,1.7826336975273058,positive,-1.1214953271028036,negative
2018-11-20 23:01:41.470,522.8,528.05,521.3,522.0,1748940.0,Cipla faces heat due to lower offtake of HIV drugs in tender market,Cipla’s management in its recent investor call indicated that the global tender business sales could be lower by $100-120m in FY19 led by funding crunch and competition.,negative,negative,-0.1530221882172828,neutral,-0.917782026768634,negative
2018-12-07 13:00:24.838,520.0,530.65,512.0,513.65,3502057.0,"D-Street Buzz: Media stocks gain led by Zee Entertainment; Cipla jumps 2%, Premier Explosives rallies","74 stocks have hit new 52-week low including names like Ashapura Intimates, Balkrishna Industries, Coal India, Deepak Fertilizers, GPT Infraprojects, HT Media and IL&FS Transportation Networks among others.",positive,negative,-1.2211538461538505,negative,0.5099039027260291,neutral
2018-12-11 13:01:42.338,522.9,534.3,521.1,532.05,1682859.0,"Over 200 stocks hit new 52-week low on NSE; volumes of Zensar Tech, Titagarh Wagons surge","200 stocks have hit fresh 52-week low on the NSE as market sentiment remains weak. The stocks to hit the new 52-week low in this morning session included NMDC, Tata Steel, Vodafone Idea, Mahindra & Mahindra, ONGC, Oil India and Cipla.",negative,negative,1.7498565691336732,positive,-0.8552631578947282,neutral
2018-12-28 23:01:27.831,514.3,525.35,514.3,522.0,1932882.0,A look at how Cipla is trying to consolidate its position in respiratory segment,"Cipla sells a range of products including pills, nasal sprays and inhalers to treat respiratory diseases.",neutral,neutral,1.4971806338712903,positive,-0.5747126436781609,neutral
2018-12-30 18:02:37.244,522.0,526.0,517.2,519.0,1897568.0,"Cipla recalls 4,800 bottles of anti-HIV tablets from US","As per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is 'failed dissolution specifications'.",neutral,negative,-0.5747126436781609,neutral,0.5288461538461539,neutral
2018-12-31 10:02:18.688,522.0,526.0,517.2,519.0,1897568.0,"Stocks in the news: Jet Airways, Infibeam, Cipla and Fortis Healthcare",Here are a few stocks whuich may buzz the most in today's trade.  ,neutral,neutral,-0.5747126436781609,neutral,0.5288461538461539,neutral
2019-01-01 13:00:04.057,521.9,522.5,513.15,514.35,1242076.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Cipla, Sun Pharma; Atul Auto gains 10%","Bharti Airtel, Bharat Wire Rope, Maruti Suzuki, Sangam India and Suyog Telematics are the most active shares on BSE.",positive,neutral,-1.44663728683655,negative,-0.8325266214907947,neutral
2019-01-01 18:00:55.066,521.9,522.5,513.15,514.35,1242076.0,Cipla Q2 FY19 Earnings Conference Call,This is the verbatim transcript of Cipla management call with analysts.,neutral,neutral,-1.44663728683655,negative,-0.8325266214907947,neutral
2019-01-07 13:01:41.828,516.0,517.2,511.25,514.0,1764242.0,"Cadila, Cipla shares gain after HSBC upgrades to buy",HSBC said risk-reward turned favourable post corrections in Cadila Healthcare & Cipla.,positive,positive,-0.3875968992248062,neutral,-0.9795364174182823,negative
2019-01-11 18:00:42.235,513.4,519.0,508.25,510.95,2051108.0,Cipla Q3 PAT may dip 27.6% YoY to Rs. 290.1 cr: ICICI Direct,"Net Sales are expected to increase by 4.3 percent Y-o-Y (up 1.7 percent Q-o-Q) to Rs. 4,081.6 crore, according to ICICI Direct.",neutral,positive,-0.4772107518504068,neutral,0.5978047824382617,neutral
2019-01-28 18:00:21.452,489.1,507.55,483.75,501.0,2674728.0,Cipla gets USFDA nod for contraceptive injection,The injection is indicated only for the prevention of pregnancy.,neutral,neutral,2.4330402780617413,positive,-0.0297059114763793,neutral
2019-01-28 18:00:54.198,489.1,507.55,483.75,501.0,2674728.0,Cipla gets USFDA nod for contraceptive injection,"Depo-Provera and its generic equivalents had US sales of around USD 159 million for the 12-month period ending November 2018, Cipla further said. ",neutral,neutral,2.4330402780617413,positive,-0.0297059114763793,neutral
2019-01-29 13:01:07.125,504.95,507.1,497.7,504.8,1523894.0,"D-Street Buzz: Nifty Energy in red dragged by RIL; PSU banks gain led by BOI, Adani Ports spikes 5%","The top gainers from NSE included Adani Ports, Zee Entertainment, Sun Pharma, Cipla and Bajaj Finserv while the top losers included Indiabulls Housing Finance which was down 5 percent followed by Eicher Motors, Reliance Industries, Power Grid and YES Bank.",positive,neutral,-0.0297059114763793,neutral,2.005928853754936,positive
2019-02-05 23:00:55.069,510.5,546.7,504.1,545.25,8774140.0,"Cipla, Graphite, Vodafone results"," About 80 firms will declare their Q3 FY19 results on Wednesday. Among these are Adani Ports, Adani Power, Allahabad Bank, AstraZeneca, BA Sugars, Cipla, CG Power, Cummins, Future Consumer, Graphite I",neutral,neutral,6.807051909892263,positive,-0.9495438465835082,negative
2019-02-06 10:00:08.874,510.5,546.7,504.1,545.25,8774140.0,"Tech Mahindra, Cipla, Lupin and Jubilant FoodWorks may hog the limelight",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,6.807051909892263,positive,-0.9495438465835082,negative
2019-02-06 18:00:33.147,537.1,546.6,528.15,532.0,4417025.0,"Cipla Q3 profit declines 17% to Rs 333 crore, misses estimates",ET NOW analysts had anticipated a profit of Rs 400 crore for the December quarter. ,negative,positive,-0.9495438465835082,negative,0.3471896406118087,neutral
2019-02-06 18:01:08.053,537.1,546.6,528.15,532.0,4417025.0,Cipla US business gains traction: Q3 takeaways,"Earnings per share of the pharma major, with a face value of Rs 2 each, stood at Rs 4.12.",positive,neutral,-0.9495438465835082,negative,0.3471896406118087,neutral
2019-02-07 10:02:53.447,537.1,546.6,528.15,532.0,4417025.0,Cipla rises 3% even as profit sees 17% dip in Q3,"Cipla reported a drop of 17 percent (year on year) in its profit for the December quarter at Rs 332.2 crore against Rs 400.5 crore posted last year.

",positive,negative,-0.9495438465835082,negative,0.3471896406118087,neutral
2019-02-07 23:02:23.156,532.85,543.7,531.2,534.7,2746002.0,"Cipla to continue cost cutting via portfolio rationalisation, manufacturing network review",Cipla had exited certain low margin products from the portfolio of its subsidiary Invagen in US.,positive,neutral,0.3471896406118087,neutral,0.8353443475032484,neutral
2019-02-08 10:00:21.466,532.85,543.7,531.2,534.7,2746002.0,Broker's call: Cipla (Reduce),"Prabhudas LilladherCipla (Reduce)CMP: ₹533.85Target: ₹475Cipla’s adjusted sales, adjusted EBITDA and PAT of ₹3,910 crore, ₹610 crore and ₹330 crore missed our estimates by 4 per cent, 7 per cent and 1",neutral,negative,0.3471896406118087,neutral,0.8353443475032484,neutral
2019-02-10 18:01:34.140,538.7,545.9,535.85,543.2,2988303.0,Cipla slips up," Cipla reported a 17 per cent Y-o-Y decline in its consolidated net profit in the December quarter to ₹332 crore. Higher tax expenses, coupled with the modest show in its key domestic market impacted",neutral,negative,0.8353443475032484,neutral,0.5555041199888899,neutral
2019-02-11 18:02:04.962,540.05,545.7,536.1,543.05,2252020.0,Hold Cipla; target of Rs 545: ICICI Direct,"ICICI Direct recommended hold rating on Cipla with a target price of Rs 545 in its research report dated February 07, 2019.",neutral,positive,0.5555041199888899,neutral,-0.0092081031307466,neutral
2019-02-14 10:01:34.539,542.9,556.0,537.4,542.1,2766202.0,Cipla (₹543.5): Buy,"Investors with a short-term perspective can buy the stock of Cipla at current levels. After an intermediate-term downtrend from the September 2018 high at around ₹678, the stock found support at ₹483",neutral,positive,-0.1473567876220214,neutral,0.3518518518518476,neutral
2019-02-19 10:00:43.391,544.8,545.0,536.75,539.45,1877337.0,"Stocks in the news: Grasim, Emami, Ambuja Cements, Cipla and IOC","Meanwhile, Infy has settled a case pertaining to the severance package for former CFO. ",neutral,negative,-0.982011747430233,negative,0.5553498704183636,neutral
2019-02-22 13:02:23.704,543.8,546.1,539.1,541.5,1590866.0,"D-Street Buzz: Oil & gas stocks gain led by HPCL, IOC; Wipro at new 52-week high, Suzlon rallies","The top gainers from NSE included Indian Oil Corporation, HPCL, Vedanta, BPCL and Indiabulls Housing Finance while the top losers included Kotak Mahindra Bank, Reliance Industries, Cipla, HDFC Bank and Asian Paints.",positive,neutral,-0.4229496138286051,neutral,1.0249307479224292,positive
2019-03-01 10:02:19.550,555.0,555.3,547.4,550.7,2429901.0,"D-Street Buzz: Nifty Metal outperforms led by Vedanta; Bharti Airtel down 2%, SBI Life most active","The top gainers from NSE included Vedanta, Zee Entertainment, YES Bank, Indiabulls Housing and Hindalco Industries while the top losers included Bharti Airtel, Dr Reddy's Labs, Cipla, Bajaj Auto and Coal India.",neutral,neutral,-0.7747747747747666,neutral,-0.4272727272727314,neutral
2019-03-06 13:00:13.873,547.65,550.0,539.65,542.95,1144395.0,Cipla to launch cinacalcet hydrochloride tablets in US,"Drug major Cipla and its subsidiary Cipla USA on Wednesday announced a phased launch of generic cinacalcet hydrochloride tablets, used in the treatment of secondary hyperparathyroidism (HPT) in adult",neutral,positive,-0.8582123619099666,neutral,-0.4158964879852125,neutral
2019-03-06 23:02:25.261,547.65,550.0,539.65,542.95,1144395.0,India requires pragmatic compulsive licensing system: Cipla,The industry doyen pointed out that 70 percent of the major drugs are in-licensed and it is what India should look to do.,neutral,neutral,-0.8582123619099666,neutral,-0.4158964879852125,neutral
2019-03-26 18:02:49.435,531.4,533.6,524.05,525.3,1217346.0,Laurus Labs seals deal with Global Fund to supply ARV combination medicine,"Laurus staved off competition from drug makers such as Mylan, Cipla, Sun Pharma and Macleods to win the contract.",positive,positive,-1.1479111780203282,negative,0.0571102227298816,neutral
2019-04-01 10:01:43.161,516.3,528.75,516.3,526.75,4090031.0,Cipla gets 8 observations from USFDA for Kurkumbh plant,Drug major Cipla on Sunday said it has received eight good manufacturing practices (GMP) observations from the US health regulator for its Kurkumbh facility in Maharashtra. The company has also receiv,neutral,positive,2.024017044354067,positive,-1.4057929993395688,negative
2019-04-02 10:00:55.327,529.95,529.95,521.15,522.5,1267098.0,"Stocks in the news: ZEEL, Godrej Properties, Cipla, CIL and Adani Enterprises",Here are a few stocks which may buzz the most in today's trade.,neutral,neutral,-1.4057929993395688,negative,-0.4780114722753346,neutral
2019-04-02 10:01:28.167,529.95,529.95,521.15,522.5,1267098.0,"Zee Entertainment, Cipla, Eicher Motors among top stocks to track today",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-1.4057929993395688,negative,-0.4780114722753346,neutral
2019-04-04 23:00:33.610,531.4,541.0,526.0,532.1,9783485.0,USFDA clearance may strengthen Cipla,"Cipla on Thursday said that it has received the Establishment Inspection Report for its Goa plant from the United States Food and Drug Administration, indicating closure of the inspection. The inspect",positive,neutral,0.1317275122318489,neutral,-1.95712954333644,negative
2019-04-05 10:02:49.205,531.4,541.0,526.0,532.1,9783485.0,Cipla rises 2% on EIR from USFDA for Goa facility,"The share touched its 52-week high Rs 678.00 and 52-week low Rs 483.75 on 19 September, 2018 and 29 January, 2019, respectively. ",neutral,positive,0.1317275122318489,neutral,-1.95712954333644,negative
2019-04-05 18:01:15.732,531.4,541.0,526.0,532.1,9783485.0,"D-Street Buzz: Tata Steel, Cipla jump 3% each; DHFL extends gains, SBI drags","The top Nifty gainers include Tata Steel, Cipla, Eicher Motors, UltraTech Cement and Vedanta while State Bank of India, Power Grid, Britannia Industries, Tata Motors and Zee Entertainment are the top losers.",positive,neutral,0.1317275122318489,neutral,-1.95712954333644,negative
2019-04-05 18:01:22.901,531.4,541.0,526.0,532.1,9783485.0,"D-Street Buzz: Metal stocks shine led by Tata Steel; DHFL jumps 7%, PSU banks drag","The top Nifty gainers include Cipla which jumped over 3 percent followed by Tata Steel, JSW Steel, Bajaj Finance and Adani Ports while State Bank of India, Power Grid, Britannia Industries, Tata Motors and HCL Tech are the top losers.",positive,positive,0.1317275122318489,neutral,-1.95712954333644,negative
2019-04-05 18:02:48.672,531.4,541.0,526.0,532.1,9783485.0,Cipla share price rose 3.49% to 540.30 intra day on BSE. Cipla share was the top Nifty gainer rising 3.42% to 538.30 on the index.,Cipla share price rose 3.49% to 540.30 intra day on BSE. Cipla share was the top Nifty gainer rising 3.42% to 538.30 on the index.,positive,positive,0.1317275122318489,neutral,-1.95712954333644,negative
2019-04-08 10:01:26.958,536.5,536.9,522.7,526.0,2279060.0,"D-Street Buzz: Oil & gas stocks slide led by BPCL, HPCL; DLF down 3%, HDFC at new 52-week high","The top Nifty gainers include Power Grid, Bharti Airtel, JSW Steel, Zee Enterprises and Hindustan Unilever while BPCL, IOC, Asian Paints, Cipla and YES Bank are the top losers.",negative,neutral,-1.95712954333644,negative,0.9596199524940532,positive
2019-04-08 13:01:16.579,526.25,534.5,525.4,531.3,2301642.0,"D-Street Buzz: DLF tanks 6% as Nifty Realty underperforms; PSU banks gain, NIIT zooms 17%","The top Nifty gainers include ONGC, NTPC, Mahindra & Mahindra, IndusInd Bank and Hindustan Unilever while Bajaj Finance, IOC, Adani Ports, Asian Paints and Cipla are the top losers.",positive,neutral,0.9596199524940532,positive,2.7184648668987013,positive
2019-04-10 13:02:37.947,546.35,554.7,542.0,545.3,2977218.0,"D-Street Buzz: Realty stocks shine led by Indiabulls Real Estate; Cipla jumps 2%, HDFC Bank most active","The top Nifty gainers include Cipla, Indiabulls Housing Finance, ONGC, Zee Entertainment and Kotak Mahindra Bank while TCS, Hindalco Industries, HCL Tech, Hero MotoCorp and HDFC are the top losers.",positive,neutral,-0.192184497117245,neutral,0.9216169358518028,positive
2019-04-10 13:02:54.186,546.35,554.7,542.0,545.3,2977218.0,Top intraday trading ideas for afternoon trade for Wednesday 10 April 2019,Cipla is a 'Buy' call with a target price of Rs 565 and a stop loss of Rs 539.,neutral,neutral,-0.192184497117245,neutral,0.9216169358518028,positive
2019-04-10 18:00:58.622,546.35,554.7,542.0,545.3,2977218.0,"D-Street Buzz: Bank Nifty in red as HDFC Bank falls 2%; TCS top IT loser, Tata Motors surges","The top Nifty gainers include Tata Motors, Cipla, Hindustan Unilever, Wipro and Indian Oil Corporation while Hindalco Industries, Asian Paints, HDFC Bank, TCS and Vedanta are the top losers.",neutral,neutral,-0.192184497117245,neutral,0.9216169358518028,positive
2019-04-11 10:00:35.916,546.35,554.7,542.0,545.3,2977218.0,"D-Street Buzz: Realty stocks gain led by Indiabulls Real Estate; Bharti Airtel rises, Infosys drags","The top Nifty gainers include IOC, Indiabulls Housing Finance, Asian Paints, BPCL and Bharti Airtel while Zee Entertainment, Vedanta, Kotak Mahindra Bank, Cipla and Adani Ports are the top losers.",positive,neutral,-0.192184497117245,neutral,0.9216169358518028,positive
2019-04-11 10:01:37.679,546.35,554.7,542.0,545.3,2977218.0,"Top trading ideas by Prabhudas Lilladher: Buy Jubilant Life, Cipla","Nifty outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.",neutral,neutral,-0.192184497117245,neutral,0.9216169358518028,positive
2019-04-12 13:01:45.298,547.95,556.7,545.3,553.0,4346454.0,Cipla launches Niveoli inhaler in India,"Niveoli is used in respiratory inhalation therapy that addresses an unmet need associated with obstructive airway diseases (OAD) such as asthma and chronic obstructive pulmonary disorder (COPD), Cipla said in a BSE filing.",neutral,neutral,0.9216169358518028,positive,2.1081081081081163,positive
2019-04-12 18:03:46.932,547.95,556.7,545.3,553.0,4346454.0,Cipla targets small airway respiratory disease with an innovative two-in-one inhaler,"In an effort to address patients with small airway respiratory diseases, drugmaker Cipla has rolled out its extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler fo",positive,neutral,0.9216169358518028,positive,2.1081081081081163,positive
2019-04-12 18:04:02.476,547.95,556.7,545.3,553.0,4346454.0,"D-Street Buzz: ITC, Maruti jump 2% each, push market higher; PC Jeweller zooms 15%","The top Nifty gainers include GAIL India, ITC, Maruti Suzuki, Cipla and Adani Ports while IOC, Indiabulls Housing, Bharti Airtel, Bajaj Finance and Larsen & Toubro.",positive,neutral,0.9216169358518028,positive,2.1081081081081163,positive
2019-04-15 23:01:41.817,570.0,571.75,556.6,558.65,2246324.0,"Cipla, Pulmatrix to co-develop asthma drug","Cipla and Pulmatrix inks agreement for the co-development and commercialisation of Pulmazole.As per the pact, Cipla will make an upfront payment of $22 million to Pulmatrix in exchange for assignment of all rights for Pulmazole in relation to pulmonary indications",neutral,positive,-1.9912280701754423,negative,-0.1779359430604982,neutral
2019-04-16 10:00:34.002,570.0,571.75,556.6,558.65,2246324.0,"Stocks in the news: Polycab India, Wipro, Nestle, Jet Airways, Cipla and Hathway Cable","UBS has maintained buy rating on Axis Bank and raised target price to Rs 1,010 from Rs 780. ",neutral,positive,-1.9912280701754423,negative,-0.1779359430604982,neutral
2019-04-16 13:00:16.804,570.0,571.75,556.6,558.65,2246324.0,"D-Street Buzz: Bank Nifty outshines led by ICICI Bank; L&T jumps 2%, Bharti Airtel drags","The top Nifty gainers include ICICI Bank, Asian Paints, IndusInd Bank, Titan Company and Larsen & Toubro while Tata Motors, Cipla, Infosys, Bharti Airtel and BPCL are the top losers.",positive,neutral,-1.9912280701754423,negative,-0.1779359430604982,neutral
2019-04-17 18:00:50.903,562.0,566.65,553.2,561.0,2304331.0,Cipla Q4 PAT seen up 93.2% YoY to Rs. 295.8 cr: Kotak,"Net Sales are expected to increase by 7.3 percent Y-o-Y (down 1 percent Q-o-Q) to Rs. 3,969.1 crore, according to Kotak.",positive,positive,-0.1779359430604982,neutral,0.0,neutral
2019-04-22 23:01:17.306,562.5,575.95,560.4,562.0,2178980.0,Cipla appoints Dr Raju Mistry as global chief people officer,Mistry is a veteran Human Resources (HR) professional with over 27 years of global experience across diverse sectors.,neutral,neutral,-0.0888888888888888,neutral,-0.4809405058781496,neutral
2019-04-26 13:01:23.147,558.25,572.9,557.2,568.75,2591930.0,"D-St Buzz: Metal stocks shine led by Tata Steel; HCL Tech at new 52-week high, autos drag","The top Nifty gainers include Tata Steel, JSW Steel, Cipla, GAIL India and BPCL while Tata Motors, Maruti Suzuki, Grasim Industries, Kotak Mahindra Bank and IndusInd Bank are the top losers.",positive,neutral,1.8808777429467085,positive,-1.210738726092293,negative
2019-04-26 18:00:59.184,558.25,572.9,557.2,568.75,2591930.0,D-Street Buzz: Nifty Auto underperforms dragged by Tata Motors; Aurobindo Pharma at 4-month high,"The top Nifty gainers include Tata Steel, BPCL, Axis Bank, Cipla and GAIL India while Tata Motors, Maruti Suzuki, Grasim Industries, Dr Reddy's Labs and Bharti Airtel are the top losers.",neutral,neutral,1.8808777429467085,positive,-1.210738726092293,negative
2019-04-30 13:01:15.285,569.9,571.05,558.65,563.0,1912947.0,Cipla gets USFDA nod for pulmonary arterial hypertension drug,"Cipla said the US sales of Letairis tablets USP stood at USD 943 million in 2018.
",neutral,neutral,-1.210738726092293,negative,0.8880994671403196,neutral
2019-05-03 18:02:31.863,568.0,573.0,561.65,562.95,2758339.0,U.S. District Court Denies Amgen’s Request For Preliminary Injunction Against Cipla,Cipla had announced a phased launch of generic cinacalcet hydrochloride tablets in the U.S. market in March this year.,neutral,neutral,-0.8890845070422456,neutral,1.4388489208633095,positive
2019-05-05 10:00:09.463,556.0,564.5,556.0,564.0,1715196.0,"What we had done for India, we are now doing for US: Umang Vohra, MD, Cipla","In an interview with Suman Layak, Vohra explains his strategy of taking Cipla products to global markets.",neutral,neutral,1.4388489208633095,positive,-1.1170212765957366,negative
2019-05-05 10:01:13.586,556.0,564.5,556.0,564.0,1715196.0,"We see faster and significant growth in US: Samina Vaziralli, executive vice-chairperson, Cipla","As executive vice-chairperson of Cipla, Samina Vaziralli represents the third generation from the promoters family involved in its management. ",positive,neutral,1.4388489208633095,positive,-1.1170212765957366,negative
2019-05-17 23:02:03.889,549.0,551.95,541.0,542.25,1193985.0,USFDA inspection at Indore facility ends with zero observations: Cipla,"'We would like to inform you that the USFDA (US Food and Drug Administration) conducted a post-approval inspection at our Indore facility from 13th May to 17th May, 2019. The inspection ended with zero observations,' the company said in a BSE filing.

",neutral,neutral,-1.2295081967213115,negative,1.0535714285714246,positive
2019-05-19 13:01:47.962,560.0,567.0,550.4,565.9,1586356.0,"Quarterly earnings would also impact trading as some major companies are scheduled to announce their financial report card this week, including Tata Motors, Canara Bank and Cipla.","Quarterly earnings would also impact trading as some major companies are scheduled to announce their financial report card this week, including Tata Motors, Canara Bank and Cipla.",neutral,neutral,1.0535714285714246,positive,-1.1406844106463958,negative
2019-05-20 10:01:07.424,560.0,567.0,550.4,565.9,1586356.0,Cipla gains 2% on zero observations for Indore facility,"The share touched its 52-week high Rs 678 and 52-week low Rs 483.75 on 19 September, 2018 and 29 January, 2019, respectively. ",positive,negative,1.0535714285714246,positive,-1.1406844106463958,negative
2019-05-22 10:01:58.442,562.0,574.0,550.05,553.0,7757775.0,"Stocks in the news: DHFL, Cipla, IndusInd Bank, TechM, DLF, Maruti and IDFC First Bank","HSBC has maintained buy rating on PI Industries with a target price of Rs 1,250. ",neutral,positive,-1.601423487544484,negative,0.5872931126535091,neutral
2019-05-22 10:02:37.313,562.0,574.0,550.05,553.0,7757775.0,"What to watch: BoB, Canara Bank, Cipla, Central Bank results","Over 80 companies including Allcargo, Asahi India, Ashoka Buildcon, Bajaj Electricals, Bajaj Hindusthan, BoB, Canara Bank, Can Fin Homes, Central Bank, Cipla, Cummins India, Future Consumer, GSFC, Ind",neutral,neutral,-1.601423487544484,negative,0.5872931126535091,neutral
2019-05-22 18:02:35.198,561.9,568.9,543.75,565.2,5640344.0,Cipla Q4 net more than doubles to  ₹367 cr; board okays plan to raise  ₹6k cr,"The consolidated net sales rose 22% to  ₹4,271 crore.The company's board recommends a dividend of  ₹3 per share",positive,positive,0.5872931126535091,neutral,0.1932536893885996,neutral
2019-05-22 23:01:08.388,561.9,568.9,543.75,565.2,5640344.0,"After Market: IndusInd, Jet gain; DHFL, Cipla, TechM in the red",The market endured bouts of volatility throughout the day but there was decent buying in the last two hours of trade. ,neutral,positive,0.5872931126535091,neutral,0.1932536893885996,neutral
2019-05-23 10:02:26.745,561.9,568.9,543.75,565.2,5640344.0,Street cautious on Cipla despite healthy March quarter numbers,"Higher competitive intensity, increasing investments, and moderate growth could weigh on returns",positive,negative,0.5872931126535091,neutral,0.1932536893885996,neutral
2019-05-24 10:00:34.106,569.2,572.5,559.45,570.3,1795819.0,"Grasim Ind, Ashok Leyland, RNAM, Cipla, Greaves Cotton top stocks to watch",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,0.1932536893885996,neutral,1.3157894736842104,positive
2019-05-24 10:01:27.492,569.2,572.5,559.45,570.3,1795819.0,What to watch: Cipla acquisition may power up stock,"Cipla has signed an agreement on Thursday to acquire 26 per cent stake on a fully diluted basis in AMP Solar Power Systems Private Limited, which is formed for the purpose of setting up a captive sola",positive,positive,0.1932536893885996,neutral,1.3157894736842104,positive
2019-05-24 23:00:22.997,569.2,572.5,559.45,570.3,1795819.0,Broker's call: Cipla (Accumulate),"Elara CapitalCipla (Accumulate)CMP: ₹570.35Target: ₹615Cipla posted an EBITDA of ₹960 crore, 28 per cent ahead of our estimates of ₹770 crore, on account of higher US sales and other operating income",neutral,positive,0.1932536893885996,neutral,1.3157894736842104,positive
2019-05-27 13:00:42.491,579.0,584.2,571.5,578.05,2469308.0,"D-Street Buzz: 50 stocks hit new 52-week high on BSE; L&T jumps 2%, YES Bank spikes","The top Nifty gainers included YES Bank, NTPC, Tata Steel, Cipla and L&T while the top losers are Bharti Airtel, Tech Mahindra, JSW Steel, Zee Entertainment and IndusInd Bank.",positive,neutral,-0.164075993091545,neutral,-2.49393834430204,negative
2019-05-30 13:02:01.589,562.7,569.0,550.85,558.55,1911899.0,"D-Street Buzz: Infra stocks gain led by NTPC; Bharti Airtel gains, Eicher Motors falls","The top Nifty gainers included NTPC, YES Bank, Bharti Airtel, TCS and UPL while the top losers are Sun Pharma, Eicher Motors, Mahindra & Mahindra, Cipla and ONGC.",positive,neutral,-0.7375155500266733,neutral,1.6547406082289804,positive
2019-06-07 13:03:15.859,565.0,565.0,542.0,549.55,2695754.0,"D-Street Buzz: Over 100 stocks hit new 52-week low on BSE; Dr Reddy's Labs down 2%, RIL drags","The top gainers from the NSE include Bharti Infratel, Indiabulls Housing Finance, Bharti Airtel, Vedanta and IndusInd Bank while the top losers are Dr Reddy's Labs, Cipla, Coal India, Reliance Industries and Adani Ports.",negative,neutral,-2.734513274336291,negative,0.6810751907010534,neutral
2019-06-10 18:01:21.445,555.4,566.4,551.0,562.0,2517995.0,Cipla gets inspection report from USFDA for Kurkumbh site,"The site, which consisted of three units, was inspected by the USFDA from March 11 to March 20, this year. Receipt of EIR indicates closure of the inspection. ",neutral,neutral,1.1883327331652904,positive,0.5278225084988452,neutral
2019-06-10 23:01:12.706,555.4,566.4,551.0,562.0,2517995.0,Cipla gets EIR from USFDA for Kurkumbh facility,Pharma major Cipla on Monday said it has received the establishment inspection report (EIR) from the US health regulator after inspection of the Kurkumbh facility in Maharashtra. The Kurkumbh manufact,neutral,neutral,1.1883327331652904,positive,0.5278225084988452,neutral
2019-06-18 13:00:40.867,550.6,551.9,532.55,533.3,1137455.0,D-Street Buzz: Media stocks gain led by Zee Entertainment; ICICI Bank jumps 2%,"The top gainers from the NSE include IndusInd Bank, Zee Entertainment, ICICI Bank, Cipla and Power Grid while the top losers are Indiabulls Housing Finance, Bharti Infratel, Asian Paints, Hindalco Industries and Britannia Industries.",positive,neutral,-3.1420268797675384,negative,3.779616397141787,positive
2019-06-21 13:00:35.749,549.85,553.8,545.2,550.15,1529511.0,Despite a 1% decline in Nifty Pharma index Deutsche Bank is betting on these 3 stocks,"Deutsche's top picks are Torrent Pharma, Aurobindo Pharma and Cipla which all are buy calls.",neutral,neutral,0.0545603346367108,neutral,0.2643332421839477,neutral
2019-07-12 18:00:43.808,554.0,566.5,547.2,555.8,1485483.0,Cipla Q1 PAT seen up 4.1% YoY to Rs. 465.1 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 10.7 percent Y-o-Y (down 0.3 percent Q-o-Q) to Rs. 4,257.3 crore, according to Prabhudas Lilladher.",positive,positive,0.3249097472924105,neutral,-1.5895695659939235,negative
2019-07-16 10:00:15.126,554.75,558.45,549.4,554.0,1460302.0,"Stocks to watch: Indiabulls Housing Finance, Jet Airways, HDFC, Cipla",Here's a look at some of the counters which are likely to trade actively on Tuesday,neutral,neutral,-0.135196034249662,neutral,0.5415162454873645,neutral
2019-07-16 10:00:16.941,554.75,558.45,549.4,554.0,1460302.0,"Cipla EU enters JV with Jiangsu Acebright Pharma, China; stock up 1%","As per the agreement, Cipla EU will hold 80% stake and Acebright will hold 20% stake in the JV Co. Cipla EU's investment in the JV Co. is estimated up to $24mn over a period of 4 years.",positive,neutral,-0.135196034249662,neutral,0.5415162454873645,neutral
2019-07-17 10:01:23.535,554.0,558.5,547.45,557.0,1034119.0,Cipla eyes Chinese respiratory market through JV with Jiangsu Acebright,The JV will set up a manufacturing facility of respiratory products; the plant is expected to be commissioned in 2020,neutral,neutral,0.5415162454873645,neutral,-2.281470877695267,negative
2019-07-22 10:00:44.622,536.7,540.0,526.2,530.85,1816800.0,Cipla unit gets final approval for generic of Pfizer's Lyrica,"InvaGen’s Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg is AB-rated generic therapeutic equivalent version of Pfizer’s Lyrica.",positive,neutral,-1.0899944102850796,negative,-0.3766478342749529,neutral
2019-07-22 10:02:18.123,536.7,540.0,526.2,530.85,1816800.0,"Cipla gets 7 observations for its API manufacturing facility in Virgonangar, Bengaluru","The inspection ended with 7 observations, none of which were a repeat or related to data integrity, the company said on Saturday.",neutral,neutral,-1.0899944102850796,negative,-0.3766478342749529,neutral
2019-07-24 10:00:14.067,529.0,529.0,517.05,519.95,2706942.0,"Nifty slips below 11,300 mark; Reliance, ICICI Bank stocks drag","Yes Bank, HDFC and Zee shares are among the biggest gainers on the NSE, while losers include BPCL, IOC and Cipla.",neutral,positive,-1.7107750472589704,negative,3.0018221923851494,positive
2019-07-25 10:00:17.335,521.35,539.2,519.0,537.0,3183299.0,"Nifty above 11,300 mark; Cipla, Cadila stocks surge","The Sensex gained 206 points to 38,054, while the Nifty jumped 56 points at 11,328-mark. Pharma, FMCG, auto and realty stocks gained, while PSU Bank is trading in the negative zone.",positive,positive,3.0018221923851494,positive,0.1500375093773358,neutral
2019-07-25 13:01:07.077,533.2,539.9,528.25,534.0,1370608.0,"Nifty Pharma index gains over 1.5% led by Cadila, Lupin, Cipla","Divi’s Lab, Aurobindo Pharma, Dr Reddy’s, and Sun Pharma also gained in today’s session in the range of 1-2% respectively.",positive,positive,0.1500375093773358,neutral,-1.7964635063957992,negative
2019-07-25 13:01:26.547,533.2,539.9,528.25,534.0,1370608.0,"D-Street Buzz: Bank Nifty in green led by IndusInd Bank; Bharti Infratel jumps 3%, VIX falls","The top gainers from NSE include Cipla, Bharti Infratel, IndusInd Bank, Bajaj Auto and UltraTech Cement while the top losers are Coal India, Tata Motors, Indian Oil Corporation, Mahindra & Mahindra and JSW Steel.",positive,neutral,0.1500375093773358,neutral,-1.7964635063957992,negative
2019-07-28 13:00:47.977,531.6,534.95,520.25,522.05,734609.0,"Cipla seeks favourable policy for domestic pharma cos, ease of doing biz","Cipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a strong mandate, expectations are high.",positive,positive,-1.7964635063957992,negative,-0.7181156644963614,neutral
2019-07-29 10:00:39.843,531.6,534.95,520.25,522.05,734609.0,"Alvotech, Cipla pact for Arthritis Drug Humira’s Biosimilar","Under the partnership, Alvotech will be responsible for the development and supply of the product, while Cipla Gulf will be responsible for registration and commercialization.",positive,neutral,-1.7964635063957992,negative,-0.7181156644963614,neutral
2019-07-29 23:02:57.061,522.2,533.6,517.8,518.45,1665072.0,Indian drug makers scouting for partners in China: report,"Indian pharma firms are seeking partners that can make tangible business contributions, safeguard IP, ensure operational control and manage talent, says a BofA-ML report.Dr Reddy’s, Aurobindo Pharma, Cipla, Sun Pharmaceuticals Industries are looking at China as a big opportunity",neutral,neutral,-0.7181156644963614,neutral,0.1257496614432148,neutral
2019-08-05 13:01:26.164,518.0,527.0,496.85,502.35,7424396.0,"D-Street Buzz: Over 500 stocks hit 52-week low on BSE including Tata Motors, YES Bank; IT stocks gain","The top gainers from NSE include TCS, Bajaj Auto, Infosys, Cipla and HDFC while the top losers are YES Bank, Tata Motors, Indiabulls Housing Finance, Power Grid and SBI.",positive,neutral,-3.021235521235517,negative,2.237915257608923,positive
2019-08-06 18:02:15.023,502.7,525.85,501.65,513.95,4668605.0,Cipla Q1FY20E Result Expectation,"On yoy basis, higher N. American and Indian revenues would aid ~33% yoy EBITDA growth.",neutral,positive,2.237915257608923,positive,-0.1684001981178846,neutral
2019-08-07 10:00:10.307,502.7,525.85,501.65,513.95,4668605.0,"Nifty below 10,950 mark ahead of RBI policy; Indiabulls Housing, Tata Steel stocks drag","Cipla, Yes Bank and Tech Mahindra among top gainers, while losers include BPCL, Reliance, Tata Steel and Titan on the Nifty.",neutral,neutral,2.237915257608923,positive,-0.1684001981178846,neutral
2019-08-07 10:03:15.112,502.7,525.85,501.65,513.95,4668605.0,"Board Meetings Today: Adani Ports, Cipla, HCL Technologies, M&M, Tata Steel","HPCL, Lupin, Adani Power, Aurobindo Pharma and India Cements will announce Q1 earnings today. ",neutral,neutral,2.237915257608923,positive,-0.1684001981178846,neutral
2019-08-07 18:02:50.199,504.75,510.0,493.8,503.9,6749638.0,"D-Street Buzz: PSU Bank, auto stocks slip led by BoB, M&M; Zee Ent spikes 7%, Indiabulls Housing tanks","The top gainers from NSE include Zee Entertainment, YES Bank, Cipla, Hindustan Unilever and IndusInd Bank while the top losers are Indiabulls Housing Finance, Tata Steel, Mahindra & Mahindra, Tata Motors and BPCL.",neutral,neutral,-0.1684001981178846,neutral,-4.111484483099418,negative
2019-08-08 10:01:27.015,504.75,510.0,493.8,503.9,6749638.0,"Lupin, Cipla numbers raise hopes of a recovery","We are pleased with the robust all-round performance in our key markets, said Lupin MD.",positive,positive,-0.1684001981178846,neutral,-4.111484483099418,negative
2019-08-08 18:00:54.836,505.9,511.7,481.55,485.1,5171539.0,Cipla to target industry-leading growth from Q2 onwards: Umang Vohra,"
In South Africa, our private market business is up. It is growing faster than the market.",positive,positive,-4.111484483099418,negative,-1.6511867905056758,negative
2019-08-09 10:01:52.276,505.9,511.7,481.55,485.1,5171539.0,Cipla realigns domestic generics distribution to eliminate supply chain issues,"The company has undertaken a major realignment of its generics distribution in India, where it had terminated supplies to over 100 existing distributors, even as it scouts for signing up with new ones.",neutral,neutral,-4.111484483099418,negative,-1.6511867905056758,negative
2019-09-05 18:00:21.663,479.0,482.5,473.75,474.2,1668457.0,"ICICI Securities upgrades Cipla from ‘reduce’ to ‘hold’,  target price Rs 464",India business declined 12.2% in Q1FY20 due to revenue loss of Rs2bn in the trade generic business because of realignment of distributors. ,positive,negative,-1.0020876826722362,negative,0.0,neutral
2019-09-06 18:01:40.977,479.0,482.5,473.75,474.2,1668457.0,"D-Street Buzz: Maruti, Eicher Motors jump 3%; RIL gains, midcaps advance","The top Nifty50 gainers include Eicher Motors, Tech Mahindra, Maruti Suzuki, Tata Motors and Axis Bank while the top losers are Indiabulls Housing Finance, YES Bank, Sun Pharma, Wipro and Cipla.",positive,neutral,-1.0020876826722362,negative,0.0,neutral
2019-09-10 10:00:30.158,474.0,478.3,468.05,470.7,996284.0,Royal Society honour for Cipla chairman,"Dr Yusuf Hamied, chairman, Cipla, was recently inducted as honorary fellow of the Royal Society for his service to the cause of science. Earlier, Dr. Hamied delivered a 15-minute speech explaining his",neutral,neutral,-0.696202531645572,neutral,-1.392405063291144,negative
2019-09-22 18:00:22.738,468.0,472.3,445.0,447.45,3066007.0,Cipla announces closure of USFDA inspection at Bengaluru facility,The company had earlier said that USFDA issued seven observations after conducting a routine 'CGMP inspection'.Cipla announced the closure of inspection by the US health regulator at the company's API manufacturing facility in Bengaluru,neutral,negative,-4.391025641025643,negative,-0.0222222222222272,neutral
2019-09-23 10:00:29.815,468.0,472.3,445.0,447.45,3066007.0,"Top stocks in focus: Biocon, Cipla, Reliance Capital, Future Consumer",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.391025641025643,negative,-0.0222222222222272,neutral
2019-09-23 10:00:40.103,468.0,472.3,445.0,447.45,3066007.0,"Stocks to watch: Dr Reddy's, Petronet LNG, Biocon, Cipla, Alkem Labs, autos",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-4.391025641025643,negative,-0.0222222222222272,neutral
2019-09-24 18:00:57.329,449.9,450.0,432.2,434.0,3521532.0,Cipla matter: Employee settles case with Sebi; pays Rs 3 lakh,Sebi would not initiate any enforcement action against the applicant for the defaults.,neutral,neutral,-3.534118693042894,negative,-0.5694760820045558,neutral
2019-09-25 23:00:28.809,439.0,440.45,430.4,436.5,3958368.0,Cipla launches skin treatment drug in US,"According to IQVIA Health, Cubicin injection brand and generics had sales of around USD 606 million for the most recent 12 months ending in June 2019.

",neutral,neutral,-0.5694760820045558,neutral,0.695632341201964,neutral
2019-09-26 10:02:41.158,439.0,440.45,430.4,436.5,3958368.0,Cipla launches Daptomycin injection in the US,Cipla launches Daptomycin injection in the US,neutral,neutral,-0.5694760820045558,neutral,0.695632341201964,neutral
2019-09-26 10:03:38.805,439.0,440.45,430.4,436.5,3958368.0,"Top stocks in focus: Cipla, AstraZeneca Pharma, Adani Enterprises",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.5694760820045558,neutral,0.695632341201964,neutral
2019-09-30 10:03:18.983,430.0,432.8,418.0,425.0,6305234.0,"Stocks to watch: Cipla, Bandhan Bank, LVB, IBHFL, DHFL, Reliance Nippon",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-1.162790697674419,negative,-3.5371281330522293,negative
2019-09-30 10:03:23.063,430.0,432.8,418.0,425.0,6305234.0,"Market slips in early trade; Yes Bank, Cipla stocks drag","Axis Bank, TCS, HCL Tech and ITC are among the top gainers, while Yes Bank, Cipla and Sun Pharma were the top laggards on the Nifty50.",neutral,neutral,-1.162790697674419,negative,-3.5371281330522293,negative
2019-10-01 10:01:24.576,426.9,426.9,402.7,411.8,4913449.0,Goa facility issue worsens Cipla's growth worries; stock falls over 3%,India business has been soft given the realignment of the sales channel,negative,negative,-3.5371281330522293,negative,1.4476885644768829,positive
2019-10-06 23:02:19.890,419.95,419.95,405.5,408.3,2810082.0,"Cipla's unbranded drug business may take a hit in FY20, says analysts",Analysts see full recovery by Q3 as company revamps distribution network,negative,positive,-2.7741397785450594,negative,3.624785696791578,positive
2019-10-07 18:00:50.256,419.95,419.95,405.5,408.3,2810082.0,"D-Street Buzz: 170 stocks hit 52-week low; Yes Bank, Zee Ent top gainers","BPCL, Cipla, Tata Steel, UltraTechCement and JSW Steel are the top losers on the Nifty.",positive,negative,-2.7741397785450594,negative,3.624785696791578,positive
2019-10-10 10:01:37.745,423.1,427.3,418.55,422.95,2381381.0,Cipla (₹423.5): Buy,"Investors with a short-term perspective and contrarian view can buy the stock of Cipla at current levels.On Wednesday, the stock advanced 3.6 per cent with good volume after taking support at ₹410. In",neutral,positive,-0.0354526116757348,neutral,4.6148384806531775,positive
2019-10-11 13:02:34.545,422.55,443.0,389.55,442.05,17352740.0,Cipla share price has lost 2.51% in last 2 days. The US drug regulator carried out inspection from September 16-September 27 in the Goa unit of the firm.  It has subsequently issued form 483 comprising 38 pages which carries 12 observations for the Cipla's Goa facility. ,Cipla share price has lost 2.51% in last 2 days. The US drug regulator carried out inspection from September 16-September 27 in the Goa unit of the firm.  It has subsequently issued form 483 comprising 38 pages which carries 12 observations for the Cipla's Goa facility. ,negative,negative,4.6148384806531775,positive,-0.101959895774339,neutral
2019-10-11 18:00:37.304,422.55,443.0,389.55,442.05,17352740.0,"F&O: Nifty50 trading range shifts to 11,000-11,600 zone; Vix slips 0.52%","There was long buildup in Biocon, Indiabulls Housing, Tata Global, PVR and Cipla.",neutral,neutral,4.6148384806531775,positive,-0.101959895774339,neutral
2019-10-14 10:01:22.458,441.35,446.45,433.5,440.9,5861372.0,Cipla looks at digital media for expanding footprint and reach customers,"The pharma major looks to expand its footprint by driving up the diagnosis around diseases, uses digital media to take the brand directly to the end-user",neutral,positive,-0.101959895774339,neutral,1.4318181818181843,positive
2019-10-17 23:00:59.856,448.5,451.15,440.1,440.2,2849585.0,Cipla acquires novel anti-infective drug Elores from Venus Remedies,Cipla is the third largest pharmaceutical company in India.The drug was launched in India in 2013 after approval from the Drug Controller General of India,neutral,neutral,-1.8506131549609837,negative,2.810198300283281,positive
2019-10-18 10:00:44.845,448.5,451.15,440.1,440.2,2849585.0,"Stocks to watch: Cipla, L&T Info, RIL, DHFL, Alicon Castalloy, ZEEL, Nocil",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,-1.8506131549609837,negative,2.810198300283281,positive
2019-10-18 10:01:18.425,448.5,451.15,440.1,440.2,2849585.0,Cipla acquires novel anti-infective Elores from Venus Remedies,"Today, Cipla is the market leader in the anti-infectives segment in India, and has a large portfolio of oral and injectable anti-microbial brands that serve over 20 million patients every year.",neutral,positive,-1.8506131549609837,negative,2.810198300283281,positive
2019-10-21 10:00:54.049,441.25,457.75,440.2,453.65,2333556.0,Stock pick of the week: What has made Cipla a favourite of analysts,"Due to the recent price correction, the risk-reward ratio of Cipla has turned favourable. Despite the tough environment, the company is taking steps to increase its US business by introducing one limited product every quarter and that is also yielding results.",positive,positive,2.810198300283281,positive,-0.0771519894191482,neutral
2019-10-25 13:02:35.456,447.1,461.45,441.75,459.6,2647242.0,Cipla may raise bar with digital therapeutics push,"The company has taken early steps to brace itself for a paradigm shift in the role of drug companies, from pill makers to care givers and therapeutic service providers. The new role of a pharma company is being envisioned.",positive,positive,2.795795124133304,positive,0.0,neutral
2019-10-25 18:03:15.992,447.1,461.45,441.75,459.6,2647242.0,"F&O: Nifty stuck between 11,500 & 11,700 levels; needs to hold support to go higher","There was long buildup in Star, Glenmark, UBL, Sun TV and Cipla.",negative,neutral,2.795795124133304,positive,0.0,neutral
2019-10-29 18:01:24.652,478.95,478.95,462.25,463.15,2640091.0,D-Street Buzz: Indiabulls Housing among most active on BSE; 78 stocks at 52-week low,"Cipla, Piramal Enterprises, Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs are among major gainers in the pharma space.",neutral,positive,-3.29888297317048,negative,1.5053763440860215,positive
2019-10-30 13:04:04.958,465.0,472.7,460.15,472.0,3943513.0,"D-Street Buzz: PSU bank gains led by Central Bank, Syndicate Bank; auto stocks dip","Bharti Airtel, Infosys, Bharti Infratel, ITC and Zee Entertainment are the top gainers on the Nifty, while losers are Coal India, UPL, Cipla, Tata Motors and ICICI Bank.",positive,neutral,1.5053763440860215,positive,0.256794350524286,neutral
2019-11-06 10:01:05.048,469.05,487.95,464.25,482.0,17748042.0,"What to watch: Tata Steel, Canara Bank, Cipla, Lupin results","Over 60 firms including Bannari Amman Sugars, Bajaj Electricals, Bosch, BSE, Canara Bank, Cipla, Clariant Chem, Corporation Bank, Exide, EID Parry, Emami, Fortis Health, Firstsource, Godrej Consumer,",neutral,neutral,2.7608996908645107,positive,-2.1161825726141057,negative
2019-11-06 10:04:13.792,469.05,487.95,464.25,482.0,17748042.0,"Board Meetings Today: Tata Steel, Cipla, Canara Bank, Lupin and IB Housing",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges. ,neutral,neutral,2.7608996908645107,positive,-2.1161825726141057,negative
2019-11-06 18:00:14.480,482.0,487.4,470.0,471.8,5890945.0,"Cipla clocks revenue growth of 10 pc in Q2, EBITDA up by 21 pc","Mumbai (Maharashtra) [India], Nov 6 (ANI): Pharmaceutical major Cipla on Wednesday reported 25 per cent year-on-year increase in its consolidated net profit at Rs 471 crore for the second quarter ended September 30.",positive,positive,-2.1161825726141057,negative,-1.6060412678153608,negative
2019-11-06 18:00:39.491,482.0,487.4,470.0,471.8,5890945.0,"Sensex gains 222 points, Cipla and ICICI Bank top gainers","Mumbai (Maharashtra) [India], Nov 6 (ANI): Equity benchmark indices erased early losses and made a dramatic recovery in the afternoon trade on Wednesday due to heavy buying in metal, banking and realty stocks.",positive,positive,-2.1161825726141057,negative,-1.6060412678153608,negative
2019-11-07 23:03:03.542,470.1,470.1,461.25,462.55,4299879.0,Cipla expects to end FY20 with gross margins of 65-66% led by new launches in second half,The EBITDA margins of Cipla stood at 20.7 percent and gross margins at 65.7 percent in Q2FY20.,positive,neutral,-1.6060412678153608,negative,-1.08837614279495,negative
2019-11-15 10:00:37.814,448.0,468.05,435.4,462.2,10692903.0,USFDA routine cGMP inspection completed at Cipla's Patalganga facility,"The inspection ended with 4 observations, none of which were repeat or related to data integrity.",positive,neutral,3.169642857142855,positive,-0.8747300215982745,neutral
2019-11-15 13:02:52.456,448.0,468.05,435.4,462.2,10692903.0,Cipla down on US FDA observations,"Shares of Cipla fell today after the company said that the US drug regulator had completed its inspection at Patalganga facility with 4 observations.At 11.30 am, the stock was quoted loewr by 1.52% at",neutral,negative,3.169642857142855,positive,-0.8747300215982745,neutral
2019-11-15 18:00:13.806,448.0,468.05,435.4,462.2,10692903.0,"Exclusive | Cipla, Dr Reddy's, Carlyle and Hong Kong fund in fray for Wockhardt divisions","Wockhardt has a diversified product portfolio with presence in therapeutic segments such as cardiology, dermatology, diabetes, respiratory and ophthalmology. It is not clear which of these divisions will be sold. ",neutral,neutral,3.169642857142855,positive,-0.8747300215982745,neutral
2019-11-15 18:01:54.663,448.0,468.05,435.4,462.2,10692903.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Glenmark; Airtel surges 8%, IOC drags","The pharma index gained 2 percent led by Glenmark Phrama, Divis Labs, Cipla, Aurobindo Pharma, Biocon and Piramal Enterprises.",positive,positive,3.169642857142855,positive,-0.8747300215982745,neutral
2019-11-19 18:03:21.103,472.0,483.7,468.65,480.65,4076828.0,"D-Street Buzz: Nifty PSU Bank jumps 4% led by OBC, Syndicate Bank; RIL up 3%, YES Bank drags","The top gainers from Nifty index are Bharti Infratel, Bharti Airtel, Cipla, Axis Bank and Reliance Industries.",positive,neutral,1.8326271186440628,positive,0.4973062577704055,neutral
2019-11-27 13:02:53.003,472.0,476.5,464.1,470.0,2932986.0,"D-Street Buzz: Auto stocks gain led by Tata Motors; L&T falls 2%, Dr Reddy's Labs hits 52-week high","The top gainers from Nifty index are YES Bank, Tata Motors, UPL, UltraTech Cement and Mahindra & Mahindra while the top losers included Cipla, Larsen & Toubro, ICICI Bank, Tata Steel and Bharti Infratel.",positive,neutral,-0.423728813559322,neutral,-0.5961886511231672,neutral
2019-11-27 18:04:16.874,472.0,476.5,464.1,470.0,2932986.0,Pharma Inc agrees to cap margins on non-price control drugs at 30%,"Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.",neutral,negative,-0.423728813559322,neutral,-0.5961886511231672,neutral
2019-11-27 18:04:24.439,472.0,476.5,464.1,470.0,2932986.0,Pharma Inc agrees to cap margins on non-price control drugs at 30%,"Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.",neutral,negative,-0.423728813559322,neutral,-0.5961886511231672,neutral
2019-11-28 10:04:19.037,472.0,476.5,464.1,470.0,2932986.0,Cipla to acquire remaining 40% stake in Cipla Pharma Lanka,"Cipla Pharma Lanka (Private) Limited has aturnover of LKR 3,244,483,618 in FY19 and a market share of 6.5% in Sri Lankan market.",neutral,neutral,-0.423728813559322,neutral,-0.5961886511231672,neutral
2019-11-28 13:03:16.816,469.65,473.4,465.6,466.85,1306683.0,Cipla arm to acquire remaining stake in Cipla Pharma Lanka,"Mumbai (Maharashtra) [India], Nov 28 (ANI): Pharmaceutical major Cipla's arm Cipla EU Ltd has signed an agreement with CitiHealth Imports to acquire remaining 40 per cent stake in Cipla Pharma Lanka.",neutral,neutral,-0.5961886511231672,neutral,-1.267035775127778,negative
2019-11-29 18:01:46.158,469.65,473.4,465.6,466.85,1306683.0,Wockhardt share price up 4% on report Cipla leading race to buy select biz segments,Cipla is in pole position currently and is leading the race to buy a clutch of Wockhardt's business divisions.,positive,neutral,-0.5961886511231672,neutral,-1.267035775127778,negative
2019-12-02 23:00:15.752,465.0,465.85,460.0,465.5,1066746.0,Will sale of assets be enough to resolve Wockhardt's problems?,Moneycontrol on November 29 reported on Cipla emerging as a major contender for some of these divisions of Wockhardt that are up for sale. ,neutral,positive,0.1075268817204301,neutral,1.2958963282937366,positive
2019-12-12 10:02:52.074,452.2,463.1,452.2,460.0,2728979.0,"Stocks to watch: Nestle India, Cipla, NBFCs, HFCs, SBI, DHFL, L&T Infotech",Here's a list of companies whose shares are expected to trade actively in today's session.,neutral,neutral,1.7249004865103963,positive,-0.0867584860644255,neutral
2019-12-12 23:00:18.323,461.05,465.0,456.6,460.65,1211897.0,"Corporate governance: Reddy’s Labs, Cipla, Tata Power in top-10, says study","Ensuring facilities for shareholders in AGMs and gender diversity in the board, are among the 63 key parameters used",neutral,neutral,-0.0867584860644255,neutral,-1.090594968145991,negative
2019-12-13 10:03:11.396,461.05,465.0,456.6,460.65,1211897.0,"Top stocks in focus: Tata Motors, Wipro, Cipla, Biocon",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.0867584860644255,neutral,-1.090594968145991,negative
2019-12-13 18:02:47.672,461.05,465.0,456.6,460.65,1211897.0,Half of the Nifty50 companies yet to induct one woman in their leadership team: study,Cipla ranks at the top and is the only one with balanced top tier amongst all of Nifty50,neutral,neutral,-0.0867584860644255,neutral,-1.090594968145991,negative
2019-12-16 18:00:17.635,462.05,466.2,460.35,463.5,2434808.0,"Cipla acquires brand, trademark for anti-diabetic drug Vysov in India","The market size of Vildagliptin in India is Rs 818 crore as per IQVIA MAT data of November 2019, Cipla said",neutral,neutral,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-16 18:03:32.334,462.05,466.2,460.35,463.5,2434808.0,"Cipla acquires brand, trademark rights for for anti-diabetic drug Vysov in India","Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus Metformin), the company said in a regulatory filing.

",neutral,positive,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-16 18:03:46.110,462.05,466.2,460.35,463.5,2434808.0,"Cipla acquires brand, trademark rights for for anti-diabetic drug Vysov in India",Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M.The products have witnessed a strong uptake in India for the last couple of years,neutral,positive,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-16 23:00:11.149,462.05,466.2,460.35,463.5,2434808.0,Cipla acquires trademark rights of Vysov,"Vildagliptin is an orally active, potent and selective DPP-4 inhibitor that improves glycemic control in patients primarily by enhancing pancreatic (α and β) islet functions.",neutral,positive,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-17 10:00:22.427,462.05,466.2,460.35,463.5,2434808.0,"Stocks to watch: Tata Motors, Vedanta, Maruti, Cipla, PSBs, STFC, UCO Bank",Here's a look at the top stocks that may remain in focus today,neutral,neutral,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-17 10:00:47.857,462.05,466.2,460.35,463.5,2434808.0,"Stocks in the news: YES Bank, Cipla, Magma Fincorp, JM Financial, Shriram Transport among others are the top stocks to watch out for Tuesday's trading session","Stocks in the news: YES Bank, Cipla, Magma Fincorp, JM Financial, Shriram Transport among others are the top stocks to watch out for Tuesday's trading session",neutral,neutral,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-17 10:02:06.502,462.05,466.2,460.35,463.5,2434808.0,Vysov rights may boost Cipla stock,Cipla has acquired the brand name and trademark rights of Vysov (Vildagliptin + Metformin) of the anti-diabetic drug Vildagliptin for the Indian market. The company has been co-marketing Vildagliptin,positive,positive,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-17 10:03:48.202,462.05,466.2,460.35,463.5,2434808.0,"Top stocks in focus: RIL, Cipla, IRB Infra, Maruti",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.3138188507737233,neutral,0.7866379310344779,neutral
2019-12-17 13:00:40.925,464.0,469.25,461.5,467.65,1705797.0,Cipla shares rise after Vysov anti-diabetic drug acquisition,The stock gained as much as 1.73 per cent to trade at Rs 464.25 apiece on the National Stock Exchange,positive,positive,0.7866379310344779,neutral,0.3650810694727897,neutral
2019-12-17 13:01:23.309,464.0,469.25,461.5,467.65,1705797.0,Cipla shares rise after Vysov anti-diabetic drug acquisition,The stock gained as much as 1.73 per cent to trade at Rs 464.25 apiece on the NSE.,positive,positive,0.7866379310344779,neutral,0.3650810694727897,neutral
2019-12-17 13:02:00.564,464.0,469.25,461.5,467.65,1705797.0,Cipla share price up nearly 2% on trademark acquisition of anti-diabetic drug,The drug is backed by strong clinical data & is therefore a widely prescribed antidiabetic medicine for adults with type 2 diabetes mellitus.,positive,positive,0.7866379310344779,neutral,0.3650810694727897,neutral
2019-12-18 13:03:39.910,465.65,471.5,464.8,467.35,1484880.0,Cipla plans to partner Ayushman Bharat; start dialogue with insurance firms,"There is a plan to identify a list of essential medicines, including antibiotics, painkillers, etc, which the company may supply to the Ayushman Bharat-empanelled hospitals.",neutral,neutral,0.3650810694727897,neutral,0.1927607624759122,neutral
2019-12-27 10:05:37.593,474.55,483.5,472.8,482.0,2004128.0,"Zydus Cadila in talks to sell two units for Rs 1,200 crore","This is part of a broader strategy to reduce debt in the companys capital structure after it borrowed more to help finance the Rs 4,600-crore acquisition earlier this year of Heinz Indias consumer wellness business. Zydus has approached larger rivals, such as Cipla and Sun Pharmaceutical Industries, besides financial investors.",neutral,positive,1.5699083342113556,positive,-0.2286426938266519,neutral
2020-01-09 10:08:51.398,467.5,473.3,467.5,470.7,1700269.0,"Cipla, Glenmark get NPPA nod for inhaler pricing over 'innovative' quotient",Glenmark had appealed to the pricing regulator in 2016 asking for a differential price for its Digihaler,neutral,neutral,0.6844919786096232,neutral,0.7232503722612161,neutral
2020-01-10 13:01:05.902,470.1,477.0,469.75,473.5,1213435.0,"HC Bars Cipla, 3 others from launching generic version of Bristol-Myers’ drug","Delhi High Court has granted an injunction restraining the domestic pharma companies such as Cipla, Torrent, Emcure, Alkem from selling a medicine used for prevention and treatment of thromboembolic diseases, the patent for which is held by Bristol-Myers Squibb (BMS) as it filed its claims for patent infringement of Apixaban in Delhi HC.",neutral,positive,0.7232503722612161,neutral,0.6322444678609063,neutral
2020-01-20 11:52:14.096,480.45,483.15,476.65,479.85,1206708.0,Cipla gets Establishment Inspection Report from USFDA; stock down ~1%,"The inspection has been conducted at the Patalganga manufacturing facility of the company from November 4-13, 2019.",neutral,neutral,-0.1248829222603737,neutral,-1.2423008664787534,negative
2020-01-20 11:55:18.193,480.45,483.15,476.65,479.85,1206708.0,Cipla announces closure of USFDA inspection at Patalganga facility,Cipla recently announced the closure of inspection by United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility in Maharashtra. Shares of Cipla were trading 0.40 per cent lower at Rs 478.35 apiece on the BSE in the morning trade. ,neutral,negative,-0.1248829222603737,neutral,-1.2423008664787534,negative
2020-01-20 11:55:53.698,480.45,483.15,476.65,479.85,1206708.0,Cipla announces closure of USFDA inspection at Patalganga facility,"""Following the inspection by the United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility of the company from November 4, 2019 to November 13, 2019, the company has received the Establishment Inspection Report (EIR), indicating closure of the inspection,"" the homegrown pharma major said in a filing to the BSE.",neutral,neutral,-0.1248829222603737,neutral,-1.2423008664787534,negative
2020-01-20 13:03:18.011,478.95,479.55,472.2,473.0,1448267.0,Cipla announces closure of USFDA inspection at Patalganga facility,Cipla on Monday announced the closure of inspection by the US health regulator at its Patalganga manufacturing facility in Maharashtra.“Following the inspection by the United States Food and Drug Admi,neutral,negative,-1.2423008664787534,negative,-0.7797681770284486,neutral
2020-01-20 18:01:19.142,478.95,479.55,472.2,473.0,1448267.0,Cipla gets US FDA clearance for Patalganga manufacturing plant,"The Patalganga plant manufactures both active pharmaceutical ingredients, which are key raw materials for medicines, as well as formulations, and these are largely exported to markets like the US",neutral,neutral,-1.2423008664787534,negative,-0.7797681770284486,neutral
2020-01-21 13:00:26.386,474.5,480.3,470.25,470.8,2380225.0,Mitsubishi UFJ Financial sells 2.10% shares in Cipla,"""MUFG has sold an indirect interest in Cipla Ltd on account of sale of the following entities: First State Investment Management (UK) Ltd, First Sentier Investors (Australia) IM Ltd, First Sentier Investors (Australia) RE Ltd...on January 17, 2020,"" the homegrown pharma major said in a BSE filing.",neutral,neutral,-0.7797681770284486,neutral,0.1076426264800861,neutral
2020-01-21 13:04:02.732,474.5,480.3,470.25,470.8,2380225.0,Mitsubishi UFJ Financial sells 2.10% shares in Cipla,"Prior to the sale, MUFG had 5.56 per cent shares in Cipla.",neutral,neutral,-0.7797681770284486,neutral,0.1076426264800861,neutral
2020-01-23 10:01:11.044,464.5,475.85,459.35,465.0,5783361.0,Cipla gets USFDA observations for its Goa facility,"""The United States Food and Drug Administration (USFDA) has classified the inspection conducted at its Goa manufacturing facility from 16-27 September 2019 as Official Action Indicated (OAI).",neutral,neutral,0.1076426264800861,neutral,-1.3870967741935458,negative
2020-01-23 10:01:14.913,464.5,475.85,459.35,465.0,5783361.0,USFDA classifies Cipla's Goa facility as OAI,The Company does not believe that this will have any material impact on the US business at this stage.,neutral,neutral,0.1076426264800861,neutral,-1.3870967741935458,negative
2020-01-23 10:01:45.306,464.5,475.85,459.35,465.0,5783361.0,Cipla share price falls 2% post USFDA observations,The company believes that it does not have any material impact on the US business at this stage.,negative,neutral,0.1076426264800861,neutral,-1.3870967741935458,negative
2020-01-23 10:04:28.018,464.5,475.85,459.35,465.0,5783361.0,"Top stocks in focus: Asian Paints, L&T, Ceat, Cipla, Axis Bank, Biocon, Tata Motors",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.1076426264800861,neutral,-1.3870967741935458,negative
2020-01-23 13:05:14.997,465.0,467.75,456.85,458.55,2711337.0,"Stocks In News: AU Small Finance Bank, Axis Bank, Cipla, Vodafone Idea, Yes Bank",Here’s a look at the stocks in news moving the markets today.,neutral,neutral,-1.3870967741935458,negative,1.4644808743169373,positive
2020-01-28 10:03:48.047,465.0,468.0,458.95,464.45,3592212.0,Cipla receives EIR for Invagen facility from USFDA; stock trades lower,USFDA closes inspection at Cipla Global's Invagen (US) manufacturing unit.,negative,neutral,-0.1182795698924755,neutral,-0.7854529804174688,neutral
2020-01-28 10:06:55.492,465.0,468.0,458.95,464.45,3592212.0,"Cipla, PAG eye Wockhardt’s formulations business","Wockhardt employs more than 7,000 people and has a presence in the US, Britain, Ireland, Switzerland, France, Mexico, Russia and other countries. It has manufacturing and research facilities in India, the US and Britain, and a plant in Ireland.",neutral,neutral,-0.1182795698924755,neutral,-0.7854529804174688,neutral
2020-01-28 18:03:30.080,464.7,467.4,460.35,461.05,1736785.0,Cipla gets EIR for Invagen manufacturing facility,Homegrown pharma major Cipla on Tuesday said it has received a report from the US health regulator indicating closure of the inspection at its US Invagen manufacturing facility.“Following the inspecti,neutral,negative,-0.7854529804174688,neutral,-2.169197396963124,negative
2020-01-29 13:00:53.524,461.0,461.0,446.35,451.0,2765489.0,"Nifty crosses 12,150-mark; Bajaj twins in focus","Tata Motors, Adani Ports, Infratel and JSW Steel among top gainers, while losers included Eicher, TCS, Yes Bank and Cipla.",neutral,neutral,-2.169197396963124,negative,-1.3217314682233727,negative
2020-02-05 10:01:00.038,449.55,459.15,437.5,455.0,3636128.0,"Stocks to watch today on February 5: Airtel, TVS Motors, Adani Enterprises, Adani Gas, Indiabulls Housing, Bosch, Cipla, Berger Paints, DLF, among others are the top stocks to watch out for in Wednesday's trading session","Stocks to watch today on February 5: Airtel, TVS Motors, Adani Enterprises, Adani Gas, Indiabulls Housing, Bosch, Cipla, Berger Paints, DLF, among others are the top stocks to watch out for in Wednesday's trading session",neutral,neutral,1.2123234345456542,positive,-5.167567567567563,negative
2020-02-05 10:01:01.067,449.55,459.15,437.5,455.0,3636128.0,"Top stocks in focus: Sun Pharma, Bharti airtel, Cipla, Vedanta, Cadila",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.2123234345456542,positive,-5.167567567567563,negative
2020-02-05 10:01:13.336,449.55,459.15,437.5,455.0,3636128.0,"Board Meetings Today: Cipla, DLF, Berger Paints, Adani Gas, HPCL and Godrej Agrovet","Bosch, Max Financial and Apollo Tyres are some of the companies which will report their December quarter earnings today.
",neutral,neutral,1.2123234345456542,positive,-5.167567567567563,negative
2020-02-05 10:02:18.455,449.55,459.15,437.5,455.0,3636128.0,"Bosch, NIIT, HPCL, Adani Gas results eyed"," Almost 100 companies will declare their quarterly results on Wednesday. Among them are Adani Gas, Adani Enterprises, Ajanta Pharma, Andhra Bank, Apollo Tyres, Berger Paints, Bosch, Brigade, Cipla, Ca",neutral,neutral,1.2123234345456542,positive,-5.167567567567563,negative
2020-02-05 10:02:21.690,449.55,459.15,437.5,455.0,3636128.0,"Stocks to watch: Bharti Airtel, Cipla, Berger Paints, Adani Enterprises",Here's a look at the top stocks that may remain in focus today,neutral,neutral,1.2123234345456542,positive,-5.167567567567563,negative
2020-02-05 13:01:50.809,462.5,464.35,435.35,438.6,7117691.0,Cipla Q3 results preview: Profit likely to rise 25-27%,The company will report its quarterly numbers on Wednesday.,positive,neutral,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-05 23:00:24.969,462.5,464.35,435.35,438.6,7117691.0,Cipla posts net profit at Rs351.03cr in Q3FY20,"The net revenue of the company was at Rs4,371cr, up 9% from Rs4,007.54cr in Q3FY19.",neutral,positive,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-05 23:00:31.593,462.5,464.35,435.35,438.6,7117691.0,Cipla posts 5.7% rise in net profit to  ₹351 crore for fiscal Q3,"Profit was lower than  ₹431.2 crore estimated by a Bloomberg poll of 24 analysts.Consolidated revenue from operations stood at  ₹4,371 crore, up 9.1% from  ₹4,007.54 crore reported a year ago",positive,positive,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-05 23:01:21.136,462.5,464.35,435.35,438.6,7117691.0,"Limited product launches, tepid sales in US dent Cipla's Dec quarter show",Niche product launches are key triggers for North American market,neutral,positive,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-05 23:03:23.449,462.5,464.35,435.35,438.6,7117691.0,"Cipla Q3 profit rises 5.7% to Rs 351 cr, but operating margin contracts",Company said active pharmaceutical ingredient (API) business increased 6 percent YoY.,positive,positive,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-05 23:03:47.009,462.5,464.35,435.35,438.6,7117691.0,"Cipla rejigs India biz, integrates domestic, generics and consumer divisions","The company said the new structure will unlock synergies across portfolio, distribution and consumer-focused initiatives.",neutral,positive,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-06 10:02:59.561,462.5,464.35,435.35,438.6,7117691.0,Cipla sees opportunity for its anti-HIV drug as coronavirus toll nears 500,"Doctors are scrambling for a potent treatment for the virus, which is spreading fast and has no vaccines available yet",positive,neutral,-5.167567567567563,negative,0.5454545454545403,neutral
2020-02-07 18:04:30.299,440.0,445.9,437.3,442.4,6385205.0,Cipla share price rises as Nomura upgrades to buy,Nomura revised earnings estimate lower to 11 percent/8 percent/9 percent for FY21/21/22 on delay in provential launch.,positive,negative,0.5454545454545403,neutral,0.1800990544799665,neutral
2020-02-09 13:01:10.826,444.2,451.0,442.1,445.0,3556779.0,Cipla acquires 4 women's health brands from Wanbury to strengthen segment,"Cipla said the nutraceutical products, to be sold under the four umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies",positive,neutral,0.1800990544799665,neutral,1.0064862446879892,positive
2020-02-09 13:01:22.563,444.2,451.0,442.1,445.0,3556779.0,Cipla buys 4 key Wanbury brands,"Drug firm Cipla on Saturday said it had acquired four brands from Wanbury Ltd. While Cipla did not provide any financial details of the acquisition, as per a regulatory filing by Wanbury, it has recei",neutral,neutral,0.1800990544799665,neutral,1.0064862446879892,positive
2020-02-10 10:03:29.562,444.2,451.0,442.1,445.0,3556779.0,Cipla expands women's health portfolio through acquisition of 4 key brands from Wanbury,"The nutraceutical products, to be sold under the 4 umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies.",positive,neutral,0.1800990544799665,neutral,1.0064862446879892,positive
2020-02-10 10:06:49.455,444.2,451.0,442.1,445.0,3556779.0,"Nifty below 12,100-mark led by auto, metal stocks","UPL, Yes Bank, GAIL, Cipla, and Hero MotoCorp were the top gainers on the Nifty50 index, while Tata Steel, Vedanta, JSW Steel, Tata Motors, and Hindalco led the losses.",neutral,positive,0.1800990544799665,neutral,1.0064862446879892,positive
2020-02-10 13:02:44.537,447.1,452.0,443.35,451.6,1888959.0,"Nifty below 12,050-mark; Tata Steel, Motherson Sumi stocks tank","Shares of UPL surged 4.5%, followed by Bajaj Finance, Cipla and HDFC, while losers include Zee, M&M, Tata Steel and Britannia.",neutral,positive,1.0064862446879892,positive,-1.8243763050884736,negative
2020-02-11 10:00:27.078,447.1,452.0,443.35,451.6,1888959.0,Cipla SA signs agreement for anti-psychotic drug,Cipla to market and distribute the Medicine in South Africa and neighbouring countries.,positive,neutral,1.0064862446879892,positive,-1.8243763050884736,negative
2020-02-11 10:04:05.791,447.1,452.0,443.35,451.6,1888959.0,"Top stocks in focus: Coal India, Avenue Supermarts, Cipla, ICICI Bank, M&M, Oil India",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.0064862446879892,positive,-1.8243763050884736,negative
2020-02-11 13:00:58.231,454.95,454.95,445.0,446.65,1682923.0,Cipla share price rises on distribution agreement for antipsychotic drug,The transaction allows Cipla Medpro to market and distribute the Medicine in South Africa and neighbouring countries.,positive,neutral,-1.8243763050884736,negative,-0.6154879140555058,neutral
2020-02-11 18:00:46.438,454.95,454.95,445.0,446.65,1682923.0,Share price of Cipla rose 1.34% to Rs 450.85 compared to the previous close of Rs 444.85 on BSE,Share price of Cipla rose 1.34% to Rs 450.85 compared to the previous close of Rs 444.85 on BSE,positive,positive,-1.8243763050884736,negative,-0.6154879140555058,neutral
2020-02-11 18:00:53.330,454.95,454.95,445.0,446.65,1682923.0,Hold Cipla; target of Rs 490: ICICI Direct,"ICICI Direct recommended hold rating on Cipla with a target price of Rs 490 in its research report dated February 07, 2019.",neutral,positive,-1.8243763050884736,negative,-0.6154879140555058,neutral
2020-02-19 18:00:21.426,448.0,448.8,434.5,436.8,3046676.0,Are Indian imports worth $70.4 bn from China at risk due to coronavirus?,"Dixon Technologies, Havells India, Voltas and Cipla are some of the Indian companies that could face issues over the next few months",negative,neutral,-2.4999999999999973,negative,-1.834862385321101,negative
2020-02-24 10:03:37.060,436.0,436.7,426.55,428.0,2569217.0,"Stocks to watch today on February 24: YES Bank, Cipla, Tech Mahindra, Escorts among others are the top stocks to watch out for in Monday's trading session","Stocks to watch today on February 24: YES Bank, Cipla, Tech Mahindra, Escorts among others are the top stocks to watch out for in Monday's trading session",neutral,neutral,-1.834862385321101,negative,-1.1622501162250116,negative
2020-02-26 13:00:39.294,411.1,424.0,409.0,424.0,5105633.0,USFDA issues warning letter to Cipla for Goa manufacturing facility,The company further said that it remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations,neutral,positive,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 13:01:28.318,411.1,424.0,409.0,424.0,5105633.0,Cipla shares plunge nearly 6% after USFDA issues warning letter,Shares of drug firm Cipla tumbled nearly 6 per cent on Wednesday after the US health regulator issued a warning letter for its Goa manufacturing facility.The shares plunged as much as 5.72 per cent to,negative,negative,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 13:01:45.948,411.1,424.0,409.0,424.0,5105633.0,USFDA issues warning letter to Cipla for Goa manufacturing facility,Drug firm Cipla Ltd. on Wednesday said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa.“Further to our earlier communication on the Goa ma,neutral,negative,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 13:04:23.516,411.1,424.0,409.0,424.0,5105633.0,USFDA issues warning letter to Cipla for Goa manufacturing facility, Drug firm Cipla Ltd said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa.  The company further said that it remains committed to maintain highest standards of compliance and will work closely with the agency to comprehensively address all the observations.,neutral,negative,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 13:04:41.166,411.1,424.0,409.0,424.0,5105633.0,USFDA issues warning letter to Cipla for Goa manufacturing facility, Drug firm Cipla Ltd said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa.  The company further said that it remains committed to maintain highest standards of compliance and will work closely with the agency to comprehensively address all the observations.,neutral,negative,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 13:05:06.339,411.1,424.0,409.0,424.0,5105633.0,USFDA issues warning letter to Cipla for Goa manufacturing facility,The company further said that it remains committed to maintain highest standards of compliance and will work closely with the agency to comprehensively address all the observations,neutral,positive,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 18:02:12.538,411.1,424.0,409.0,424.0,5105633.0,Share price of Cipla lost up to 5.72% to Rs 401 compared to the previous close of Rs 425.35 on BSE,Share price of Cipla lost up to 5.72% to Rs 401 compared to the previous close of Rs 425.35 on BSE,negative,negative,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-26 23:04:43.554,411.1,424.0,409.0,424.0,5105633.0,Cipla shares end marginally lower after USFDA issues warning letter for Goa facility,"On the NSE, the stock slumped 4.69 per cent to Rs 405.80. ",negative,negative,3.137922646558009,positive,-1.9249394673123457,negative
2020-02-27 13:01:47.270,413.0,416.45,398.05,405.05,4200608.0,"Cipla down 8% in 5 days, nears 52-week low on warning letter for Goa plant",The Company said it remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations.,negative,positive,-1.9249394673123457,negative,-0.4914004914004914,neutral
2020-02-28 10:01:08.239,413.0,416.45,398.05,405.05,4200608.0,"HSBC downgrades Cipla to 'hold', target price Rs 450",The stock ended down 0.2% at Rs 421.45 on Thursday.,positive,negative,-1.9249394673123457,negative,-0.4914004914004914,neutral
2020-03-04 13:03:49.414,447.85,472.0,437.45,440.0,9636622.0,"Nifty Pharma index gain led by Sun Pharma, Cipla",The pharma stocks gained as rupee edged lower against the dollar. As weakness in rupee could boost sales of pharma companies in rupee terms as pharma firms derive substantial revenue from exports.,positive,positive,-1.7528190242268666,negative,1.458823529411762,positive
2020-03-12 23:01:31.496,388.0,434.95,356.0,425.0,6087867.0,"Shares of Sun Pharmaceutical Industries, Cipla, Zee Entertainment and HCL Technologies from Nifty were trading close to their 52-week lows. Meanwhile, Asian Paints stock price was trading close to its 52-week high.","Shares of Sun Pharmaceutical Industries, Cipla, Zee Entertainment and HCL Technologies from Nifty were trading close to their 52-week lows. Meanwhile, Asian Paints stock price was trading close to its 52-week high.",neutral,neutral,9.536082474226804,positive,-4.6995192307692335,negative
2020-03-18 18:00:52.227,374.8,390.75,362.9,374.75,2924588.0,Cipla and CSIR-IICT to develop drugs to treat Covid-19,Zoom in on three promising chemical compounds,neutral,neutral,-0.0133404482390638,neutral,1.4218009478672926,positive
2020-03-18 18:01:07.033,374.8,390.75,362.9,374.75,2924588.0,"Cipla, CSIR-IICT join hands for COVID-19 drugs",‘It could take about six to 10 weeks to make two of the three chemical compounds’,neutral,neutral,-0.0133404482390638,neutral,1.4218009478672926,positive
2020-03-18 23:02:16.647,374.8,390.75,362.9,374.75,2924588.0,USFDA issues warning letter to Cipla for Goa plant,"The USFDA said the company's cleaning procedure for non-dedicated equipment, including equipment is inadequate.

",neutral,neutral,-0.0133404482390638,neutral,1.4218009478672926,positive
2020-03-20 23:00:38.244,379.8,399.8,372.45,385.2,4711720.0,How off-the-shelf drugs are making Indian pharma firms interested in fight against COVID-19,Cipla has come forward to work with Hyderabad-based Indian Institute of Chemical Technology to develop three broadspectrum antiviral drugs to tackle novel coronavirus.,positive,positive,1.4218009478672926,positive,2.837837837837838,positive
2020-03-20 23:02:08.874,379.8,399.8,372.45,385.2,4711720.0,Cipla doyen sees opportunity to tackle Covid-19 like they did HIV,"It’s yesterday once more for Cipla doyen Dr YK Hamied, as the medicines are being evaluated for their possible impact on the novel coronavirus (Covid-19) are all available with the Mumbai-based drugma",positive,neutral,1.4218009478672926,positive,2.837837837837838,positive
2020-03-23 23:02:20.864,380.0,409.75,372.55,379.5,6648476.0,"Covid-19 throws up drug supply opportunity for Ipca, other pharma firms","Sun Pharma, Dr Reddy's, Torrent Pharma, Cipla, Cadila Healthcare and Natco Pharma would also benefit from malaria drug supplies, Alembic Pharma from azithromycin sales",neutral,positive,-0.131578947368421,neutral,-0.7407407407407437,neutral
2020-03-25 23:00:09.189,383.0,394.7,380.5,390.0,4290800.0,"Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. Cipla and Aurobindo are making anti-HIV medicines","Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. Cipla and Aurobindo are making anti-HIV medicines",neutral,neutral,1.827676240208877,positive,4.198473282442748,positive
2020-03-26 10:00:20.058,383.0,394.7,380.5,390.0,4290800.0,Cipla share price gains over 3% on USFDA approval,The company received final approval for its ANDA for Esomeprazole  from USFDA.,positive,positive,1.827676240208877,positive,4.198473282442748,positive
2020-03-26 10:03:18.659,383.0,394.7,380.5,390.0,4290800.0,Cipla receives final approval for generic version of AstraZeneca Pharmaceutical’s Nexium,Cipla is the first company to file for the 10mg strength.,positive,neutral,1.827676240208877,positive,4.198473282442748,positive
2020-03-26 18:00:45.550,393.0,411.0,391.95,409.5,6470641.0,Cipla gets USFDA nod for generic acid reflux drug,Drug major Cipla on Thursday said it has received final approval from the US health regulator for generic Esomeprazole for oral suspension used for treatment of gastroesophageal reflux disease. The co,neutral,positive,4.198473282442748,positive,5.123247945867566,positive
2020-03-26 18:01:29.302,393.0,411.0,391.95,409.5,6470641.0,"Top headlines: FM's relief package for poor, Cipla gets USFDA nod, and more",Business Standard brings to you the top headlines of the day,neutral,neutral,4.198473282442748,positive,5.123247945867566,positive
2020-03-26 18:02:47.057,393.0,411.0,391.95,409.5,6470641.0,Pharma major Cipla gets USFDA nod for generic oral acid reflux drug,"According to IQVIA, Nexium and its generic equivalents had US sales of around $70 million for the 12 months ended November 2019",neutral,neutral,4.198473282442748,positive,5.123247945867566,positive
2020-03-29 18:02:03.160,413.8,438.7,407.65,435.0,9019158.0,CSIR ties up with corporates to fight coronavirus,"Five-pronged battle is in partnership with TCS, BHEL and Cipla, among others",neutral,positive,5.123247945867566,positive,-5.269058295964125,negative
2020-04-03 10:02:37.808,425.0,454.7,416.25,448.0,17902456.0,"Stocks to watch today on April 3: Kilpest India, Cipla, TVS Motor, Aurobindo Pharma, JB Chemicals, AIMCO Pesticides among others are the top stocks to watch out for in Friday's trading session","Stocks to watch today on April 3: Kilpest India, Cipla, TVS Motor, Aurobindo Pharma, JB Chemicals, AIMCO Pesticides among others are the top stocks to watch out for in Friday's trading session",neutral,neutral,5.411764705882352,positive,2.7139874739039667,positive
2020-04-03 10:03:28.440,425.0,454.7,416.25,448.0,17902456.0,Cipla announces successful completion of Phase-3 clinical study of GSK’s Advair Diskus; stock up 3%,"The product is indicated to treat asthma in patients 4 years and older as a twice-daily prescription medicine and in long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups.",positive,neutral,5.411764705882352,positive,2.7139874739039667,positive
2020-04-03 13:00:33.095,425.0,454.7,416.25,448.0,17902456.0,Cipla surges 8% on completing Phase-3 study of asthma generic drug,Advair Diskus and its generic equivalents had US sales of approximately US$2.9bn for the 12-month period ending February 2020.,positive,neutral,5.411764705882352,positive,2.7139874739039667,positive
2020-04-03 13:02:37.874,425.0,454.7,416.25,448.0,17902456.0,"D-Street Buzz: Nifty Pharma outperforms led by Cipla, Lupin; ICICI Bank, Kotak Bank drag","The most active stocks included Reliance Industries, HDFC Bank, Bajaj Finance, ICICI Bank and Axis Bank.",neutral,neutral,5.411764705882352,positive,2.7139874739039667,positive
2020-04-03 13:04:07.215,425.0,454.7,416.25,448.0,17902456.0,"Following the update, share price of Cipla opened with a gain of 2.77% and touched an intraday high of Rs 441, rising 6.76% on BSE.","Following the update, share price of Cipla opened with a gain of 2.77% and touched an intraday high of Rs 441, rising 6.76% on BSE.",positive,positive,5.411764705882352,positive,2.7139874739039667,positive
2020-04-03 18:02:22.886,425.0,454.7,416.25,448.0,17902456.0,Cipla share price up 8% on successful completion of Phase-3 clinical study of asthma drug,"Fluticasone propionate and salmeterol inhalation powder 100/50 mcg, 250/50 mcg and 500/50 mcg are generic versions of GSK's Advair Diskus.",positive,neutral,5.411764705882352,positive,2.7139874739039667,positive
2020-04-07 10:01:51.742,479.0,513.4,452.0,492.0,20841453.0,Cipla (₹449.1): Buy,"Investors with a short-term view can buy the stock of Cipla at current levels. After encountering a key resistance at around ₹490 in November 2019 and again this January, the stock resumed the long-t",neutral,positive,2.7139874739039667,positive,3.6321561525304378,positive
2020-04-08 15:45:56.000,564.0,610.0,564.0,580.0,27203383.0,"Sensex down 173.25 points, Nifty settles at 8748.75; Vedanta, Sun Pharma, Cipla major gainers",The Indian rupee also settled 70 paise lower at 76.34 (provisional) against the US dollar today amid rise in coronavirus cases in the country and weak domestic equities.,neutral,negative,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-08 18:02:53.077,564.0,610.0,564.0,580.0,27203383.0,"Nifty Pharma index gains led by Cadila, Sun Pharma","Cipla rose 4%, Dr Reddy’s, Piramal, Glenmark and Lupin was up in the range of 2-1% respectively and Biocon was up 1.5%.",positive,positive,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 08:43:00.000,564.0,610.0,564.0,580.0,27203383.0,"Stocks to watch: Titan, Marico, IDBI Bank, HDFC Bank, Cipla, Future Group",Heres a look at the top stocks that may remain in focus today,neutral,neutral,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 09:33:00.000,564.0,610.0,564.0,580.0,27203383.0,Cipla surges 15% on USFDA nod for first generic Proventil HFA inhaler,Proventil HFA (albuterol sulfate) metered-dose inhaler is used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.,positive,neutral,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 10:00:21.672,564.0,610.0,564.0,580.0,27203383.0,Cipla Gets U.S. FDA Nod For Generic Inhaler Amid Coronavirus Pandemic,Cipla is likely to benefit from two factors: limited competition and surge in demand due to the spread of Covid-19 in the U.S.,neutral,positive,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 10:13:01.000,564.0,610.0,564.0,580.0,27203383.0,"Sensex, Nifty trade with healthy gains, pvt banks, IT stocks rally; key factors from today’s trade","Among all sectoral indices, Nifty Pharma was the top gainer, up 5.6 per cent led by gains in Cipla, Lupin and Sun Pharma. SImilarly, Nifty Bank index gained 620 points with IDFC First Bank, Kotak Mahindra Bank and Axis Bank as top index gainers.",positive,positive,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 13:01:17.533,564.0,610.0,564.0,580.0,27203383.0,Cipla said that the drug is used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.,Cipla said that the drug is used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.,neutral,neutral,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 13:01:46.764,564.0,610.0,564.0,580.0,27203383.0,Cipla stocks surge 15 per cent on USFDA nod for asthmatic drug,The pharma major Cipla is the top gainer today on the Nifty index. The shares surged as much as 15 per cent to ₹589.65. It had got the final approval for its Abbreviated New Drug Application (ANDA) fo,positive,positive,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 14:32:00.000,564.0,610.0,564.0,580.0,27203383.0,"D-Street Buzz: 490 stocks hit upper circuit on BSE; volumes of Tata Motors, Cipla surge","490 stocks hit upper circuit on BSE including SpiceJet, Future Retail, RAIL Vikas Nigam, IRCTC, Wockhardt, KRBL and Jubilant Lifesciences among others.",neutral,neutral,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 15:48:31.000,564.0,610.0,564.0,580.0,27203383.0,"Sensex surges 1,265.66 points, Nifty ends above 9000; Maruti Suzuki, M&M, Cipla major gainers","Major gainers on the Nifty were Maruti Suzuki, M&M, Cipla, Tata Motors and Titan Company while HUL, Tech Mahindra, Dr Reddys Lab, and IndusInd Bank were the top laggards.",positive,neutral,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 18:01:03.564,564.0,610.0,564.0,580.0,27203383.0,"Market Movers: M&M, Maruti, Cipla soar; 19 stocks turn ‘overbought’",As many as 19 stocks turned ‘overbought as they crossed the 70 mark on RSI indicator.,positive,positive,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-09 21:21:00.000,564.0,610.0,564.0,580.0,27203383.0,Coronavirus outbreak: Quick USFDA approvals for asthma drug makers,Cipla gets nod for drug from USFDA earlier than expected; Lupin in fray,positive,neutral,2.8368794326241136,positive,-1.9504132231404885,negative
2020-04-12 09:34:00.000,605.0,605.0,583.0,593.2,15480008.0,"Slideshow | Top 10 stocks that moved the most last week; Cipla, M&M, RBL Bank top charts","Suven Lifesciences, Cipla, Maruti Suzuki, Mahindra &amp; Mahindra, PVR and RBL Bank are some of the stocks that moved the most last week.",neutral,neutral,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 07:59:00.000,605.0,605.0,583.0,593.2,15480008.0,"Top 10 stocks that moved the most last week; Cipla, M&M, RBL Bank top charts","Suven Lifesciences, Cipla, Maruti Suzuki, Mahindra &amp; Mahindra, PVR and RBL Bank are some of the stocks that moved the most last week.",neutral,neutral,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 09:00:00.000,605.0,605.0,583.0,593.2,15480008.0,"Lupin, Cipla, Cadila, Maruti, M&M, CONCOR good buys",. Traders are advised to keep following stock-centric approach and should keep booking timely profits on a regular basis.,positive,neutral,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 09:54:00.000,605.0,605.0,583.0,593.2,15480008.0,"BSE Healthcare index hits 52-week high, zooms 36% from March low","Dr Reddys Laboratories, Cipla, and seven other frontline pharma stocks have hit their respective 52-week highs in the past one week",positive,neutral,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 09:55:00.000,605.0,605.0,583.0,593.2,15480008.0,"Buy Cipla, target price Rs 522: Emkay Global",Cipla has received approval for generic proventil MDI (Albuterol Sulphate 90mcg/inhalation). This can lead to 3-4 per cent EPS accretion to FY21 estimates.,neutral,positive,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 11:17:00.000,605.0,605.0,583.0,593.2,15480008.0,"Cipla, ICICI Bank, Infosys among 7 stocks that should be on buyers’ radar: Shrikant Chouhan","If India does well in terms of handling the outbreak of coronavirus then the FIIs flows will increase for the top 5 companies of Nifty 50, says Shrikant Chouhan.",neutral,positive,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 12:08:00.000,605.0,605.0,583.0,593.2,15480008.0,"Buy Cipla, target price Rs 668: ICICI Securities",The brokerage has raised FY21-FY22 EPS estimates by 11-12 per cent on generic Proventil approval and the increase in Rs/$ rate to 74 from 70.,neutral,positive,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-13 15:42:37.000,605.0,605.0,583.0,593.2,15480008.0,"Pharmaceutical stocks rally yet again: Cipla shares hit all-time high; Cadila Healthcare, Lupin jump","Even after a three-day break from trading, the story for pharma shares such as Cipla, Cadila Healthcare and Lupin remains the same -- hitting fresh highs and moving up, defying the benchmark indices which have been unable to exit the red on Monday.",positive,neutral,-1.9504132231404885,negative,-1.3979650922326157,negative
2020-04-14 00:55:20.000,604.45,614.0,578.6,596.0,16212111.0,Swiggy expands essential services to over 125 cities,"The company has tied up with various national brands and retailers including HUL, P&G, Godrej, Dabur, Marico, Cipla, Vishal Mega Mart, Adani Wilmers and many other city-specific stores",positive,neutral,-1.3979650922326157,negative,2.025423728813567,positive
2020-04-14 02:24:27.000,604.45,614.0,578.6,596.0,16212111.0,Cipla Rating: Neutral; Approval for inhaler in US boosts prospects,FY21/22e EPS up 6.4/3.8%; TP raised to Rs 535; ‘Neutral’ retained as return ratios are yet to improve significantly,positive,positive,-1.3979650922326157,negative,2.025423728813567,positive
2020-04-14 08:38:00.000,604.45,614.0,578.6,596.0,16212111.0,Swiggy expands essential services to over 125 cities,"The company has partnered with several national brands and retailers such as HUL, P&amp;G, Godrej, Dabur, Marico, Vishal Mega Mart, Cipla and many other city specific stores to supply branded essential products and food items to the customers’ doorstep, Swiggy said in a statement.",positive,positive,-1.3979650922326157,negative,2.025423728813567,positive
2020-04-15 11:44:00.000,604.45,614.0,578.6,596.0,16212111.0,"Cipla Health partners Swiggy, Zomato, Dunzo for home delivery of OTC wellness products","Leveraging on the extensive service delivery mechanism of the partners, Cipla Health will cater to 4 lakh people and cover 250 stores in 45 cities across the country.",neutral,neutral,-1.3979650922326157,negative,2.025423728813567,positive
2020-04-15 11:54:50.000,604.45,614.0,578.6,596.0,16212111.0,"Cipla Health partners Swiggy, Zomato, Dunzo for home delivery of OTC products","Leveraging on the extensive service delivery mechanism of the partners, Cipla Health will cater to 4 lakh people and cover 250 stores in 45 cities across the country.A home-delivery system makes it very convenient and safe for customers to get access to the wellness products, which otherwi…",neutral,neutral,-1.3979650922326157,negative,2.025423728813567,positive
2020-04-15 12:55:00.000,590.0,612.8,582.0,601.95,12708870.0,"Cipla Health partners Swiggy, Zomato, Dunzo to deliver wellness products",Cipla Health will cater to 4 lakh people and cover 250 stores in 45 cities across the country,neutral,neutral,2.025423728813567,positive,-3.008130081300813,negative
2020-04-16 08:49:00.000,590.0,612.8,582.0,601.95,12708870.0,Covid medicine: Dr Reddy’s Laboratories begins work on Gilead drug clone,"While scientists across the world are racing to develop drugs and vaccines against the coronavirus, remdesivir is among the few that have shown promise. Indian drugmaker Cipla said a few weeks ago that it was also working on the drug along with the state-run Council of Scientific and Industrial Rese…",neutral,neutral,2.025423728813567,positive,-3.008130081300813,negative
2020-04-17 11:44:00.000,615.0,615.0,595.0,596.5,8301766.0,Share market update: 10 stocks hit 52-week highs on NSE,"Ruchi Soya Inds, Sanofi India, Dr. Reddy’s Lab and Cipla hit their fresh 52-week high during the day.",positive,positive,-3.008130081300813,negative,-2.240802675585281,negative
2020-04-20 06:00:00.000,598.0,599.4,580.0,584.6,5854740.0,Nifty Pharma index declines; Nifty PSU Bank outperforms in trade today,"Dr Reddy’s and Cipla fell 2% each, followed by Lupin and Aurobindo Pharma, which are also down 1% on the Nifty Pharma index.",negative,negative,-2.240802675585281,negative,1.6782006920415304,positive
2020-04-20 13:13:00.000,578.0,609.8,570.0,587.7,14470211.0,"‘ACC, Cipla & HDFC Life are a good buy for medium term’","We are convinced about certain stocks and sectors which are expected to perform better during and after the pandemic. Out top picks include names like ACC, Cipla, and HDFC Life.",positive,positive,1.6782006920415304,positive,-0.991763321566646,negative
2020-04-21 16:54:00.000,594.9,599.75,585.0,589.0,6181409.0,Coronavirus outbreak: Cipla employees donate Rs 3 crore to fight pandemic,"The social responsibility arm of Cipla, Cipla Foundation, also pledged Rs 4 crore towards coronavirus response programmes, many of which are already underway.",neutral,positive,-0.991763321566646,negative,-0.1694915254237288,neutral
2020-04-24 09:07:00.000,586.4,606.0,583.6,596.0,11126841.0,Chris Wood rejigs India exposure; says lockdown disastrous for economy,"Wood has rejigged his exposure to Indian stocks in his Asia ex-Japan long-only portfolio with HDFC Bank and ICICI Bank paving the way for Cipla. Besides, he remains bullish Reliance Industries.",neutral,positive,1.6371077762619413,positive,1.8333333333333333,positive
2020-04-24 14:03:00.000,586.4,606.0,583.6,596.0,11126841.0,Coronavirus treatment: Hyderabad-based IICT develops lab process to produce Favipiravir; signs deal with Cipla,"The Indian Institute of Chemical Technology (IICT) has developed a lab process to produce favipiravir, an anti-retroviral drug considered to be effective against influenza viruses.",neutral,positive,1.6371077762619413,positive,1.8333333333333333,positive
2020-04-27 04:01:00.000,600.0,632.65,600.0,611.0,14088319.0,"Sensex, Nifty open higher tracking global cues; IndusInd Bank in focus","IndusInd Bank, Zee, Cipla and Hindalco among top gainers on the Nifty index.",neutral,neutral,1.8333333333333333,positive,-2.7156290531776914,negative
2020-04-27 07:17:00.000,600.0,632.65,600.0,611.0,14088319.0,"Analyst Calls: Cipla, Mindtree, Sun TV",Elara Capital has a buy rating on Cipla with a target price of Rs 685.,neutral,positive,1.8333333333333333,positive,-2.7156290531776914,negative
2020-04-27 08:27:00.000,600.0,632.65,600.0,611.0,14088319.0,"Buy Cipla, target price Rs 685: Elara Capital",Ciplas recent inhaler approval of generic of Proventil from the USFDA would aid in strong earnings visibility in the near term.,neutral,positive,1.8333333333333333,positive,-2.7156290531776914,negative
2020-04-27 09:46:00.000,600.0,632.65,600.0,611.0,14088319.0,"Buzzing stocks: Vodafone Idea, RIL , Sun Pharma, Cipla",​RIL (Rs 644.89 crore) was leading the pack of most active stocks in value terms.,neutral,positive,1.8333333333333333,positive,-2.7156290531776914,negative
2020-04-27 10:30:00.000,600.0,632.65,600.0,611.0,14088319.0,"Share Market LIVE: Sensex rises over 700 points, Nifty at 9,350; Cipla, IndusInd Bank, Maruti top performers","Dalal Street Today: Bajaj Auto, Sun Pharma, IndusInd Bank, Maruti, HDFC, Axis Bank, Reliance Industries and Kotak Bank were among the top gainer in the Sensex pack. On the other hand, NTPC, PowerGrid and Asian Paints were among the top laggards.",positive,positive,1.8333333333333333,positive,-2.7156290531776914,negative
2020-05-04 10:07:00.000,589.0,616.95,580.6,612.0,16813134.0,"Indices joins global selloff; Sensex plunges 2,000 points","Cipla, Bharti Airtel and Sun Pharma closed higher, while Hindalco, ICICI Bank, Vedanta and Bajaj Finance stocks dragged.",negative,positive,3.904923599320883,positive,-4.1168445550116335,negative
2020-05-04 11:27:00.000,589.0,616.95,580.6,612.0,16813134.0,Share market update: 11 stocks hit 52-week highs on NSE,"In the Nifty 50 index, Cipla, Sun Pharma, Dr. Reddy’s Labs, Bharti Airtel and RIL were among top gainers.",positive,positive,3.904923599320883,positive,-4.1168445550116335,negative
2020-05-04 11:30:00.000,589.0,616.95,580.6,612.0,16813134.0,"Pharma shares trade firm in the weak market; Cipla, Lupin gain over 2%",Pharma stocks got a new lease of life as coronavirus pandemic got a tighter grip on the country in April.,positive,neutral,3.904923599320883,positive,-4.1168445550116335,negative
2020-05-04 12:59:00.000,623.05,623.05,595.0,597.4,9254409.0,"Sensex slides to 31K, Nifty loses 500 points: 5 factors behind market crash today","UPL, GAIL, Vedanta, Hindalco, Tata Motors, ICICI Bank were among the top losers today, while Cipla, Sun Pharma, Dr Reddy’s Laboratories were among the top gainers on Nifty.",neutral,negative,-4.1168445550116335,negative,-0.9205020920502092,negative
2020-05-04 22:26:50.000,623.05,623.05,595.0,597.4,9254409.0,Pharma sales drop 19% in April vs March on demand slump,"The worst hit among the top 20 companies was Cipla, whose sales fall by 28%, while that of Zydus Cadila, GSK Pharma and Dr Reddy’s down by 25%, each.There seemes to be less panic buying of medicines for chronic illnesses in the last two weeks of April",negative,negative,-4.1168445550116335,negative,-0.9205020920502092,negative
2020-05-05 14:08:00.000,597.5,606.0,590.0,592.0,6974923.0,"Share Market LIVE: Sensex up 250 points, Nifty above 9,350; ONGC, M&M, BPCL, Vedanta top performers","Sensex, Nifty Live News Today: Bharti Infratel, ONGC, M&M, BPCL and Zee Entertainment were the top gainers on Nifty, while Asian Paints, Bajaj Finance, Britannia, Dr Reddy and Cipla were among the losers on Nifty.",positive,positive,-0.9205020920502092,negative,-1.1705685618729096,negative
2020-05-07 13:13:00.000,598.0,601.2,589.5,592.95,5049303.0,"Cipla, Sun Pharma, Lupin top picks in pharma space: MOFSL",’Investors should increase allocation as the pharma story is here to stay,positive,neutral,-0.844481605351163,neutral,-2.1965221732257336,negative
2020-05-08 07:18:00.000,598.0,601.2,589.5,592.95,5049303.0,"CLSA bullish on Sun, Cipla, Cadila Health and Aurobindo",Nifty Pharma is up 12.4 per cent since February while Nifty is down 23.1 %,positive,positive,-0.844481605351163,neutral,-2.1965221732257336,negative
2020-05-08 14:14:35.000,598.0,601.2,589.5,592.95,5049303.0,"Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%","Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a ‘buy’ rating on them",positive,positive,-0.844481605351163,neutral,-2.1965221732257336,negative
2020-05-11 02:22:00.000,600.95,600.95,583.45,587.75,5852955.0,"Top stocks in focus: ICICI Bank, Shree Cement, Cipla, HDFC AMC, Tata Motors",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.1965221732257336,negative,-2.810902896081772,negative
2020-05-11 03:41:00.000,600.95,600.95,583.45,587.75,5852955.0,Cipla gets EIR for Bengaluru API facility from USFDA; ahead of Q4 nos on May 15,"The company said that it’s a manufacturing facility in Bommasandra, Bangalore has received the EIR, indicating closure of the inspection.",neutral,negative,-2.1965221732257336,negative,-2.810902896081772,negative
2020-05-11 09:33:00.000,600.95,600.95,583.45,587.75,5852955.0,"Stocks in news: RIL, HDFC AMC, ICICI Bank, Adani Transmission, Cipla, Lupin, Shree Cement, SBI Cards and more","Stocks to watch today on May 11: RIL, HDFC AMC, ICICI Bank, Adani Transmission, Cipla, Lupin, Shree Cement, SBI Cards among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,-2.1965221732257336,negative,-2.810902896081772,negative
2020-05-13 07:16:00.000,600.0,605.0,568.9,571.7,10436293.0,"COVID-19 treatment | Gilead signs pact with Cipla, Jubilant and Hetero to manufacture, distribute Remdesivir in 127 countries","The licenses are royalty-free until the World Health Organization (WHO) declares the end of the Public Health Emergency of International Concern regarding COVID-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent COVID-19, whichever is earlier.",neutral,neutral,-4.71666666666666,negative,-0.0875656742556917,neutral
2020-05-13 09:40:00.000,600.0,605.0,568.9,571.7,10436293.0,Cipla enters into a licensing agreement with Gilead; stock up over 1%,This agreement is part of Cipla’s efforts to enhance global access to life-saving treatments for patients affected by the pandemic.,positive,positive,-4.71666666666666,negative,-0.0875656742556917,neutral
2020-05-13 09:44:00.000,600.0,605.0,568.9,571.7,10436293.0,Cipla share price rises nearly 6% on partnership with Gilead for COVID-19 treatment,"Cipla will receive the manufacturing know-how from Gilead Sciences, Inc. to manufacture the API and Finished product at a commercial scale.",positive,neutral,-4.71666666666666,negative,-0.0875656742556917,neutral
2020-05-13 09:57:00.000,600.0,605.0,568.9,571.7,10436293.0,"Jubilant Life, Cipla rally up to 6% on inking pact with Gilead Sciences","According to the statements issued by Jubilant Life and Cipla, both the firms will have the right to register, manufacture and sell Gileads Remdesivir drug in 127 countries including India",positive,neutral,-4.71666666666666,negative,-0.0875656742556917,neutral
2020-05-13 10:08:00.000,600.0,605.0,568.9,571.7,10436293.0,"Gilead enters licensing pact with 5 drug firms in India, Pak for remdesivir","According to the agreement the companies Cipla, Hetero Labs, Jubilant Life Sciences, Mylan, and Pakistan based Ferozsons Labs, to manufacture and sell remdesivir in 127 countries",positive,neutral,-4.71666666666666,negative,-0.0875656742556917,neutral
2020-05-13 11:44:55.000,600.0,605.0,568.9,571.7,10436293.0,Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir,The medicine has been issued an Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) to treat COVID-19 patients.,positive,neutral,-4.71666666666666,negative,-0.0875656742556917,neutral
2020-05-13 15:10:53.000,571.0,577.9,566.1,570.5,8544358.0,Gilead’s voluntary licensing deals on remdesivir get off the blocks,"VL pact features Cipla, Hetero, Mylan, Jubilant and Ferozsons Laboratories",neutral,neutral,-0.0875656742556917,neutral,-0.7867132867132868,neutral
2020-05-13 15:43:55.000,571.0,577.9,566.1,570.5,8544358.0,"Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir - Health News , Firstpost","Homegrown pharma major Cipla Ltd on Wednesday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of investigational drug remdesivir, a potential therapy for COVID-19",positive,positive,-0.0875656742556917,neutral,-0.7867132867132868,neutral
2020-05-14 08:49:00.000,571.0,577.9,566.1,570.5,8544358.0,"Stocks in the news: Biocon, DRL, PFC, Cipla, Indiabulls Realty, Escorts and REC - The Economic Times",Here are a few stocks which may create some buzz in Thursdays trade.,neutral,neutral,-0.0875656742556917,neutral,-0.7867132867132868,neutral
2020-05-14 17:39:00.000,572.0,585.0,565.6,567.5,14384023.0,Cipla Q4 results preview: Here’s what analysts say,Phillip Capital expects 8.1 per cent YoY growth in net profit of Cipla.,neutral,positive,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 05:30:00.000,572.0,585.0,565.6,567.5,14384023.0,BRIEF-Cipla Ltd - Approved Raising Of Funds Of Upto 30 Billion Rupees - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 05:30:00.000,572.0,585.0,565.6,567.5,14384023.0,BRIEF-India’s Cipla March Quarter Consol Net Profit Falls - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 06:51:59.000,572.0,585.0,565.6,567.5,14384023.0,"Stocks To Watch: Aurobindo Pharma, Cipla, Indiabulls Real Estate, L&T Tech, Manappuram Finance, M&M Financial, Nippon Life",Here are the stocks to watch in trade today.,neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 07:30:00.000,572.0,585.0,565.6,567.5,14384023.0,"Market Ahead, May 15: All You Need To Know Before The Opening Bell","Today, a total of 12 companies including Cipla, Aaarti Drugs, and M&M Finance are scheduled to announce their results",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 07:45:00.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla Q4 profit, revenue could decline due to high-base effect","At operating level, there could be a big fall on year-on-year basis, but the sequential decline may be much less compared to YoY.",negative,negative,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 07:59:00.000,572.0,585.0,565.6,567.5,14384023.0,"Top stocks in focus: Cipla, Unichem Labs, L&T Finance, Aurobindo Pharma, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 08:09:00.000,572.0,585.0,565.6,567.5,14384023.0,"Stocks to watch: Biocon, Cipla, Aurobindo Pharma, Tata Group stocks, Nocil",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 09:00:24.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla, Ashok Leyland, Tata Chemicals, Escorts, agri stocks to remain in action today","Aarti Drugs, Cipla, Crompton Greaves, IIFL Securities, Nippon Life India Asset Management, Tata Chemicals and L&T Technology Services are among 12 companies that are scheduled to announce their March quarter earnings today.",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 09:05:00.000,572.0,585.0,565.6,567.5,14384023.0,More companies in talks for Remdesivir licence,"This week, Cipla, Jubilant Life Sciences, Hetero and Mylan signed non-exclusive licensing agreements for the antiviral drug which received emergency use authorisation from the US Food and Drug Administration after trial results showed that it halved the recovery time to five days for moderately affe…",neutral,positive,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 09:09:00.000,572.0,585.0,565.6,567.5,14384023.0,"Board Meetings Today: Cipla, Crompton Greaves Consumer, L&T Finance Holdings, MMFS, Nippon Life AM and Tata Chemicals","L&T Technology Services, IIFL Securities: are scheduled to announce their March quarter earnings on Friday.",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 09:50:00.000,572.0,585.0,565.6,567.5,14384023.0,"Stocks in news: Biocon, Tata Consumer, Escorts, Cipla, L&T Tech, M&M Financial, Manappuram Finance and more","Stocks to watch today on May 15: Biocon, Tata Consumer, Escorts, Cipla, L&T Tech, M&M Financial, Manappuram Finance among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 10:21:00.000,572.0,585.0,565.6,567.5,14384023.0,Trending stocks: Cipla shares rise over 2% ahead of Q4 results,"A total of 100,150 shares changed hands on the counter till 10:18AM (IST).",positive,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 10:22:00.000,572.0,585.0,565.6,567.5,14384023.0,"Stocks in the news: Cipla, Aurobindo Pharma, GMR Infra, Indiabulls Real Estate and Ashok leyland",Here are a few stocks which may create some buzz in Fridays trade.,neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 11:23:00.000,572.0,585.0,565.6,567.5,14384023.0,"Important results today: Cipla, L&T Tech, Crompton Greaves, M&M Financial","Quarterly results that are expected today include Cipla, Crompton Greaves Consumer, IIFL Securities.",neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 16:04:00.000,572.0,585.0,565.6,567.5,14384023.0,"Will Gilead’s Covid-19 drug lift sustain for Jubilant Life, Cipla?",Use of remdesivir is said to reduce hospital stay by 31 per cent to 11 days from 15 days.,neutral,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 16:07:00.000,572.0,585.0,565.6,567.5,14384023.0,"Share Market Update: Sensex ends 25 points lower, Nifty at 9,136; M&M, Zee Ent, Axis Bank top losers","Dalal Street today:Cipla, Crompton Greaves Consumer Electrical, L&T Technology Services, Mahindra & Mahindra Financial Services and Nippon Life India Asset Management will be reporting Q4 results today",negative,neutral,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 19:59:00.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla reports Q4 profit at Rs 246 crore, FY20 net grows 1% to Rs 1,547 crore",The stock in the past year gained only 2.6 percent and rose 19.2 percent year-to-date.,positive,positive,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 20:00:00.000,572.0,585.0,565.6,567.5,14384023.0,Cipla Q4 results: Profit drops 33% to Rs 238 crore; misses Street estimates,The profit figure missed ET NOW poll estimate of Rs 355 crore.,negative,negative,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 20:23:00.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla to raise Rs 3,000 crore, Q4 net misses Street view: Key takeaways",It had posted a net profit of Rs 357.68 crore in the same quarter a year ago.,positive,positive,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 20:59:03.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla’s board approves Rs3,000 crore fundraising proposal","The fundraising plans come at a time when the pharma stocks have outperformed the broader market, despite the economic impact of the covid-19 pandemic.Cipla’s stock has gained 19% since the start of the year to close at Rs570.2 on Friday, on the BSE",neutral,positive,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 21:07:00.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla FY20 profit grows to Rs 1,546 crore; COVID-19 hits supply chain in March",Cipla’s net profit during the March quarter of FY20 took a beating on account of the coronavirus pandemic. The company posted a 33 per cent decline in consolidated net profit during the quarter ended March 2020,positive,negative,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 21:42:11.000,572.0,585.0,565.6,567.5,14384023.0,Covid-19 effect: Cipla Q4 net declines 33% to ₹246 cr,"Cipla’s consolidated operating margin contracted by 7 percentage points to 15%.Sales of medicine for acute diseases, especially anti-infectives, have been severely hit in April by the lockdown",negative,positive,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-15 22:08:58.000,572.0,585.0,565.6,567.5,14384023.0,"Cipla Q4 Results: Profit Falls 33%, Margin Contracts","Cipla’s profit fell 33% year-on-year to Rs 246 crore in the March quarter on the back of revenue that fell 1% to Rs 4,376 crore.",neutral,negative,-0.7867132867132868,neutral,5.327725201542232,positive
2020-05-17 21:29:00.000,570.6,605.0,570.5,601.0,22895610.0,Buy Cipla target of Rs 650: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 15, 2020.",neutral,positive,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-17 22:16:00.000,570.6,605.0,570.5,601.0,22895610.0,Cipla working on multiple therapies to fight spread of coronavirus,"Besides, the company is reworking its domestic market sales strategy, and scrutinising its capital and operating expenditure plans",neutral,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 05:30:00.000,570.6,605.0,570.5,601.0,22895610.0,BRIEF-Cipla Files ANDA For Generic Version Of GSK’s Advair Diskus - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 06:46:18.000,570.6,605.0,570.5,601.0,22895610.0,"Stocks To Watch: Reliance Industries, Cipla, Bharti Airtel, M&M Finance, L&T Finance",Here are the stocks to watch in trade today.,neutral,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 07:56:00.000,570.6,605.0,570.5,601.0,22895610.0,"Top stocks in focus: Reliance Industries, Bharti Airtel, Maruti Suzuki, Cipla, L&T Technology",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 08:55:00.000,570.6,605.0,570.5,601.0,22895610.0,"Stocks to watch: RIL, Cipla, Coal India, Bharti Airtel, KNR Constructions",Heres a look at the top stocks that may remain in focus today,neutral,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 09:40:05.000,570.6,605.0,570.5,601.0,22895610.0,"Nifty, Sensex fall as economic package fails to impress; Reliance rises","Indian shares slipped on Monday as investors were unimpressed by the government’s economic relief measures and coronavirus cases continued to rise steadily, while a boost in Reliance Industries and Cipla limited losses.",negative,negative,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 09:51:00.000,570.6,605.0,570.5,601.0,22895610.0,Cipla files ANDA for generic version of GSK’s Advair Diskus; Q4 net profit declines 33%,The company’s net profit declined 33% to Rs245.95cr in the quarter ended March 2020 as against Rs367.20cr during the previous quarter ended March 2019.,negative,negative,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 10:06:01.000,570.6,605.0,570.5,601.0,22895610.0,Cipla files ANDA generic version of GSK’s Advair Diskus for asthma treatment,"Global pharmaceutical company, Cipla Limited, has submitted an Abbreviated New Drug Application (ANDA) which is a generic version of GSK’s Advair Diskus to the United States Food and Drug Administration (USFDA). This is in line with Cipla’s plan towards building a respiratory franchise in the US.…",neutral,positive,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 10:27:00.000,570.6,605.0,570.5,601.0,22895610.0,Cipla share price gains 2% on Q4 numbers; files application for asthma drug with USFDA,The company announced the submission of an ANDA for Fluticasone propionate and Salmeterol inhalation powder with the US drug regulator.,positive,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 10:40:00.000,570.6,605.0,570.5,601.0,22895610.0,"Neutral on Cipla,target price Rs 550: Motilal Oswal",The brokerage continues to value Cipla at 20 times 12-month forward earnings to arrive at a price target of Rs 550.,neutral,positive,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 10:51:00.000,570.6,605.0,570.5,601.0,22895610.0,Cipla submits application with USFDA for generic version of asthma drug,"Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK’s Advair Diskus, which is used in the treatment of asthma and other respiratory disorders.",neutral,positive,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 11:08:00.000,570.6,605.0,570.5,601.0,22895610.0,"Slideshow | Cipla, ABB, Escorts among 10 buying ideas for up to 49% upside",Here are the 10 buying ideas by brokerages which could give up to 49 percent upside:,positive,positive,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 11:13:00.000,570.6,605.0,570.5,601.0,22895610.0,Trending stocks: Cipla shares gain over 3%,"A total of 292,263 shares changed hands on the counter till 11:00AM (IST).",positive,neutral,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 11:25:00.000,570.6,605.0,570.5,601.0,22895610.0,Investors cheer Cipla despite Q4 PAT decline of 33% to Rs246cr,Cipla posted a consolidated net profit of Rs246 per piece which was down by 33% from Rs367cr in the corresponding period of the previous year.,negative,negative,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 11:26:00.000,570.6,605.0,570.5,601.0,22895610.0,Cipla’s FY20: India biz grows by 12% - All details here!,Cipla’s majority business was driven by positive performance in India and South America.,positive,positive,5.327725201542232,positive,-1.0750000000000075,negative
2020-05-18 12:24:14.000,600.0,608.8,590.2,593.55,10949702.0,"Cipla: Respiratory pipeline adds oxygen, accumulate",,neutral,neutral,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 12:46:48.000,600.0,608.8,590.2,593.55,10949702.0,"Cipla submits application with USFDA for generic version of asthma drug - Business News , Firstpost","Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK’s Advair Diskus, which is used in the treatment of asthma and other respiratory disorders",neutral,positive,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 13:24:00.000,600.0,608.8,590.2,593.55,10949702.0,"Cipla Consolidated March 2020 Net Sales at Rs 4,376.19 crore, down 0.63% Y-o-Y",,negative,neutral,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 13:39:00.000,600.0,608.8,590.2,593.55,10949702.0,"Stocks in news: Airtel, RIL, M&M Financial, Cipla, L&T Financials, Future Consumer, Tata Chemicals and more","Stocks to watch today on May 18: Airtel, RIL, M&M Financial, Cipla, L&T Financials, Future Consumer, Tata Chemicals, DLF, ITC among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 15:41:00.000,600.0,608.8,590.2,593.55,10949702.0,A big opportunity is beginning to unlock for us in the US: Cipla,‘Inhaler opportunity can add to Ciplas position in lung medicines.’,positive,positive,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 16:37:00.000,600.0,608.8,590.2,593.55,10949702.0,"In pics | Stocks in the news: Reliance Industries, ITC, Eveready Industries, M&M Financial, Cipla","Nelco, Future Consumer, KNR Construction, Liberty Shoes, L&amp;T Technology are some stocks that will be in focus today.",neutral,neutral,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 16:59:00.000,600.0,608.8,590.2,593.55,10949702.0,Buy Cipla; target of Rs 670: ICICI Direct,"ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 670 in its research report dated May 18, 2020.",neutral,positive,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 17:02:00.000,600.0,608.8,590.2,593.55,10949702.0,Buy Cipla; target of Rs 655: HDFC Securities,"HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 655 in its research report dated May 16, 2020.",neutral,positive,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-18 20:11:00.000,600.0,608.8,590.2,593.55,10949702.0,"Cipla expects margin, RoCE expansion in FY21; ability to supply crucial, says CFO","&quot;In pharma, demand is there, but growth depends more on our ability to supply,&quot; Upadhye said in the context of COVID-19 pandemic that’s threatening operations. The lockdown had impacted sales of Rs 200 crore for Q4FY20",positive,neutral,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-19 01:17:00.000,600.0,608.8,590.2,593.55,10949702.0,US respiratory pipeline breathes in fresh optimism for Cipla; stock up 5%,Improving growth in North America will complement strong domestic sales,positive,positive,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-19 01:17:31.000,600.0,608.8,590.2,593.55,10949702.0,Cipla eyes multi-drug portfolio for virus cure,"Cipla is among four companies—the other three being Mylan, Jubilant Life Sciences and Hetero Drugs—who have signed a pact with US-based Gilead for manufacturing of the patented intravenous drug remdesivir",neutral,neutral,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-19 08:25:00.000,600.0,608.8,590.2,593.55,10949702.0,"Buy Cipla, target price Rs 664: ICICI Securities","The brokerage has reduced FY21-FY22 earnings estimates by 1-4%, to factor in the marginal reduction in India growth estimate in the acute portfolio.",neutral,negative,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-19 08:38:31.000,600.0,608.8,590.2,593.55,10949702.0,Retain ‘hold’ on Cipla with higher TP of Rs 575,Cipla saw a sales impact of Rs 200 crore in Q4FY20 (~5% of total sales) due to challenges in the movement of logistics mainly for its India formulations business and exports to emerging markets in the initial lockdown phase.,neutral,negative,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-19 09:18:00.000,600.0,608.8,590.2,593.55,10949702.0,COVID-19 treatment | Cipla eyes multi-drug portfolio for novel coronavirus cure: Report,"Cipla is reportedly fine tuning its pact with United States-based Gilead Sciences Inc. on patented intravenous drug remdesivir, a potential treatment for the respiratory infection.",neutral,negative,-1.0750000000000075,negative,4.0201005025125625,positive
2020-05-19 13:40:00.000,597.0,624.35,595.4,621.0,13438739.0,Cipla’s Q4 results could set the tone for what to expect from its peers for the quarter,"The company, aspiring to become a lung leader globally, could not escape the impact of coronavirus.",neutral,neutral,4.0201005025125625,positive,-0.6525416901635309,neutral
2020-05-20 06:20:18.000,597.0,624.35,595.4,621.0,13438739.0,"Stocks To Watch: Bajaj Auto, Bajaj Finance, Cipla, Dr. Reddy’s, Piramal Enterprises, SpiceJet, Tata Power, UltraTech Cement",Here are the stocks to watch in trade today.,neutral,neutral,4.0201005025125625,positive,-0.6525416901635309,neutral
2020-05-20 07:57:00.000,597.0,624.35,595.4,621.0,13438739.0,"Top stocks in focus: Bajaj Auto, Dr Reddy’s, Spicejet, Bajaj Finance, Cipla, Tata Power",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,4.0201005025125625,positive,-0.6525416901635309,neutral
2020-05-20 12:16:00.000,620.65,626.85,612.3,616.6,7915039.0,Share market update: Pharma shares rise; Cipla gains 3%,The Nifty Pharma index was trading 1.31 per cent up at 9203.2.,positive,positive,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-20 12:49:00.000,620.65,626.85,612.3,616.6,7915039.0,Nifty Pharma index gains ~2%; Dr Reddy’s Lab in focus,"Cipla and Lupin surged 3% in the Nifty Pharma index, followed by Piramal, Aurobindo and Divi’s Lab are up 2%.",positive,positive,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-21 05:30:00.000,620.65,626.85,612.3,616.6,7915039.0,BRIEF-Cipla Ltd -Gets Final Approval For Generic Version Of Migranal - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-21 09:23:00.000,620.65,626.85,612.3,616.6,7915039.0,"Cipla Consolidated March 2020 Net Sales at Rs 4,376.19 crore, down 0.63% Y-o-Y",,negative,neutral,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-21 09:52:00.000,620.65,626.85,612.3,616.6,7915039.0,Cipla gets final nod from USFDA for migraine treatment nasal spray,"&quot;It has received final approval for its Abbreviated New Drug Application (ANDA) for Dihydroergotamine Mesylate nasal spray 4mg/mL from the United States Food and Drug Administration (USFDA) with a competitive generic therapy (CGT) designation,&quot; the company said in a filing to BSE.",neutral,positive,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-21 10:56:00.000,620.65,626.85,612.3,616.6,7915039.0,Cipla’s nasal spray gets approval from USFDA for migraine treatment,This is Cipla’s first ANDA approval for a nasal spray. It is indicated for the acute treatment of migraine headaches with or without aura.,positive,positive,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-21 11:57:06.000,620.65,626.85,612.3,616.6,7915039.0,Cipla Gets Final Nod From U.S. FDA For Migraine Treatment Nasal Spray,This is Cipla’s first ANDA approval for a nasal spray for the treatment of acute attacks of migraines with or without aura.,neutral,positive,-0.6525416901635309,neutral,3.291713961407484,positive
2020-05-22 06:29:34.000,616.7,641.85,610.1,637.0,10868194.0,"Stocks To Watch: Cipla, Godrej Industries, Hero MotoCorp, IDFC First Bank, InterGlobe Aviation, JSW Steel, UPL",Here are the stocks to watch in trade today.,neutral,neutral,3.291713961407484,positive,-1.7968749999999998,negative
2020-05-22 11:17:00.000,616.7,641.85,610.1,637.0,10868194.0,"Doctors hesitate to use life-saving COVID-19 drug, considering patient’s expenses: Report","Marketed as Actemra in India by Cipla, Roche pharma’s Tocilizumab costs Rs 60,000 per dose",neutral,neutral,3.291713961407484,positive,-1.7968749999999998,negative
2020-05-25 08:22:00.000,640.0,646.9,624.05,628.5,8852112.0,"Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell Remdesivir","Cipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.",neutral,positive,-1.7968749999999998,negative,0.6190476190476154,neutral
2020-05-25 22:55:41.000,640.0,646.9,624.05,628.5,8852112.0,Gilead eyes trials of remdesivir combo with other drugs,"In India, Gilead has signed a voluntary licensing agreement with four firms—Cipla, Hetero Drugs, Jubilant Life Sciences and Mylan.Gilead will transfer the technology to its partners, and the sale will be royalty-free until an alternative drug for covid is found",neutral,positive,-1.7968749999999998,negative,0.6190476190476154,neutral
2020-05-26 09:05:00.000,640.0,646.9,624.05,628.5,8852112.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","Sudarshan Sukhani of s2analytics.com recommends buying ACC with a stop loss of Rs 1,200, target at Rs 1,270 and Cipla with a stop loss of Rs 620, target at Rs 655.",neutral,neutral,-1.7968749999999998,negative,0.6190476190476154,neutral
2020-05-28 12:54:00.000,633.0,650.95,631.0,648.05,10578317.0,"Value Pick: Anand Rathi has buy on Cipla, target price Rs 738","The brokerage believes that with healthy earnings growth and core ROCE expansion over FY20-22e, Ciplas valuations are likely to witness re-rating.",positive,positive,2.3775671406003087,positive,-1.294298921417562,negative
2020-05-28 15:09:00.000,633.0,650.95,631.0,648.05,10578317.0,Buy Cipla target of Rs 738: Anand Rathi,"Anand Rathi is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 738 in its research report dated May 28, 2020.",neutral,positive,2.3775671406003087,positive,-1.294298921417562,negative
2020-05-29 11:00:00.000,633.0,650.95,631.0,648.05,10578317.0,Bank Nifty index down 100 points; Vodafone Idea extends rally,"Infratel, Eicher, Wipro, Cipla and IndusInd Bank among top gainers on the NSE, while Tata Motors, Adani Ports and Titan among top laggards.",negative,neutral,2.3775671406003087,positive,-1.294298921417562,negative
2020-05-29 13:44:00.000,633.0,650.95,631.0,648.05,10578317.0,"Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high","Dr Reddys, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the range of 3% to 5%.",neutral,positive,2.3775671406003087,positive,-1.294298921417562,negative
2020-06-01 07:06:00.000,649.0,652.6,634.55,640.6,7438121.0,Remdesivir use may be managed by government,"The recommendations come as four Indian drug companies, Cipla, Hetero, Mylan and Jubilant, gear up to get an approval for the drug in the treatment of Covid-19.",neutral,positive,-1.294298921417562,negative,-0.8838579624747918,neutral
2020-06-01 07:08:00.000,649.0,652.6,634.55,640.6,7438121.0,BDR in pact to make Gilead drug for Cipla,"In late May, BDR had sought the approval of Indias drug regulator to make and sell remdesivir in India without entering into an arrangement with Gilead. The Mumbai-based company has now signed a contract to make the drug for Cipla, which is one of the licensed companies.",positive,positive,-1.294298921417562,negative,-0.8838579624747918,neutral
2020-06-01 09:02:56.000,649.0,652.6,634.55,640.6,7438121.0,"Top Buy And Sell Ideas By Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar For Short Term","Mitessh Thakkar of mitesshthakkar.com recommends buying Cipla with a stop loss of Rs 639, target at Rs 667 and Mahanagar Gas with a stop loss of Rs 959, target at Rs 999.",neutral,neutral,-1.294298921417562,negative,-0.8838579624747918,neutral
2020-06-01 11:32:00.000,649.0,652.6,634.55,640.6,7438121.0,Stock market update: 12 stocks hit 52-week lows on NSE,"However, Dr. Reddy’s Labs, Cipla, Sun Pharma, Nestle India and Bharti Infratel were among the top losers.",negative,negative,-1.294298921417562,negative,-0.8838579624747918,neutral
2020-06-02 11:25:00.000,644.9,658.65,636.0,639.2,6881677.0,"Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018","Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.",positive,positive,-0.8838579624747918,neutral,-0.6956790600602921,neutral
2020-06-04 11:48:12.000,643.0,664.8,642.5,663.0,10450697.0,"D-Street Buzz: Nifty Pharma Gains Led By Biocon; Lupin; Volumes Of Sun Pharma, Aurobindo Pharma Rise","Among the sectors, Nifty Pharma added over a percent led by Sun Pharma, Biocon, Lupin and Torrent Pharma which gained 2 percent each followed by Aurobindo Pharma, Cipla, Divis Labs and Dr Reddy’s Labs among others.",neutral,positive,3.1104199066874028,positive,-1.6541353383458646,negative
2020-06-04 17:13:00.000,665.0,669.75,649.0,654.0,6480954.0,"Sensex, Nifty trade lower; Aurobindo Pharma, Cipla stocks hit 52-week high","Vedanta, Tech Mahindra, Sun Pharma, Cipla and BPCL were among top gainers, on the other hand, Titan, Asian Paints, Kotak Bank, Britannia and HDFC were trading in the red.",neutral,neutral,-1.6541353383458646,negative,-3.13689660423329,negative
2020-06-04 22:22:00.000,665.0,669.75,649.0,654.0,6480954.0,Indian licensees free to price Remdesivir: Gilead,"US drug maker to launch own brand of Covid-19 experimental drug in the country next month. Gilead has licensed the drug to four companies — Cipla, Mylan, Hetero and Jubilant Life Sciences — for sale in India, but none of these firms has received approval from the drug controller. most of the four …",neutral,neutral,-1.6541353383458646,negative,-3.13689660423329,negative
2020-06-10 09:44:06.000,646.8,650.75,639.8,645.65,5424937.0,Cipla to acquire stake worth Rs 9 crore in GoApptiv,"In order to widen reach in the tier three plus towns, pharmaceutical company, Cipla, has decided to acquire a 21.85 per cent stake in GoApptiv Private Limited, a digital solution providing company. This acquisition will be in two phases — Rs 5.80 crore will be paid in first phase and Rs 3.2 crore…",neutral,positive,-0.1777983920841028,neutral,-1.5255943622705836,negative
2020-06-10 10:23:05.000,646.8,650.75,639.8,645.65,5424937.0,"Sensex trades higher, Nifty holds 10,050; check what’s moving Dalal Street today","Nifty Pharma index was up 0.75 per cent led by gains in Cadila Healthcare, Lupin and Cipla. While Nifty Metal index was down half a per cent dragged by Tata Steel, Ratnamani Metals & Tubes and Welspun Corp.",positive,positive,-0.1777983920841028,neutral,-1.5255943622705836,negative
2020-06-10 10:55:06.000,646.8,650.75,639.8,645.65,5424937.0,Cipla To Acquire 21.85% Stake In GoApptiv,"In the first stage, subscription of 15,392 compulsorily convertible preference shares and purchase of 6,927 equity shares is expected to be closed within 30 days from the execution date, subject to certain conditions precedent.",neutral,neutral,-0.1777983920841028,neutral,-1.5255943622705836,negative
2020-06-10 11:17:05.000,646.8,650.75,639.8,645.65,5424937.0,Cipla to acquire 21.85 pc stake in GoApptiv,"GoApptiv offers digital solutions for integrated brand sales management, digital marketing and channel engagement for pharmaceutical companies.",neutral,neutral,-0.1777983920841028,neutral,-1.5255943622705836,negative
2020-06-10 13:59:00.000,645.65,646.95,632.8,635.8,3170657.0,Cipla to acquire 22% stake in GoApptiv,"In the second stage, subscription of 12,314 compulsorily convertible preference shares is expected to close by October 31, subject to certain conditions precedent, it added.",neutral,neutral,-1.5255943622705836,negative,4.364757423332807,positive
2020-06-10 14:44:00.000,645.65,646.95,632.8,635.8,3170657.0,Cipla share price climbs 2% as firm plans to buy stake in GoApptiv,"Following the latest deal, Cipla share price rose 1.65% intraday to the day’s high of Rs 650.50 compared to its earlier close of Rs 639.90 on BSE. The stock has gained 2.19% in the last 2 sessions.",positive,positive,-1.5255943622705836,negative,4.364757423332807,positive
2020-06-10 15:44:00.000,645.65,646.95,632.8,635.8,3170657.0,Cipla to acquire stake in GoApptiv; stock up nearly 2%,"The first stage of the acquisition will be done for Rs5.8cr, while the second stage will have a cash consideration of Rs3.2cr.",positive,neutral,-1.5255943622705836,negative,4.364757423332807,positive
2020-06-10 20:52:11.000,645.65,646.95,632.8,635.8,3170657.0,Cipla to acquire 21.85% stake in GoApptiv,Pharma major Cipla on Wednesday said it will acquire 21.85 per cent stake in GoApptiv on a fully-diluted basis in two phases. The cost of acquisition is ₹9 crore (₹5.80 crore in the first stage and ₹3,neutral,neutral,-1.5255943622705836,negative,4.364757423332807,positive
2020-06-12 19:02:24.000,616.3,645.0,616.3,643.2,5577671.0,Why Wait For Gilead’s Antiviral Remdesivir May Not End Soon,"Indian drug regulator has been reviewing the marketing authorisation applications of Remdesivir of four Indian companies: Cipla, Hetero, Jubilant Life Sciences and BDR Pharmaceuticals",neutral,neutral,4.364757423332807,positive,-0.077760497667185,neutral
2020-06-12 21:56:00.000,616.3,645.0,616.3,643.2,5577671.0,India’s Zydus Cadila to make Gilead’s potential COVID-19 drug remdesivir,"Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for the drug.",neutral,positive,4.364757423332807,positive,-0.077760497667185,neutral
2020-06-16 10:46:00.000,644.5,650.0,632.45,640.0,2925511.0,"US revokes decision to treat Covid-19 patients with hydroxychloroquine; jolt for Zydus Cadila, Ipca Lab","About six Indian companies like Cipla, Jubilant, Hetero, Syngene, Dr Reddy’s and Zydus Cadila were licensed to make and distribute the drug in over 120 geographies",neutral,neutral,-0.6982156710628394,neutral,0.1640624999999929,neutral
2020-06-18 05:30:00.000,641.65,644.8,636.4,641.6,2160471.0,BRIEF-Cipla Signs Pact With Roche Products (India) Pvt. Ltd - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.0077924101924654,neutral,-0.5933574786160164,neutral
2020-06-18 11:45:00.000,641.65,644.8,636.4,641.6,2160471.0,Roche Pharma India expands partnership with Cipla for key oncology medicines,"Roche Pharma India has signed a distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India, the company said in a statement.",positive,positive,-0.0077924101924654,neutral,-0.5933574786160164,neutral
2020-06-18 13:41:00.000,648.85,648.85,631.5,645.0,4475185.0,Roche Pharma India expands partnership with Cipla for oncology medicines,The two companies had previously entered into a similar agreement in February 2018 for promotion and distribution of tocilizumab (Actemra) and other products,positive,positive,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-18 13:53:15.000,648.85,648.85,631.5,645.0,4475185.0,Roche Pharma expands partnership with Cipla to improve access to oncology drugs,"Roche Products (India) and Cipla Ltd have entered into an agreement to improve access to innovative medicines for patients in India, the companies said.Under the agreement, Cipla will be responsible",positive,positive,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-18 20:07:19.000,648.85,648.85,631.5,645.0,4475185.0,Roche rolls-out cluster strategy to cater to differing customer-needs,"Expands partnership with Cipla, inks another with Entero Healthcare for cancer and nephrology products, respectively",neutral,positive,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-18 22:43:48.000,648.85,648.85,631.5,645.0,4475185.0,"Roche announces distribution pacts with Entero, Cipla",Roche Products (India) Pvt. Ltd. has announced distribution agreements with Entero Healthcare Solutions Pvt. Ltd. for its nephrology drugs and Cipla for its oncology drugs in India.Entero Healthcare S,neutral,positive,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 06:31:30.000,648.85,648.85,631.5,645.0,4475185.0,"Stocks To Watch: Bajaj Consumer Care, Cipla, IRB Infra, LIC Housing, Oil India, PNB, RIL, Tata Motors, Thermax",Here are the stocks to watch in trade today.,neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 07:48:46.000,648.85,648.85,631.5,645.0,4475185.0,"In Pics | Stocks In The News: RIL, Cipla, Tata Motors, Whirlpool, City Union Bank, MOIL",Tata Motors | RIL | HIL | ASM Technologies | Orient Bell | Waterbase | Lumax Industries | IRB Infrastructure | Bajaj Consumer Care | MOIL | Dredging Corporation | Thermax | Satin Creditcare Network are some more stocks in focus today.,neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 09:11:23.000,648.85,648.85,631.5,645.0,4475185.0,"Stocks in focus: RIL, Tata Motors, Cipla, Future Group shares to remain on investors watch list",Sensex and Nifty are expected to open in the red on Friday after staging a strong 700 point recovery the previous day.,neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 09:39:00.000,648.85,648.85,631.5,645.0,4475185.0,"Stocks in news: RIL, Cipla, Bajaj Consumer, Whirlpool, PNB, LIC Housing, Oil India, Cadila and more","Stocks to watch today on June 19: RIL, Cipla, Bajaj Consumer, Whirlpool, City Union Bank, PNB, LIC Housing, Oil India, Cadila among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 09:43:15.000,648.85,648.85,631.5,645.0,4475185.0,Cipla Share Price Rises As It Expands Partnership With Roche Pharma,The two companies have entered into an agreement to provide better access to innovative medicines for patients in India.,neutral,positive,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 10:30:37.000,648.85,648.85,631.5,645.0,4475185.0,"Stocks To Watch: RIL, Cipla & Tata Motor","Stocks To Watch: RIL, Cipla & Tata Motor",neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 13:18:00.000,648.85,648.85,631.5,645.0,4475185.0,"Top stocks in focus: RIL, Cipla, Tata Motors, Bajaj Consumer, IRB Infra, LIC Housing",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 16:33:00.000,648.85,648.85,631.5,645.0,4475185.0,Cipla expands partnership with Roche Pharma India to further improve access to key oncology medicines,Roche and Cipla had previously entered into a similar agreement in February 2018 for promotion and distribution of Tocilizumab (Actemra) and other products.,positive,positive,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-19 21:39:00.000,648.85,648.85,631.5,645.0,4475185.0,"Glenmark Pharma gets nod for favipiravir; Cipla, Hetero for remdesivir","Glenmark gets nod for oral favipiravir, Maha health minister says Cipla and Hetero get nod for remdesivir",neutral,neutral,-0.5933574786160164,neutral,-4.934876989869758,negative
2020-06-21 05:30:00.000,691.0,692.5,651.65,656.9,29307905.0,India gives Hetero Labs and Cipla approval to make Gilead’s COVID-19 drug - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 09:49:27.000,691.0,692.5,651.65,656.9,29307905.0,"Coronavirus medicine: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir for Covid-19","Written informed consent of each patient is required before the use of remdesivir and results of additional clinical trials, active post-marketing surveillance data and reporting of serious adverse events have to be submitted.",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 10:58:05.000,691.0,692.5,651.65,656.9,29307905.0,"COVID-19 | Hetero, Cipla Get Nod To Manufacture, Market Antiviral Drug Remdesivir","Remdesivir, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 17:45:00.000,691.0,692.5,651.65,656.9,29307905.0,"Hetero to launch remdesivir at Rs 5,000-6,000/dose, Cipla to follow suit","Industry sources estimate that at least 10,000 patients need the drug urgently in the areas with high case load",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 19:41:42.000,691.0,692.5,651.65,656.9,29307905.0,Three Indian firms get nod for Covid anti-viral drugs,"Three Indian companies have got off the blocks for Covid-19 anti-viral drugs, remdesivir and favipiravir.Hetero and Cipla received the Indian regulator’s approval for remdesivir, an injectable drug. G",neutral,positive,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 20:34:26.000,691.0,692.5,651.65,656.9,29307905.0,"5-day Coronavirus Treatment To Cost No More Than Rs 30,000: Hetero","Cipla has not disclosed the pricing of the drug, Hetero said it will supply its version of remdesivir at Rs 5,000- Rs 6,000 per vial.",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 21:09:00.000,691.0,692.5,651.65,656.9,29307905.0,"Coronavirus drug update: Cipla, Hetero to launch Remdesivir at Rs 3,000-6,000","Cipla plans to launch the drug in a couple of days, while Hetero’s drug is expected to hit the market in a week",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 22:25:42.000,691.0,692.5,651.65,656.9,29307905.0,Covid drug: Cipla launches generic remdesivir for coronavirus patients,Remdesivir is the only USFDA approved Emergency Use Authorisation treatment for adult and paediatric patients hospitalised with suspected or laboratory confirmed COVID-19 infection.,neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 22:26:00.000,691.0,692.5,651.65,656.9,29307905.0,Covid-19 crisis: Cipla launches generic remdesivir under brand name Cipremi,The USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of Covid-19 patients,neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 22:30:00.000,691.0,692.5,651.65,656.9,29307905.0,Coronavirus update: Cipla launches US FDA approved treatment for COVID-19,"Gilead Sciences, in May, had extended a voluntary non-exclusive license to Cipla to manufacture and market Cipla’s generic version of remedisvir called CIPREMI",positive,positive,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-21 23:35:49.000,691.0,692.5,651.65,656.9,29307905.0,"Covid drug: Hetero, Cipla get DCGI nod to make Remdesivir for coronavirus treatment",The product is launched under a licensing agreement with US-based Gilead Sciences to expand the access to Covid-19 treatment in low and middle-income countries.,neutral,positive,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 08:46:00.000,691.0,692.5,651.65,656.9,29307905.0,"Stocks to watch: Glenmark, Cipla, IT stocks, HDFC, Sudarshan Chemical Ind",Heres a look at the top stocks that may remain on focus today,neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 08:54:53.000,691.0,692.5,651.65,656.9,29307905.0,"Stocks in focus: Glenmark Pharma, Cipla, Reliance Capital, HDFC Bank shares to remain in news today","Market sentiments would be swayed by global cues, development around geopolitical tensions, coronavirus cases, monthly F&O expiry and foreign fund movement",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 09:07:00.000,691.0,692.5,651.65,656.9,29307905.0,"Stocks in the news: Glenmark Pharma, HDFC, HDFC Bank, Cipla, Bajaj Electricals, Cadila and Dhanlaxmi Bank","Stocks to watch today on June 22: Glenmark Pharma, HDFC, HDFC Bank, Cipla, Bajaj Electricals, Cadila and Dhanlaxmi Bank among others are the top stocks to watch out for in Monday’s trading session.",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 09:38:00.000,691.0,692.5,651.65,656.9,29307905.0,Cipla launches generic remdesivir for coronavirus patients,The USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of coronavirus patients.,neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 09:42:31.000,691.0,692.5,651.65,656.9,29307905.0,Cipla Shares End Almost 3% Higher On Regulator Nod To Manufacture Remdesivir,"India’s Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir for ""restricted emergency use"" on hospitalised COVID-19 patients, official sources said.",neutral,positive,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 10:24:00.000,691.0,692.5,651.65,656.9,29307905.0,"Stocks in the news: Glenmark Pharma, HDFC, Cipla, Info Edge, UCO Bank and Cochin Shipyard","Kirloskar Industries, Info Edge (India), NDTV, Onmobile Global, Skipper are scheduled to announce their March quarter earnings on Monday.",neutral,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 11:08:00.000,691.0,692.5,651.65,656.9,29307905.0,Cipla hits 52-wk high on launch of generic remdesivir for Covid-19 patients,Remdesivir is the only USFDA approved emergency use authorization treatment in severe (hospitalised) Covid-19 patients.,positive,neutral,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 11:49:00.000,691.0,692.5,651.65,656.9,29307905.0,Share market update: Pharma shares advance; Cipla gains 4%,The Nifty Pharma index was trading 2.4 per cent up at 10241.95.,positive,positive,-4.934876989869758,negative,-1.9436201780415463,negative
2020-06-22 12:03:00.000,674.0,674.0,655.4,660.9,8285130.0,Cipla share price hits 52-week high on DCGI’s nod to produce Remdesivir,India’s Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir for,positive,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 12:45:31.000,674.0,674.0,655.4,660.9,8285130.0,"D-Street Buzz: Pharma Stocks Rally; Glenmark Zooms 35%, Cipla, Sun Pharma, Biocon Gain","Cipla jumped over 4 percent after the country’s drug regulator on June 20 gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir while Lupin, Sun Pharma, Torrent Pharma, Biocon and Divis Labs were the other gainers.",neutral,positive,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 13:26:00.000,674.0,674.0,655.4,660.9,8285130.0,"Top stocks in focus: Glenmark, Cipla, HDFC, Yes Bank, Piramal Enterprises",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 14:05:00.000,674.0,674.0,655.4,660.9,8285130.0,Cipla launches generic remdesivir under brand name Cipremi for Covid-19 patients,"As part of a risk management plan, Cipla will provide training on the use of the drug, informed patient consent documents, conduct post-marketing surveillance as well as to conduct a Phase IV clinical trial on Indian patients.",neutral,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 14:46:39.000,674.0,674.0,655.4,660.9,8285130.0,"Glenmark, Cipla stocks surge after nod to launch drugs for COVID-19",Shares of pharma companies Glenmark and Cipla surged on Monday after both companies announced getting nod to launch drugs for mild-to-moderate COVID-19 infections.,positive,positive,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 16:00:00.000,674.0,674.0,655.4,660.9,8285130.0,Cipla soars 9% on launching generic version of Covid-19 drug remdesivir,Remdesivir is the only USFDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspected or laboratory confirmed COVID-19 infection.,neutral,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 16:02:00.000,674.0,674.0,655.4,660.9,8285130.0,"Share Market Highlights: Sensex ends 179 points higher, Nifty at 10,311; Bajaj twins, Cipla top performers","Stock Market LIVE Updates on June 19: Reliance Industries, Bajaj Finserv, Bajaj Finance, Bajaj Auto, IndusInd Bank and ICICI Bank were among the top gaines on Sensex pack. On the contrary, TCS, ONGC, M&M and Infosys were among the top laggards",positive,positive,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 17:53:00.000,674.0,674.0,655.4,660.9,8285130.0,"China-sponsored hacker groups could target Indian businesses, media, govt","According to the report, leading Indian companies such as Reliance Jio, Bharti Airtel, L&T, BSNL, ApolloTyres, Micromax and Cipla could be targeted, along with the Defence, Foreign Affairs and Information and Broadcasting ministries",neutral,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 19:16:01.000,674.0,674.0,655.4,660.9,8285130.0,"Analysts Say Glenmark, Cipla’s Covid-19 Medicines To Benefit In Short Term, But…",What analysts have to say about Glenmark and Cipla’s Covid-19 drug launch...,neutral,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-22 20:35:00.000,674.0,674.0,655.4,660.9,8285130.0,"Can’t call Remdesiver, Favipiravir game changers in Covid-19 fight: Experts","Glenmark Pharmaceuticals has launched the antiviral drug Favipiravir, while Cipla and Hetero have received approvals from the Drug Controller General of India to launch Remdesivir",neutral,positive,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-23 05:30:00.000,674.0,674.0,655.4,660.9,8285130.0,Cipla to price remdesivir version for COVID-19 under $66 - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-23 10:16:00.000,674.0,674.0,655.4,660.9,8285130.0,Coronavirus vaccine: Gilead aims remdesivir supply for 2 million patients by year-end,Indian drugmakers Hetero Labs and Cipla Ltd on Sunday gained approval to begin selling their generic versions of remdesivir in the country,positive,positive,-1.9436201780415463,negative,-4.090909090909091,negative
2020-06-23 15:49:00.000,660.0,662.25,628.3,633.0,6953730.0,"Coronavirus vaccine, drug update: Patanjali launches ‘Coronil’; Hetero, Cipla get nod to sell Remdesivir","COVID-19 vaccine latest news update: Herbal medicine company Patanjali Ayurved, on Tuesday, launched ‘Coronil’ and ‘Swasari’, its Ayurvedic medicines claiming to treat COVID-19 patients within 14 days",neutral,neutral,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 17:29:00.000,660.0,662.25,628.3,633.0,6953730.0,"Cipla to price remdesivir version for COVID-19 under 5,000 rupees","Indian pharma major Cipla Ltd and Hetero Labs gained approval to sell generic versions of remdesivir in the country. Remdesivir, intravenously administered in hospitals, is the first treatment to show improvement in COVID-19 trials.",neutral,positive,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 19:18:00.000,660.0,662.25,628.3,633.0,6953730.0,"Coronavirus treatment: Cipla to price remdesivir version under Rs 5,000","Cipla and privately held Indian drugmaker Hetero Labs on Sunday gained approval to sell generic versions of remdesivir in the country. Hetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees",neutral,positive,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 21:02:00.000,660.0,662.25,628.3,633.0,6953730.0,"Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial","Hyderbad-based drug firm Hetero on Sunday said that it will price its generic version of the drug in the range of Rs 5,000-6,000 per dose",neutral,neutral,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 21:02:36.000,660.0,662.25,628.3,633.0,6953730.0,"COVID-19 drug: Cipla to price generic version of remdesivir below Rs 5,000 per vial, to be available in 8-10 days","Hyderabad-based drug firm Hetero on Sunday said that it will price its generic version of the drug in the range of Rs 5,000-6,000 per dose.",neutral,neutral,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 21:25:00.000,660.0,662.25,628.3,633.0,6953730.0,"Cipla, Hetero receive drug controller’s emergency approval for Remdesivir for severe Covid-19 patients",Remdesivir is an experimental drug from drug maker Gilead that has shown to bring down the viral load on patients and hence help in faster discharge. The efficacy of the drug on severe patients is still under study. US drug maker Gilead has given voluntary licenses to five Indian companies to manufa…,positive,neutral,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 21:39:05.000,660.0,662.25,628.3,633.0,6953730.0,"Cipla To Price Generic Version Of COVID-19 Drug Remdesivir At Less Than Rs 5,000 Per Vial",Remdesivir is the only United States Food and Drug Administration (USFDA)-approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspected or laboratory confirmed COVID-19 infection.,neutral,neutral,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-23 22:45:26.000,660.0,662.25,628.3,633.0,6953730.0,Gilead to test inhaled version of remdesivir,"In India, the Central Drugs Standard Control Organisation on Saturday approved the manufacturing and marketing of remdesivir by Hetero and Cipla for ‘restricted emergency use’ among hospitalized covid patients",neutral,positive,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-24 09:08:00.000,660.0,662.25,628.3,633.0,6953730.0,"Sensex, Nifty snap 4-day’s winning streak; ICICI Bank top loser","The Nifty Pharma index dropped 2% with all the constituents in the red. Glenmark, Cipla, Sun Pharma and Lupin fell in the range 2-5% each.",positive,negative,-4.090909090909091,negative,0.9414556962025388,positive
2020-06-24 12:38:00.000,632.0,642.0,629.15,637.95,5813849.0,Share market update: Pharma shares dip; Cipla down over 2%,The Nifty Pharma index was trading 1.0 per cent down at 10256.8.,negative,negative,0.9414556962025388,positive,-0.6259780907668232,neutral
2020-06-24 19:12:00.000,632.0,642.0,629.15,637.95,5813849.0,"Share Market Highlights: Sensex ends 561 points lower, Nifty at 10,305; PowerGrid, Cipla, BPCL top losers","Stock Market LIVE Updates on June 24: HCL Tech, IndusInd Bank, PowerGrid and Infosys were among the laggards. On the other hand, ITC, Bajaj Auto, Bajaj Finance, NTPC and Titan were among the top gainers",neutral,positive,0.9414556962025388,positive,-0.6259780907668232,neutral
2020-06-24 19:51:08.000,632.0,642.0,629.15,637.95,5813849.0,Cipla-BDR Pharmaceuticals Eyeing Early Approval Of Favipiravir,"Both companies have given a commitment to conduct clinical trials and submit data, following approval",neutral,neutral,0.9414556962025388,positive,-0.6259780907668232,neutral
2020-06-24 20:42:00.000,632.0,642.0,629.15,637.95,5813849.0,"A pricing war? Cipla pips Hetero, fixes remdesivir under Rs 5,000",A senior government official said it is in wait-and-watch mode and has not decided to take any suo motu action on the pricing of the drug,neutral,neutral,0.9414556962025388,positive,-0.6259780907668232,neutral
2020-06-25 10:40:00.000,632.0,642.0,629.15,637.95,5813849.0,"Coronavirus drug: Hyderabad-based Hetero Labs prices Remdesivir version at Rs 5,400 per vial","Cipla and Hetero are among a bevy of drugmakers which have licensing agreements with US-based Gilead Sciences Inc, the original manufacturer of remdesivir, to make and sell the drug in 127 low- and middle-income countries",neutral,neutral,0.9414556962025388,positive,-0.6259780907668232,neutral
2020-06-25 21:09:00.000,639.0,643.65,631.6,635.0,3842189.0,India’s coronavirus drug market set for price war as firms ready launches,Sources say Cipla-BDRs favipiravir will be at least 30 per cent cheaper than Glenmarks price of Rs 103 per tablet. Cipla did not confirm.,negative,positive,-0.6259780907668232,neutral,1.098901098901099,positive
2020-06-26 08:20:00.000,639.0,643.65,631.6,635.0,3842189.0,"Remdesivir rollout to take more time as pharma firms working on providing safety, quality data","Four companies -- Hetero, Jubilant Life Sciences, Cipla and Mylan NV -- with which the original drug maker, Gilead Sciences Inc, have entered into non-exclusive licensing agreements are still awaiting nod from the DCGI for manufacturing and selling of remdesivir in India",neutral,neutral,-0.6259780907668232,neutral,1.098901098901099,positive
2020-06-29 07:35:00.000,637.0,648.0,635.4,644.0,6770533.0,Cipla and Boehringer Ingelheim join hands to co-market three oral anti-diabetic drugs,"It will also help in reducing the pill burden for patients and help improve adherence to the prescribed treatment, Cipla said in the filing.",neutral,positive,1.098901098901099,positive,-1.1189134964117602,negative
2020-06-29 12:09:00.000,647.95,649.9,638.0,640.7,4318295.0,Share market update: Pharma shares mixed; Cipla up over 1%,The Nifty Pharma index was trading 0.04 per cent up at 10142.25.,positive,positive,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-29 15:19:18.000,647.95,649.9,638.0,640.7,4318295.0,"Cipla, Boehringer Ingelheim partner on three anti-diabetic drugs","Drugmakers Cipla and Boehringer Ingelheim (India) have entered into a partnership to co-market three new oral anti-diabetic drugs in India. They are Oboravo (empagliflozin), Oboravo Met (empagliflozin",neutral,positive,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-29 15:28:52.000,647.95,649.9,638.0,640.7,4318295.0,Cipla Shares Gain 2% On Partnership With A German Firm For Anti-diabetic Drugs,The stock has rallied 72 percent in last three months as pharma sector has been in focus during COVID-19 crisis,neutral,positive,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-29 17:22:32.000,647.95,649.9,638.0,640.7,4318295.0,"Taking Stock: Lockdown Extension, Weak Global Cues Weigh On D-St; Sensex Below 35,000","Top Nifty gainers included HUL, Cipla, Britannia Industries, and HDFC Bank.",neutral,neutral,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-29 20:29:00.000,647.95,649.9,638.0,640.7,4318295.0,Cipla share price gains 2% on deal with German firm for anti-diabetic drug,Cipla share price rose up to 2.1% to Rs 648 against earlier close of Rs 634.70 on BSE,positive,positive,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-29 23:10:00.000,647.95,649.9,638.0,640.7,4318295.0,"Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient","Gilead has tied up with generic drugmakers based in India and Pakistan, including Cipla Ltd and Hetero Labs Ltd, to make and supply remdesivir in 127 developing countries. Cipla’s version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab’s version is priced at 5,400 rupees.",neutral,positive,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-30 08:52:00.000,647.95,649.9,638.0,640.7,4318295.0,"Notorious Chinese hackers attack Indian entities; Defence Ministry, Jio, Airtel, Cipla, L&T top targets","Hackers particularly targeted three central government ministries - Ministry of Foreign Affairs, Ministry of Defence, and Ministry of Information and Broadcasting",neutral,neutral,-1.1189134964117602,negative,-2.240896358543414,negative
2020-06-30 09:03:00.000,647.95,649.9,638.0,640.7,4318295.0,"Markets closed on a volatile note; Nifty holds 10,300 level","The Nifty Pharma index slipped ~1.5% as stocks like Sun Pharma, Dr Reddys, Cipla & Aurobindo Pharma trended lower along with an addition of short positions.",neutral,negative,-1.1189134964117602,negative,-2.240896358543414,negative
2020-07-01 09:08:00.000,642.6,642.6,621.05,628.2,4807946.0,"Nifty settles above 10,400-mark; Axis Bank stocks outperforms","Axis Bank surged over 6% followed by Bajaj Finserv, ITC, HDFC and UPL, which were the top gainers, while NTPC, Nestle, L&T, Shree Cement and Cipla among top losers on the Nifty50 index.",neutral,positive,-2.240896358543414,negative,3.333333333333333,positive
2020-07-01 09:23:00.000,642.6,642.6,621.05,628.2,4807946.0,Cipla and Glenmark top picks in the pharma space: Deven R Choksey,"’Fortunately with market volatility, there are good opportunities to enter at low prices",positive,positive,-2.240896358543414,negative,3.333333333333333,positive
2020-07-01 12:15:00.000,630.0,654.45,626.0,651.0,6166316.0,Share market update: Pharma shares dip; Cipla down over 2%,The Nifty Pharma index was trading 1.33 per cent down at 9852.4.,negative,negative,3.333333333333333,positive,-2.213033157209594,negative
2020-07-02 16:01:00.000,652.95,652.95,635.5,638.5,5373238.0,"Share Market Highlights: Sensex ends 429 points higher, Nifty at 10,551; M&M, Cipla, Titan top performers","Stock Market LIVE Updates on July 2: ONGC, followed by M&M, IndusInd Bank, HDFC Bank, SBI and Titan were among the top gainers in the Sensex pack. On the other hand, Tech Mahindra and HUL were the top laggards",positive,positive,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-02 17:26:00.000,652.95,652.95,635.5,638.5,5373238.0,Pharma major Mylan gets go-ahead to make remdesivir for ‘restricted emergency use’,"Written informed consent of each patient is required before the use of the drug while active post-marketing surveillance data and reporting of serious adverse events have to be submitted. On June 21, Hetero and Cipla were given permission to manufacture and market the drug on the same conditions.",neutral,neutral,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-02 18:04:38.000,652.95,652.95,635.5,638.5,5373238.0,"After Cipla and Hetero, Mylan gets govt nod to make Remdesivir for Coronavirus treatment",Pharmaceutical major Mylan has received permission from India’s drug regulator to manufacture as well as market Remdesivir- an antiviral drug used in the treatment of the novel Coronavirus.,neutral,positive,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-03 00:09:40.000,652.95,652.95,635.5,638.5,5373238.0,Spurt in IT stocks lifts markets to 4-month high,"The biggest gainers on Nifty were Mahindra and Mahindra, Hero Motocorp, Cipla, Titan, and HCL Technologies. Shares of Mahindra and Mahindra as well as Hero Motocorp rallied by 6.42% and 5.2%.",positive,positive,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-03 11:30:00.000,652.95,652.95,635.5,638.5,5373238.0,Share market update: 3 stocks hit 52-week lows on NSE,"However, Vedanta , Hindalco Inds., Cipla, IndusInd Bank and HDFC Bank were among the top losers.",negative,negative,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-03 16:08:00.000,652.95,652.95,635.5,638.5,5373238.0,"Share Market Highlights: Sensex ends 177 points higher, Nifty at 10,607; Sun Pharma, Cipla top gainers","Stock Market LIVE Updates on July 3: Bajaj Auto, followed by Asian Paints, Bharti Airtel, HUL, Reliance Industries, HUL and Kotak Bank were among the top gainers in the Sensex pack. On the contrary, Tata Steel, HDFC, M&M and Bajaj Finance were among the laggards",positive,neutral,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-03 18:37:00.000,652.95,652.95,635.5,638.5,5373238.0,"Sensex reclaims 36K mark, Nifty above 10,600; Sun Pharma, Cipla top gainers",Positive news around the development of a potential coronavirus vaccine and not so weak key economic data from US and China also kept momentum positive in equity markets worldwide.,positive,positive,-2.213033157209594,negative,-0.7890624999999929,neutral
2020-07-06 17:11:00.000,637.95,642.6,635.2,636.6,3780812.0,"Exclusive: COVID-19 drug Remdesivir in short supply, prices go up by 6x in black market","While Cipla’s drug is yet to be available in the market, Hetero’s initial supply of 20,000 vials is nearly exhausted.",neutral,neutral,-0.211615330355047,neutral,-1.4686455824073423,negative
2020-07-06 19:03:00.000,637.95,642.6,635.2,636.6,3780812.0,"Mylan gets DGCI nod, to launch generic remdesivir at Rs 4,800 per vial","Mylans version comes after two Indian drugmakers, Cipla Ltd and privately-held Hetero Labs Ltd, launched their generic versions of the drug",neutral,neutral,-0.211615330355047,neutral,-1.4686455824073423,negative
2020-07-07 05:30:00.000,637.95,642.6,635.2,636.6,3780812.0,BRIEF-India’s Sovereign Pharma Dispatches First Batch Of Remdesivir For Cipla - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.211615330355047,neutral,-1.4686455824073423,negative
2020-07-07 05:30:00.000,637.95,642.6,635.2,636.6,3780812.0,India’s Sovereign Pharma dispatches first batch of remdesivir to Cipla - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.211615330355047,neutral,-1.4686455824073423,negative
2020-07-07 06:00:00.000,637.95,642.6,635.2,636.6,3780812.0,Government to soon decide on floating tender for Remdesivir vial purchase,"In view of rising demand for Remdesivir vial, the Maharashtra Public Health Department will soon take a call on floating a tender for its procurement. Currently, Cipla and Hetero are the leading producers.Minister of Public Health Rajesh Tope told the Free Press Journal, “The department is…",neutral,neutral,-0.211615330355047,neutral,-1.4686455824073423,negative
2020-07-07 20:06:00.000,643.45,648.0,632.5,634.0,6948838.0,First batch of Cipla’s Remdesivir leaves contract manufacturer’s site in Daman,"Sovereign Pharma has the capacity to scale up production up to 95,000 vials per month",neutral,positive,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-07 20:44:00.000,643.45,648.0,632.5,634.0,6948838.0,India’s Sovereign Pharma dispatches first batch of remdesivir to Cipla,Privately held Sovereign Pharma is manufacturing and packaging Ciplas remdesivir version,neutral,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-07 22:54:00.000,643.45,648.0,632.5,634.0,6948838.0,Drug controller asks states to enforce maximum retail price for Remdesivir,"The drug controller has said that the importer of the drug (Gilead pharma) took an import licence on 1st of June and is yet to supply the drug. The other companies who have licence to supply the drug include Hetero, Cipla and Mylan.",neutral,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-08 05:30:00.000,643.45,648.0,632.5,634.0,6948838.0,"BRIEF-Cipla Says Prices Generic Remdesivir At INR 4,000 - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-08 05:30:00.000,643.45,648.0,632.5,634.0,6948838.0,BRIEF-Cipla Commercially Launches Generic Version Of Remdesivir - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-08 05:30:00.000,643.45,648.0,632.5,634.0,6948838.0,"UPDATE 1-India’s Cipla prices its generic remdesivir at $53.34 per vial, below rivals - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",negative,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-08 05:30:00.000,643.45,648.0,632.5,634.0,6948838.0,India’s Cipla set to undercut rivals with generic remdesivir -sources - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-08 10:01:00.000,643.45,648.0,632.5,634.0,6948838.0,"Stocks in news: Cipla, Maruti Suzuki, Yes Bank, Titan, Adani Ports","Stocks to watch today on July 8: Cipla, Maruti Suzuki, Yes Bank, Titan, Adani Ports among others are the top stocks to watch out for in Wednesday’s trading session.",neutral,neutral,-1.4686455824073423,negative,-0.7686932215234172,neutral
2020-07-08 13:23:00.000,643.95,643.95,636.25,639.0,4353094.0,Cipla share gains 2% on plan to launch own version of Remdesivir,"Privately held Indian firm Sovereign Pharma, that is manufacturing and packaging generic Remdesivir for Cipla said it has dispatched the first batch on Tuesday",positive,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 21:05:00.000,643.95,643.95,636.25,639.0,4353094.0,Cipla set to undercut rivals with low-priced generic remdesivir: Report,"The drug will be available through the government and hospitals only, the company said",positive,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 21:10:31.000,643.95,643.95,636.25,639.0,4353094.0,Cipla Launches Generic Version Of Remdesivir In India,The drug will be available through government and hospital channels only.,neutral,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 21:48:00.000,643.95,643.95,636.25,639.0,4353094.0,Cipla launches generic version of remdesivir in India,Cipremi has been approved by the Drug Controller General of India (DCGI) for restricted emergency use in the country as part of the accelerated approval process considering the urgent and unmet medical need.,neutral,positive,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 22:40:00.000,643.95,643.95,636.25,639.0,4353094.0,"Cipla launches generic version of remdesivir at Rs 4,000 per vial","We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials within the first month itself, Cipla Executive Vice-President and CEO (India Business) Nikhil Chopra said in an e-mailed statement.",neutral,positive,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 23:10:41.000,643.95,643.95,636.25,639.0,4353094.0,Cipla launches generic version of Remdesivir in India at lower rates,"Pharma major Cipla on Wednesday said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month. The company, however, did not disclose the price of the medicine. Ci…",neutral,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 23:16:25.000,643.95,643.95,636.25,639.0,4353094.0,Cipla’s pricing for Remdesivir among lowest,"Drugmaker Cipla Ltd. has priced its generic version of Remdesivir, Cipremi, at ₹4,000 rupees per 100 mg vial, according to several sources, making it among the lowest priced versions of the COVID-19",neutral,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-08 23:18:00.000,643.95,643.95,636.25,639.0,4353094.0,"Cipla Set to Undercut Rivals With Generic Version of Remdesivir Cipremi Priced at Rs 4,000: Report","Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option launched by European competitor Mylan this week.",neutral,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-09 07:37:00.000,643.95,643.95,636.25,639.0,4353094.0,"Coronavirus: Cipla prices generic remdesivir, Cipremi, at Rs 4,000","Coronavirus update: The first batch of 10,000 vials had been printed with a price of 4,000 rupees, 800 rupees below the cheapest option, launched by European competitor Mylan this week",neutral,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-09 07:56:00.000,643.95,643.95,636.25,639.0,4353094.0,"Stocks in the news: YES Bank, TCS, Cipla, NCC, ICICI Bank, IOC and SBI",TCS is scheduled to announce its June quarter earnings on Thursday.,neutral,neutral,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-09 08:22:52.000,643.95,643.95,636.25,639.0,4353094.0,"Indian stock markets seen higher on Thursday; TCS, Cipla, Yes Bank in focus","MSCI’s broadest index of Asia-Pacific shares outside Japan were 1.29% higher, helped by Chinese stocks, which have rallied for 7 straight days. Emerging market stocks rose 1.67%",positive,positive,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-09 08:59:42.000,643.95,643.95,636.25,639.0,4353094.0,"Stocks in focus: TCS, SBI, Yes Bank, Cipla, Sadbhav Engineering, Arvind Fashions, PI Industries","Market participants are eyeing TCS June quarter earnings along with surge in COVID-19 cases, global cures and geopolitical tensions",neutral,positive,-0.7686932215234172,neutral,-0.1718750000000035,neutral
2020-07-09 12:12:55.000,640.0,647.0,636.7,638.9,4116598.0,"Latest Coronavirus Vaccine Update: Cipla launches generic version of remdesivir at Rs 4,000 per vial","Pharma major Cipla on Wednesday said it has launched its generic version of antiviral drug Remdesivir at Rs 4,000 per vial, which is among the lowest globally, and is looking to supply over 80,000 vials within the first month.",neutral,neutral,-0.1718750000000035,neutral,-0.3900156006240249,neutral
2020-07-09 13:57:41.000,640.0,647.0,636.7,638.9,4116598.0,"Coronavirus drug: Cipla launches Cipremi’s, claims it is the cheapest Remdesivir","Cipla’s Cipremi: Claimed to be priced the lowest in the market, the product is launched under a licensing agreement with the US-based Gilead Sciences Inc.",positive,positive,-0.1718750000000035,neutral,-0.3900156006240249,neutral
2020-07-09 15:49:28.000,640.0,647.0,636.7,638.9,4116598.0,"Cipla to sell generic version of Remdesivir for ₹4,000 to Covid-19 patients","Indian multinational pharmaceutical company Cipla has developed a generic version of Remdesivir, which would be the lowest-priced Covid drug around the world, according to media reports.The US Food a",neutral,neutral,-0.1718750000000035,neutral,-0.3900156006240249,neutral
2020-07-09 15:51:00.000,640.0,647.0,636.7,638.9,4116598.0,"Cipla rises 2% as drugmaker launches remdesivir generic at Rs 4,000 per vial","Pharmaceutical major Mylan NV said its generic version of remdesivir will be priced at Rs 4,800",neutral,neutral,-0.1718750000000035,neutral,-0.3900156006240249,neutral
2020-07-10 10:34:00.000,640.0,647.0,636.7,638.9,4116598.0,"Pharma stocks gain led by Sun Pharma, Biocon; Aurobindo Pharma hits new 52-week high","Cipla, Dr Reddy’s Labs, Divis Labs and Torrent Pharma added 1-2 percent each.",positive,neutral,-0.1718750000000035,neutral,-0.3900156006240249,neutral
2020-07-12 07:00:00.000,641.0,646.0,636.6,638.5,3447723.0,"Cipla & Hetero to supply 21,500 Remdesivir vials within a week","In a big relief to the Covid-19 patients, the availability of Remdesivir will be increased in a week as Cipla and Hetero have agreed to supply 21,500 vials for Mumbai and rest of Maharashtra. Besides, Cipla and distributors will also try to import more Tocilizumab vials which currently come from …",neutral,positive,-0.3900156006240249,neutral,-1.1563403390890057,negative
2020-07-13 08:54:00.000,641.0,646.0,636.6,638.5,3447723.0,Coronavirus treatment | Cipla ramps up remdesivir capacity to meet surge in demand,Cipla also launched a dedicated 24x7 helpline and email channel to support patient access to these critical drugs exclusively during this pandemic outbreak.,positive,neutral,-0.3900156006240249,neutral,-1.1563403390890057,negative
2020-07-13 19:42:00.000,639.95,644.0,631.25,632.55,5431268.0,Coronavirus drug: Cipla ramps up production of antiviral remdesivir amid demand spurt,"Last month, Cipla introduced Remdesivir under the brand name ‘CIPREMI’ after receiving approval from DCGI for",positive,positive,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 08:16:59.000,639.95,644.0,631.25,632.55,5431268.0,"Stocks to Watch: RIL, Bharti Airtel, Biocon, Godrej Industries, Cipla","Biocon will launch biologic drug Itolizumab for the treatment of moderate to severe covid-19 patients at a price of around ₹8,000 per vial.Jio Platforms, a wholly owned subsidiary of Reliance Industries Ltd, has received subscription amount of ₹420.5 billion from five investors",neutral,neutral,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 08:45:00.000,639.95,644.0,631.25,632.55,5431268.0,"Stocks to watch: Wipro, Mindtree, Cipla, HDFC, Lakshmi Vilas Bk, Bata India",Heres a list of stocks that may remain in focus today,neutral,neutral,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 08:46:00.000,639.95,644.0,631.25,632.55,5431268.0,Cipla gets USFDA approval for Icatibant Injectable pre-Filled syringe,"Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older, Cipla said.",positive,neutral,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 09:18:00.000,639.95,644.0,631.25,632.55,5431268.0,Cipla receives USFDA nod for Firazyr generic,The drug major on Tuesday (14 July) said it received final approval for its abbreviated new drug application (ANDA) for Icatibant injectable from the United States Food and Drug Administration (USFDA).,neutral,positive,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 09:31:00.000,639.95,644.0,631.25,632.55,5431268.0,Cipla receives USFDA final approval for Icatibant Injectable 30mg/3mL,Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version of Shire’s Firazyr. Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.,positive,neutral,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 09:56:00.000,639.95,644.0,631.25,632.55,5431268.0,Cipla share price rises on USFDA nod; surges 45% in 9 months,Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version of Shire’s Firazyr.,positive,neutral,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 10:40:00.000,639.95,644.0,631.25,632.55,5431268.0,Cipla update on renegotiation for development &amp; commercialization of Pulmazole,"Discussions to renegotiate the terms of the Agreement are now in progress. Due to the delays in patient enrolment for the Phase 2a clinical study managed by Pulmatrix, the Joint Steering Committee has terminated the Phase 2a clinical study in order",neutral,negative,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 11:49:51.000,639.95,644.0,631.25,632.55,5431268.0,Cipla gets USFDA nod for rare genetic condition treatment drug,The firm received final approval for its abbreviated new drug application for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration.,neutral,positive,-1.1563403390890057,negative,0.7881462799495587,neutral
2020-07-14 13:19:00.000,634.4,643.5,633.1,639.4,4252738.0,Pharma major Cipla gets USFDA nod for rare genetic condition treatment drug - The Economic Times,"Cipla’s Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire’s Firazyr, the company said in a regulatory filing.",neutral,neutral,0.7881462799495587,neutral,5.31291507148996,positive
2020-07-14 16:09:07.000,634.4,643.5,633.1,639.4,4252738.0,Cipla gets USFDA nod for rare genetic condition treatment drug,"Cipla’s Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire’s Firazyr, the company said in a regulatory filing.",neutral,neutral,0.7881462799495587,neutral,5.31291507148996,positive
2020-07-14 16:11:04.000,634.4,643.5,633.1,639.4,4252738.0,Cipla gets USFDA nod for drug to treat rare genetic condition angioedema,"Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Icatibant Injectable, indicated for treatment of acute attacks of heredi",neutral,positive,0.7881462799495587,neutral,5.31291507148996,positive
2020-07-14 18:41:00.000,634.4,643.5,633.1,639.4,4252738.0,These 7 pharma stocks gave over 50% return since COVID-19 outbreak,"Sun Pharma, Dr Reddy’s Laboratories, Cipla, Torrent Pharmaceuticals, Lupin and Cadila Healthcare have given over 50 per cent return since January 30 when the first coronavirus case was reported",positive,neutral,0.7881462799495587,neutral,5.31291507148996,positive
2020-07-16 14:37:00.000,674.5,696.65,669.25,687.0,15233995.0,Share market update: Pharma shares advance; Cipla jumps 5% - The Economic Times,The Nifty Pharma index was trading 1.27 per cent up at 10340.1.,positive,positive,1.853224610822832,positive,-2.133526850507989,negative
2020-07-16 16:05:00.000,674.5,696.65,669.25,687.0,15233995.0,"Share Market Highlights: Sensex ends 419 points, Nifty at 10,739; Infosys, BPCL, M&M, Cipla top gainers","Stock Market Highlights on July 16: Balkrishna Industries, Britannia Industries, Granules India and ICICI General Insurance are among the top companies that will be reporting their April-June quarterly earnings",neutral,neutral,1.853224610822832,positive,-2.133526850507989,negative
2020-07-16 17:49:26.000,674.5,696.65,669.25,687.0,15233995.0,Infosys saves the day for Sensex. What analysts say on today’s market gain,"Infosys shares hit a record high, powering gains in IT stocks.Pharma shares also posted strong gains with Cipla surging over 5%",positive,positive,1.853224610822832,positive,-2.133526850507989,negative
2020-07-16 20:46:00.000,674.5,696.65,669.25,687.0,15233995.0,"Cipla allots 37,102 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,26,16,206 /- comprising of 80,63,08,103 equity shares of face value Rs.2/- each.",neutral,neutral,1.853224610822832,positive,-2.133526850507989,negative
2020-07-17 13:17:28.000,674.5,696.65,669.25,687.0,15233995.0,"Cipla Ltd spurts 2.19%, rises for third straight session","Cipla Ltd is quoting at Rs 689.3, up 2.19% on the day as on 12:54 IST on the NSE. The stock is up 26.01% in last one year as compared to a 6.76% fall in NIFTY and a 27.39% fall in the Nifty Pharma index.",positive,positive,1.853224610822832,positive,-2.133526850507989,negative
2020-07-19 07:24:00.000,689.0,690.85,672.35,674.3,5466715.0,In pics | Movers & Shakers: Top 10 stocks that moved the most this week,"Infosys, Cipla and Avenue Supermarts among 10 stocks that were in action this week",positive,neutral,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-19 18:15:00.000,689.0,690.85,672.35,674.3,5466715.0,Indiscriminate use led to bogus tocilizumab injections: FDCA,"The patented drug is manufactured only by Switzerland-based Roche Pharma and marketed in India by Cipla, he said, adding that since May, as many as 6,400 tocilizumab injections have so far been imported in Gujarat.",neutral,neutral,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 10:32:00.000,689.0,690.85,672.35,674.3,5466715.0,"Cipla, Amgen settle case involving generic drug",The drug major has reached a settlement with Amgen Inc on pending litigation involving generic cinacalcet hydrochloride tablets.,neutral,positive,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 10:34:00.000,689.0,690.85,672.35,674.3,5466715.0,"Cipla, Amgen reach settlement; stock trades lower by 1%","The resolution entitles Cipla and its affiliates to continue importing, marketing, and selling its generic cinacalcet hydrochloride tablets 30mg, 60mg and 90mg in the United States, the company added.",negative,neutral,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 11:23:37.000,689.0,690.85,672.35,674.3,5466715.0,"Cipla, Amgen settle case involving generic cinacalcet hydrochloride tablets",Shares of Cipla were trading 1.43% lower at ₹679.75 apiece on the BSE,neutral,negative,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 11:30:00.000,689.0,690.85,672.35,674.3,5466715.0,Share market update: 5 stocks hit 52-week lows on NSE,"However, Sun Pharma, Cipla, Hind. Unilever, Maruti Suzuki and Tata Steel were among the top losers.",negative,negative,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 11:52:00.000,689.0,690.85,672.35,674.3,5466715.0,"D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher","Glenmark Pharma was down over 3 percent followed by Sun Pharma, Lupin, Aurobindo Pharma, Cipla and Biocon.",positive,negative,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 12:00:00.000,689.0,690.85,672.35,674.3,5466715.0,Cipla settles case with Amgen Inc involving generic cinacalcet hydrochloride tablets,"A formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added.",neutral,neutral,-2.133526850507989,negative,-1.9375831977518152,negative
2020-07-20 13:23:00.000,676.1,682.1,660.0,663.0,4311878.0,Gladiator Stocks - Cipla: ICICI Direct,"According to ICICI Direct, Buy Cipla in the range of Rs 645.00–667.00 for target price of Rs 750.00 with a stop loss of Rs 595.00. Time Frame: Six months.",neutral,neutral,-1.9375831977518152,negative,-0.6004653606545073,neutral
2020-07-20 23:18:00.000,676.1,682.1,660.0,663.0,4311878.0,Jubilant Generics gets DCGI nod to manufacture Covid-19 drug Remdesivir,"On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions",neutral,neutral,-1.9375831977518152,negative,-0.6004653606545073,neutral
2020-07-22 07:52:07.000,666.15,677.8,657.5,662.15,5916603.0,"Stocks to Watch: HUL, Axis Bank, Bajaj Finserv, Cipla, Yes Bank, CSB Bank","Hindustan Unilever on Tuesday reported a 7.1% year-on-year jump in its June quarter net profit to ₹1,881 crore.Axis Bank reported a net profit of ₹1,112.17 crore in the June quarter of FY21, down 18.8% y-o-y, owing to higher provisions",neutral,positive,-0.6004653606545073,neutral,1.2952782589050242,positive
2020-07-22 12:11:00.000,663.95,674.0,662.2,672.55,4617985.0,Cipla amalgamates two Sri Lanka-based subsidiaries; stock trades flat,There is no change in the shareholding pattern.,neutral,neutral,1.2952782589050242,positive,-1.196136701337289,negative
2020-07-23 21:28:40.000,673.0,681.0,658.2,664.95,4958956.0,"Cipla to Launch Affordable Favipiravir Drug for Treatment of Covid-19 Patients, Says CSIR","An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of COVID-19 patients, especially in mild and moderate cases..",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-23 21:39:00.000,673.0,681.0,658.2,664.95,4958956.0,Cipla all set to launch Favipiravir drug for treatment of COVID patients: CSIR,"An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of COVID-19 patients, especially in mild and moderate cases.",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-23 21:39:18.000,673.0,681.0,658.2,664.95,4958956.0,Cipla set to launch Favipiravir drug for treatment of Covid-19 patients,"An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of Covid-19 patients, especially in mild and moderate cases",positive,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-23 22:01:51.000,673.0,681.0,658.2,664.95,4958956.0,Covid drug: Cipla all set to launch Favipiravir for treatment of coronavirus patients,"An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of COVID-19 patients, especially in mild and moderate cases.",positive,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 05:21:00.000,673.0,681.0,658.2,664.95,4958956.0,Cipla gets DCGI nod for launch of Ciplenza in India to treat mild to moderate COVID-19,"As part of its efforts to enable speedy access to cater to the demand, Cipla will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet.",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 05:30:00.000,673.0,681.0,658.2,664.95,4958956.0,Cipla gets India approval to sell COVID-19 drug favipiravir - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 07:33:00.000,673.0,681.0,658.2,664.95,4958956.0,"Stocks in the news: Asian Paints, Axis Bank, ITC, Wipro, Cipla and Zee Entertainment","Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process.",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 07:41:20.000,673.0,681.0,658.2,664.95,4958956.0,Coronavirus in India: Pharmaceutical giant Cipla set to launch Favipiravir to treat COVID-19 patients,"Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients, according to an official statement on Thursday.An off-patent anti-viral drug, Favipiravir, …",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 10:47:04.000,673.0,681.0,658.2,664.95,4958956.0,Cipla ready to launch coronavirus COVID-19 treatment drug Favipiravir: CSIR,"Mumbai-based pharmaceutical firm Cipla is ready to launch coronavirus drug Favipiravir for the treatment of COVID-19 patients, according to an official statement released by the Council of Scientific and Industrial Research (CSIR) on Thursday (July 23, 2020). The drug has been developed CSIR and in",positive,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 11:18:00.000,673.0,681.0,658.2,664.95,4958956.0,Cipla set to launch Covid antiviral drug; stock trades lower,"Favipiravir is an off-patent anti-viral drug, which was originally discovered by Fuji Pharma in Japan.",negative,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 13:53:10.000,673.0,681.0,658.2,664.95,4958956.0,Cost-effective process of Favipiravir developed by CSIR-IICT used by Cipla,"An off-patent anti-viral drug Favipiravir, originally discovered by Fuji, Japan, has shown promise in clinical trials for treatment of Covid-19 patients, especially mild and moderate patients.CSIR co",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 17:28:41.000,673.0,681.0,658.2,664.95,4958956.0,"At ₹68 per tablet, Cipla to soon launch Ciplenza for coronavirus treatment",It will be used in treatment of mild to moderate COVID-19 patients.Cipla plans to launch the drug in first week of August,neutral,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 17:57:12.000,673.0,681.0,658.2,664.95,4958956.0,Cipla Gets Nod to Sell Drug Favipiravir in India to Meet ‘Urgent’ Need for Covid-19 Treatment,"Indian drugmakers icluding Glenmark Pharmaceuticals Ltd are racing to supply generic versions of favipiravir, originally developed by Japan’s Fujifilm Holdings Corp as Avigan for treating influenza.",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 18:17:00.000,673.0,681.0,658.2,664.95,4958956.0,Cipla to launch Favipiravir drug for coronavirus treatment at Rs 68 per tablet,"Favipiravir, which is used to treat mild to moderate COVID-19 patients, will be commercially launched under the brand name Ciplenza in the first week of August, priced at Rs 68 per tablet",neutral,positive,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 19:22:00.000,673.0,681.0,658.2,664.95,4958956.0,Cipla gets DCGI approval to sell Covid-19 drug favipiravir in India,"Cipla said it would launch favipiravir as Ciplenza in the first week of August, priced at 68 Indian rupees (91 cents) per 200 mg tablet",positive,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 20:00:20.000,673.0,681.0,658.2,664.95,4958956.0,Cipla to launch favipiravir under Ciplenza in August at 68 rupees per pill,"The drug was jointly developed by Cipla and Council of Scientific and Industrial Research’s Indian Institute of Chemical Technology.Under the partnership, it has transferred the entire process to Cipla to produce and market the drug at scale",neutral,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 20:02:25.000,673.0,681.0,658.2,664.95,4958956.0,Covid drug: Cipla gets DCGI nod to launch Favipiravir for treatment of coronavirus patients,"“To ensure fair and equitable distribution of the drug, supplies will be undertaken predominantly through hospital channels and via open channels, prioritised for regions with a high burden of COVID-19 case,” Cipla said.",neutral,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 20:25:00.000,673.0,681.0,658.2,664.95,4958956.0,Coronavirus India | Cipla to soon launch COVID-19 drug Ciplenza at Rs 68 per tablet,"Favipiravir, which is known to quicken the pace of clinical recovery of COVID-19 patients, is an oral anti-viral drug under the brand name Ciplenza",neutral,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-24 23:03:00.000,673.0,681.0,658.2,664.95,4958956.0,Indian drug companies start off a price war on experimental Covid-19 drug,"Over the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddys Laboratories are expected to launch their own brands of favipiravir, despite inconclusive evidence of its effectiveness.",negative,neutral,-1.196136701337289,negative,-3.256918169003642,negative
2020-07-27 02:12:00.000,673.95,673.95,650.4,652.0,4460794.0,Cipla clarifies on news item; stock down ~2%,"The press release was a voluntary submission to the stock exchanges and contained relevant information relating to the product,” the company said.",negative,neutral,-3.256918169003642,negative,1.6897081413210446,positive
2020-07-27 07:19:00.000,673.95,673.95,650.4,652.0,4460794.0,"In pics | Stocks in the news: RIL, JSW Steel, Vodafone Idea, Escorts, BHEL, ITC, Cipla, InterGlobe Aviation","Bharti Airtel, Khadim India, Schaeffler India, Ambuja Cements, Chennai Petroleum Corporation, Usha Martin, Texmaco Rail and Kaveri Seed Company are also among the stocks in focus today.",neutral,neutral,-3.256918169003642,negative,1.6897081413210446,positive
2020-07-27 07:52:28.000,673.95,673.95,650.4,652.0,4460794.0,"Stocks to Watch: Cipla, Adani Power, ICICI Bank, HDFC Bank, Infosys","Cipla has received approval from DCGI to launch Favipiravir in the country under the brand name Ciplenza.Adani Power has received shareholders’ approval for its ₹3,264-crore delisting proposal",neutral,positive,-3.256918169003642,negative,1.6897081413210446,positive
2020-07-27 08:36:00.000,673.95,673.95,650.4,652.0,4460794.0,Cipla gets regulatory approval for launch of Ciplenza,Cipla announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.,positive,positive,-3.256918169003642,negative,1.6897081413210446,positive
2020-07-27 08:45:00.000,673.95,673.95,650.4,652.0,4460794.0,"Stocks to watch: HDFC Bank, ITC, ICICI Bank, Tech Mahindra, Escorts, Cipla",Heres a list of stocks that may remain in focus today.,neutral,neutral,-3.256918169003642,negative,1.6897081413210446,positive
2020-07-27 09:26:00.000,673.95,673.95,650.4,652.0,4460794.0,"Stocks in news: Cipla, ICICI Bank, InterGlobe Aviation, Adani Power, Infosys","Stocks to watch today on July 27: Cipla, ICICI Bank, InterGlobe Aviation, Adani Power, Infosys among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,-3.256918169003642,negative,1.6897081413210446,positive
2020-07-27 13:53:00.000,651.0,665.75,644.25,662.0,4581846.0,Avra Laboratories gets regulatory approval for Covid-19 drug Favipiravir,"The company said the drug is cheaper than alternatives and would be supplied to Cipla for the launch of Ciplenza, the generic version of Favipiravir",positive,positive,1.6897081413210446,positive,2.7014790220344063,positive
2020-07-27 16:05:00.000,651.0,665.75,644.25,662.0,4581846.0,"Coronavirus update: Hyderabad’s Avra Labs to produce Favipiravir, supply to Cipla","Avra Lab has developed an alternative low-cost and highly efficient manufacturing process and is now supplying commercial quantities to Cipla for the launch of Ciplenza, the generic version of Favipiravir",neutral,positive,1.6897081413210446,positive,2.7014790220344063,positive
2020-07-27 20:22:00.000,651.0,665.75,644.25,662.0,4581846.0,Avra Laboratories gets CDSCO nod to make Favipiravir API,"The company, in a press release, said it has developed an alternative low cost and highly efficient manufacturing process and is now supplying commercial quantities to drug maker Cipla for the launch of Ciplenza, the generic version of Favipiravir.",neutral,positive,1.6897081413210446,positive,2.7014790220344063,positive
2020-07-29 11:37:00.000,662.6,685.55,662.6,680.5,7288203.0,"TCS, Cipla, Tata Coffee among 30 stocks set to rally, signals MACD","The momentum indicator signalled bullish crossovers on these counters, hinting at possible upsides in the days ahead.",positive,positive,2.7014790220344063,positive,0.8073987081620668,neutral
2020-07-29 17:55:00.000,681.2,698.95,681.0,686.7,7169692.0,Hetero joins long list of firms to launch Covid-19 drug favipiravir,"Will sell its oral anitiviral for Rs 59 a pill, Cipla and DRL to launch soon",neutral,neutral,0.8073987081620668,neutral,4.9490538573508,positive
2020-07-29 18:02:00.000,681.2,698.95,681.0,686.7,7169692.0,Hetero latest among 10 firms to launch Favipiravir; drug priced at Rs 59 per tablet,"With this, close to 10 players -- Glenmark, Cipla and Dr Reddy’s and others -- are either in the market or soon to launch. Currently, the drug is being sold in prices ranging between Rs 39 and Rs 75 per tablet for 200mg",neutral,neutral,0.8073987081620668,neutral,4.9490538573508,positive
2020-07-30 10:53:00.000,681.2,698.95,681.0,686.7,7169692.0,"Pharma stocks gain led by Dr Reddy’s Labs, stock hits 52-week high; Cadila Health, Lupin rise","Dr Reddy’s Labs was the top gainer hitting new 52-week high followed by Divis Labs, Torrent Pharma, Lupin, Cadila Healthcare, Cipla and Aurobindo Pharma.",positive,positive,0.8073987081620668,neutral,4.9490538573508,positive
2020-07-31 10:33:00.000,687.0,724.0,687.0,721.0,18891646.0,"Sensex, Nifty witness volatility; Cipla, Infosys, HCL Tech take the lead",Buying in IT and pharma stocks continued to mellow the benchmarks.,neutral,positive,4.9490538573508,positive,-1.5745856353591128,negative
2020-08-03 05:30:00.000,724.0,734.2,701.0,712.6,12497890.0,BRIEF-Cipla India Business CEO Leaves - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.5745856353591128,negative,0.9604519774011236,positive
2020-08-03 13:16:32.000,708.0,718.9,703.2,714.8,6970371.0,Cipla Ltd up for five straight sessions,"Cipla Ltd is quoting at Rs 721.65, up 0.21% on the day as on 12:49 IST on the NSE. The stock is up 39.07% in last one year as compared to a 0.62% gain in NIFTY and a 44.45% gain in the Nifty Pharma.",positive,positive,0.9604519774011236,positive,0.3745837957824702,neutral
2020-08-03 20:50:08.000,708.0,718.9,703.2,714.8,6970371.0,"Jubilant Life arm launches covid drug remdesivir as JUBI-R at ₹4,700/vial","Jubilant is the fourth company to launch its licensed generic brand of remdesivir after Hetero Drugs, Cipla and Mylan.Gilead has given the firms the license on a royalty-free basis till an alternative drug is discovered",neutral,neutral,0.9604519774011236,positive,0.3745837957824702,neutral
2020-08-03 21:20:16.000,708.0,718.9,703.2,714.8,6970371.0,"No revamp under way, top-level exits a positive sign: Cipla","Drug-maker Cipla has seen some top management-level exits, raising questions if the company was undergoing a restructuring exercise, possibly induced by the difficult economy in the times of Covid. Th",positive,negative,0.9604519774011236,positive,0.3745837957824702,neutral
2020-08-04 01:23:00.000,708.0,718.9,703.2,714.8,6970371.0,Big shake-up: Cipla sees 3 big exits from top management of India business,Those who have left include India business head Nikhil Chopra,neutral,neutral,0.9604519774011236,positive,0.3745837957824702,neutral
2020-08-04 06:43:36.000,708.0,718.9,703.2,714.8,6970371.0,"Cipla’s India boss, two top execs resign in shake-up","The company has appointed Arunesh Verma as CEO of its North America business in December.The exits had been in the works for a few months and were due to personal reasons, two company officials said",neutral,neutral,0.9604519774011236,positive,0.3745837957824702,neutral
2020-08-04 12:58:00.000,720.8,729.95,716.0,723.5,5260757.0,Three senior executives exit Cipla’s India unit,Nikhil Chopra will be in charge of Cipla’s India business until September 2020.,neutral,neutral,0.3745837957824702,neutral,1.248361955996959,positive
2020-08-04 17:20:40.000,720.8,729.95,716.0,723.5,5260757.0,Cipla witnesses 3 senior-level exits including India business CEO,"Drug firm Cipla has witnessed three senior-level exits, including that of the company’s Executive Vice-President and CEO for India business Nikhil Chopra. The other two executives are Nikhil Lalwani,",neutral,neutral,0.3745837957824702,neutral,1.248361955996959,positive
2020-08-04 19:56:00.000,720.8,729.95,716.0,723.5,5260757.0,Cipla witnesses 3 senior-level exits including India biz CEO Nikhil Chopra,The companys rich legacy of care and strong sense of purpose rooted in a culture of meritocracy and high performance standards have made Cipla an employer of choice for several industry leaders,neutral,positive,0.3745837957824702,neutral,1.248361955996959,positive
2020-08-04 21:18:03.000,720.8,729.95,716.0,723.5,5260757.0,"CSIR-IICT, Cipla Foundation team up for distribution of masks in Telangana","The Indian Institute of Chemical Sciences (CSIR-IICT) is collaborating with the Cipla Foundation (CF) for a project on face-masks in the wake of Covid-19.The project, “Affordable, multi-layered, hydro",neutral,neutral,0.3745837957824702,neutral,1.248361955996959,positive
2020-08-04 23:43:25.000,720.8,729.95,716.0,723.5,5260757.0,Cipla witnesses 3 senior-level exits including India biz CEO,"Drug firm Cipla has witnessed three senior-level exits, including that of the company’s Executive Vice-President and CEO for India business Nikhil Chopra.",neutral,negative,0.3745837957824702,neutral,1.248361955996959,positive
2020-08-05 07:33:00.000,720.8,729.95,716.0,723.5,5260757.0,"Stocks in the news: Axis Bank, Vodafone Idea, Sun Pharma, Adani Ports, Cipla, SBI Card","Axis Bank has launched its qualified institutional placement (QIP) on Tuesday to raise up to Rs 10,000 crore.",neutral,positive,0.3745837957824702,neutral,1.248361955996959,positive
2020-08-05 15:22:00.000,724.95,739.7,720.1,734.0,9661427.0,Collaborating with government agencies to develop treatment for COVID-19: Cipla,"Besides scaling up production of medicines that show potency against the virus -- Lopinavir + Ritonavir, Hydroxychloroquine and Azithromycin, the company is also ramping up manufacturing of drugs for chronic ailments such as asthma, COPD, among others.",neutral,positive,1.248361955996959,positive,-0.7046070460704669,neutral
2020-08-05 15:35:00.000,724.95,739.7,720.1,734.0,9661427.0,Cipla working with govt agencies to develop treatment for COVID-19,"In 2001, the company developed the world’s first triple anti-retroviral drug combination, Triomune for HIV/AIDS patients and offered it at below USD 1 per day as against the then prevailing international pricing of USD 12,000-USD 15,000 per year.",neutral,positive,1.248361955996959,positive,-0.7046070460704669,neutral
2020-08-05 15:46:00.000,724.95,739.7,720.1,734.0,9661427.0,Collaborating with govt agencies to develop treatment for COVID-19: Cipla,"Sharing information with company’s shareholders in the drug firm’s annual report for 2019-20, Hamied said the company is at the forefront in the fight against COVID-19.",neutral,neutral,1.248361955996959,positive,-0.7046070460704669,neutral
2020-08-05 16:30:00.000,724.95,739.7,720.1,734.0,9661427.0,Collaborating with govt agencies to develop treatment for Covid-19: Cipla,"The company is offering drugs, which have shown potency in treating Covid-19, in partnership with its global partners",neutral,positive,1.248361955996959,positive,-0.7046070460704669,neutral
2020-08-06 14:05:46.000,738.0,739.65,724.5,732.8,6158410.0,Cipla Ltd up for third consecutive session,"Cipla Ltd is quoting at Rs 733.5, up 1.57% on the day as on 12:54 IST on the NSE. The stock is up 41.52% in last one year as compared to a 3.53% jump in NIFTY and a 44.68% jump in the Nifty Pharma index.",positive,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 02:29:00.000,738.0,739.65,724.5,732.8,6158410.0,"Sensex, Nifty trade volatile; Lupin, Biocon stocks dip","Biocon, Torrent Pharma, Sun Pharma, Aurobindo Pharma and Cipla also fell in the pharma index.",neutral,negative,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 05:30:00.000,738.0,739.65,724.5,732.8,6158410.0,BRIEF-India’s Cipla June-Qtr Consol Net Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 06:33:00.000,738.0,739.65,724.5,732.8,6158410.0,Cipla Q1FY21; consolidated profit rises by ~27% yoy,The company recorded a consolidated profit of ~Rs566cr in Q1FY21.,positive,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 07:24:00.000,738.0,739.65,724.5,732.8,6158410.0,"Top stocks in focus: M&M, Cipla, Jubilant FoodWorks, Lupin, HPCL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 07:59:00.000,738.0,739.65,724.5,732.8,6158410.0,"Stocks in the news: Mindspace REIT, Vodafone Idea, M&M, Cipla, Dalmia Bharat and HPCL","Hindustan Petroleum reported over three fold or 246.97 per cent jump in consolidated net profits at Rs 2,813.83 crore for the June quarter.",neutral,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 08:31:03.000,738.0,739.65,724.5,732.8,6158410.0,"Markets likely to be volatile; Yes Bank, M&M, Cipla in focus","Asia shares were mostly lower on Friday, even as global equity markets gained overnight .Major companies which will declare their June quarter earnings are Bata India, Mahindra & Mahindra, Cipla among others",neutral,negative,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 08:43:00.000,738.0,739.65,724.5,732.8,6158410.0,"Stocks to watch: HPCL, Voda Idea, Mindspace REIT, Lupin, M&M, Cipla, Abbott",Heres a list of stocks that may trade acively in todays trading session.,neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 08:52:00.000,738.0,739.65,724.5,732.8,6158410.0,"Board Meetings Today: Mahindra & Mahindra, Cipla, Bata India, BEML, Emami and Sobha",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges.,neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 09:08:22.000,738.0,739.65,724.5,732.8,6158410.0,"Stocks in focus: Vodafone Idea, Mindspace REIT, Yes Bank, HPCL, PNB Housing Finance, Cipla","Mahindra & Mahindra, Cipla, Siemens, Abbott India, Balrampur Chini Mills, BEML, Birla Corporation, Container Corporation of India, Mahanagar Gas, REC and Sobha, etc., are among companies scheduled to announce their quarterly earnings",neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 09:46:00.000,738.0,739.65,724.5,732.8,6158410.0,Trending stocks: Cipla shares advance nearly 1%,"A total of 46,013 shares changed hands on the counter till 09:35AM (IST).",positive,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 10:06:00.000,738.0,739.65,724.5,732.8,6158410.0,"Share Market News Live: Sensex slips 60 points, Nifty at 11,210; HDFC Bank, Infosys, HCL Tech top losers","India Stock Market News Updates Today: M&M, Cipla, Siemens, Abbott, Aditya Birla Capital, Adani Transmission, Alkem Labs, Bata among others are the top companies that will be reporting their April-June quarterly earnings",neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 12:51:00.000,738.0,739.65,724.5,732.8,6158410.0,"Cipla Q1 results preview: Profit to tank 30-50%, sharp margins fall likely","Nirmal Bang expects the company to report a 45 per cent decline in net profit at Rs 262.80 crore on a 0.8 per cent fall in net sales at Rs 3,958 crore.",negative,negative,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 14:07:00.000,738.0,739.65,724.5,732.8,6158410.0,Goa coronavirus update: State to start administering remdesivir to patients,"Goas Health Ministry received 1,008 vials of Remdesivir from pharma major Cipla",neutral,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 17:36:00.000,738.0,739.65,724.5,732.8,6158410.0,"Cipla share hits fresh 52-week high ahead of Q1 earnings, check what brokerages say","As per brokerages, the pharma company may see its profit dip in Q1 quarter. Many brokerages expect around 30-40 % fall in profit, and flat sales in US markets sequentially.",neutral,negative,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 18:45:00.000,738.0,739.65,724.5,732.8,6158410.0,Cipla Q1 results: Net profit rises 27% to Rs 566 crore; beats Street expectations,The company had reported a net profit of Rs 447.15 crore in the same quarter a year ago. An ET Now poll had expected the company to report a drop in profit to Rs 310 crore.,positive,negative,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 19:25:00.000,738.0,739.65,724.5,732.8,6158410.0,"Cipla Q1 results: Profit rises 21% to Rs 578 crore, generics segment boosts sales",Cipla on Friday reported a 21 per cent rise in consolidated profit after tax at Rs 578 crore in the April-June quarter,positive,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 19:52:40.000,738.0,739.65,724.5,732.8,6158410.0,Strong sales lift Cipla’s Q1 net profit 27 per cent to Rs 566 cr,Drug firm Cipla on Friday reported a 26.58 per cent rise in its consolidated net profit to Rs 566.04 crore for the quarter ended June on the back of robust sales.The company had posted a net profit of,neutral,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 20:26:00.000,738.0,739.65,724.5,732.8,6158410.0,Cipla Q1 pre-tax profit jumps 20% to Rs 799 crore on strong revenues,"Firms domestic business did well, up 16% YoY during the quarter when Cipla launched licensed version of Gileads remdesivir",positive,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 20:40:00.000,738.0,739.65,724.5,732.8,6158410.0,Cost optimization saves the day for Cipla: Q1 results key takeaways,"The company posted a net profit of Rs 566.04 crore in quarter ended June, an increase of 26.6 per cent from a year ago.",neutral,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 20:43:06.000,738.0,739.65,724.5,732.8,6158410.0,"Cipla posts Q1 net profit up 21% yoy on strong India, emerging markets sales","Consolidated net sales of the company were up 9% at ₹4,346 crore, with growth led by India, emerging markets, Europe and its Global Access business",positive,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 21:19:00.000,738.0,739.65,724.5,732.8,6158410.0,"Cipla Q1 profit jumps 27% YoY to Rs 566 crore, beats analysts’ expectations","The North America business fell 9 percent YoY but grew 19 percent sequentially to Rs 1,021 crore in Q1 FY21",positive,neutral,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-07 21:52:18.000,738.0,739.65,724.5,732.8,6158410.0,Cipla Q1 net profit up 27% on robust sales,Drug firm Cipla on Friday reported a 26.58 per cent rise in its consolidated net profit to Rs 566.04 crore for the quarter ended June on the back of robust sales.,positive,positive,-0.7046070460704669,neutral,4.927631578947374,positive
2020-08-09 17:30:00.000,760.0,814.5,751.35,797.45,56887603.0,"‘Quality’ stocks come at a premium, valuations have crossed pre-Covid level","The P/E for Bharti Airtel and Avenue Supermarts is currently below the pre-Covid levels. Reliance Industries, Cipla, Havells India, and Eicher Motors have seen the maximum P/E expansion",positive,negative,4.927631578947374,positive,-2.821120958681816,negative
2020-08-09 21:17:00.000,760.0,814.5,751.35,797.45,56887603.0,Accumulate Cipla; target of Rs 804: Dolat Capital,"Dolat Capital recommended accumulate rating on Cipla with a target price of Rs 804 in its research report dated August 09, 2020.",neutral,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 01:33:00.000,760.0,814.5,751.35,797.45,56887603.0,"Nifty Pharma index outperforms; Cipla, Divi’s Lab extends gain","Shares of Lupin climbed over 7%, followed by Aurobindo Pharma, Cadila, Sun Pharma and Torrent Pharma which are up in the range of 5-3%, respectively.",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 03:27:00.000,760.0,814.5,751.35,797.45,56887603.0,Markets close higher; Pharma stocks outperform,"The Nifty Pharma index closed ~5% higher as the share price of its major heavyweights like Lupin, Divis labs & Cipla surged ~10% higher.",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 05:30:00.000,760.0,814.5,751.35,797.45,56887603.0,"Nifty rise on pharma boost, Cipla hits record high - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 05:30:00.000,760.0,814.5,751.35,797.45,56887603.0,Indian shares rise as Cipla gains after solid results - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 07:03:25.000,760.0,814.5,751.35,797.45,56887603.0,"Stocks To Watch: Affle India, Bata, Cipla, Defence Stocks, IndusInd Bank, Shree Cement, Titan",Here are the stocks to watch out for in today’s session.,neutral,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 07:35:00.000,760.0,814.5,751.35,797.45,56887603.0,"Top stocks in focus: Power Grid, Shree Cement, Cipla, Titan, Divi’s Lab, Defence stocks",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 07:52:29.000,760.0,814.5,751.35,797.45,56887603.0,"Stocks to Watch: Cipla, IndusInd Bank, Eveready Industries, Abbott India",Cipla reported a 26.58% rise in its consolidated net profit to ₹566.04 crore for the quarter ended June on the back of robust sales.IndusInd Bank has acquired 7.82% stake in battery maker Eveready Industries by invoking pledged shares following loan default,neutral,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 07:59:00.000,760.0,814.5,751.35,797.45,56887603.0,"Stocks in the news: Bharat Forge, Prestige Estates, Titan, Eveready, BEL, Cipla, BoB and Divi’s Lab",Defence stocks may gain after the Ministry of Defence said it has prepared a list of 101 items for which there would be an embargo on the import.,neutral,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 08:08:00.000,760.0,814.5,751.35,797.45,56887603.0,"In pics | Stocks in the news: IndusInd Bank, Bharti Airtel, Cipla, JSW Energy, Aditya Birla Capital, Bata, Birla Corp",REC | JSW Steel | Phoenix Mills | Container Corporation of India | PSP Projects | Amara Raja Batteries | Siemens | Shipping Corporation of India | Century Textiles | Gateway Distriparks RE | Mindspace Business Parks REIT are also some of the stocks in focus today.,neutral,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 08:15:35.000,760.0,814.5,751.35,797.45,56887603.0,Prospects for US business and leadership in respiratory therapies make Cipla attractive,"Cipla’s US revenues clocked a sequential improvement to about $135 million, backed by a ramp-up in the generic version of gProventil HFA",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 08:32:23.000,760.0,814.5,751.35,797.45,56887603.0,"Stocks in focus: Airtel, Vodafone Idea, RCom, Bharat Forge, BEL, Titan, Cipla, UltraTech Cement","Bank of Baroda, Power Grid Corporation of India, Titan Company, AstraZeneca Pharma, Ujjivan Financial Services, CARE Ratings, Equitas Holdings, Force Motors, etc., are scheduled to announce their quarterly earnings today",neutral,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 08:38:00.000,760.0,814.5,751.35,797.45,56887603.0,"Cipla, Siemens, telecom stocks in spotlight","Cipla’s consolidated net profit rose 20.85% to Rs 577.91 crore on 8.46% rise in total income to Rs 4,411.61 crore in Q1 June 2020 over Q1 June 2019.",neutral,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 08:48:00.000,760.0,814.5,751.35,797.45,56887603.0,"Stocks to watch: Defence-related stocks, telcos, RIL, Cipla, Eveready, BPCL",Heres a list of stocks that may remain in focus today,neutral,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 08:56:00.000,760.0,814.5,751.35,797.45,56887603.0,Analysis: A tale of three pharma companies and a quarter,"Cipla beat expectations riding the demand for Covid medication. The Street is likely to push the stock to its record high hit in 2015. While US business revenues declined, the company’s domestic business sales grew in double-digits.",neutral,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 09:29:00.000,760.0,814.5,751.35,797.45,56887603.0,"Sensex rallies over 300 points; Cipla, L&T, HAL stocks lead","Among sectors, the pharma index has opened 2.2% higher led by gains in Cipla, followed by the Nifty Auto, financial, IT and PSU Bank index have opened with gains of over 0.5%.",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 09:30:00.000,760.0,814.5,751.35,797.45,56887603.0,"Stocks in news: Cipla, IndusInd Bank, Siemens, Punjab & Sind Bank, Concor","Stocks to watch today on August 10: Cipla, IndusInd Bank, Siemens, Punjab & Sind Bank, Concor among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 09:33:00.000,760.0,814.5,751.35,797.45,56887603.0,"Share Market News Live: Sensex up 250 points, Nifty at 11,285; Cipla, Dr Reddy, Bajaj Finance top gainers",Dalal Street today: Asian stocks were trading lower on Monday as investors kept one eye on flaring tensions between the United States and China with President Donald Trump’s move to ban WeChat and TikTok,positive,negative,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 09:43:00.000,760.0,814.5,751.35,797.45,56887603.0,"Cipla shares jump after Q1 earnings beat estimates; Citi upgrades to buy, Morgan Stanley remains overweight","Numbers surpassed analysts’ expectations on all fronts. Profit was estimated at Rs 338 crore and revenue at Rs 4,184 crore.",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 10:05:00.000,760.0,814.5,751.35,797.45,56887603.0,Cipla share price hits 52-week high after sales propel Q1 net profit,Cipla share price gained over 6% today after the firm reported a 26.58 per cent rise in its consolidated net profit in June quarter. Cipla share price rose 6.64% in early trade to fresh 52 week high of Rs 777 against earlier close of Rs 728.60 on BSE.,positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 11:19:00.000,760.0,814.5,751.35,797.45,56887603.0,Stock jumps 9%! Investors tap Cipla on D-Street on stellar Q1FY21 results,"The company’s consolidated net profit in Q1FY21 came in at Rs566.04cr which rose by 26.59%, as compared to Rs447.15cr in Q1FY20.",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 11:37:00.000,760.0,814.5,751.35,797.45,56887603.0,"D-Street Buzz: Pharma stocks rally led by Divis Labs, Cipla; Lupin, Sun Pharma gain 3% each","Lupin gained over 5 percent followed by Sun Pharma and Dr Reddy’s Labs up 3 percent each while Biocon, Cadila Healthcare and Aurobindo Pharma were the other gainers.",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 11:44:00.000,760.0,814.5,751.35,797.45,56887603.0,Cipla hits record high on strong Q1 result; Morgan Stanley sees 30% upside,"Mumbai headquartered pharma firm posted 20% growth in profit before tax for the first quarter of the current financial year to Rs 799 crore, on a 9% YoY growth in revenues to Rs 4,346 crore",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 11:54:38.000,760.0,814.5,751.35,797.45,56887603.0,Cipla gains 10% after a strong Q1 performance,"The company posted a net profit of ₹566.04 crore in quarter ended June, an increase of 26.6% from ₹447.15 crore a year ago",positive,positive,4.927631578947374,positive,-2.821120958681816,negative
2020-08-10 12:18:00.000,801.1,801.85,768.75,778.5,14860021.0,Share market update: Nifty Pharma index soars 6%; Cipla surges 10%,The Nifty Pharma index was trading 5.9 per cent up at 12001.7.,positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 12:31:00.000,801.1,801.85,768.75,778.5,14860021.0,Cipla shares rally 10% after Q1 earnings,Shares of drug firm Cipla on Monday jumped 10 per cent after the company reported a 26.58 per cent rise in its consolidated net profit for the quarter ended June.,positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 13:35:36.000,801.1,801.85,768.75,778.5,14860021.0,"Cipla shares hit new 52-week high, surge 128% since March; Morgan Stanley sees this much upside in stock","Cipla said that the company continues to closely monitor the impact of the coronavirus pandemic on all aspects of its business, including how it will impact its customers, employees, vendors and business partners",positive,neutral,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 14:44:00.000,801.1,801.85,768.75,778.5,14860021.0,"Nifty pharma index gains 6% on upbeat Q1 earnings, Cipla rises 11%","Pharma stocks powered the rally in benchmark indices today on the back of a slew of upbeat pharma earnings reports. BSE healthcare index rose 959 points intra day to 19,719 against previous close of 18,760.",positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 15:47:00.000,801.1,801.85,768.75,778.5,14860021.0,"Cipla- Solid Quarter, Outlook Reaffirmed - Investing.com India","Read Cipla- Solid Quarter, Outlook Reaffirmed by Bansi Desai on Investing.com India",neutral,neutral,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 16:34:00.000,801.1,801.85,768.75,778.5,14860021.0,Nifty Aug futures trade at premium,"Cipla, RIL and Bajaj Finance top traded stock futures in F&O segment.",neutral,neutral,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 17:09:00.000,801.1,801.85,768.75,778.5,14860021.0,"L&T, financials drive Sensex 142 points higher; Nifty above 11,250","Nifty Pharma rallied 5.46 per cent led by up to 12 per cent gains in Divis Labs, Lupin, Cipla, Aurobindo Pharma and Cadila Healthcare.",positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 17:44:00.000,801.1,801.85,768.75,778.5,14860021.0,"Sensex ends 141 points higher, Nifty at 11,270; Cipla, L&T, M&M top gainers",Shares of defence companies were rallying in Monday’s opening trade after Ministry of Defence announced over the weekend banning of 101 defence weapons and military platform items,positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 18:09:00.000,801.1,801.85,768.75,778.5,14860021.0,"Taking Stock: Profit booking at higher levels; pharma, defence stocks shine","Top Nifty gainers included Tata Motors, M&M, L&T, and Cipla.",positive,neutral,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 19:46:19.000,801.1,801.85,768.75,778.5,14860021.0,Nifty Pharma index hits 4-year high. What analysts say on today’s market action,"Divi’s Laboratories Ltd and Cipla Ltd scales record highs, closing 12.06% and 9.48% higher",positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 21:21:23.000,801.1,801.85,768.75,778.5,14860021.0,"With Cipla turning healthy post Q1 results, analysts increase target price","Brokerages give thumbs to pharma major’s cost-saving efforts, robust operating margin",positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-10 23:19:04.000,801.1,801.85,768.75,778.5,14860021.0,"Cipla delivers despite troubles, but outsized pharma rally is a concern","Cipla’s revenue growth of 9% y-o-y was on the back of all-round growth across geographies.Operating profit rose 16% on major cost savings, some of which are sustainable",negative,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 00:10:17.000,801.1,801.85,768.75,778.5,14860021.0,Cipla rating: Neutral — Opex fall led to strong beat on earnings in Q1,Ebitda margin registered a high; FY21/22e EPS up by 19/14%; ‘Neutral’ retained with revised TP of Rs 790.,positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 02:47:00.000,801.1,801.85,768.75,778.5,14860021.0,"Nifty Pharma index slips; Alkem Lab, Cipla stocks drag","The Nifty Pharma index is trading under pressure in today’s trade as selling pressure witnessed in Alkem Lab, Torrent Pharma and Cipla.",negative,negative,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 05:30:00.000,801.1,801.85,768.75,778.5,14860021.0,"India’s shortage of remdesivir is easing, says producer Cipla - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 06:27:03.000,801.1,801.85,768.75,778.5,14860021.0,Cipla shifts remdesivir production to Goa plant,Cipla CFO Kedar Upadhye says that he expects the supply gap to narrow considerably as more Indian companies launch the licensed generic version of remdesivir,neutral,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 07:33:00.000,801.1,801.85,768.75,778.5,14860021.0,Brokerages raise targets on Cipla,"Ciplas shares hit a record high of Rs 814.45 on Monday before ending at Rs 795.65, up 9.2 per cent from the previous close. Cipla reported a 26.6 per cent rise in its consolidated net profit to Rs 566 crore.",positive,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 07:57:00.000,801.1,801.85,768.75,778.5,14860021.0,"Trade Spotlight: Cipla, Divi’s Laboratories, & GMM Pfaudler in focus","More than 200 stocks on the BSE hit their fresh 52-week high that includes names like Cipla, Divi’s Laboratories, GMM Pfaudler were among the top stocks.",neutral,neutral,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 10:32:00.000,801.1,801.85,768.75,778.5,14860021.0,Share market update: 6 stocks hit 52-week lows on NSE,"However, Titan Company , Shree Cements, UPL , Cipla and Bharti Infratel were among the top losers.",negative,negative,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 11:28:00.000,801.1,801.85,768.75,778.5,14860021.0,Pharma cos getting advantage of API bandwidth: Deven R Choksey,I have been liking Cipla because of the fact that it is invested in formulation plants and is reaping its benefit.,neutral,positive,-2.821120958681816,negative,-2.056555269922879,negative
2020-08-11 14:40:00.000,778.0,778.0,755.6,762.0,7838711.0,Covid crisis has given us an opportunity to re-imagine our business: Cipla,New respiratory portfolio could sustainably grow Ciplas business and we are looking forward to that over the next two to three years.,neutral,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-11 19:12:00.000,778.0,778.0,755.6,762.0,7838711.0,Neutral Cipla; target of Rs 790: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 790 in its research report dated August 08, 2020.",neutral,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-11 20:06:05.000,778.0,778.0,755.6,762.0,7838711.0,"India’s shortage of remdesivir is easing, says producer Cipla","India’s supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID19 medicine at hospitals, according to a top executive at one of the country’s big drugmakers, Cipla Ltd.",positive,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-11 20:28:00.000,778.0,778.0,755.6,762.0,7838711.0,"India’s shortage of remdesivir is easing, Goa plant to ramp up production: Cipla","Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are authorised to make and sell generic versions in 127 developing nations.",positive,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-11 20:47:00.000,778.0,778.0,755.6,762.0,7838711.0,Covid-19 vaccine: Cipla scales up manufacturing of remdesivir to meet high demand,"Besides remdesivir, tocilizumab that Cipla markets under licensing pact with Swiss pharma company Roche is also seeing huge demand",positive,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-11 20:55:00.000,778.0,778.0,755.6,762.0,7838711.0,India’s supply of remdesivir is stabilising after shortages: Cipla,"Ciplas launch of remdesivir in late June, along with subsequent launches by others, has helped ease supply bottlenecks in India",positive,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-12 11:03:00.000,778.0,778.0,755.6,762.0,7838711.0,Was June quarter show a one-time surprise from Divi’s Lab?,"During a spectacular rally on Monday post June quarter earnings, the stock beat the likes of Cipla and Aurobindo Pharma to become the second-most valuable listed pharma company in India.",positive,positive,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-12 11:45:00.000,778.0,778.0,755.6,762.0,7838711.0,"Share Market News Live: Sensex drops 245 points, Nifty at 11,254; Cipla, Dr Reddy, Bajaj twins top losers","Dalal Street today: April-June quarterly earnings announcements by Aurobindo Pharma, Bharat Forge, Ashok Leyland, Tata Power, Cummins, Advanced Enzyme, Aster DM Healthcare, Natco Pharma will also set the tone for the stock market today",neutral,neutral,-2.056555269922879,negative,-0.7050068542333169,neutral
2020-08-12 12:15:00.000,765.95,782.9,754.1,760.55,13738043.0,"D-Street Buzz: Pharma stocks under pressure; Lupin, Biocon, Divis Labs, Cipla shed 2% each","Lupin, Cadila Healthcare, Divis Laboratories and Biocon shed over 2 percent each while Sun Pharma and Aurobindo Pharma were down a percent.",negative,neutral,-0.7050068542333169,neutral,1.5091863517060369,positive
2020-08-12 18:33:08.000,765.95,782.9,754.1,760.55,13738043.0,"Antiviral drug remdesivir shortage in India easing, says producer Cipla","Antiviral drug remdesivir has been in high demand globally, and a handful of companies including Cipla are authorised to make and sell generic versions in 127 developing nations",positive,positive,-0.7050068542333169,neutral,1.5091863517060369,positive
2020-08-13 06:03:00.000,765.95,782.9,754.1,760.55,13738043.0,Cipla tweaks management structure to mobilise second level of executives,Do these changes augur well for the future business growth plans? Analysts think so,neutral,positive,-0.7050068542333169,neutral,1.5091863517060369,positive
2020-08-13 10:20:53.000,765.95,782.9,754.1,760.55,13738043.0,"Zydus Cadila Launches Cheapest Version of Covid-19 Drug Remdesivir in India at Rs 2,800 per Vial","Officials in some Indian states had a few weeks ago complained of supply issues, but a top executive at drugmaker Cipla Ltd had earlier this week said the supplies were stabilising.",neutral,negative,-0.7050068542333169,neutral,1.5091863517060369,positive
2020-08-13 10:56:00.000,765.95,782.9,754.1,760.55,13738043.0,"Zydus Cadila launches India’s ‘cheapest’ remdesivir at Rs 2,800 per vial","Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd",neutral,neutral,-0.7050068542333169,neutral,1.5091863517060369,positive
2020-08-13 12:25:00.000,762.0,787.75,752.55,773.5,16272057.0,"Cipla allots 25,343 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,26,66,892 /- comprising of 80,63,33,446 equity shares of face value Rs.2/- each.",neutral,neutral,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-13 13:19:00.000,762.0,787.75,752.55,773.5,16272057.0,"Share Market News Live: Sensex drops 40 points, Nifty at 11,300; Kotak Bank, Dr Reddy, Cipla top losers","Dalal Street today: Overseas, Asian stocks are mostly trading higher following a surge in the US markets overnight as traders shrugged off uncertainty over a second coronavirus stimulus bill",neutral,positive,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-13 13:38:00.000,762.0,787.75,752.55,773.5,16272057.0,"Zydus Cadila’s Remdesivir at Rs 2,800 cheapest so far; triggers price war in COVID-19 treatment","Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand ‘Remdac’ will be the most econ",negative,neutral,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-13 17:10:00.000,762.0,787.75,752.55,773.5,16272057.0,"Zydus Cadila launches India’s cheapest remdesivir version at Rs 2,800 per 100 mg vial","Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd. Gilead has also entered into licensing agreements with Dr.Reddy’s Laboratories Ltd and Syngene International Ltd to make remdesivir for distribu…",positive,neutral,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-13 18:15:00.000,762.0,787.75,752.55,773.5,16272057.0,"Sensex, Nifty end lower for second straight session; pharma stocks lead losses","Kotak Bank, Cipla, Sun Pharma, Britannia and Dr Reddy’s were among the laggards today on NSE, while HCL Tech, Tech Mahindra, SBI, Eicher Motors and Tata Motors were among the top gainers.",negative,neutral,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-14 11:11:00.000,762.0,787.75,752.55,773.5,16272057.0,"Nifty Pharma index rallies nearly 3%; Lupin surges 10%, Cipla, Cadila up 3%",All the 10 constituents of the Nifty Pharma index were trading in the green.,positive,neutral,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-14 11:56:00.000,762.0,787.75,752.55,773.5,16272057.0,"D-Street Buzz: Pharma stocks gain led by Lupin; Glenmark, Cipla, Sun Pharma up 2%","S&P BSE Healthcare gained over a percent led by Bliss GVS which jumped over 4 percent followed by Glenmark Pharma, Hikal, Indoco Remedies, Marksans Pharma, Neuland Lab, Vivimed Labs and Eris Lifesciences.",positive,positive,1.5091863517060369,positive,-0.9306803594351734,negative
2020-08-20 02:16:00.000,758.35,771.75,758.35,763.25,8165794.0,Cipla and Stempeutics collaborate for launch of Stempeucel to treat Critical Limb Ischemia (CLI),It is the first allogeneic cell therapy product to be approved for commercial use in India and the first stem cell product to be approved globally for CLI treatment.,positive,neutral,0.6461396452825182,neutral,-1.0470182740456615,negative
2020-08-20 02:55:00.000,758.35,771.75,758.35,763.25,8165794.0,Cipla to sell entire stake in Anmarate Proprietary to SA-based Regipharm Medical; stock trades in green,Regipharm runs a pharmaceutical regulation consultancy in South Africa.,neutral,neutral,0.6461396452825182,neutral,-1.0470182740456615,negative
2020-08-20 04:50:00.000,758.35,771.75,758.35,763.25,8165794.0,Cipla and partner Stempeutics Research gets DGCI nod to launch Stempeucel in India,Stempeutics has been developing the product over a period of twelve years.,neutral,neutral,0.6461396452825182,neutral,-1.0470182740456615,negative
2020-08-20 05:30:00.000,758.35,771.75,758.35,763.25,8165794.0,BRIEF-Cipla And Stempeutics Collaborate For Launch Of Stempeucel - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.6461396452825182,neutral,-1.0470182740456615,negative
2020-08-20 09:31:00.000,758.35,771.75,758.35,763.25,8165794.0,"Sensex sheds 300 points dragged by metal, banking stocks","Zee, Cipla and Dr Reddy’s are trading higher while L&T, ICICI Bank, JSW Steel, Hindalco and Axis Bank led the losses.",neutral,positive,0.6461396452825182,neutral,-1.0470182740456615,negative
2020-08-21 02:03:00.000,768.85,770.6,759.05,760.8,4699912.0,Cipla subsidiaries enter in a business transfer agreement; stock trades in green,"As per the deal, QCL will sell entire human healthcare business to CQCIL for a consideration of over $1.27M.",neutral,neutral,-1.0470182740456615,negative,-1.2319790301441649,negative
2020-08-21 17:35:02.000,768.85,770.6,759.05,760.8,4699912.0,Covid-19: Three Indian companies start supply of life-saving Remdesivir to Nepal,"‘Mylan, Cipla, and Hetero Drugs will be supplying the drugs as per our demands,’ says Narayan Prasad Dhakal, the Director-General of Department of Drug Administration.Remdesivir has been proved to be efficient for patients who have been put in the Intensive Care Unit and take them out of danger zone",neutral,positive,-1.0470182740456615,negative,-1.2319790301441649,negative
2020-08-26 23:37:40.000,750.8,764.0,749.95,759.35,6983440.0,"Lupin gets USFDA nod for gProAir HFA, launch likely in September",All three brands launched authorised generics in 2019. The USFDA also approved the first generic of ProAir in February (Perrigo’s ANDA) and Proventil in April (CIPLA’s ANDA).,neutral,positive,1.1387852956846125,positive,-1.769331585845347,negative
2020-08-28 09:36:00.000,763.0,771.0,746.7,749.5,8193556.0,"Share Market News Live: Sensex rises 150 points, Nifty at 11,602; Infosys, L&T, M&M, Cipla top performers",Dalal Street today: Global equities were buoyed today as positive macroeconomic data flow and hopes of a COVID-19 vaccine boosted investor sentiment.,positive,positive,-1.769331585845347,negative,-5.804521276595741,negative
2020-08-28 16:52:28.000,763.0,771.0,746.7,749.5,8193556.0,Pandemic flags need for every nation to be self-reliant: Cipla chief,"At the company’s AGM, YK Hamied, Chairman traces its role in the battle, from HIV/AIDS to Covid-19",neutral,neutral,-1.769331585845347,negative,-5.804521276595741,negative
2020-09-15 10:59:00.000,723.0,754.0,722.65,742.1,14544745.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Cipla, Dr Reddy’s Labs; JB Chemicals jumps 10%","The top gainers included Aurobindo Pharma which gained over 4 percent followed by Cipla, Dr Reddy’s Labs, Lupin and Sun Pharma which added 3 percent each.",positive,positive,2.641770401106504,positive,1.3240137105988183,positive
2020-09-15 13:24:00.000,743.95,756.5,732.0,753.8,6759241.0,Barometers sharply pare gains; most European shares decline,"Cipla (up 3.52), Dr. Reddy (up 3.41%), Sun Pharma (up 2.67%), UPL (up 2.12%) and Grasim (up 1.82%) were the top Nifty gainers.",positive,positive,1.3240137105988183,positive,0.0199733688415415,neutral
2020-09-16 13:18:00.000,751.0,762.0,746.7,751.15,7091696.0,"Cipla allots 4,010 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to
Rs. 1,61,26,74,912 /- comprising of 80,63,37,456 equity shares of face value Rs.2/- each.",neutral,neutral,0.0199733688415415,neutral,3.0897435897435925,positive
2020-09-17 09:07:00.000,751.0,762.0,746.7,751.15,7091696.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","Sudarshan Sukhani of s2analytics.com recommends buying Cipla with a stop loss of Rs 729, target at Rs 805 and UltraTech Cement with a stop loss of Rs 3,900, target at Rs 4,060.",neutral,neutral,0.0199733688415415,neutral,3.0897435897435925,positive
2020-09-18 01:38:00.000,780.0,819.3,776.15,804.1,35437458.0,"Bulls of D-Street! Nifty Pharma spurts over 5%; Dr Reddy’s, Cipla, Lupin in the fast lane","The Nifty Pharma has surged over 5%, while the S&P BSE Healthcare also trades higher by 4%.",neutral,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 09:32:00.000,780.0,819.3,776.15,804.1,35437458.0,Bull run has just started & here’s what you should buy: Sanjiv Bhasin,"I am very bullish on Dr Reddys, Sun Pharma and the whole pack of pharma stocks including Cipla, Cadila.",neutral,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 10:08:00.000,780.0,819.3,776.15,804.1,35437458.0,"Share Market News Live: Sensex rises 120 points, Nifty at 11,566; Sun Pharma, Cipla, Dr Reddy top gainers",Dalal Street today: Equities overseas were buoyed also today after central banks globally pledged to keep interest rate near zero for prolonged period to support economy in coronavirus induced downturn,positive,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 11:22:00.000,780.0,819.3,776.15,804.1,35437458.0,"Lupin shares hit 52-week high, Cipla shares jump 6% after Perrigo recalls albuterol sulfate",Both stocks attracted traction after the Irish pharma company Perrigo voluntarily recalled albuterol sulfate inhalation aerosols over concerns that some may not dispense properly due to clogging.,positive,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 11:24:00.000,780.0,819.3,776.15,804.1,35437458.0,"Lupin, Cipla spurt after Perrigo recalls albuterol sulfate inhalation aerosols",Shares of Lupin and Cipla rose 5% to 6% after Perrigo Company plc announced a voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol over concerns that some may not dispense properly due to clogging.,positive,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 12:16:10.000,780.0,819.3,776.15,804.1,35437458.0,Natco Pharma Ltd leads gainers in ‘A’ group,"Sudarshan Chemical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd and Lupin Ltd are among the other gainers in the BSEs A group today, 18 September 2020.",positive,neutral,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 12:36:00.000,780.0,819.3,776.15,804.1,35437458.0,Stock market news: Cipla shares up soars over 7%,"A total of 953,359 shares changed hands on the counter till 12:32PM (IST).",positive,neutral,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 13:28:50.000,780.0,819.3,776.15,804.1,35437458.0,"Stocks Across Pharma, Auto and Other Sectors to Keep An Eye On","In the pharmaceutical sector, top Indian firms Cipla and Lupin can expect notable gains owing to the fresh setback to Perrigo Company.",neutral,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 14:41:00.000,780.0,819.3,776.15,804.1,35437458.0,"Lupin, Cipla to benefit from Perrigo’s recall of asthma drug albuterol sulphate MDI in the US","Cipla has already launched the gProventil in April, while Lupin’s gProAir launch is expected this month. Dublin-based Perrigo recalled the device, saying some units may fail to dispense due to clogging",positive,negative,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 15:14:00.000,780.0,819.3,776.15,804.1,35437458.0,New Covid-19 drugs provide additional fuel as Cipla fires on all cylinders,"Stronger show in US market led by gains in key respiratory product launched ahead of peers, lower R&D spends, sharp cut in expenses also help",neutral,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 15:22:00.000,780.0,819.3,776.15,804.1,35437458.0,"Cipla, Lupin may gain from Perrigo’s drug recall, says Macquarie",Perrigo announced the voluntary nationwide recall of albuterol sulfate following complaints that some units may not dispense due to clogging. A definitive timeline for reintroduction has not been determined.,positive,negative,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-18 17:57:37.000,780.0,819.3,776.15,804.1,35437458.0,"Pharma stocks today have their best day in over a month. Cipla, Dr Reddy’s surge","The Nifty Pharma index closed up 5%, led by gains in Dr Reddy’s, Cipla and Lupin",positive,positive,3.0897435897435925,positive,-5.364341085271319,negative
2020-09-21 14:03:36.000,777.05,787.95,755.15,778.0,14471592.0,Motilal Oswal: Perrigo’s Loss Can Be Lupin’s Chance To Gain Market Share Versus Cipla,Motilal Oswal: Perrigo’s Loss Can Be Lupin’s Chance To Gain Market Share Versus Cipla,neutral,neutral,0.1222572550029014,neutral,-2.302442757828952,negative
2020-09-21 18:16:00.000,777.05,787.95,755.15,778.0,14471592.0,"Innovative diabetes drug portfolio, local partnerships help Boehringer Ingelheim take big strides in India","The German drugmaker, working on its own and through tie-ups with Lupin and Cipla, has cornered half the Sodium Glucose co-Transporter-2 market with its new class of oral anti-diabetic drugs. The rapidly growing SGLT segment currently accounts for 10 percent of the total oral anti-diabetic market, w…",positive,positive,0.1222572550029014,neutral,-2.302442757828952,negative
2020-09-25 00:30:00.000,752.0,777.0,740.4,771.0,13338255.0,"Supply delays, rise in Covid-19 cases lead to Remdesivir shortage","​​In India, companies such as Cipla, Dr Reddys, Hetero, Mylan, Zydus Cadila and Jubilant have the licence to manufacture the drug. Each of these companies is estimated to manufacture 100,000 vials every month.",negative,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 05:30:00.000,752.0,777.0,740.4,771.0,13338255.0,BRIEF-Cipla Ltd Gets Final Nod For Generic Version Of Biogen IDEC Inc’s Tecfidera - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 08:24:00.000,752.0,777.0,740.4,771.0,13338255.0,"Cipla gets USFDA nod for Dimethyl Fumarate DR Capsules 120 mg, 240 mg",The product is available for shipping immediately. Cipla will be providing Co-Pay Assistance.,neutral,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 08:48:00.000,752.0,777.0,740.4,771.0,13338255.0,"Stocks to watch: IT stks, Cipla, RIL, TCS, Tata Coffee, Mahindra & Mahindra",Heres a list of stocks that may trade actively in todays session,neutral,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 09:11:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla receives USFDA final approval for Dimethyl Fumarate DR Capsules,"Cipla’s Dimethyl Fumarate DR Caps 120mg, 240mg and 120mg/240mg Starter Pak is AB-rated generic therapeutic equivalent version of Biogen IDEC Inc.’s Tecfidera. It is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to",positive,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 09:16:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla gains after USFDA approval for multiple sclerosis drug,Cipla rose 3.17% to Rs 756.05 after the drug major received US drug regulators final approval for Dimethyl Fumarate DR capsules in various strengths.,positive,positive,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 09:38:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla share price gains 4% on USFDA approval for multiple sclerosis drug,The product is available for shipping immediately and the company will provide co-pay assistance.,positive,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 10:40:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla spurts 4% as USFDA gives final ANDA approval for Dimethyl Fumarate DR capsules,The company states that the product is available for shipping immediately.,positive,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 11:15:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla gets final approval from USFDA for multiple sclerosis drug,"Drug major Cipla on Friday said it has received final approval from the US health regulator for Dimethyl Fumarate capsules, indicated for the treatment of relapsing forms of multiple sclerosis.",positive,positive,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 11:16:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla gets final nod from USFDA for multiple sclerosis drug,The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc″s Tecfidera.,neutral,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 11:23:04.000,752.0,777.0,740.4,771.0,13338255.0,Cipla gains over 2% on getting USFDA nod for multiple sclerosis drug,"Drug major Cipla on Friday said it had received final approval from the US health regulator for Dimethyl Fumarate capsules, indicated for the treatment of relapsing forms of multiple sclerosis. The ne",positive,positive,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 12:57:00.000,752.0,777.0,740.4,771.0,13338255.0,Cipla surges 5% on USFDA approval for dimethyl fumarate DR capsules,"The drug, indicated for treatment of relapsing forms of multiple sclerosis, had annual US sales of US$3.8 billion as per IQVIA MAT July 2020.",positive,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 16:37:00.000,752.0,777.0,740.4,771.0,13338255.0,Taking Stock: Sensex rallies 800 points; 4 factors that worked for bulls,"Top Nifty gainers include names like Bharti Airtel, Cipla, HCL Tech, and Bajaj Finserv.",neutral,neutral,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-25 20:36:00.000,752.0,777.0,740.4,771.0,13338255.0,"Cipla shares gain 5% after USFDA okays capsules; m-cap rises by Rs 3,021 cr","The stock jumped 5.10 per cent to close at Rs 770.20 on the BSE. During the day, it rose by 5.97 per cent to Rs 776.60.",positive,positive,2.5265957446808507,positive,0.1036135215645582,neutral
2020-09-29 15:17:00.000,762.35,794.9,761.05,775.5,14327535.0,"COVID-19: Even as domestic demand for Remdesivir outstrips supply, manufacturers are exporting the drug","One drug company executive says as per the licensing agreement with Gilead, companies will have to cater to 127 countries. Gilead has signed deals with Cipla, Dr. Reddy’s, Hetero Labs, Jubilant Life Sciences, Mylan, Syngene and Zydus Cadila.",positive,neutral,1.7249294943267497,positive,-0.5450115414208772,neutral
2020-09-30 11:34:00.000,762.35,794.9,761.05,775.5,14327535.0,"Share Market News Live: Sensex rises 50 points, Nifty at 11,240; Cipla, Nestle, HUL top gainers","Dalal Street today: Asian stocks traded mixed on Wednesday, tracking weakness from European and US markets and as investors reacted to the release of key economic data for September",positive,negative,1.7249294943267497,positive,-0.5450115414208772,neutral
2020-09-30 11:41:00.000,762.35,794.9,761.05,775.5,14327535.0,"Nifty Pharma index outperforms; Torrent Pharma, Dr Reddy’s, Cipla top gainers","On Wednesday, the Ministry of Healthcare and Family Welfare said, India continues to report a high number of recoveries. The recovered cases have exceeded the new confirmed again during the past 24 hours. With this, India’s Recovery Rate has leapt past 83% today.",positive,positive,1.7249294943267497,positive,-0.5450115414208772,neutral
2020-09-30 13:27:00.000,779.8,781.0,765.75,775.55,5846632.0,"Sensex, Nifty bounce back; Nifty crosses 11,250","Dr Reddy Labs (up 3.69%), Cipla (up 2.08%), Tata Motors (up 1.90%), Shree Cement (up 1.87%) and Asian Paints (up 1.84%) were the top Nifty gainers.",neutral,positive,-0.5450115414208772,neutral,0.7667525773195935,neutral
2020-10-01 16:15:52.000,779.8,781.0,765.75,775.55,5846632.0,3 pharma stocks set to gain 25% as cardiac remains dominant therapy in Indian pharma market,"According to the brokerage firm, Lupin, Glenmark, JB Chemicals, and Cipla are likely to gain market share among listed players.",positive,positive,-0.5450115414208772,neutral,0.7667525773195935,neutral
2020-10-06 07:43:00.000,782.0,788.0,777.0,779.1,4780415.0,"Asian Paints, RIL, Cipla and TechM among stocks likely to shine",Analysts are looking at mostly blue-chips and larger mid-cap stocks that are in a better position to advance further in the October-December period.,neutral,positive,-0.370843989769818,neutral,-0.6987179487179546,neutral
2020-10-06 09:59:00.000,782.0,788.0,777.0,779.1,4780415.0,"Buy Cipla, target price Rs 842: ICICI Securities","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 62780.29 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.370843989769818,neutral,-0.6987179487179546,neutral
2020-10-08 15:07:00.000,813.0,825.0,800.35,804.65,11646937.0,Cipla up 5% on hope of healthy Q2 performance; rallies 56% in six months,"The company is expected to report strong growth in the recently concluded quarter, driven by the portfolio of drugs it manufactures to combat Covid-19",positive,positive,-1.0270602706027088,negative,1.5714285714285687,positive
2020-10-08 19:38:00.000,813.0,825.0,800.35,804.65,11646937.0,"Sensex ends 300 points higher, Nifty at 11,834; Wipro, Cipla, TCS top performers","Most Asian equities closed higher today, tracking an overnight surge on Wall Street. US stocks rose sharply yesterday after US President Donald Trump tweeted support for aid to airlines and other stimulus measures",positive,positive,-1.0270602706027088,negative,1.5714285714285687,positive
2020-10-08 19:58:00.000,813.0,825.0,800.35,804.65,11646937.0,"Cipla scouts for remedies, vaccine collaborations to cure COVID-19 pandemic",Cipla’s research and development department is working on a couple of therapies that can be used in the treatment of COVID-19 and it could consider entering into marketing collaborations with companies that are currently developing vaccines for COVID-19,neutral,neutral,-1.0270602706027088,negative,1.5714285714285687,positive
2020-10-09 09:16:57.000,813.0,825.0,800.35,804.65,11646937.0,Cipla (₹811.4): Buy,"Investors with a short-term perspective can buy the stock of Cipla at current levels. The stock jumped 4.8 per cent accompanied by above-average volume on Thursday, decisively breaching a key resistan",neutral,positive,-1.0270602706027088,negative,1.5714285714285687,positive
2020-10-11 14:40:00.000,805.0,819.75,800.15,817.65,6606834.0,Smaller pharma firms post faster domestic sales growth in September,"Barring Cipla and Glenmark, whose sales have grown in double digits due to demand for their Covid-19 drugs like favipiravir, tocilizumab, most big players have posted tepid growth",positive,positive,1.5714285714285687,positive,-3.148148148148148,negative
2020-10-13 07:25:00.000,810.0,829.05,778.5,784.5,13920097.0,"Top stocks in focus: RIL, Infosys, Cipla, DFM Foods, UTI AMC",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 07:31:43.000,810.0,829.05,778.5,784.5,13920097.0,"Stocks To Watch: Cipla, Deepak Fertilisers, Lakshmi Vilas Bank, SRF, Rane Brake, Wipro",Here are the stocks to watch out for in today’s session.,neutral,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 08:00:00.000,810.0,829.05,778.5,784.5,13920097.0,"Companies and stocks to track today: Oct 13, 2020","Scrips likely to see action: Tata Steel Long Products, Karnataka Bank, California Software, Wipro, Cipla, SRF, Vivimed Labs",neutral,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 08:25:00.000,810.0,829.05,778.5,784.5,13920097.0,"Stocks in the news | RIL, Lakshmi Vilas Bank, Shalby, Cipla, ADF Foods, Wipro, Rane Brake","DFM Foods, Mcnally Bharat Engineering, Gujarat Craft Industries, Shakti Pumps India, Rane Brake Lining, UTI Asset Management Company, Bal Pharma, SRF, are also among the stocks in focus today.",neutral,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 08:30:00.000,810.0,829.05,778.5,784.5,13920097.0,"Infosys, Wipro, Cipla in focus","Infosys announced that it has completed the acquisition of Kaleidoscope Innovation, a full-spectrum product design, development and insights firm innovating across medical, consumer and industrial markets, bolstering capabilities in the design of",neutral,positive,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 09:02:00.000,810.0,829.05,778.5,784.5,13920097.0,"Stocks in news: RIL, Wipro, Godrej Properties, Infosys, Cipla, Lakshmi Vilas Bank","Stocks to watch today on October 13: RIL, Wipro, Godrej Properties, Infosys, Cipla, Lakshmi Vilas Bank among others are the top stocks to watch out for in Tuesday’s trading session",neutral,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 09:25:00.000,810.0,829.05,778.5,784.5,13920097.0,Cipla US arm gets complete response letter from USFDA,The drug major said that its step-down US-based subsidiary received complete response letter (CRL) from the US drug regulator for IV Trambol.,neutral,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 11:16:00.000,810.0,829.05,778.5,784.5,13920097.0,Cipla gains 2% as Avenue Therapeutics bags complete response letter from USFDA for IV tramadol,Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol.,positive,neutral,-3.148148148148148,negative,-1.0966024340770764,negative
2020-10-13 12:25:00.000,788.8,794.55,766.8,780.15,8660910.0,"Pharma stocks gain; Cipla hits record high, Lupin nears 52-week high","In the past month, Cipla and Lupin outperformed the market by gaining 12 per cent each, against 8 per cent rise in Nifty Pharma index",positive,positive,-1.0966024340770764,negative,-1.6140395823992857,negative
2020-10-13 15:46:00.000,788.8,794.55,766.8,780.15,8660910.0,"Covid medicines help Cipla, Glenmark post strong sales growth in a subdued pharma market",The recovery was led by easing of lockdown restrictions and resumption of non-Covid related treatments.,positive,positive,-1.0966024340770764,negative,-1.6140395823992857,negative
2020-10-14 02:27:00.000,788.8,794.55,766.8,780.15,8660910.0,"Nifty Pharma index underperform; Lupin, Cipla stocks drag","Lupin and Torrent Pharma dipped 2% each, Cipla fell over 1.5%, Dr Reddy’s and Divis Lab was also down nearly 1% on the pharma index.",negative,negative,-1.0966024340770764,negative,-1.6140395823992857,negative
2020-10-14 02:27:00.000,788.8,794.55,766.8,780.15,8660910.0,"Nifty Pharma index underperforms; Lupin, Cipla stocks drag","Lupin and Torrent Pharma dipped 2% each, Cipla fell over 1.5%, Dr Reddy’s and Divis Lab was also down nearly 1% on the pharma index.",neutral,negative,-1.0966024340770764,negative,-1.6140395823992857,negative
2020-10-14 08:05:12.000,788.8,794.55,766.8,780.15,8660910.0,Analyst Corner: Fair value of Rs 30 on Cipla for concerns on IV Tramadol,"Cipla as future payment is based on several conditions being met, failing which Cipla can renegotiate deal terms.",neutral,neutral,-1.0966024340770764,negative,-1.6140395823992857,negative
2020-10-14 11:49:00.000,788.8,794.55,766.8,780.15,8660910.0,Reduce Cipla; target of Rs 657: Prabhudas Lilladher,"Prabhudas Lilladher recommended Reduce rating on Cipla with a target price of Rs 657 in its research report dated October 13, 2020.",neutral,positive,-1.0966024340770764,negative,-1.6140395823992857,negative
2020-10-15 13:51:00.000,766.95,787.5,758.4,780.6,9078820.0,"Cipla allots 28,298 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,27,31,508/- comprising of 80,63,65,754 equity shares of face value Rs.2/- each.",neutral,neutral,1.7797770389203955,positive,-2.4265644955300125,negative
2020-10-16 12:22:00.000,766.95,787.5,758.4,780.6,9078820.0,"Share Market News Live: Sensex rises 200 points, Nifty at 11,745; Cipla, Tata Steel, BPCL top gainers",Dalal Street today: RBI is set to release its weekly FX reserves figures today,positive,neutral,1.7797770389203955,positive,-2.4265644955300125,negative
2020-10-16 12:49:00.000,766.95,787.5,758.4,780.6,9078820.0,"Nifty Pharma gains over 1%; Cadila, Lupin, Biocon in the fast lane","Cadila, Lupin and Biocon were among top gainers to drive the index. While Dr Reddy’s, Cipla and Aurobindo Pharma also lifted the performance.",positive,positive,1.7797770389203955,positive,-2.4265644955300125,negative
2020-10-19 01:55:00.000,783.0,784.1,762.15,764.0,4340416.0,"Pharma stocks slump; Divis lab, Cipla struggle the most",Divis Lab and Cipla are the major losers. Divis Lab is trading below 3% whilr Cipla is below 2%.,negative,negative,-2.4265644955300125,negative,-0.2287581699346405,neutral
2020-10-19 11:15:00.000,783.0,784.1,762.15,764.0,4340416.0,Stock market update: 30 stocks hit 52-week highs on NSE,"In the Nifty 50 index, ICICI Bank, Axis Bank, HDFC, ONGC and GAIL were among top gainers, while UPL , Eicher Motors, Divis Laboratories, Hero MotoCorp and Cipla were trading in red.",positive,neutral,-2.4265644955300125,negative,-0.2287581699346405,neutral
2020-10-20 03:47:00.000,765.0,774.7,756.3,763.25,6019509.0,Cipla launches Nintib to treat Idiopathic Pulmonary Fibrosis,"The generic drug Nintedanib is available as 100 mg, 150 mg capsules in bid to fight against rare lung diseases.",neutral,neutral,-0.2287581699346405,neutral,-0.4340502720912036,neutral
2020-10-20 19:33:00.000,771.8,771.8,756.5,768.45,6917535.0,Cipla launches generic Nintedanib for treatment of Idiopathic Pulmonary Fibrosis,"Cipla’s journey in IPF began in 2010 with the introduction of Pirfenex, the world’s first generic Pirfenidone and the first ever approved drug for IPF in India. Further to this, Cipla reduced the cost of its IPF therapy by 40% in 2013 to provide",neutral,positive,-0.4340502720912036,neutral,-0.7843137254901961,neutral
2020-10-21 08:33:00.000,771.8,771.8,756.5,768.45,6917535.0,"Cipla, Hindustan Zinc, Indian Energy Exchange in spotlight","Cipla announced that it has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Available as 100 mg and 150 mg capsules, it will be marketed under the brand name Nintib. This launch marks yet another milestone in",neutral,positive,-0.4340502720912036,neutral,-0.7843137254901961,neutral
2020-10-21 08:33:00.000,771.8,771.8,756.5,768.45,6917535.0,"Stocks in the news | Hindustan Zinc, Shiva Cement, Cipla, Indian Energy Exchange, HFCL, Mahindra CIE Automotive","HSIL, Likhitha Infrastructure, IRB InvIT Fund, Brigade Enterprises, Bajaj Auto, Bajaj Finance, Autoline Industries, Bombay Dyeing, Bharat Forge, L&T, Urja Global, Punjab Alkalies & Chemicals, NHPC, Arman Financial Services, are also among the stocks in focus today.",neutral,neutral,-0.4340502720912036,neutral,-0.7843137254901961,neutral
2020-10-21 08:39:00.000,771.8,771.8,756.5,768.45,6917535.0,Cipla launches Nintib to treat Idiopathic Pulmonary Fibrosis,Cipla announced that it has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF).,neutral,positive,-0.4340502720912036,neutral,-0.7843137254901961,neutral
2020-10-21 10:51:18.000,771.8,771.8,756.5,768.45,6917535.0,"From Prabhat Dairy, Cipla to Hindustan Zinc: Stocks to Watch Today",Larsen & Toubro Infotech: The board of the company has given its nod for the merger of Syncordis Software Services and Ruletronics Systems with the company.,neutral,neutral,-0.4340502720912036,neutral,-0.7843137254901961,neutral
2020-10-22 10:50:00.000,765.0,769.85,744.0,759.0,8419999.0,Nifty Pharma index slumps 2%; Aurobindo Pharma sinks 6%,"Shares of Dr Reddy is ~3% down, Cipla slipped over 2%, while Cadila, Lupin and Biocon are down over 1.5% each. On other hand, Divis Lab is slightly down on the pharma index.",negative,negative,-0.7843137254901961,neutral,-0.4466338259441678,neutral
2020-10-23 03:06:00.000,761.25,774.65,755.0,757.85,8499771.0,"Nifty Pharma trades flat as FDA nods Gilead’s remdesivir for Covid-19 treatment; Torrent Pharma, Cipla top gainers",Majority Indian listed pharma companies have the approval from Gilead to sell ‘Remdesivir’ under their respective brand name for Covid-19 treatment.,neutral,positive,-0.4466338259441678,neutral,-2.1939043615344254,negative
2020-10-23 09:28:00.000,761.25,774.65,755.0,757.85,8499771.0,"Sensex opens 200 points higher; financial, auto stocks gain","Tata Steel, Cipla, ICICI Bank, Dr Reddy’s and Infosys were the top gainers on the Nifty50 index while GAIL, Shree Cement, HUL and Bajaj Auto led the losses.",positive,positive,-0.4466338259441678,neutral,-2.1939043615344254,negative
2020-10-27 11:02:00.000,750.0,773.55,747.0,771.0,6992518.0,3 stocks to buy if the market corrects from here,"HDFC, Cipla and Bajaj Auto are some of the stocks we would be adding on dips, says Deven Choksey.",neutral,neutral,2.8000000000000003,positive,-0.7389162561576267,neutral
2020-10-28 04:37:00.000,771.4,780.0,762.15,765.7,7041454.0,Cipla launches ‘ELIFast’ for COVID-19 antibody detection,Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA Ltd.,neutral,neutral,-0.7389162561576267,neutral,-0.4633859809424446,neutral
2020-10-28 16:25:00.000,766.1,774.65,757.0,762.55,6076057.0,Cipla launches ‘ELIFast’ (IgG ELISA test) for dectection of COVID-19 antibody,"As part of this collaborative effort, Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA. ICMR has provided the requisite technological know-how and process",neutral,neutral,-0.4633859809424446,neutral,-1.2668146793783526,negative
2020-10-28 18:38:00.000,766.1,774.65,757.0,762.55,6076057.0,"Cipla gets into COVID-19 testing, with the launch of antibody test kits",The company has partnered with KARWA under the technology transfer from the Indian Council of Medical Research (ICMR).,neutral,neutral,-0.4633859809424446,neutral,-1.2668146793783526,negative
2020-10-28 19:53:00.000,766.1,774.65,757.0,762.55,6076057.0,Cipla launches ‘ELIFast’ for COVID-19 antibody detection,"Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla’s ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively",neutral,neutral,-0.4633859809424446,neutral,-1.2668146793783526,negative
2020-10-28 22:11:09.000,766.1,774.65,757.0,762.55,6076057.0,Cipla Launches Antibody Detection Kit for Covid-19 in India,ICMR has provided the requisite technological know-how and process for developing the test kits to the approved manufacturers.,neutral,neutral,-0.4633859809424446,neutral,-1.2668146793783526,negative
2020-10-29 07:25:00.000,766.1,774.65,757.0,762.55,6076057.0,"Top stocks in focus: Maruti Suzuki, BPCL, Axis Bank, Sun Pharma, Hero MotoCorp, Cipla, NTPC",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.4633859809424446,neutral,-1.2668146793783526,negative
2020-10-29 07:36:00.000,766.1,774.65,757.0,762.55,6076057.0,"Stocks in the news | Infosys, Wipro, SBI, Cipla, RBL Bank, HUDCO, Ajanta Pharma, Blue Star, PI Industries","Tata Coffee, Schaeffler India, RBL Bank, Larsen & Toubro, Axis Bank, GSK Pharma, Can Fin Homes, PNB Housing Finance, Balaji Amines, ICICI Securities, Hatsun Agro Products are also among the stocks in focus today.",neutral,neutral,-0.4633859809424446,neutral,-1.2668146793783526,negative
2020-11-04 07:49:00.000,757.8,783.8,757.2,782.9,9029130.0,"Nifty Pharma outperforms by over 2%; Sun Pharma advances 5%, Divis Lab, Cipla among gainers",Pharma stocks were in focus following corporate result announcements by major companies like Sun Pharma. Lupin will present Q2 result today.,positive,neutral,3.3122195830034338,positive,1.1513994910941416,positive
2020-11-06 05:30:00.000,797.4,802.0,786.55,788.55,7742205.0,BRIEF-Cipla Sept-Quarter Consol Net Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 07:54:00.000,797.4,802.0,786.55,788.55,7742205.0,"Market Ahead, November 6: All you need to know before the opening bell","A total of 219 companies including ITC, Cipla, Ashok Leyland, and Bank of India are scheduled to declare their quarterly earnings today",neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 07:56:35.000,797.4,802.0,786.55,788.55,7742205.0,"Stocks To Watch: Adani Power, Berger Paints, Cipla, Inox Leisure, ITC, RIL",Here are the stcks to watch in trade today.,neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 07:58:00.000,797.4,802.0,786.55,788.55,7742205.0,"MARKET LIVE: RIL, financials lead gainers as Sensex zooms 500 points","Catch all the live market updates here. ITC, CIpla, Ashok Leyland among 219 companies set to declare quarterly results today",positive,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 08:13:00.000,797.4,802.0,786.55,788.55,7742205.0,"Stocks in the news: SBI, RIL, ITC, Cipla, Vedanta, Dalmia Bharat & Glenmark",Here are key stocks that may buzz the most during the day.,neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 08:43:38.000,797.4,802.0,786.55,788.55,7742205.0,"Stocks in focus: RIL, ITC, Cipla, SBI, Adani Power, Indiabulls Housing Finance, Ashok Leyland","A total of 219 listed companies including ITC, Cipla, Ashok Leyland and Tata Consumer Products will announce their July-September quarterly earnings today.",neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 08:50:00.000,797.4,802.0,786.55,788.55,7742205.0,"Stocks to watch: Birlasoft, ITC, RIL, Cipla, Ashok Leyland, Glenmark, BHEL",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 11:13:00.000,797.4,802.0,786.55,788.55,7742205.0,Cipla Q2 results: Firm may report strong earnings on Covid-19 wave,"​Kotak Institutional Equities expects Cipla to report a 14.1 per cent rise in net profit, while net sales may have increased 6 per cent from a year ago.",positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 11:31:33.000,797.4,802.0,786.55,788.55,7742205.0,From RIL to Tata Group: A Look at the Stocks in Focus Today,"More than 200 companies, including ITC, Cipla, Ashok Leyland, and Bank of India are expected to announce quarterly earnings today.",neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 12:50:00.000,797.4,802.0,786.55,788.55,7742205.0,"Top stocks in focus: RIL, ITC, Cipla, Dalmia Bharat, Adani Green",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 16:45:00.000,797.4,802.0,786.55,788.55,7742205.0,Cipla Ltd Q2 reports 37.8% growth in net profits at Rs661.85cr,"Cipla Ltd reported 14.62% rise in the Sep-20 quarter top line sales revenues at Rs5,038.29cr.",positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 17:02:00.000,797.4,802.0,786.55,788.55,7742205.0,"Important results today: ITC, Cipla, Ashok Leyland, Vedanta, BHEL","Bharat Electronics, BEML, BHEL, Bosch, Voltas, 8K Miles Software, Aditya Birla Fashion will announce their quarterly earnings on November 6.",neutral,neutral,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 18:33:00.000,797.4,802.0,786.55,788.55,7742205.0,"Cipla Q2 Results: Consolidated net jumps 41% at Rs 665 crore, beats St estimates","Cipla’s total revenue from operations rose to Rs 5,038.29 crore, up 14.62 per cent from Rs 4,395.78 crore a year ago.",positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 19:31:00.000,797.4,802.0,786.55,788.55,7742205.0,"Cipla Q2 earnings beat street estimates; profit spikes 38% to Rs 662 crore, India sales up 17%",The European operations reported 24 percent growth on a YoY basis in USD terms led by strong performance in key DTM markets.,positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 20:13:00.000,797.4,802.0,786.55,788.55,7742205.0,"Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%",The companys prescription biz grew 14% YoY supported by continued traction in the Covid portfolio,neutral,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 20:26:42.000,797.4,802.0,786.55,788.55,7742205.0,Cipla Q2 net profit up 39 per cent at Rs 659 cr,"Pharma major Cipla on Friday reported a 38.95 per cent rise in its consolidated net profit to Rs 659.35 crore for the quarter ended September 30, 2020, mainly on account of robust sales in all markets",positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 21:31:00.000,797.4,802.0,786.55,788.55,7742205.0,"Cipla Q2 results: Profit jumps 41% to Rs 665 crore, revenue up 15%",Cipla Q2 results: India business grew by 17 per cent YoY and 33 per cent QoQ on the back of strong growth across businesses and continued servicing of patients with COVID-19 portfolio,positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 22:10:00.000,797.4,802.0,786.55,788.55,7742205.0,Q2 takeaways: Will Cipla’s earnings drive the stock further?,Its India business grew by 17 per cent YoY with strong growth across the three businesses and continued servicing of patients with Covid-19 portfolio.,positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-06 22:32:00.000,797.4,802.0,786.55,788.55,7742205.0,"Cipla expects Q2 growth momentum to continue on back of India business, albuterol sales in US","The firm’s prescription business in India grew 14 percent YoY, as COVID-related products contributed about Rs 250 crore in Q2FY21.",positive,positive,-1.1098570353649388,negative,-3.65991699157339,negative
2020-11-08 14:47:00.000,795.1,804.0,752.3,766.0,21032748.0,Looking at sustaining growth through pandemic: Pharma major Cipla,"The company is adopting digital transformation for patient and channel connect to expand access and leverage demand patterns, Cipla said.",neutral,positive,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-08 15:45:00.000,795.1,804.0,752.3,766.0,21032748.0,Looking at sustaining growth through pandemic: Cipla,Quality and compliance will be another key priority of the company for the coming quarters.,neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-08 17:22:00.000,795.1,804.0,752.3,766.0,21032748.0,Looking at sustaining growth through COVID-19 pandemic: Cipla,"In South Africa, the company plans to continue market out-performance in the private market and over-the-counter (OTC) portfolio with new launch momentum.",positive,positive,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-08 23:13:00.000,795.1,804.0,752.3,766.0,21032748.0,Cipla asks its IT team to be on alert after cyber attacks on major pharma firms,"Cipla CFO Kedar Upadhye has asked his IT team to be as paranoid as possible and take the help of experts, and continue to track some hostile activities like conversations on the dark web, and multiple other things that one can do",neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 01:13:00.000,795.1,804.0,752.3,766.0,21032748.0,"Cipla expects surge in demand for respiratory drugs, inhalers in winter",The firm enjoys a massive 68.7 per cent market share in the respiratory inhalation segment in India and has started working on aligning supplies so that there is no shortage of these critical medicine,positive,positive,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 07:45:00.000,795.1,804.0,752.3,766.0,21032748.0,"Stocks in the news: RIL, ITC, Cipla, LVB, Dilip Buildcon and IRCON International",Lakshmi Vilas Bank has reached out to the Clix Group with “all the documents” on its contingent liability related to Religare Finvest deposits.,neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 08:21:20.000,795.1,804.0,752.3,766.0,21032748.0,ICICI Direct: Cipla Q2 Review - Strong Growth Across Segments,ICICI Direct: Cipla Q2 Review - Strong Growth Across Segments,neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 08:22:00.000,795.1,804.0,752.3,766.0,21032748.0,"Stocks in the news: ITC, Biocon, SAIL, United Breweries, BHEL, Maruti, Cipla, BEL, Ashok Leyland","SAIL, Allcargo Logistics, BHEL, Tata Consumer, Maruti Suzuki, Cipla, Union Bank of India, Bharat Electronics and Ashok Leyland are some of the stocks which are in news today.",neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 08:24:00.000,795.1,804.0,752.3,766.0,21032748.0,Cipla stock faces heat on D-Street despite strong Q2 earnings,"Consolidated net profit stood at Rs665.43cr in Q2FY21 compared to Rs471.35cr a year ago same period, registering a growth of 41.18%.",positive,positive,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 08:32:00.000,795.1,804.0,752.3,766.0,21032748.0,"ITC, Cipla, Biocon in focus","ITC posted a 20% fall in standalone net profit to Rs 3232.40 crore in Q2 September 2020 from Rs 4023 crore reported in Q2 September 2019. Net sales fell 3.81% to Rs 11,098.24 crore in Q2 September 2020 over Q2 September 2019.",neutral,negative,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 09:16:52.000,795.1,804.0,752.3,766.0,21032748.0,Cipla: Covid opportunity and traction for Albuterol strong positives; accumulate,Cipla continues to be a significant pharma play during the pandemic because of its strong respiratory and a growing Covid portfolio,positive,positive,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 09:21:17.000,795.1,804.0,752.3,766.0,21032748.0,"Stocks To Watch: Cipla, Ashok Leyland & Balkrishna Industries","Stocks To Watch: Cipla, Ashok Leyland & Balkrishna Industries",neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 10:34:00.000,795.1,804.0,752.3,766.0,21032748.0,"Neutral on Cipla, target price Rs 815: Motilal Oswal","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 63571.65 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 11:53:00.000,795.1,804.0,752.3,766.0,21032748.0,Buy Cipla; target of Rs 925: ICICI Direct,"ICICI Direct is bullish on Cipla recommended buy rating on the stock with a target price of Rs 925 in its research report dated November 07, 2020.",neutral,positive,-3.65991699157339,negative,-6.241881008054034,negative
2020-11-09 12:13:00.000,769.8,769.8,706.5,721.75,22514363.0,"Analysts give a thumbs up to Cipla’s Q2 report card, see 30% upside in the stock","​Jefferies was the most optimistic as it maintained its buy rating on the stock, and raised the target price to Rs 1,024 from Rs 914 earlier.",positive,positive,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 12:50:00.000,769.8,769.8,706.5,721.75,22514363.0,"Top stocks in focus: Biocon, Dilip Buildcon, Adani Gas, NTPC, Cipla, ITC",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 13:38:00.000,769.8,769.8,706.5,721.75,22514363.0,Buy Cipla; target of Rs 942: Dolat Capital Market,"Dolat Capital Market is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 942 in its research report dated November 07, 2020.",neutral,positive,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 14:28:19.000,769.8,769.8,706.5,721.75,22514363.0,Indian Demand For COVID-19 Drug Remdesivir Rising Sharply - Cipla,"Demand for COVID19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.",neutral,positive,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 14:44:00.000,769.8,769.8,706.5,721.75,22514363.0,Indian demand for COVID-19 drug remdesivir rising sharply: Cipla,"Remdesivir was developed by U.S. drugmaker Gilead Sciences Inc, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment. Cipla is among several firms licensed to make and sell generic versions in developing nations.",positive,negative,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 14:44:08.000,769.8,769.8,706.5,721.75,22514363.0,"Demand of Covid-19 Drug Remdesivir Rising Sharply in India, Experts Divided Over Drug’s Efficacy","Remdesivir was developed by US drugmaker Gilead Sciences Inc , which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment. Cipla is among several firms licensed to make and sell generic versions in developing nations.",neutral,negative,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 14:58:00.000,769.8,769.8,706.5,721.75,22514363.0,Indian demand for COVID-19 drug Remdesivir rising sharply: Cipla,"Remdesivir was developed by US drugmaker Gilead Sciences Inc , which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment. Cipla is among several firms licensed to make and sell generic versions in developing nations.",positive,negative,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 15:07:00.000,769.8,769.8,706.5,721.75,22514363.0,"Demand for Covid-19 drug Remdesivir rising sharply in India, says Cipla","Ciplas version, Cipremi, was commercially launched in July and costs just above $50 per 100 mg vial",positive,neutral,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 17:15:00.000,769.8,769.8,706.5,721.75,22514363.0,"Cipla allots 80,347 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to
Rs. 1,61,28,92,202/- comprising of 80,64,46,101 equity shares of face value Rs.2/- each.",neutral,neutral,-6.241881008054034,negative,1.994497936726272,positive
2020-11-09 18:25:00.000,769.8,769.8,706.5,721.75,22514363.0,Nifty Pharma in a volatile session; Divis Lab zooms 4% post Q2 result,Cipla is the biggest loser so far. The stock has slumped despite reporting higher consolidated profit at Rs661.8cr. in Q2FY21 results.,negative,negative,-6.241881008054034,negative,1.994497936726272,positive
2020-11-10 08:22:00.000,769.8,769.8,706.5,721.75,22514363.0,"Nifty Pharma index nosedives by 4% despite Covid-19 vaccine hopes rise; Cipla, Cadila, Lupin stocks tumble 6% each",Drugmaker Pfizer achieved success in the first interim analysis from the Phase 3 study.,negative,positive,-6.241881008054034,negative,1.994497936726272,positive
2020-11-10 09:18:09.000,769.8,769.8,706.5,721.75,22514363.0,‘Buy’ on Cipla; firm likely to beat its cost-saving targets,Covid products now account of 5% of India sales and company also saw a healthy uptick in trade generics.,positive,positive,-6.241881008054034,negative,1.994497936726272,positive
2020-11-10 13:22:00.000,727.0,745.5,718.6,741.5,18873370.0,Stock market update: Nifty Pharma index dips nearly 4%; Cipla sheds 6%,The index was trading 3.63 per cent down at 11250.15.,neutral,negative,1.994497936726272,positive,-0.1885775862068935,neutral
2020-11-10 16:36:00.000,727.0,745.5,718.6,741.5,18873370.0,Taking Stock | Market closes at record high for 2nd straight day on COVID vaccine hopes,"Bajaj Finance, IndusInd Bank, L&T, Bajaj Finserv and HDFC were among the top gainers on the Nifty while losers were Cipla, Tech Mahindra, HCL Tech, Divis Labs and Nestle.",positive,positive,1.994497936726272,positive,-0.1885775862068935,neutral
2020-11-11 12:21:00.000,742.4,758.85,733.5,741.0,10407820.0,"ITC, Cipla and Dabur among 10 stocks that brokerages are betting on","Sonata Software, Bharti Airtel, Siyaram Silk Mills are also on the list of stocks that could give 10-33 percent return",neutral,neutral,-0.1885775862068935,neutral,0.404040404040404,neutral
2020-11-12 16:01:00.000,742.5,751.0,740.15,745.5,6937741.0,Hold Cipla; target of Rs 836: Prabhudas Lilladher,"Prabhudas Lilladher recommended Hold rating on Cipla with a target price of Rs 836 in its research report dated November 09, 2020.",neutral,positive,0.404040404040404,neutral,-0.4936624416277579,neutral
2020-11-13 08:08:00.000,742.5,751.0,740.15,745.5,6937741.0,"Adani Green Energy, Laurus Labs among top value creators in Samvat 2076","Meanwhile, Dr Reddys Laboratories, Cipla, Infosys, HCL Technologies were up between 25 per cent and 75 per cent.",neutral,positive,0.404040404040404,neutral,-0.4936624416277579,neutral
2020-11-17 21:51:00.000,747.3,752.0,733.5,744.8,7172873.0,"Pharma grows 9.8% in October; Glenmark, Cipla, 4 others post double-digit jump","“The strong growth for Glenmark, Cipla and Cadila can be attributed to COVID-19-related products such as favipiravir, remdesivir and tocilizumab,” said a Nomura report",positive,positive,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 08:56:00.000,747.3,752.0,733.5,744.8,7172873.0,Covid spike fails to spook India Inc as operations with limited workforce continue,"Some companies like Coca-Cola India, PepsiCo, Dabur, Maruti, Cipla, Whirlpool and MakeMyTrip have opened some of their offices, plants and labs. None of these firms are planning to down the shutters even temporarily.",negative,neutral,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 09:17:00.000,747.3,752.0,733.5,744.8,7172873.0,Cipla climbs on launching COVID-19 antibody detection kit,"Cipla gained 1.23% to Rs 751.6 after the drug major announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across most Emerging markets and Europe.",positive,positive,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 09:53:47.000,747.3,752.0,733.5,744.8,7172873.0,Covid-19: Cipla in pact with Belgium firm to bring in rapid antibody test kit,Drugmaker Cipla has signed a licensing agreement with Belgium-based firm Multi G for the distribution of its Covid-19 rapid antibody test kit across emerging markets and Europe. This licencing agreem,positive,positive,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 10:04:31.000,747.3,752.0,733.5,744.8,7172873.0,Cipla launches Covi-G,For antibody detection,neutral,neutral,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 10:43:00.000,747.3,752.0,733.5,744.8,7172873.0,Cipla inks licensing deal with Belgium’s MultiG for distribution of COVID-19 antibody test kit,"As part of this agreement, Cipla will be responsible for distribution of the COVID-19 rapid antibody kit that will be manufactured by MultiG the company added.",positive,positive,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 11:50:00.000,747.3,752.0,733.5,744.8,7172873.0,Cipla enters pact with Belgium-based Multi-G to distribute 10-minute COVID-19 antibody test kit,"Cipla will be selling the RAT kits under brand name Covi-G, which will detect both IgM and IgG antibodies, using a single-prick blood test. The kit gives results within 10 minutes.",positive,neutral,-0.3345376689415228,neutral,-0.0740690862568116,neutral
2020-11-18 12:38:00.000,742.55,751.9,737.95,742.0,5788365.0,Cipla launches rapid antibody test kit ‘Covi-G’ for COVID-19 detection,"Cipla will sell these kits across 25 markets in Asia, Middle-East and North Africa, Latin America, EU and Australia",neutral,neutral,-0.0740690862568116,neutral,-0.215633423180596,neutral
2020-11-18 15:05:00.000,742.55,751.9,737.95,742.0,5788365.0,Cipla launches ‘Covi-G’ for Covid-19 rapid antibody detection; stock in green,Cipla signed a licensing agreement with MultiG for COVID-19 rapid antibody test kit.,neutral,positive,-0.0740690862568116,neutral,-0.215633423180596,neutral
2020-11-19 03:19:00.000,742.55,751.9,737.95,742.0,5788365.0,"Cipla, MultiG ink deal to supply antibody test kit","Drug major Cipla on Wednesday said it had signed a licensing agreement with Belgium-based MultiG for distribution of their COVID-19 rapid antibody test kit, Covi-G, across most emerging markets and Eu",positive,positive,-0.0740690862568116,neutral,-0.215633423180596,neutral
2020-11-26 10:37:00.000,734.0,741.0,726.5,740.75,6075068.0,"Buy Cipla, target price Rs 910: Edelweiss","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 58995.68 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.9196185286103544,positive,-0.2631578947368482,neutral
2020-11-26 14:34:00.000,741.0,749.0,735.0,739.05,12761402.0,Over 20 stocks saw FY22E earnings upgrades in 3 out of past 4 quarters; worth a look?,"Among stocks, which saw consistent upward FY22 earnings revision (three out of the past four quarters) were Dr. Reddy’s, Aurobindo Pharma, Cipla, Tata Motors, and TATA Steel, Elara Capital highlighted in the report.",positive,positive,-0.2631578947368482,neutral,0.4648074369189907,neutral
2020-12-01 20:30:39.000,758.0,761.0,751.15,757.5,3976595.0,Cambridge University names chemistry department after Cipla’s Yusuf Hamied,Dr Hamied is a former alumnus of the world-renowned university and made a “transformational gift” to his alma mater to ensure that chemistry at Cambridge University will continue to be “world-leading in both teaching and research”.,neutral,neutral,-0.0659630606860158,neutral,0.2631578947368421,neutral
2020-12-03 06:41:00.000,760.0,764.8,756.05,762.0,3754811.0,Broker’s call: Cipla (Long),"CapitalVia GlobalCipla (Long)Target: ₹818.00CMP: ₹758.35Cipla focuses on novel formulations for production and has a wide variety of pharmaceutical products. They sell prescription medications, bulk d",neutral,neutral,0.2631578947368421,neutral,0.4783748361729983,neutral
2020-12-03 13:16:48.000,763.0,770.6,757.0,766.65,5415847.0,Cipla Ltd up for fifth session,"Cipla Ltd is quoting at Rs 760.7, up 0.31% on the day as on 12:44 IST on the NSE. The stock is up 61.85% in last one year as compared to a 9.14% spurt in NIFTY and a 49.76% spurt in the Nifty Pharma.",neutral,positive,0.4783748361729983,neutral,0.7627615881087305,neutral
2020-12-07 18:25:00.000,777.0,779.45,757.8,766.7,4161142.0,"Nifty Pharma rallies by 2% as Covid-19 vaccine progress lifts mood; Sun Pharma, Dr Reddys top gainers","Lupin also advanced 2.49% higher. Biocon (up 1.77%, Auro Pharma (up 1.40%) and Cipla (up 1.02%) also stayed 1% higher.",positive,positive,-1.3256113256113198,negative,-0.9027146382647008,negative
2020-12-07 18:36:08.000,777.0,779.45,757.8,766.7,4161142.0,Cambridge chemistry dept to be renamed after Yusuf Hamied: All you need to know about Indian scientist and Cipla chairman,The University of Cambridge has announced that it’s Chemistry Department will be named after Indian scientist and Cipla non-executive chairman Yusuf Hamied until 2050. Recognizing the former Cambridge alumus’ “generous benefaction” the Chemistry department has been named as the Yusuf Hamied Depar…,neutral,neutral,-1.3256113256113198,negative,-0.9027146382647008,negative
2020-12-07 19:41:00.000,777.0,779.45,757.8,766.7,4161142.0,Chronic portfolio may help Cipla sustain growth outperformance in near term,Margin gains in the September quarter too are expected to continue,positive,positive,-1.3256113256113198,negative,-0.9027146382647008,negative
2020-12-11 05:30:00.000,764.0,766.1,753.0,756.2,3171839.0,BRIEF-Bristol Myers Squibb Announces Settlement Of U.S. Patent Litigation For Revlimid (Lenalidomide) With Cipla - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.0209424083769574,negative,1.104972375690611,positive
2020-12-11 11:44:00.000,764.0,766.1,753.0,756.2,3171839.0,"ACC, Cipla: 66 stocks from Nifty 500 index are showing weakness on charts",Few pharma stocks are expected to weaken at higher levels.,negative,positive,-1.0209424083769574,negative,1.104972375690611,positive
2020-12-11 19:46:00.000,764.0,766.1,753.0,756.2,3171839.0,Cipla settles blood cancer drug litigation with Bristol Myers in US,"As it takes away the legal overhang, Cipla can launch the drug once its ANDA is approved",neutral,neutral,-1.0209424083769574,negative,1.104972375690611,positive
2020-12-11 20:33:19.000,764.0,766.1,753.0,756.2,3171839.0,"IIM Ahmedabad Completes Summer Placements, 131 Firms Take Part","There were 33 new recruiters this year, including Atlassian, Bayer, BPCL, Cipla, DuPont, Everest Instruments, Godrej Fund Management, Phillips, Purplle.com Oracle, Reserve Bank of India, Unacademy and Walmart Global Tech.",neutral,neutral,-1.0209424083769574,negative,1.104972375690611,positive
2020-12-14 07:45:40.000,778.3,793.3,776.35,786.9,19705805.0,"Stocks In The News | Cipla, JSPL, JSW Steel, Hero Moto, KEC International, Power Grid, Muthoot Finance","Panacea Biotec, Snowman Logistics, KEC International, Power Grid and Muthoot Finance are some of the stocks which are in news today.",neutral,neutral,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 08:47:00.000,778.3,793.3,776.35,786.9,19705805.0,"Stocks to watch: Cipla, eClerx, KEC International, Burger King India, JSPL",Heres a list of stocks that may remain in focus today.,neutral,neutral,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 09:04:00.000,778.3,793.3,776.35,786.9,19705805.0,"Top stocks in focus: JSW Steel, Cipla & more","Here are the top stocks that are likely to be in focus in today’s trading. JSW Steel, Cipla, ICICI Pru, BEL",neutral,neutral,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 09:39:17.000,778.3,793.3,776.35,786.9,19705805.0,Cipla Share Price Jumps 5% After Settlement With Celgene Corp,Nomura has maintained buy rating with a target at Rs 861 per share.,neutral,positive,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 10:21:00.000,778.3,793.3,776.35,786.9,19705805.0,Cipla rallies 5% after settling litigation with Bristol Myers in US,"Bristol Myers (Celgene) will provide Cipla with a license to sell generic volume-limited amounts of gRevlimid capsules in the US sometime after March 2022, subject to regulatory approval",positive,positive,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 10:30:00.000,778.3,793.3,776.35,786.9,19705805.0,"Sensex rises 200 points to fresh highs on stimulus, Brexit hopes","In the 50-share pack Nifty, Cipla was the biggest gainer, up 3.84 per cent.",positive,positive,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 10:33:36.000,778.3,793.3,776.35,786.9,19705805.0,"From Cipla to Eveready Industries, Here Are the Stocks in Focus Today",Cipla: Pharma major Cipla on Friday said that it had settled its patent litigation with Celgene Corporation relating to patents for Revlimid (lenalidomide).,neutral,positive,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 10:53:00.000,778.3,793.3,776.35,786.9,19705805.0,"Stocks in news: Power Grid, Burger King, YES Bank, Muthoot Finance, Jindal Steel, Cipla, L&T Tech","Stocks to watch today on December 14: Power Grid, YES Bank, Muthoot Finance, Jindal Steel, Cipla, L&T Tec among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 11:36:22.000,778.3,793.3,776.35,786.9,19705805.0,Prabhudas Lilladher: Cipla’s Revlimid Settlement With BMS - A Positive Surprise,Prabhudas Lilladher: Cipla’s Revlimid Settlement With BMS - A Positive Surprise,neutral,neutral,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 11:48:00.000,778.3,793.3,776.35,786.9,19705805.0,Cipla spurts on settling litigation with Celgene Corp for cancer drug Revlimid,Cipla rose 3.70% to Rs 783.85 after the drug major announced the settlement of its litigation with Celgene Corporation relating to patents for Revlimid (lenalidomide).,neutral,positive,1.104972375690611,positive,-1.0515646775623917,negative
2020-12-14 13:00:00.000,789.3,798.0,779.25,781.0,8224535.0,"Top stocks in focus: Hero MotoCorp, Cipla, Yes Bank, KEC International, JSPL, Muthoot Finance",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-14 13:37:03.000,789.3,798.0,779.25,781.0,8224535.0,Buy Cipla; Target Of Rs 887: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 887 in its research report dated December 14, 2020.",neutral,positive,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-14 13:39:57.000,789.3,798.0,779.25,781.0,8224535.0,Buy Cipla; Target Of Rs 940: HDFC Securities,"HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated December 14, 2020.",neutral,positive,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-14 13:41:00.000,789.3,798.0,779.25,781.0,8224535.0,Cipla shares gain nearly 4% in afternoon trade,"A total of 651,963 shares changed hands on the counter till 01:38PM (IST).",positive,neutral,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-14 15:06:00.000,789.3,798.0,779.25,781.0,8224535.0,Cipla surges ~5% in early trade after settling litigation with Celgene Corporation,"As part of the settlement, the Parties will file Consent Judgments in New Jersey that enjoin Cipla from marketing generic lenalidomide before the expiration of the patents-in-suit.",positive,neutral,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-14 17:48:00.000,789.3,798.0,779.25,781.0,8224535.0,Cipla share rises 5% after settlement with Celgene Corp,"Cipla share rises 5% ,settlement with Celgene Corp,Cipla share price, Celgene Corporation,United States,Arunesh Verma, CEO, Cipla North America, Cipla share",positive,neutral,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-15 00:20:31.000,789.3,798.0,779.25,781.0,8224535.0,"‘Neutral’ on Cipla, co well-placed to deliver 24% earnings CAGR","Considering other settlements, limited build-up of sales over FY23-26E, and unlimited quantities of g-Revlimid by Cipla post Jan-26E, there could be a potential NPV addition of `40 per share from this opportunity. We await clarity on further details of the agreement.",positive,positive,-1.0515646775623917,negative,-0.3985576010628174,neutral
2020-12-15 16:06:34.000,790.35,790.35,782.3,787.2,3783431.0,Cipla shares: Analysts turn bullish on Cipla post Revlimid patent settlement; see nearly 30% rally,"With Cipla having achieved a commanding market share in gProventil, US growth is now expected to be driven by market share gains from other Albuterol inhalers",positive,positive,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-15 16:25:00.000,790.35,790.35,782.3,787.2,3783431.0,"Sensex, Nifty end flat as investors book profit; Bajaj Finance becomes Rs 3 trillion stock","Hindustan Unilever was the top loser in Nifty index, down 2.07 per cent to Rs 2,321.60. Nestle India, BPCL, ICICI Bank, Axis Bank, SBI, TCS, ITC, ONGC and Cipla were other top losers in the pack.",neutral,negative,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 09:12:00.000,790.35,790.35,782.3,787.2,3783431.0,Cipla partners with Premier Medical Corporation to supply CIPtest,"This is Cipla’s second launch in the diagnostics space after Elifast: SARS CoV-2 IgG
ELISA Test Kit. In this collaboration, Cipla will be responsible for the marketing and
distribution of the Rapid Antigen Detection Test for the qualitative",neutral,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 09:36:30.000,790.35,790.35,782.3,787.2,3783431.0,Cipla Share Price Gains On Launching Rapid Antigen Detection Test,The company will commence the supply of rapid antigen test kits for COVID-19 in India from this week.,neutral,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 09:59:00.000,790.35,790.35,782.3,787.2,3783431.0,Cipla launches Covid-19 diagnosis test kit,The drug major on Wednesday announced its partnership with the Premier Medical Corporation for commercialisation of the rapid antigen test kits for Covid-19 in India from this week.,neutral,positive,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 10:05:00.000,790.35,790.35,782.3,787.2,3783431.0,"Why Cipla, Dr Reddy’s could be good pharma picks","Abhimanyu Sofat talks about his preferences in pharma, NBFC, sugar and IT stocks",positive,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 10:25:00.000,790.35,790.35,782.3,787.2,3783431.0,Cipla ties with Premier Medical Corporation; Launches rapid antigen test kits,Such would be the second launch of Cipla in the diagnostics space after Elifast: SARS CoV-2 IgG ELISA Test Kit.,neutral,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 10:34:12.000,790.35,790.35,782.3,787.2,3783431.0,"Cipla, Premier Medical in tie-up to launch Covid-19 test kits in India",Company to commence supply from this week; test to be marketed under the brand name ‘CIPtest’,positive,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 10:39:11.000,790.35,790.35,782.3,787.2,3783431.0,Cipla Partners Premier Medical Corporation To Launch COVID-19 Rapid Antigen Test Kits In India,"""In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Pvt Ltd,"" Cipla said in a regulatory filing.",neutral,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 11:16:00.000,790.35,790.35,782.3,787.2,3783431.0,Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India,"In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Pvt Ltd, Cipla said in a regulatory filing.",neutral,neutral,-0.3985576010628174,neutral,-0.961112867530828,negative
2020-12-16 14:44:00.000,790.75,794.85,781.1,783.15,3970608.0,Cipla launches rapid antigen detection ‘CIPtest’ for COVID-19 diagnosis,"Rapid antigen detection test directly detects presence or absence of coronavirus antigen in patient’s body, generating results in 15-20 minutes; ICMR-approved CIPtest is found to have specificity and sensitivity of 98.09 per cent and up to 75 per cent",neutral,neutral,-0.961112867530828,negative,1.3898629263627642,positive
2020-12-16 16:36:52.000,790.75,794.85,781.1,783.15,3970608.0,COVID-19 | Cipla partners with Premier Medical Corporation to launch rapid antigen test kits in India,The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week.,positive,positive,-0.961112867530828,negative,1.3898629263627642,positive
2020-12-16 23:09:13.000,790.75,794.85,781.1,783.15,3970608.0,Coronavirus | Cipla partners with Premier Medical Corporation to launch rapid antigen test kits in India,The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week.,positive,positive,-0.961112867530828,negative,1.3898629263627642,positive
2020-12-16 23:28:41.000,790.75,794.85,781.1,783.15,3970608.0,"Corona Vaccine Tracker on Dec 16, 2020",Cipla has announced its partnership with the Premier Medical Corporation Private Limited for commercialisation of the rapid antigen test kits for Covid-19 in India. The company will commence supply from this week. This is Cipla’s second launch in the diagnostics space after Elifast ELISA Test Kit.,neutral,positive,-0.961112867530828,negative,1.3898629263627642,positive
2020-12-18 07:51:00.000,784.25,796.0,781.5,795.15,6483069.0,Cipla’s USA associate receives CRL from USFDA for IV Tramadol,The company is anticipating NDA re-submission in February 2021.,neutral,neutral,1.3898629263627642,positive,-1.8915510718789408,negative
2020-12-18 12:45:00.000,784.25,796.0,781.5,795.15,6483069.0,"Avenue Therapeutics gets regulatory update for intravenous tramadol, says Cipla","In October this year, Avenue Therapeutics Inc had received a complete response letter (CRL) from the USFDA which stated that the regulator has determined that it cannot approve the application for IV tramadol in its present form.",positive,neutral,1.3898629263627642,positive,-1.8915510718789408,negative
2020-12-18 17:28:00.000,784.25,796.0,781.5,795.15,6483069.0,Nifty Pharma index maintains upside on vaccine trials; Dr Reddys leads the gains,"DR Reddys led the gains while Biocon, Lupin, and Cipla also continued the winning streak.",positive,positive,1.3898629263627642,positive,-1.8915510718789408,negative
2020-12-24 09:09:06.000,828.8,834.9,815.3,833.5,7275367.0,"Top Buy And Sell Ideas By Sudarshan Sukhani, Mitessh Thakkar For Short Term","Mitessh Thakkar of mitesshthakkar.com suggests buying Biocon with a stop loss of Rs 470, target at Rs 505 and Cipla with a stop loss of Rs 807, target at Rs 860.",neutral,neutral,0.5670849420849476,neutral,-0.9133237822349544,negative
2020-12-24 14:54:00.000,828.8,834.9,815.3,833.5,7275367.0,India Coronavirus Dispatch: New strain might have already reached India,"Cipla seeks to tweak remdesivir composition, Patanjalis Coronil found on sale in London shops, how the homeless in Delhi are braving the winter and other news relevant to Indias fight against Covid",neutral,neutral,0.5670849420849476,neutral,-0.9133237822349544,negative
2020-12-24 18:15:00.000,828.8,834.9,815.3,833.5,7275367.0,Pharma stocks rally ahead of the festive season amid fresh Covid-19 restrictions; Divis Lab leads,"Pharma majors Cadila, Biocon and Cipla were trading flat. Torrent Pharma and Dr Reddy were on the downside.",positive,neutral,0.5670849420849476,neutral,-0.9133237822349544,negative
2020-12-28 09:12:41.000,837.6,839.0,825.2,829.95,4800274.0,"Top Buy And Sell Ideas By Rahul Mohindar, Mitessh Thakkar For Short Term","Rahul Mohindar of viratechindia.com suggests buying Bajaj Auto with a stop loss of Rs 3,295, target at Rs 3,520 and Cipla with a stop loss of Rs 813, target at Rs 870.",neutral,positive,-0.9133237822349544,negative,-0.6083237969041685,neutral
2020-12-28 23:53:21.000,830.15,835.75,817.5,825.1,3305978.0,Cipla to invest Rs 498 crore in Pithampur,The company will make respiratory apparatus.,neutral,neutral,-0.6083237969041685,neutral,-0.8012048192771057,neutral
2020-12-30 08:30:00.000,830.0,830.0,816.05,823.35,2705060.0,"Pharma stocks trade bearish as India extends restriction with UK amid Covid-19 stress; Sun Pharma, Cipla drags",A total of 20 persons have been found with the mutant variant of SARS- CoV-2 virus reported from the UK.,negative,neutral,-0.8012048192771057,neutral,-0.5643203883495118,neutral
2020-12-31 07:29:00.000,824.0,833.35,816.4,819.35,4837970.0,"Trading calls by Ajit Mishra of Religare Broking: Buy Cipla, Eicher Motors","Eicher Motors stock has been witnessing profit taking for the last one month, and is likely to see a gradual recovery from hereon",neutral,positive,-0.5643203883495118,neutral,0.5469129800680603,neutral
2020-12-31 10:14:00.000,824.0,833.35,816.4,819.35,4837970.0,Sensex wipes morning losses to trade 40 points up,"In the 50-share pack Nifty, Dr Reddys Laboratories was the biggest gainer, up 1.41 per cent. ONGC, ICICI Bank, Sun Pharma, Cipla, Tata Motors, HDFC, Divis Labs and Reliance Industries were among other gainers.",neutral,positive,-0.5643203883495118,neutral,0.5469129800680603,neutral
2021-01-08 18:53:00.000,830.7,846.2,827.4,836.2,5056523.0,TISS Mumbai completes 100% summer placements with Rs 2 lakh median stipend for two months,"Amazon was the biggest recruiter making seven offers, followed by ABG, Cipla, DRL, Flipkart, HPCL and Wipro.",neutral,neutral,0.662092211387986,neutral,2.3837902264600714,positive
2021-01-10 13:02:02.000,839.0,860.0,832.75,859.0,5322148.0,Cipla Recalls Over 5.8 Lakh Packets of Gastric Ulcer Treatment Drug in US,"The drug major is recalling esomeprazole magnesium for delayed release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market, the latest Enforcement Report by the USFDA said.",neutral,negative,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-10 13:24:11.000,839.0,860.0,832.75,859.0,5322148.0,Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US,"Drug major Cipla is recalling over 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the United States (US) market, as per a report by the US Food and Drug Administ",negative,negative,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-10 14:05:00.000,839.0,860.0,832.75,859.0,5322148.0,Cipla recalls 5.8 lakh packets of gastric ulcer treatment drug from US market,The drug firm has manufactured the affected lot at its Kurkumbh facility in Maharashtra and then supplied to its New Jersey-based subsidiary,neutral,neutral,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-11 06:10:00.000,839.0,860.0,832.75,859.0,5322148.0,"Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost",Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities,neutral,positive,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-11 08:24:34.000,839.0,860.0,832.75,859.0,5322148.0,"Stocks in focus: TCS, Tata Steel, Sobha, Cipla, among others to remain in news today","Nifty futures were trading 19.50 points or 0.13 per cent down at 14,427.20 on Singaporean Exchange in early trade on Monday",neutral,negative,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-11 08:46:00.000,839.0,860.0,832.75,859.0,5322148.0,"Stocks in the news: TCS, DMart, Vedanta, Sobha, Cipla, SCI and Star Cement",Cipla is recalling over 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US market,neutral,negative,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-11 08:48:00.000,839.0,860.0,832.75,859.0,5322148.0,"Stocks to watch: TCS, Wipro, Avenue Supermarts, Tata Steel, Vedanta, Cipla",Bharti Airtel announced the appointment of Pradipt Kapoor as its Chief Information Officer,neutral,neutral,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-11 09:35:00.000,839.0,860.0,832.75,859.0,5322148.0,"Stocks in news: TCS, Tata Steel, Avenue Supermarts, Airtel, SAIL, PVR, Cipla","Stocks to watch today on January 11: TCS, Tata Steel, Avenue Supermarts, Airtel, SAIL, PVR, Cipla among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,2.3837902264600714,positive,-1.8604651162790695,negative
2021-01-12 08:22:00.000,860.0,864.6,841.0,844.0,4324923.0,"Pharma stocks under pressure; Sun Pharma, Divis lab drag","Heavyweights Sun Pharma, Divis Lab, Cipla, Lupin and DR Reddy’s led the losses.",negative,negative,-1.8604651162790695,negative,-0.7611966719773464,neutral
2021-01-12 10:17:00.000,860.0,864.6,841.0,844.0,4324923.0,Back on the growth wagon: Cipla is a favourite of analysts and this week’s stock pick,"Cipla reported an FCF of around Rs 3,400 crore in 2019-20 and is expected to report bigger numbers in the coming years due to increased growth rates and cost savings due to domestic synergies. This has made the company a favourite of analysts.",positive,positive,-1.8604651162790695,negative,-0.7611966719773464,neutral
2021-01-18 20:08:19.000,802.5,825.4,802.5,825.0,3784700.0,Cipla Q3 PAT Seen Up 73.2% YoY To Rs. 608.1 Cr: ICICI Direct,"Net Sales are expected to increase by 15.7 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 5,057.6 crore, according to ICICI Direct.",neutral,positive,2.803738317757009,positive,1.2583586626139849,positive
2021-01-18 22:57:04.000,802.5,825.4,802.5,825.0,3784700.0,Cipla Q3 PAT Seen Up 77.2% YoY To Rs. 351 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 15.3 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 4,234.6 crore, according to Prabhudas Lilladher.",neutral,positive,2.803738317757009,positive,1.2583586626139849,positive
2021-01-21 10:25:00.000,835.0,839.3,809.0,817.0,3318546.0,"Cipla allots 5,217 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,29,20,892/- comprising of 80,64,60,446 equity shares of face value Rs.2/- each.",neutral,neutral,-2.155688622754491,negative,-0.845795538122086,neutral
2021-01-22 12:59:59.000,815.8,822.5,798.25,808.9,3877084.0,Cipla Q3 PAT Seen Up 74.3% YoY To Rs. 612 Cr: Yash Securities,"Net Sales are expected to increase by 14 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 4985 crore, according to Yash Securities.",neutral,positive,-0.845795538122086,neutral,3.198031980319803,positive
2021-01-25 02:48:00.000,813.0,857.0,808.25,839.0,10699362.0,Pharma stocks escape bears amid weak markets; Nifty Pharma tops 2%; Auro Pharma hits fresh 52-week high,"Auro Pharma gained ~8%, Cipla was 4.55% higher. Sun Pharma (up 2.41%) and Cadila (up 1.69%) also made significant gains to drive the Nifty Pharma Index.",neutral,positive,3.198031980319803,positive,-0.0238123586141126,neutral
2021-01-25 08:59:00.000,813.0,857.0,808.25,839.0,10699362.0,Markets close lower; Reliance Industries underperform,"Pharma index closed ~2% higher led by a strong rally in the stocks like Aurobindo Pharma, Cipla & Dr Reddys.",negative,positive,3.198031980319803,positive,-0.0238123586141126,neutral
2021-01-27 08:04:00.000,839.9,856.45,825.2,839.7,7401457.0,Cipla champions commitment to carbon neutrality with 30 MW solar plant in Maharashtra,Cipla is the first pharmaceutical company in Maharashtra with group captive open access solar power project of this scale.,positive,neutral,-0.0238123586141126,neutral,0.5745062836624721,neutral
2021-01-27 08:46:00.000,839.9,856.45,825.2,839.7,7401457.0,"Nifty Pharma dives by 252 pts on broad-based selloff; Aurobindo, Dr Reddy’s worst hit; Cipla top gainer","The index has tumbled to an intraday low of 12,403.80.",neutral,negative,-0.0238123586141126,neutral,0.5745062836624721,neutral
2021-01-27 09:09:00.000,839.9,856.45,825.2,839.7,7401457.0,"Buy Cipla, target price Rs 885: Edelweiss","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 67484.17 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.0238123586141126,neutral,0.5745062836624721,neutral
2021-01-27 20:26:00.000,835.5,848.85,825.7,840.3,4483815.0,Cipla sets up 30 MW solar group captive project,"This is in line with the Company’s ESG initiatives aimed at developing a holistic sustainability
road map for the future. By 2025, Cipla plans to achieve carbon and water neutrality, zerowaste to landfill, anti-microbial resistance stewardship and",neutral,positive,0.5745062836624721,neutral,-2.3527330620909304,negative
2021-01-28 22:08:00.000,847.95,850.85,820.75,828.0,7174077.0,"Cipla Q3 preview: Consolidated PAT seen rising 76% YoY aided by strong India, US ops","Analysts expect Cipla to report a consolidated net profit of Rs 616.8 crore on net sales of Rs 5,003 crore, according to estimates from six brokerages polled by ETMarkets.com. The company will report its earnings on Friday.",positive,neutral,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 07:22:35.000,847.95,850.85,820.75,828.0,7174077.0,"Hot Stocks | Tata Motors, Cummins India, Cipla Can Give Up To 19% Return In Short-term","The key support levels for Nifty in the short-term are 13,750 which is a 61.8 percent retracement level of the rise from 13,131-14,753.",neutral,positive,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 07:25:01.000,847.95,850.85,820.75,828.0,7174077.0,"Stocks To Watch: Cipla, Dr. Reddy’s, IndusInd Bank, IOC, Sun Pharma, Tata Motors, Tech Mahindra, UPL",Here are the stocks to watch in trade today.,neutral,neutral,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 11:31:00.000,847.95,850.85,820.75,828.0,7174077.0,Cipla Ltd Q3 PAT doubles to Rs752cr on yoy revenue booster,"Cipla Ltd reported 18.25% higher revenues for the Dec-20 quarter on consolidated basis at Rs5,169cr",positive,positive,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 17:07:00.000,847.95,850.85,820.75,828.0,7174077.0,"Cipla Q3 results: Net profit jumps 113% to Rs 748 crore, beats Street estimates; revenue rises 18%","Analysts had expected Cipla to report a consolidated net profit of Rs 616.8 crore on net sales of Rs 5,003 crore, according to estimates from six brokerages polled by ETMarkets.com.",positive,neutral,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 17:07:47.000,847.95,850.85,820.75,828.0,7174077.0,"Cipla Posts Strong Q3 Numbers, Profit More Than Doubles To Rs 748.15 Crore","The company’s revenue for the quarter came at Rs 5,168.7 crore, up 18.2 percent from Rs 4,371 crore in the year-ago quarter.",neutral,positive,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 17:16:00.000,847.95,850.85,820.75,828.0,7174077.0,"Nifty Pharma under pressure amid corporate earnings; Lupin dives 3%; Cipla, Sun Pharma, Dr Reddy’s in focus","The index has touched an intraday high and low of 12,482.55 and 12,482.55 respectively.",negative,negative,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-29 17:32:30.000,847.95,850.85,820.75,828.0,7174077.0,"Cipla Q3 Results: Profit Beats Estimates As Sales Jump In India, Europe",The drugmaker’s net profit rose / fell xx% to Rs xx crore year-on-year in the quarter ended December.,neutral,negative,-2.3527330620909304,negative,-1.1104294478527552,negative
2021-01-31 01:23:22.000,815.0,831.0,779.95,805.95,13783485.0,Cipla — Large Part Of COVID Opportunity Has Played Out,"In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the drugmaker may be close to maturity",neutral,positive,-1.1104294478527552,negative,2.3543990086741013,positive
2021-01-31 17:29:57.000,815.0,831.0,779.95,805.95,13783485.0,"Cipla Q3 Review - Strong Growth In India, RoW; Better Margins: ICICI Direct","Cipla Q3 Review - Strong Growth In India, RoW; Better Margins: ICICI Direct",neutral,neutral,-1.1104294478527552,negative,2.3543990086741013,positive
2021-02-01 07:59:31.000,815.0,831.0,779.95,805.95,13783485.0,"Budget 2021 Stocks In The News | Shree Cement, ICICI Bank, Tata Motors, Tech Mahindra, Cipla, DLF","Titan Company, IndusInd Bank, Vedanta, Bajaj Healthcare, Jaiprakash Associates, EIH, JK Lakshmi Cement, Sundaram-Clayton, Mahindra Logistics, Rupa & Company, Dr Lal PathLabs are also among the stocks in focus today.",neutral,neutral,-1.1104294478527552,negative,2.3543990086741013,positive
2021-02-01 08:14:00.000,815.0,831.0,779.95,805.95,13783485.0,How did India’s Big Pharma fare in the December Quarter?,"Sun Pharma reported its highest-ever quarterly sales, and Cipla posted the highest-ever Ebitda margin in the company’s recent history. Lupin’s Ebitda margin improved for the fourth consecutive quarter.",neutral,positive,-1.1104294478527552,negative,2.3543990086741013,positive
2021-02-01 08:30:42.000,815.0,831.0,779.95,805.95,13783485.0,"Stocks To Watch: ICICI Bank, Tata Motors, Cipla, UPL, Tata Power",Here are the stocks to watch out for in today’s session.,neutral,neutral,-1.1104294478527552,negative,2.3543990086741013,positive
2021-02-01 09:29:00.000,815.0,831.0,779.95,805.95,13783485.0,"Stocks in news: Titan, Airtel, ICICI Bank, SJVN, Tata Motors, Cipla","Stocks to watch today on February 1: Titan, Airtel, ICICI Bank, SJVN, Tata Motors, Cipla among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,-1.1104294478527552,negative,2.3543990086741013,positive
2021-02-01 10:54:00.000,815.0,831.0,779.95,805.95,13783485.0,"Neutral on Cipla, target price Rs 900: Motilal Oswal","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 66084.97 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.1104294478527552,negative,2.3543990086741013,positive
2021-02-01 12:55:00.000,807.0,826.35,801.5,826.0,8464052.0,"Top stocks in focus: ICICI Bank, Tata Motors, Tata Power, Cipla, Tech Mahindra, MOIL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,2.3543990086741013,positive,3.1779661016949152,positive
2021-02-01 16:27:00.000,807.0,826.35,801.5,826.0,8464052.0,Cipla’s overall biz grows 22% yoy; PAT increases 113% to Rs748cr in Q3,Overall business grew by 22% YoY with strong growth across the three businesses; demand led traction in core therapies as Covid-19 portfolio normalises,positive,positive,2.3543990086741013,positive,3.1779661016949152,positive
2021-02-01 19:26:00.000,807.0,826.35,801.5,826.0,8464052.0,"It’s a get-well-soon very fast Budget: Umang Vohra, Cipla","Umang Vohra, MD & Global CEO, Cipla in conversation with ET NOW says he rates the Budget a 8 or 9 out of a 10.",neutral,neutral,2.3543990086741013,positive,3.1779661016949152,positive
2021-02-02 09:44:25.000,807.0,826.35,801.5,826.0,8464052.0,"Cipla Consolidated December 2020 Net Sales At Rs 5,168.69 Crore, Up 18.25% Y-o-Y",,neutral,neutral,2.3543990086741013,positive,3.1779661016949152,positive
2021-02-02 14:33:11.000,826.0,878.9,824.2,852.25,15667224.0,Buy Cipla; Target Of Rs 1020: HDFC Securities,"HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1020 in its research report dated February 01, 2021.",neutral,positive,3.1779661016949152,positive,-1.4512418146421986,negative
2021-02-02 22:41:00.000,826.0,878.9,824.2,852.25,15667224.0,"India’s demand for COVID-19 drug remdesivir to fall, says Cipla","Cipla was among the first companies in India to launch a generic version of remdesivir, developed by U.S.-based Gilead Sciences, and as of September had sold more than 300,000 vials across India.",negative,neutral,3.1779661016949152,positive,-1.4512418146421986,negative
2021-02-03 12:15:18.000,847.55,856.5,832.6,835.25,4628997.0,"Pharma Stocks Rally After Rs 2.23 Lakh-crore Boost For Healthcare Sector; Cipla, Sun Pharma Hit 52-week High","The finance minister announced a new scheme called the PM Atmanirbhar Swasth Bharat Yojana for boosting the primary, secondary, and tertiary healthcare, with a budgetary outlay of Rs 64,180 crore spread over six years.",neutral,neutral,-1.4512418146421986,negative,1.0004764173415883,positive
2021-02-03 13:17:00.000,847.55,856.5,832.6,835.25,4628997.0,"Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs","At 12:57 pm, Nifty Pharma index, the top gainer among sectoral indices, was up 4.2 per cent, as compared to 1.3 per cent gain in the benchmark Nifty50 index",positive,positive,-1.4512418146421986,negative,1.0004764173415883,positive
2021-02-03 13:17:02.000,847.55,856.5,832.6,835.25,4628997.0,"Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%","For the third consecutive day, the stock market is trading in green. At 12.30 pm, Sensex touched a new high at 50,377.15 points and Nifty created a record by 14,836.10 points.The BSE Healthcare index increased by over 3.10 per cent. Panacea Biotec zoomed by over 11 per cent. Other healthc…",positive,positive,-1.4512418146421986,negative,1.0004764173415883,positive
2021-02-03 16:28:00.000,847.55,856.5,832.6,835.25,4628997.0,Market Movers: Rally in banks continue as pharma stocks join party,"As many as 182 stocks listed on the National Stock Exchange hit their 52-week highs today. The list includes prominent names like Power Grid Corporation, TVS Motor Company, Cipla, Sun Pharma, Tata Motors and Mahindra & Mahindra.",neutral,neutral,-1.4512418146421986,negative,1.0004764173415883,positive
2021-02-03 17:38:00.000,847.55,856.5,832.6,835.25,4628997.0,"Pharma stocks top bull of the day; Nifty Pharma soars 500 pts; Cipla, Sun Pharma hit new all-time high",All stocks listed in Nifty Pharma index were trading in the green with Cipla and Sun Pharma also hitting a fresh record high in early trade.,positive,positive,-1.4512418146421986,negative,1.0004764173415883,positive
2021-02-03 19:25:00.000,847.55,856.5,832.6,835.25,4628997.0,"Moderation of Covid-related products likely in Q4: Umang Vohra, Cipla","Branded portfolio is crucial for growth, says Umang Vohra, MD & Global CEO, Cipla in an interview with ET NOW.",neutral,neutral,-1.4512418146421986,negative,1.0004764173415883,positive
2021-02-04 17:23:56.000,839.6,854.9,830.5,848.0,7372689.0,Buy Cipla; Target Of Rs 975: ICICI Direct,"ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 975 in its research report dated January 30, 2021.",neutral,positive,1.0004764173415883,positive,-0.5633802816901355,neutral
2021-02-04 18:51:27.000,839.6,854.9,830.5,848.0,7372689.0,Accumulate Cipla; Target Of Rs 913: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Cipla with a target price of Rs 913 in its research report dated February 01, 2021.",neutral,positive,1.0004764173415883,positive,-0.5633802816901355,neutral
2021-02-05 22:19:24.000,839.6,854.9,830.5,848.0,7372689.0,Cipla Rating ‘Buy’; A robust performance by company,"FY21-23e EPS up 8-12%; upgraded to ‘Buy’ rating with revised TP of Rs 1,030",positive,positive,1.0004764173415883,positive,-0.5633802816901355,neutral
2021-02-08 06:10:00.000,852.0,859.25,841.05,847.2,4239693.0,"KKR-backed JB Chemicals scouts for acquisitions, plans to revamp business","With the former Cipla head at the helm, JB Chemicals now plans to diversify into paediatrics and respiratory",positive,neutral,-0.5633802816901355,neutral,-0.7429245283018814,neutral
2021-02-08 08:20:00.000,852.0,859.25,841.05,847.2,4239693.0,Nifty Pharma index trade higher as heavyweight Dr Reddy’s drive,"Auro Pharma, Cipla, Lupin and Biocon are also over 0.50% higher to support the sector. Alkem Lab, Divis Lab and Cadila drag the sector.",positive,neutral,-0.5633802816901355,neutral,-0.7429245283018814,neutral
2021-02-08 16:07:14.000,848.0,856.85,839.0,841.7,4192993.0,Buy Cipla; Target Of Rs 950: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 950 in its research report dated January 29, 2021.",neutral,positive,-0.7429245283018814,neutral,2.1236432279377064,positive
2021-02-09 23:48:01.000,847.6,867.0,841.0,865.6,5661003.0,Buy Cipla; Target Of Rs 940: Dolat Capital Market,"Dolat Capital Market is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 31, 2021.",neutral,positive,2.1236432279377064,positive,-1.152073732718894,negative
2021-02-10 06:10:00.000,847.6,867.0,841.0,865.6,5661003.0,Cipla plans to double share from consumer health business in 5 years,Transitioning brands from prescription and trade generics to over-the-counter,positive,neutral,2.1236432279377064,positive,-1.152073732718894,negative
2021-02-10 09:26:00.000,847.6,867.0,841.0,865.6,5661003.0,"Buy Cipla, target price Rs 900: Edelweiss","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 67883.37 Crore) operating in Pharmaceuticals sector.",neutral,neutral,2.1236432279377064,positive,-1.152073732718894,negative
2021-02-10 16:43:14.000,868.0,874.9,856.0,858.0,5327684.0,"Taking Stock | Market Ends Flat Amid High Volatility, But Nifty Manages To Hold 15,100","Cipla, Bajaj Finserv, SBI Life Insurance, M&M and HDFC Life were among major gainers on the Nifty, while losers were Eicher Motors, Bharti Airtel, HDFC Bank, Tata Steel and Britannia Industries.",neutral,positive,-1.152073732718894,negative,-1.0477299185098952,negative
2021-02-10 17:01:00.000,868.0,874.9,856.0,858.0,5327684.0,"Nifty Pharma index under pressure as heavyweights Sun Pharma, Dr Reddy’s drag; Cipla top gainer","The index has touched an intraday high and low of 12,895.65 and 12,689.40 respectively in early trade.",positive,negative,-1.152073732718894,negative,-1.0477299185098952,negative
2021-02-10 17:53:00.000,868.0,874.9,856.0,858.0,5327684.0,Top gainers today: List of eight shares that rose up to 3%,"Share Market, Here’s a list of 8 top gainers on 10 February: Bajaj Finserv, Mahindra & Mahindra, Cipla, HUL, Titan, Reliance Industries, Tech Mahindra and Asian Paints traded as the top gainers on BSE and NSE today",positive,neutral,-1.152073732718894,negative,-1.0477299185098952,negative
2021-02-12 07:00:00.000,859.0,864.35,845.5,850.0,2468242.0,"Bears take control on Nifty Pharma; Sun Pharma sinks 3%, Divis Lab struggles as well",Cipla was 0.56% down while Lupin trades 0.44% lower. DR Reddy and Auro Pharma were marginally lower.,neutral,negative,-1.0477299185098952,negative,-0.5352311492765637,neutral
2021-02-18 16:20:00.000,823.8,825.45,799.0,808.8,3826351.0,Cipla Health’s Naselin launches ColdPlus Rub for effective cold relief & relaxation for adults,"With the power of 6 natural ingredients, this ‘Badho Ka Rub’ gives instant relief from cold leading to relaxation and sound sleep.",positive,positive,-1.820830298616169,negative,-2.883904362829674,negative
2021-02-22 22:24:25.000,795.0,803.15,788.4,794.4,3258860.0,Cipla in talks to bring Covid antidotes to India,"Expanding into home-testing, point-of-care diagnostics, in the hunt for technology",neutral,neutral,-0.0754716981132104,neutral,-1.2594458438287155,negative
2021-03-01 22:44:35.000,792.6,815.0,790.8,811.0,4258788.0,"Cipla on a firm wicket but sustaining growth momentum, margins are key",The launch of its much-awaited generic Advair inhaler in FY22 can accrue more benefits for the firm’s US sales,positive,positive,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 05:30:00.000,792.6,815.0,790.8,811.0,4258788.0,"BRIEF-Cipla Says Unit Expands Partnership With Alvotech For Commercialization Of Biosimilars In Australia, New Zealand","BRIEF-Cipla Says Unit Expands Partnership With Alvotech For Commercialization Of Biosimilars In Australia, New Zealand",neutral,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 05:30:00.000,792.6,815.0,790.8,811.0,4258788.0,BRIEF-Cipla Says Gets Final ANDA Nod For Sumatriptan Nasal Spray From U.S. FDA,BRIEF-Cipla Says Gets Final ANDA Nod For Sumatriptan Nasal Spray From U.S. FDA,neutral,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 05:30:00.000,792.6,815.0,790.8,811.0,4258788.0,"BRIEF-Cipla Receives Final Approval For Generic Version Of Glaxosmithkline’s Imitrex® (Sumatriptan Nasal Spray, 20 Mg)","BRIEF-Cipla Receives Final Approval For Generic Version Of Glaxosmithkline’s Imitrex® (Sumatriptan Nasal Spray, 20 Mg)",neutral,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 07:15:00.000,792.6,815.0,790.8,811.0,4258788.0,"Nifty Pharma rallies over 1%; Lupin and Cipla led the pack, Sun Pharma adds significant gains too","DR Reddys Lab was the lone laggard in the sector, shedding ~1% at Rs4,410.95 per piece.",positive,negative,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 09:03:00.000,792.6,815.0,790.8,811.0,4258788.0,Cipla receives USFDA approval for Sumatriptan Nasal Spray,"Cipla’s Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic
equivalent version of GlaxoSmithKline’s Imitrex Nasal Spray.",positive,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 09:04:00.000,792.6,815.0,790.8,811.0,4258788.0,Cipla partners with Alvotech to market biosimilars in Australia and New Zealand,"As part of this strategic alliance, Cipla Gulf will be responsible for commercialization of
patented biosimilars of the biologic medicine brands, Aflibercept (Eylea), Ustekimumab
(Stelara), Denosumab (Prolia, Xgeva) and Golimumab (Simponi). These",neutral,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 09:51:00.000,792.6,815.0,790.8,811.0,4258788.0,Cipla secures USFDA nod on Sumatriptan nasal spray,"The drug major has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan nasal spray, 20 mg from the United States Food and Drug Administration (USFDA).",neutral,positive,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 10:08:00.000,792.6,815.0,790.8,811.0,4258788.0,Cipla receives USFDA nod for nasal spray for treating migraine attacks,"Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Sumatriptan Nasal Spray, indicated for the treatment of migraine attacks",neutral,positive,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 10:11:03.000,792.6,815.0,790.8,811.0,4258788.0,Cipla Gets USFDA Nod For Migraine Drug,The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex Nasal Spray.,neutral,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 10:28:00.000,792.6,815.0,790.8,811.0,4258788.0,"Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand","Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing.",positive,positive,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 10:29:02.000,792.6,815.0,790.8,811.0,4258788.0,"Cipla Gulf Expands Partnership With Alvotech For Commercialisation Of Four Drugs In Australia, New Zealand","Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing.",neutral,positive,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 10:53:33.000,792.6,815.0,790.8,811.0,4258788.0,Cipla Gulf expands partnership with Alvotech,Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand,positive,positive,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 11:16:00.000,792.6,815.0,790.8,811.0,4258788.0,Cipla gets USFDA nod for migraine drug,The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex Nasal Spray.,neutral,neutral,2.321473631087557,positive,-0.6051714652484926,neutral
2021-03-02 13:38:58.000,817.95,818.15,807.6,813.0,3252022.0,Cipla expands Alvotech partnership to market four more biosimilars in Australia and New Zealand,Gets US FDA approval for its Sumatriptan Nasal Spray,positive,positive,-0.6051714652484926,neutral,0.0743126083725567,neutral
2021-03-02 14:24:00.000,817.95,818.15,807.6,813.0,3252022.0,Cipla’s new migraine drug Sumatriptan Nasal Spray gets USFDA approval,The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex Nasal Spray,positive,neutral,-0.6051714652484926,neutral,0.0743126083725567,neutral
2021-03-02 16:21:00.000,817.95,818.15,807.6,813.0,3252022.0,Cipla receives USFDA final approval for Sumatriptan Nasal Spray,"Cipla’s Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex® Nasal Spray.",positive,neutral,-0.6051714652484926,neutral,0.0743126083725567,neutral
2021-03-02 17:56:00.000,817.95,818.15,807.6,813.0,3252022.0,Cipla’s subsidiary Cipla Gulf ties with Alvotech to market biosimilars in Australia & New Zealand,The products are developed and manufactured by Alvotech and will be distributed by Cipla Gulf through Australia and New Zealand .,positive,neutral,-0.6051714652484926,neutral,0.0743126083725567,neutral
2021-03-03 00:35:00.000,817.95,818.15,807.6,813.0,3252022.0,"Cipla’s Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand","Cipla Gulf will be responsible for commercialisation of patented biosimilars of the biologic medicine brands -- Aflibercept, Ustekimumab,Denosumab and Golimumab.",neutral,neutral,-0.6051714652484926,neutral,0.0743126083725567,neutral
2021-03-03 07:45:00.000,817.95,818.15,807.6,813.0,3252022.0,"Cipla’s Gulf arm to market, sell 4 biosimilar medicines in NZ, Australia","Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing",neutral,positive,-0.6051714652484926,neutral,0.0743126083725567,neutral
2021-03-05 18:18:00.000,806.5,812.0,800.25,806.0,3827400.0,"Nifty Pharma stocks in sell-off; Alkem Lab, Auro Pharma and Dr Reddys drag the sector",Lupin and Cipla lifted the spirit with marginal gains.,negative,positive,-0.0619962802231866,neutral,0.1732780493842412,neutral
2021-03-08 06:55:00.000,807.95,819.0,806.2,809.35,2912897.0,"Nifty Pharma gain 1%; Lupin surges 2%; Cadila, Cipla, Divis Lab contribute to the gains",Alkem Lab and Biocon were marginally in the negative zone.,positive,negative,0.1732780493842412,neutral,-1.649027811961602,negative
2021-03-08 07:44:00.000,807.95,819.0,806.2,809.35,2912897.0,"Stocks in the news: Adani Power, Mphasis, PVR, Muthoot Finance, Cipla and NMDC",Multiplex major PVR plans to invest Rs 150 crore to open up to 40 screens across the country in the next fiscal.,neutral,positive,0.1732780493842412,neutral,-1.649027811961602,negative
2021-03-08 08:24:22.000,807.95,819.0,806.2,809.35,2912897.0,"Stocks in focus: Easy Trip Planners IPO, Cipla, NMDC, Indian Oil, PVR, Reliance Home Finance","After gaining over 2.5 per cent in the previous week, BSE Sensex and Nifty 50 are set to start the week on a positive note on Monday",neutral,positive,0.1732780493842412,neutral,-1.649027811961602,negative
2021-03-08 09:22:00.000,807.95,819.0,806.2,809.35,2912897.0,Cipla liquidates UK-based subsidiary as part of internal reorganisation,"The liquidation of Cipla (UK), WOS of Cipla (EU) will not affect the performance or revenue of the company.",neutral,neutral,0.1732780493842412,neutral,-1.649027811961602,negative
2021-03-08 10:08:00.000,807.95,819.0,806.2,809.35,2912897.0,Cipla liquidates wholly-owned unit as part of internal reorganisation,"The drug maker said that its wholly owned subsidiary, Cipla (UK), has been voluntarily liquidated with effect from Friday, 5 March 2021.",neutral,negative,0.1732780493842412,neutral,-1.649027811961602,negative
2021-03-10 18:10:00.000,806.0,814.75,801.0,811.0,2494745.0,Nifty Pharma index rally 1%; Biocon and Lupin led the pack,Cipla and Sun Pharma were also bullish to push the sector further while Torrent Pharma and Alkem Lab lagged.,positive,positive,0.620347394540943,neutral,-1.5186772810777682,negative
2021-03-12 08:56:00.000,816.5,818.7,802.0,804.1,2073213.0,"Buy Cipla, target price Rs 840: Kotak Securities","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 65516.42 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.5186772810777682,negative,-0.5631885134298743,neutral
2021-03-16 07:08:00.000,805.1,808.5,787.0,792.85,3668648.0,"Nifty Pharma index under pressure as Cipla, Biocon and Divis Lab drags; DR Reddy’s top gainer","Cipla, Biocon and Divis Lab dragged the pharma index most.",positive,negative,-1.5215501179977642,negative,-3.120281831907392,negative
2021-03-17 07:26:00.000,794.8,794.8,770.0,770.0,3240335.0,"Nifty Pharma shed 164 pts amid resurgence in Covid-19 cases; Lupin, Cipla, Sun Pharma drags; Aurobindo only gainer","Except for Aurobindo Pharma, all stocks listed on Nifty Pharma were under sharp selloff with heavyweights Lupin, Cipla and Sun Pharma being top laggards.",negative,negative,-3.120281831907392,negative,-2.31958762886598,negative
2021-03-18 07:25:00.000,776.0,778.45,750.85,758.0,2892029.0,"Nifty Pharma index underperforms 1.5%; DR Reddys, Divis Lab, Cipla drags",Auro Pharma led the losses while Cadila and Lupin were also bearish. Biocon gained 1% amidst gloomy picture.,neutral,positive,-2.31958762886598,negative,1.3315579227696404,positive
2021-03-18 14:04:45.000,751.0,767.25,738.1,761.0,5259035.0,Cipla Ltd stays slippery,"Cipla Ltd is quoting at Rs 760.1, down 1.56% on the day as on 13:19 IST on the NSE. The stock jumped 102.86% in last one year as compared to a 77.36% rally in NIFTY and a 74.78% spurt in the Nifty Pharma index.",negative,positive,1.3315579227696404,positive,1.3123359580052494,positive
2021-03-19 07:25:00.000,751.0,767.25,738.1,761.0,5259035.0,"Nifty Pharma index surges 1%; Biocon, Torrent Pharma, Divis Lab and DR Reddys in fast lane","Lupin, Cadila, Auro Pharma and Cipla also gained more than 1%. Sun Pharma also advanced 0.82% higher. Alkem Lab was lone laggard.",positive,positive,1.3315579227696404,positive,1.3123359580052494,positive
2021-03-19 07:44:00.000,751.0,767.25,738.1,761.0,5259035.0,Cipla pledges support to ‘Terra Carta’ for a sustainable future; Stock climbs over 1%,"Launched in January 2021, the initiative has received support from 223 private sector organisations and 21 professional associations.",positive,positive,1.3315579227696404,positive,1.3123359580052494,positive
2021-03-19 09:40:00.000,751.0,767.25,738.1,761.0,5259035.0,Cipla pledges support to Terra Carta for driving ESG agenda,"Since its launch in January 2021, the initiative has received support from 223 private sector organisations and 21 professional associations. Cipla is one of the five Indian companies and the only Indian pharmaceutical company to participate.",neutral,neutral,1.3315579227696404,positive,1.3123359580052494,positive
2021-03-19 13:01:00.000,751.0,767.25,738.1,761.0,5259035.0,"Top stocks in focus: Cipla, GAIL, Indo Count, Godrej Industries, Hathway",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.3315579227696404,positive,1.3123359580052494,positive
2021-03-22 16:55:00.000,775.0,779.4,768.4,776.8,2115065.0,"Nifty Pharma shrugs off broader bearish markets, index outperforms by 170 pts; Cipla, Sun Pharma top bulls","Cipla, Divis Lab and Sun Pharma were the top three gainers on the index soaring by more than 2% each.",positive,positive,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-22 17:14:00.000,775.0,779.4,768.4,776.8,2115065.0,"Cipla allots 2,833 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,29,26,558/- comprising of 80,64,63,279 equity shares of face value Rs. 2/- each.",neutral,neutral,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-23 05:30:00.000,775.0,779.4,768.4,776.8,2115065.0,BRIEF-Cipla Ltd - Umang Vohra Reappointed As MD,BRIEF-Cipla Ltd - Umang Vohra Reappointed As MD,neutral,neutral,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-23 05:30:00.000,775.0,779.4,768.4,776.8,2115065.0,BRIEF-Cipla Says Cipla Therapeutics And Siga Technologies Partner For Novel Antibacterial Drugs,BRIEF-Cipla Says Cipla Therapeutics And Siga Technologies Partner For Novel Antibacterial Drugs,neutral,neutral,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-23 08:45:00.000,775.0,779.4,768.4,776.8,2115065.0,Nifty Pharma trades higher; Divis Lab lifts the sectoral index,Auro Pharma also advanced 1.35% and Torrent Pharma also gained 1%. Cipla and DR Reddys were also trading 0.53% higher each.,positive,positive,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-23 09:13:00.000,775.0,779.4,768.4,776.8,2115065.0,Cipla partners with SIGA Technologies to address challenge of AMR,"The strategic collaboration between Cipla and SIGA will provide the Biomedical Advanced Research and Development Authority (BARDA), a U.S. Department of Health and Human Services (HHS) department, with solutions for its biothreat and public health",neutral,positive,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-23 10:15:00.000,775.0,779.4,768.4,776.8,2115065.0,Cipla includes LGBTQ and live-in partners under Mediclaim policy,"This initiative is with keeping in mind the changing needs of an evolving workplace, and strengthens the company’s commitment towards inclusion and diversity by providing equal benefits to all employees.",neutral,positive,0.2322580645161231,neutral,1.6906659809719842,positive
2021-03-23 14:58:00.000,777.8,798.7,772.65,790.95,6899077.0,Cipla partners with SIGA Technologies to provide access to novel antibacterial drugs against biothreats,"According to the AMR Industry AlIiance, AMR is the ability of a microorganism to stop an antimicrobial from working against it.",positive,neutral,1.6906659809719842,positive,-1.035261638850546,negative
2021-03-23 14:58:29.000,777.8,798.7,772.65,790.95,6899077.0,Cipla arm partners US firm to develop novel antibiotics,The partnership is aimed at making novel antibiotics that Cipla develops available to the US government as part of preparations against biological threats,neutral,neutral,1.6906659809719842,positive,-1.035261638850546,negative
2021-03-23 16:45:00.000,777.8,798.7,772.65,790.95,6899077.0,Cipla board approves reappointment of Umang Vohra as MD & Global CEO,Pharma major Cipla on Tuesday said its board hasapproved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.,neutral,positive,1.6906659809719842,positive,-1.035261638850546,negative
2021-03-23 16:49:51.000,777.8,798.7,772.65,790.95,6899077.0,Cipla reappoints Umang Vohra as MD & Global CEO for 5 years,"Vohra had joined Cipla in 2015 and has been the managing director and global chief executive officer of the company since 1 September, 2016",neutral,neutral,1.6906659809719842,positive,-1.035261638850546,negative
2021-03-23 16:50:00.000,777.8,798.7,772.65,790.95,6899077.0,Cipla board approves reappointment of Umang Vohra as MD & Global CEO for 5 years,"The board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as ‘Managing Director and Global Chief Executive Officer’ of the company, for a further period of five years w.e.f. April 1, 2021 to March 31, 2026, Cipla said in a regulatory filing.",neutral,neutral,1.6906659809719842,positive,-1.035261638850546,negative
2021-03-30 07:25:00.000,790.25,815.9,790.25,810.0,4431719.0,"Nifty Pharma joins the bull bandwagon, index surges over 2%; Torrent Pharma, Cipla, Divis Lab most active","The index has gained an intraday high of 12,146.85. All stocks listed on the index were performing in green.",positive,positive,2.49920911104081,positive,0.3637484586929772,neutral
2021-03-31 05:30:00.000,811.0,823.95,805.0,813.95,3070505.0,BRIEF-Cipla Says ABCD Technologies Buys 66.02% Interest In AIOCD Pharmasofttech Awacs,BRIEF-Cipla Says ABCD Technologies Buys 66.02% Interest In AIOCD Pharmasofttech Awacs,neutral,neutral,0.3637484586929772,neutral,-0.1830384380719951,neutral
2021-03-31 05:30:00.000,811.0,823.95,805.0,813.95,3070505.0,BRIEF-Cipla Says Entered Into An Agreement To Become A Partner In ABCD Technologies LLP,BRIEF-Cipla Says Entered Into An Agreement To Become A Partner In ABCD Technologies LLP,neutral,neutral,0.3637484586929772,neutral,-0.1830384380719951,neutral
2021-03-31 07:20:00.000,811.0,823.95,805.0,813.95,3070505.0,"Nifty Pharma index gains near 1% led by sharp rally in Cadila, Lupin and Aurobindo",Auro Pharma gained 1.13% while Cipla and Sun Pharma also gained nearly 1% to lift the sectorial performance.,positive,positive,0.3637484586929772,neutral,-0.1830384380719951,neutral
2021-03-31 13:31:28.000,819.5,824.0,811.6,818.0,1907691.0,Cipla Ltd adds 1.24%,"Cipla Ltd is quoting at Rs 822.25, up 1.24% on the day as on 12:49 IST on the NSE. The stock is up 98.73% in last one year as compared to a 78.58% spurt in NIFTY and a 75.14% spurt in the Nifty Pharma index.",positive,positive,-0.1830384380719951,neutral,-0.6060606060606061,neutral
2021-03-31 15:12:00.000,819.5,824.0,811.6,818.0,1907691.0,Cipla enters agreement for stake in ABCD Technologies LLP,The transaction is in line with Company’s strategy on leveraging digital assets and philosophy of access and affordability of medicine to all. The proposed business of Target entity will be carried out with an objective to facilitate the,positive,positive,-0.1830384380719951,neutral,-0.6060606060606061,neutral
2021-04-01 05:30:00.000,819.5,824.0,811.6,818.0,1907691.0,BRIEF-Cipla Says DigiHealth Technologies To Buy 100% Ownership In Pharmarack Technologies,BRIEF-Cipla Says DigiHealth Technologies To Buy 100% Ownership In Pharmarack Technologies,neutral,neutral,-0.1830384380719951,neutral,-0.6060606060606061,neutral
2021-04-01 07:07:49.000,819.5,824.0,811.6,818.0,1907691.0,"Dr Reddy’s, Cipla invest in ABCD Technologies",Drug majors Dr Reddy’s Laboratories and Cipla on Wednesday said they have entered into a partnership agreement with ABCD Technologies LLP which is to be renamed as IndoHealth Services LLP.The two firms are contributing up to Rs 40 crore each corresponding to the contribution by the other p…,neutral,positive,-0.1830384380719951,neutral,-0.6060606060606061,neutral
2021-04-01 09:17:00.000,819.5,824.0,811.6,818.0,1907691.0,3 pharma stocks that could be worth buying: Gurmeet Chadha,"Divis Lab, Neuland Laboratories and Cipla are the three stocks to buy in pharma space, says Complete Circle Consultants co-founder.",positive,positive,-0.1830384380719951,neutral,-0.6060606060606061,neutral
2021-04-06 07:15:00.000,824.0,845.0,821.85,835.7,4559304.0,"Nifty Pharma climbs over 1% amid progress in Covid-19 vaccination drive; Cadila, Cipla, Sun Pharma, Dr Reddy’s top bulls",Nifty Pharma has outperformed benchmark Nifty 50. All stocks listed on Nifty Pharma were in the green.,positive,positive,1.4199029126213647,positive,0.2212521676732671,neutral
2021-04-09 15:25:57.000,840.9,892.3,836.65,886.95,11184938.0,D-Street Buzz: Over 200 Stocks Hit 52-week High On BSE; Pharma Stocks Outshine,"Vimta Labs, Pidilite Industries, Mindtree, NMDC, JK Lakshmi Cement, Infosys, India Cements and Cipla were among the stocks to hit a 52-week high.",neutral,positive,5.476275419193729,positive,2.02247191011236,positive
2021-04-09 19:11:00.000,840.9,892.3,836.65,886.95,11184938.0,"As Covid cases rise, Zydus to scale up Remdesivir production","Companies like Cipla, Mylan, Jubilant Life Sciences, Hetero Drugs, Syngene International and Dr Reddy’s Laboratories are also manufacturing Remdesivir for the Indian market.",positive,neutral,5.476275419193729,positive,2.02247191011236,positive
2021-04-12 05:15:29.000,890.0,940.0,879.15,908.0,30109507.0,Remdesivir exports banned as supply shortage hits hospitals,"Seven Indian firms, including Hetero, Zydus Cadila, Cipla and DRL, make injectible Remdesivir under a licensing deal with Gilead Sciences",neutral,positive,2.02247191011236,positive,-3.5739465263842987,negative
2021-04-12 10:50:00.000,890.0,940.0,879.15,908.0,30109507.0,"Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs",Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade,positive,positive,2.02247191011236,positive,-3.5739465263842987,negative
2021-04-12 12:04:19.000,921.95,932.6,878.3,889.0,11629206.0,Solara Active Pharma Sciences Ltd leads gainers in ‘A’ group,"Suven Life Sciences Ltd, Cipla Ltd, Divis Laboratories Ltd and Ipca Laboratories Ltd are among the other gainers in the BSE’s ‘A’ group today, 12 April 2021.",positive,neutral,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-12 17:46:00.000,921.95,932.6,878.3,889.0,11629206.0,"Nifty Pharma shrugs off bearish markets tone, index climbs 1%; Cipla, Dr Reddy’s lift the performance","Amid lockdown fears, pharma company stocks have become top picks as the Covid-19 vaccination drive also continues in full swing.",positive,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-12 20:12:30.000,921.95,932.6,878.3,889.0,11629206.0,Cipla Q4 PAT Seen Up 147.8% YoY To Rs. 609 Cr: Sharekhan,"Net Sales are expected to increase by 15 percent Y-o-Y (down 2.7 percent Q-o-Q) to Rs. 5,031.7 crore, according to Sharekhan.",neutral,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-13 05:30:00.000,921.95,932.6,878.3,889.0,11629206.0,India’s Cipla doubles remdesivir production to meet ‘unprecedented’ demand,India’s Cipla doubles remdesivir production to meet ‘unprecedented’ demand,positive,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-13 08:07:33.000,921.95,932.6,878.3,889.0,11629206.0,"Trade Spotlight: What Should Investors Do With Cipla, Dr Reddy’s & Infosys?","Some of the stocks in focus were Dr Reddy’s Laboratories, which gained nearly 5 percent with strong volumes, Cipla that rose more than 2 percent, and Infosys which fell 1 percent after hitting a fresh 52-week high.",neutral,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-13 11:16:31.000,921.95,932.6,878.3,889.0,11629206.0,COVID-19 drug manufacturers Cipla and Zydus Cadila scale up Remdesvir’s production,"Indian multinational pharmaceutical company Cipla, one of the manufacturers of Remdesvir in the country, stated that it scaled up production by 2x from the last wave of pandemic. The company is ramping up the production further via its network to meet demand. In addition, Zydus Cadila has increas…",neutral,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-13 13:57:00.000,921.95,932.6,878.3,889.0,11629206.0,Cipla doubles remdesivir production to meet ‘unprecedented’ demand,"“We have scaled up the production of remdesivir by 2x from the last wave of the pandemic,” Cipla said in a statement. “Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network.”",positive,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-13 14:13:33.000,921.95,932.6,878.3,889.0,11629206.0,Cipla Doubles Remdesivir Production To Meet ‘unprecedented’ Demand,"The company is working with authorities to restrict remdesivir supply just to hospitals and places with a high burden of severe COVID-19 cases, Cipla said.",neutral,neutral,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-13 20:16:00.000,921.95,932.6,878.3,889.0,11629206.0,Scaled up remdesivir production two-fold: Cipla,"“We have scaled up the production of remdesivir by 2x from the last wave of the pandemic. Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network, to service the demand,” Cipla said in a statement.",neutral,positive,-3.5739465263842987,negative,1.691143747218519,positive
2021-04-14 00:39:44.000,898.8,925.4,883.9,914.0,13193775.0,Appetite increases for pharma stocks,"Stocks of Dr Reddy’s, Cipla and Cadila Healthcare have already gained 10-14% this month so far",positive,positive,1.691143747218519,positive,2.3430279967382392,positive
2021-04-15 17:00:00.000,919.75,944.25,910.9,941.3,13727353.0,"Thusday’s Bull: Nifty Pharma soars 2% despite fragile markets; Cipla, Cadila, Sun Pharma drive the index",Biocon was the top underperformer of the day tumbling by 1.13% at Rs402.35 per piece dragging the index.,positive,negative,2.3430279967382392,positive,0.5025125628140703,neutral
2021-04-16 17:42:00.000,919.75,944.25,910.9,941.3,13727353.0,"Nifty Pharma trade higher; Auro Pharma, Cadila gain momentum",Cipla also advanced 0.83% while DR Reddys was up 0.73%. Biocon gained 0.59% while Lupin and Sun Pharma traded higher 0.38% and 0.32% respectively.,positive,positive,2.3430279967382392,positive,0.5025125628140703,neutral
2021-04-16 19:49:00.000,919.75,944.25,910.9,941.3,13727353.0,5 pharma stocks that could do well going ahead: Daljit Singh Kohli,"Cipla, Cadila, Dr Reddys, Gland Pharma and Aurobindo Pharma are in the preferred list, says Daljeet Singh Kohli",neutral,neutral,2.3430279967382392,positive,0.5025125628140703,neutral
2021-04-18 15:12:59.000,945.25,955.0,924.0,950.0,17774243.0,Cipla chairman and recent UK study hold out a new (sp)ray of hope in the face of acute Remdesivir shortage,"Maharashtra is on a massive treasure hunt. The treasure? Remdesivir! Typically 5 to 8 vials of the antiviral injection are needed to treat moderate to severe cases of Covid. Heartrending messages like these are circulating on Whatsapp groups everyday, “My friends dad needs Remdesivir urgently he’…",neutral,neutral,0.5025125628140703,neutral,-1.4609884986011834,negative
2021-04-19 18:10:00.000,965.1,966.35,941.1,951.0,10164379.0,"Nifty Pharma Index edges higher despite fragile markets; DR Reddy’s, Cipla lift the performance","Auro Pharma rose nearly 1% while Divis Lab also rallied to gain 0.58%. Biocon dragged the most, shedding 2.10%.",positive,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-19 20:31:00.000,965.1,966.35,941.1,951.0,10164379.0,US respiratory portfolio to drive medium term sales growth for Cipla,"In the domestic market, growth is expected to come from Covid-related drugs",positive,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 00:36:00.000,965.1,966.35,941.1,951.0,10164379.0,Chhattisgarh may sue Cipla for not meeting remdesivir supply requirements,"According to Singh Deo, the Indian pharma major had reneged on the contract signed on April 3 to supply Remdesivir injections to the state",neutral,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 07:40:00.000,965.1,966.35,941.1,951.0,10164379.0,"Nifty Pharma tops 310 pts despite volatile markets; Cadila, Cipla hit new record high; Dr Reddy’s, Aurobindo drive too",Cadila was the top gainer skyrocketing by 7.2% followed by Dr Reddy’s Lab surging by 4.7%.,positive,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 09:18:00.000,965.1,966.35,941.1,951.0,10164379.0,"Buy Cipla, target price Rs 1025: ICICI Securities","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 76314.86 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 10:53:58.000,965.1,966.35,941.1,951.0,10164379.0,"TCS, ACC, Cipla Caplin Point Laboratories: Top Stocks for Investors on April 20","The stock market with indications of opening in red on Tuesday, opened higher amid mixed global cues.",neutral,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 13:32:55.000,965.1,966.35,941.1,951.0,10164379.0,"D-Street Buzz: Pharma Stocks Outperform Led By Dr Reddy’s Labs; Cadila Health, Cipla, Glenmark Hit New 52-week High","S&P BSE Healthcare gained over a percent with the top gainers being RPG Life Sciences which surged over 16 percent followed by Wockhardt, Moepen Labs, Shilpa Medicare, Pfizer, Fortis Healthcare and Dr Reddy’s Labs among others.",neutral,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 14:11:00.000,965.1,966.35,941.1,951.0,10164379.0,Pharma index hits record high as govt launches phase 3 of Covid vaccination,"Cipla, Gland Pharma, JB Chemicals and Pharma, Max Healthcare, Neuland Lab and Apollo Hospital from BSE Healthcare index hit their respective record highs today",positive,positive,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-20 14:29:06.000,965.1,966.35,941.1,951.0,10164379.0,Chhattisgarh government mulls suing Remdesivir’s manufacturer Cipla amid COVID-19,"The Chhattisgarh government is mulling over dragging drug maker Cipla to court. This is over Cipla’s failure to supply Remdesivir, an antiviral drug used for COVID-19 treatment to Chhattisgarh.According to a",neutral,negative,-1.4609884986011834,negative,-1.3871506049228155,negative
2021-04-21 13:56:36.000,958.8,963.15,938.85,945.5,8490510.0,Buy Cipla: Target Of Rs 1100: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated April 16, 2021.",neutral,positive,-1.3871506049228155,negative,-0.8418488907714348,neutral
2021-04-22 13:17:05.000,944.35,952.85,922.75,936.4,7957111.0,Cipla Ltd gains for fifth session,"Cipla Ltd is quoting at Rs 951.5, up 0.23% on the day as on 12:49 IST on the NSE. The stock is up 62.18% in last one year as compared to a 53.8% spurt in NIFTY and a 43.83% spurt in the Nifty Pharma.",positive,positive,-0.8418488907714348,neutral,-2.95532278751603,negative
2021-04-27 16:08:00.000,914.35,918.0,902.95,907.0,7245070.0,MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19,"MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.",positive,positive,-0.8038497293159099,neutral,-0.6524480508799874,neutral
2021-04-27 17:40:19.000,914.35,918.0,902.95,907.0,7245070.0,MSD ties up with 5 Indian pharma majors for supply of oral COVID-19 drug Molnupiravir,"MSD has signed agreements with Cipla Ltd., Dr. Reddy’s Laboratories, Emcure Pharmaceuticals Ltd., Hetero Labs Ltd. and Sun Pharmaceutical Industries Ltd",neutral,positive,-0.8038497293159099,neutral,-0.6524480508799874,neutral
2021-04-28 06:48:52.000,914.35,918.0,902.95,907.0,7245070.0,Remdesivir shortfall likely to ease soon,"Remdesivir is manufactured by seven companies in India—Hetero Drugs, Zydus Cadila, Dr Reddy’s Laboratories, Cipla, Jubilant Pharma, Mylan and Syngene International—under a pact with the drug’s US-based innovator Gilead Sciences Inc",positive,neutral,-0.8038497293159099,neutral,-0.6524480508799874,neutral
2021-04-28 08:29:00.000,914.35,918.0,902.95,907.0,7245070.0,"Dr Reddy’s Lab, Sun Pharma, Cipla among 5 firms in license agreement with Merck for Molnupiravir",Merck will provide licenses to these manufacturers to supply molnupiravir to India and more than 100 LMICs.,neutral,positive,-0.8038497293159099,neutral,-0.6524480508799874,neutral
2021-04-28 10:05:00.000,914.35,918.0,902.95,907.0,7245070.0,Cipla inks deal with MSD to manufacture and distribute Covid-19 drug,"The dug-maker has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir.",positive,positive,-0.8038497293159099,neutral,-0.6524480508799874,neutral
2021-04-28 12:19:00.000,911.95,917.4,904.0,906.0,4941419.0,COVID-19 treatment: 5 Indian drugmakers ink pacts with Merck for molnupiravir,"The company, known as Merck in the US and Canada, has inked pacts with Cipla, Dr Reddy’s Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals",positive,positive,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-28 12:33:00.000,911.95,917.4,904.0,906.0,4941419.0,MSD in talks with Medicines Patent Pool for additional licenses for molnupiravir,"MSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddys, Emcure and Hetero for molnupiravir, an experimental drug that is currently tested to treat Covid-19 infections. Merck is running the clinical trials for molnupiravir with its partne…",positive,positive,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-28 12:48:34.000,911.95,917.4,904.0,906.0,4941419.0,American Pharmaceutical Company Signs Pacts with 5 Indian Drug Firms for Oral Candidate for Covid-19,"Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate “molnupiravir”, which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy’s, Emcure Pharma and Hetero Labs, its Indian arm said on T…",neutral,positive,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-28 15:03:29.000,911.95,917.4,904.0,906.0,4941419.0,Govt sets allocation of Covid drug Tocilizumab to states amid shortage,"Tocilizumab is an imported drug manufactured by Roche, which is being prescribed for treatment of some Covid-19 patients under certain conditions.Fresh limited stock of this drug has now been imported and is available with the lone marketer company Cipla Ltd, the govt says",neutral,neutral,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-28 17:54:00.000,911.95,917.4,904.0,906.0,4941419.0,Cipla signs licensing agreement with MSD,"For manufacture and distribution of Molnupiravir, an investigational oral antiviral drug for treatment of COVID-19",positive,neutral,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-29 01:12:27.000,911.95,917.4,904.0,906.0,4941419.0,Biocon drug itolizumab in demand,"Demand for Biocon Biologics’ itolizumab has jumped three-fold from what it was in the first wave of the covid-19 pandemic, fuelled by a shortage of the imported tocilizumab from Cipla",positive,positive,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-29 01:41:44.000,911.95,917.4,904.0,906.0,4941419.0,Coronavirus | Centre allots fresh stock of Tocilizumab to States,The drug is expensive and Cipla is its sole distributor in India.,neutral,neutral,-0.6524480508799874,neutral,1.0269220094365803,positive
2021-04-29 12:30:00.000,900.75,921.0,900.75,910.0,6445001.0,Bombay High Court dismisses corporates’ plea to form condominium at business park in Mumbai’s Lower Parel,"Cipla, HDFC Bank, Tata Capital had purchased their offices in Peninsula Business Park from Peninsula Land in and around 2012. Peninsula executed a Deed of Declaration dated 9th August 2016 to form a PBP Condominium for all units sold in Peninsula Park under the provisions of Maharashtra Apartment Ow…",neutral,neutral,1.0269220094365803,positive,-1.0989010989011014,negative
2021-05-04 06:45:00.000,912.9,912.9,876.0,881.15,8340794.0,"Tuesday’s Top Bear! Nifty Pharma sheds over 1%; Cipla, Dr Reddy’s Lab, Sun Pharma drag","DR Reddy’s, Cadila, and Sun Pharma, also struggled big time. Alkem Lab was the only pharma company on the NSE to trade higher.",neutral,negative,-3.4779274838426995,negative,0.7118644067796559,neutral
2021-05-04 07:47:00.000,912.9,912.9,876.0,881.15,8340794.0,Consolidation continues on D St; Sensex falls 465 pts; Nifty PSU Bank up 3%,"Nearly 35 of the 50 constituents on the index ended the day in the red including Tata Consumer Products (down 4.3 per cent), Cipla, Reliance Industries, Dr Reddy’s Labs, and Hindalco Industries",positive,neutral,-3.4779274838426995,negative,0.7118644067796559,neutral
2021-05-04 15:46:00.000,885.0,899.0,869.0,891.3,10480302.0,Cipla associate GoApptiv incorporates wholly owned subsidiary Iconphygital,"Since Cipla holds, 21.85% stake of GoApptiv on a fully diluted basis, Cipla will indirectly hold a 21.85 % stake in Iconphygital on a fully diluted basis.",neutral,neutral,0.7118644067796559,neutral,-2.3704520396912896,negative
2021-05-05 18:01:27.000,907.0,916.7,880.9,885.5,17969064.0,"Roche’s COVID-19 Antibody Cocktail Receives Emergency Use Authorisation, Cipla To Distribute The Drug","“The production process for this biologic medicine is very complex and Roche, as one of the largest biologics manufacturers in the world, was selected by its partner Regeneron to expand worldwide production capacity,” Roche said.",neutral,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-05 19:31:00.000,907.0,916.7,880.9,885.5,17969064.0,Cipla to market and distribute Roche’s antibody cocktail (Casirivimab and Imdevimab) in India,For treatment of mild to moderate Covid-19,neutral,neutral,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-05 20:18:47.000,907.0,916.7,880.9,885.5,17969064.0,Coronavirus | Roche gets emergency use approval for investigational drug used in COVID-19 treatment,This will enable Roche to import the globally manufactured product batches to India where it has a partnership with Cipla to market as well as distribute the same,positive,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-05 22:38:43.000,907.0,916.7,880.9,885.5,17969064.0,Roche gets Emergency Use nod for Antibody Cocktail for mild-to-moderate Covid-19,Company to partner with Cipla for pan-India distribution,neutral,neutral,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 00:22:23.000,907.0,916.7,880.9,885.5,17969064.0,India okays Roche’s antibody cocktail,"The authorisation in India will allow Roche to import the manufactured batches of the antibody cocktail of casirivimab and imdevimab, which will be marketed and distributed in India through a strategic partnership with Cipla Ltd",neutral,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 00:45:56.000,907.0,916.7,880.9,885.5,17969064.0,Cipla To Market Roche’s Drug Cocktail To Treat Covid-19 In India,Roche has received emergency approval for an antibody cocktail used to treat mild to moderate Covid-19 infections.,neutral,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 08:21:21.000,907.0,916.7,880.9,885.5,17969064.0,"Buzzing Stocks: Hero Moto, Cipla, Wipro And Others That Will Be In Focus Today",Check out the companies making the biggest headlines before the bell.,neutral,neutral,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 08:39:00.000,907.0,916.7,880.9,885.5,17969064.0,"Tata Steel, Wipro, Cipla to be watched","Tata Steel reported consolidated net profit to Rs 6,644.15 crore in Q4 March 2021 (Q4FY21) as compared with net loss of Rs 1,481.34 crore in Q4 March 2020 (Q4FY20). Total income rose 34.6% to Rs 50,430.36 crore.",neutral,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 09:53:00.000,907.0,916.7,880.9,885.5,17969064.0,India approves Roche’s antibody cocktail to treat COVID-19; Cipla to distribute the drug,The approval was granted by the Central Drugs Standards Control Organisation (CDSO) basis data filed with the US regulators as well as the scientific opinion of a European regulatory panel,neutral,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 10:18:13.000,907.0,916.7,880.9,885.5,17969064.0,KRChoksey Is Bullish On These 6 Stocks For A Upside Of Up To 16%,"SBI Life insurance, Minda Corporation, Cipla and Britannia Industries are among the top picks of the brokerage.",neutral,neutral,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 10:27:00.000,907.0,916.7,880.9,885.5,17969064.0,Cipla gains after deal to market Roche’s drug cocktail to treat Covid-19 in India,Cipla rose 1.10% to Rs 898.50 after the drug major said it will distribute Roche’s antibody cocktail (Casirivimab and Imdevimab) in India.,positive,positive,-2.3704520396912896,negative,-1.007838745800672,negative
2021-05-06 13:00:00.000,893.0,895.5,877.0,884.0,5456684.0,"Top stocks in focus: Cipla, Wipro, Tata Steel, Adani Group, Hero MotoCorp",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.007838745800672,negative,1.0420168067226838,positive
2021-05-06 17:37:00.000,893.0,895.5,877.0,884.0,5456684.0,"Roche bags Emergency Use Authorisation in India for antibody cocktail to treat Covid, Cipla will distribute","With the EUA now in India, Roche will now be able to import the globally manufactured product batches to the country.",neutral,positive,-1.007838745800672,negative,1.0420168067226838,positive
2021-05-09 10:22:00.000,892.5,906.45,877.5,901.8,8362238.0,"Q4 earnings, vaccination among key factors that may guide market this week","Among Nifty stocks, Asian Paints, Lupin, UPL, Vedanta, Cipla, Dr Reddy’s Laboratories, and Larsen & Toubro will announce numbers this week.",neutral,neutral,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 05:30:00.000,892.5,906.45,877.5,901.8,8362238.0,"BRIEF-Pulmatrix Sent Letter To Cipla Technologies Notifying Cipla It Is In Material Breach Of Development & Commercialization Agreement Dated April 15, 2019","BRIEF-Pulmatrix Sent Letter To Cipla Technologies Notifying Cipla It Is In Material Breach Of Development & Commercialization Agreement Dated April 15, 2019",neutral,neutral,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 09:07:29.000,892.5,906.45,877.5,901.8,8362238.0,Cipla enters into licensing pact with Eli Lilly for Baricitinib drug,The company said it will leverage its distribution footprint to make this therapy accessible to more patients and markets.,positive,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 09:09:15.000,892.5,906.45,877.5,901.8,8362238.0,"COVID-19 Treatment: Eli Lilly Partners With Cipla, Lupin, Sun Pharma To Manufacture, Distribute Baricitinib In India",Eli Lilly said it iwa also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses.,neutral,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 09:15:00.000,892.5,906.45,877.5,901.8,8362238.0,Cipla signs licensing agreement with Eli Lilly,For manufacture and commercialization of baricitinib for treatment of Covid-19 in India,positive,neutral,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 09:36:00.000,892.5,906.45,877.5,901.8,8362238.0,"Cipla ties up with Eli Lilly to make, sell Baricitinib to treat COVID-19 patients in India",Baricitinib was issued a restricted emergency use approval by the health ministry’s CDSCO for the use in combination with Remdesivir for treatment of Covid-19,positive,neutral,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 09:45:49.000,892.5,906.45,877.5,901.8,8362238.0,Cipla to make and sell Eli Lilly’s baricitinib to treat COVID-19,Cipla’s deal with Lilly expands the its portfolio of COVID-19 drugs.,neutral,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 10:02:35.000,892.5,906.45,877.5,901.8,8362238.0,"Cipla ties up with US pharma Eli Lilly to make, sell Baricitinib for COVID-19 treatment in India","Cipla Ltd has entered into a licensing agreement with American pharma company Eli Lilly to expand access to COVID-19 treatment in India.The Mumbai-based company said it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly for baricitinib.In a filing,…",positive,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 10:06:00.000,892.5,906.45,877.5,901.8,8362238.0,"Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly’s COVID-19 drug",Lilly said the company is also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses. These voluntary licensing agreements will ensure high quality manufacturing and accessibility of Baricitinib,neutral,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 10:18:00.000,892.5,906.45,877.5,901.8,8362238.0,India’s Cipla to make and sell Eli Lilly’s baricitinib to treat COVID-19,"Baricitinib has been given restricted emergency use approval by India’s drug regulator for use in combination with remdesivir for the treatment of hospitalised COVID-19 adult patients requiring supplemental oxygen, Cipla said in a filing to stock exchanges.",neutral,negative,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 10:26:00.000,892.5,906.45,877.5,901.8,8362238.0,Cipla gains on licensing agreement with Eli Lilly for Covid drug baricitinib,Cipla rose 1.09% to Rs 892.60 after the drug major entered into a licensing agreement with Lilly to expand access to Covid-19 treatment in India.,positive,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 11:08:30.000,892.5,906.45,877.5,901.8,8362238.0,COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly’s baricitinib in India,Cipla on Monday announced that it has signed an agreement with Eli Lilly and Company to manufacture baricitinib for COVID-19 treatment.,neutral,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 11:14:00.000,892.5,906.45,877.5,901.8,8362238.0,"Cipla inks pact with Eli Lilly to produce, sell Covid-19 treatment drug",Drug major Cipla on Monday said it has inked a pact with US-based Eli Lilly and Company to manufacture and produce baricitinib in the country for the treatment of Covid-19,positive,positive,1.0420168067226838,positive,-0.950052780710047,negative
2021-05-10 12:49:10.000,899.95,905.95,888.2,891.4,5843659.0,Covid treatment: Cipla gains on licensing pact with Eli Lilly,Signs agreement for manufacture and commercialisation of drug baricitinib,positive,positive,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-10 14:16:27.000,899.95,905.95,888.2,891.4,5843659.0,"Lilly signs agreements with Cipla, Lupin and Sun Pharma for Baricitinib",US pharma also in discussions with other Indian manufacturers to grant additional licences,positive,positive,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-10 15:04:00.000,899.95,905.95,888.2,891.4,5843659.0,Cipla signs agreement with Eli Lilly to expand access of Baricitinib drug,This collaboration is a step further in Cipla’s efforts to enhance access to critical treatments for patients affected by the pandemic.,positive,positive,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-10 16:14:02.000,899.95,905.95,888.2,891.4,5843659.0,Lilly issues voluntary licences to firms to speed up availability of baricitinib,"The royalty-free, non-exclusive voluntary licences have been issued to Cipla, Lupin and Sun Pharmaceutical Industries Ltd",neutral,neutral,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-11 00:53:00.000,899.95,905.95,888.2,891.4,5843659.0,"Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug","Olumiant, or Baricitinib, is an oral drug developed by US biopharmaceutical major, Incyte Corporation, and licensed to Eli Lilly",positive,neutral,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-11 07:00:32.000,899.95,905.95,888.2,891.4,5843659.0,"Cipla, Lupin, Sun Pharma sign deals to make Lilly’s Covid drug","These voluntary licensing pacts will ensure high-quality manufacturing and accessibility of baricitinib during the pandemic, improving the local treatment options available to those battling by the deadly infection, the company said in a statement.",positive,positive,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-11 07:47:00.000,899.95,905.95,888.2,891.4,5843659.0,"Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India","As the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements that might potentially help them stave off demands for compulsory licence from activists, and questions from courts.",positive,neutral,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-11 08:51:00.000,899.95,905.95,888.2,891.4,5843659.0,"Morning Brief: Pat(i)ent rights: Will waiver of IP rights on Covid vaccines, drugs help developing nations like India? | The Economic Times Podcast","A waiver of intellectual property rights on Covid-19 vaccines and drugs alone may not benefit developing countries including India in the battle against the deadly disease. Murali Neelakantan, former global general counsel of Cipla and Glenmark, and Vikas Dandekar, Editor, ET Prime, explain what’s a…",neutral,neutral,-0.950052780710047,negative,1.2031935229956197,positive
2021-05-11 12:47:00.000,889.3,906.75,884.3,900.0,5211508.0,Sun Pharma share hits new 52-week high after firm wins licence to make Covid-19 drug,"The three Indian drugmakers - Cipla Ltd, Lupin Ltd, and Sun Pharma will collaborate with Lilly to manufacture and distribute Baricitinib in India. The drug is approved by the Central Drugs Standard Control Organization (CDSCO) for restricted emergency use in India",positive,positive,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-11 15:53:00.000,889.3,906.75,884.3,900.0,5211508.0,Largecap-focussed PMSes lagged in April; midcap specialists fared better,"Kotak AMC Pharma Fund finished as the top performer of the month, returning 13.39 per cent. Sun Pharma, Dr Reddys Labs, Cipla, Cadila Healthcare and Aurobindo Pharma were the top five holdings in its portfolio.",positive,positive,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-11 20:17:11.000,889.3,906.75,884.3,900.0,5211508.0,"Mumbai: Khar bizman duped of Rs 40,800 for Remdesivir vials by man posing as Cipla Foundation employee","A businessman from Khar was allegedly duped to the tune of ₹40,800 on the pretext of procuring Remdesivir injection for a relative through a Cipla Foundation employee. The victim was asked to make an online payment to receive the package, but only to be cheated. The accused has been booked…",neutral,neutral,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-11 23:13:14.000,889.3,906.75,884.3,900.0,5211508.0,Karnataka Warns Cipla and Jubilant of Legal Action for Supplying Lesser Quantity of Remdesivir,The Karnataka government on Tuesday served notices to pharmaceutical majors Cipla and Jubilant warning them of legal proceedings for not supplying adequate quantities of Remdesivir injection bottles as directed by the Government of India.,neutral,negative,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-12 00:19:38.000,889.3,906.75,884.3,900.0,5211508.0,"Stocks to watch out: Cipla, Jubilant Life Sciences, Godrej Consumer Products, Siemens, Dr Reddy’s among others","During the second wave of COVID-19, stocks of pharmaceutical, oxygen and other companies involved in tackling COVID-19 have been in focus. But today, there may be some pharmaceutical stocks that may draw more attention of investors.Given is the list of stocks:",neutral,neutral,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-12 17:42:00.000,889.3,906.75,884.3,900.0,5211508.0,"Market Wrap Podcast, May 12: Here’s all that happened in the markets today","Tata Motors, PowerGrid, Titan Company, Maruti Suzuki, UPL, Cipla, State Bank of India, and NTPC were the top gainers on the 50-share index today, up between 1 per cent and 3 per cent",neutral,positive,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-12 21:34:13.000,889.3,906.75,884.3,900.0,5211508.0,Karnataka threatens action against Cipla and Jubilant,Issues notice to the companies for failure to supply requisite quantity of Remdesivir to the State as directed by the Centre,neutral,neutral,1.2031935229956197,positive,-0.5390539053905365,neutral
2021-05-13 09:25:21.000,909.0,921.0,900.8,904.1,15010269.0,"Eli Lilly Gives Out Licences For COVID-19 Drug Baricitinib To Dr Reddy’s, Torrent Pharma And MSN Labs","Lilly has so far given six licenses for Baricitinib in India. On May 10, the American pharma company signed agreements with Cipla, Lupin and Sun Pharmaceutical Industries.",neutral,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 05:30:00.000,909.0,921.0,900.8,904.1,15010269.0,BRIEF-India’s Cipla March-Quarter Consol Net Profit Jumps,BRIEF-India’s Cipla March-Quarter Consol Net Profit Jumps,neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 07:17:30.000,909.0,921.0,900.8,904.1,15010269.0,"Hot Stocks: Here’s Why MGL, Maruti Suzuki & Cipla Are Top Stocks To Buy On Friday","Support for the Nifty Index is placed at 14450 levels while resistance rests near 14950, says Patil.",neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 07:43:00.000,909.0,921.0,900.8,904.1,15010269.0,"Stocks in news: L&T, Cipla, DRL, Vedanta, Happiest Minds and Macrotech Developers","Balkrishna Industries, Macrotech Developers, Oberoi Realty, Escorts and SKF India are among companies that will announce their March quarter results today.",neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 08:01:34.000,909.0,921.0,900.8,904.1,15010269.0,"Stocks to Watch: Dr Reddy’s, Tata Power, Jindal Steel, Airtel, Happiest Minds","Among major companies that will report their March quarter earnings are Cipla, Dr Reddy’s, and Larsen & Toubro. Jindal Stainless, Aditya Birla Capital, Balkrishna Industries, , Macrotech Developers and Welspun India are a few other companies that will also declare their results today",neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 08:09:00.000,909.0,921.0,900.8,904.1,15010269.0,"Market Ahead Podcast, May 14: Top factors that could guide markets today","A total of 41 companies, including Larsen & Toubro, Dr Reddy’s Laboratories, Cipla, Aditya Birla Capital, Macrotech Developers and Welspun India are scheduled to release their quarterly results today",neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 08:17:06.000,909.0,921.0,900.8,904.1,15010269.0,"L&T, Cipla, Lupin, Dr Reddy’s, Vedanta, GAIL, Tata Power, Reliance Infrastructure stocks in focus","Nifty futures were trading 191.50 points or 1.32 per cent higher at 14,699 on Singaporean Exchange, indicating a strong opening for BSE Sensex and Nifty 50",neutral,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 12:55:30.000,909.0,921.0,900.8,904.1,15010269.0,COVID-19 crisis: Centre increases import of Tocilizumab injection amid high demand,Tocilizumab injections are manufactured by the Roche Company of Switzerland and imported and marketed by Cipla Ltd in India.,positive,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 13:21:00.000,909.0,921.0,900.8,904.1,15010269.0,"Top stocks in focus: JSPL, UPL, Infosys, Torrent Pharma, L&T, Cipla, Dr. Reddy’s",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 19:01:00.000,909.0,921.0,900.8,904.1,15010269.0,Cipla Q4 results: Consolidated PAT rises 68% YoY to Rs 413 cr; firm to pay Rs 5 dividend,"The companys consolidated revenues for the quarter rose 5.2 per cent on-year to Rs. 4,606.45 crore, which was also sharply below Streets estimate.",positive,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 19:17:32.000,909.0,921.0,900.8,904.1,15010269.0,"Cipla Q4 Profit Jumps 72% To Rs 411.5 Crore, Misses Estimates On All Earnings Parameters",Emerging markets registered a 4 percent YoY growth in revenue and Europe showed a 7 percent growth in March 2021 quarter.,neutral,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 19:28:00.000,909.0,921.0,900.8,904.1,15010269.0,"Cipla Q4 profit up 73% at Rs 412 cr, total revenue at Rs 4,606 cr","Drug major Cipla on Friday posted 73 per cent rise in consolidated net profit at Rs 412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets.",positive,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 19:46:12.000,909.0,921.0,900.8,904.1,15010269.0,Results: Cipla Q4 profit up 73% at Rs 412 crore,"Drug major Cipla on Friday posted 73 per cent rise in consolidated net profit at Rs 412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets.The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20.Total revenue…",positive,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 19:46:16.000,909.0,921.0,900.8,904.1,15010269.0,Cipla Q4 profit up 73% at ₹412 crore,"Total revenue from operations rose to ₹4,606 crore as compared with ₹4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing",positive,positive,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 20:00:36.000,909.0,921.0,900.8,904.1,15010269.0,"Cipla Standalone March 2021 Net Sales At Rs 3,233.12 Crore, Up 3.18% Y-o-Y",,neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-14 20:11:50.000,909.0,921.0,900.8,904.1,15010269.0,"Cipla Consolidated March 2021 Net Sales At Rs 4,606.45 Crore, Up 5.26% Y-o-Y",,neutral,neutral,-0.5390539053905365,neutral,-1.273743016759774,negative
2021-05-16 22:55:30.000,895.0,905.0,870.0,883.6,13959510.0,Cipla looks to expand its covid-19 portfolio over next two months,Cipla Ltd is gearing up to expand its wide portfolio of covid-19 drugs over the next two months with the expected launch of Regeneron Pharmaceuticals Inc,positive,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 00:02:00.000,895.0,905.0,870.0,883.6,13959510.0,Cipla open to forge a partnership to distribute Covid-19 vaccines in India,"The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche’s tocilizumab (Actemra)",positive,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 00:47:36.000,895.0,905.0,870.0,883.6,13959510.0,"Stocks to watch today: L&T, SKF India, Camlin Fine Sciences, Cipla, Aditya Birla Capital, Bata India, Escorts, Thyrocare, Shriram City Union, Hero MotoCorp among others","Some companies happened to perform well despite COVID-19 and subsequent lockdown. So, those companies can be of investors’ interest.Here is the list of stocks for Monday:Camlin Fine Sciences: Mumbai-based Camlin Fine Sciences has acquired Tamil Nad…",neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 07:16:00.000,895.0,905.0,870.0,883.6,13959510.0,"DRL, Cipla’s healthy outlook offsets Q4 slip, will help retain investor interest","For DRL, the US business failed to generate growth compared to the previous year partly due to high base effect as well as price erosion. India sales grew 15% over the year-ago level, aided by sales from the acquired business of Wockhardt and new product launches.",positive,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 07:35:00.000,895.0,905.0,870.0,883.6,13959510.0,Nifty Pharma index under pressure; Cipla tanks ~3%; Torrent Pharma leads,Sun Pharma declined nearly 1% at Rs685.00 per piece while Biocon was also 0.75% on the downside.,neutral,negative,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 07:57:10.000,895.0,905.0,870.0,883.6,13959510.0,"Buzzing Stocks: L&T, Cipla, Bharti Airtel And Others That Will Be In Focus Today",Check out the companies making the biggest headlines before the bell.,neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:00:16.000,895.0,905.0,870.0,883.6,13959510.0,"Stocks to Watch: Adani Green, Bharti Airtel, Cipla, Hero Moto, L&T, Wipro, PNB","Bharti Airtel is the Nifty company that will announce its March quarter earnings on Monday. 3i Infotech, Federal Bank, Gland Pharma, Mangalore Refinery, Sun Pharma Advanced are among other companies that will declare their results today",neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:08:48.000,895.0,905.0,870.0,883.6,13959510.0,"Bharti Airtel, Cipla, SBI, Gland Pharma, Tata Motors, L&T, Jindal Stainless stocks in focus",Monday could start on a positive note for domestic indices with the SGX Nifty gaining 58 points or 0.39 per cent on Singaporean Exchange during the early hours of trade.,neutral,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:09:00.000,895.0,905.0,870.0,883.6,13959510.0,"Stocks in the news: L&T, Airtel, Federal Bank, SBI, YES Bank and Cipla","Gland Pharma, Colgate Palmolive, Subex, Indo Count Industries, SPARC and Shakti Pumps are among companies that will announce their March quarter results today.",neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:22:00.000,895.0,905.0,870.0,883.6,13959510.0,"Stocks in focus: L&T, Cipla, SKF India, Indigo Paints and more",Here are the top stocks that are likely to be in focus in today’s trading.,neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:34:00.000,895.0,905.0,870.0,883.6,13959510.0,"Stocks to watch: Bharti Airtel, L&T, Cipla, Geojit Financial, Hero MotoCorp","Punjab National Bank (PNB) on Saturday said it has raised Rs 1,800 crore by selling 53 crore shares on a private placement basis to investors like LIC and Societe Generale",neutral,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:34:34.000,895.0,905.0,870.0,883.6,13959510.0,"Nifty may trade in 14,400-15,000 range this week, Bank Nifty below 20, 50, 100 day SMAs; Wipro, Cipla in focus",The chart pattern suggests that if Bank Nifty crosses and sustains above 33000 level it would witness buying which would lead the index towards 33500-34500 levels.,neutral,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 08:42:00.000,895.0,905.0,870.0,883.6,13959510.0,"L&T, Cipla, Hero MotoCorp in focus","Larsen & Toubro (L&T) reported 3% rise in consolidated net profit to Rs 3,293 crore on 9% increase in revenues to Rs 48,088 crore in Q4 FY21 over Q4 FY20.",neutral,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 09:37:04.000,895.0,905.0,870.0,883.6,13959510.0,Cipla Share Price Down 3% After Q4 Earnings Misses Expectations,Here’s what brokerages have to say about the stock and the company post Q4 results,neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 09:42:00.000,895.0,905.0,870.0,883.6,13959510.0,"Stocks in news: Bharti Airtel, Mphasis, Cipla, Hero MotoCorp and more","Stocks in news: Bharti Airtel, Mphasis, Cipla, Hero MotoCorp, Punjab National Bank, Adani Green Energy and more",neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 09:50:09.000,895.0,905.0,870.0,883.6,13959510.0,Cipla Q4 Review - Misses Estimates; Focus Remains Intact: ICICI Direct,Cipla Q4 Review - Misses Estimates; Focus Remains Intact: ICICI Direct,neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 10:08:00.000,895.0,905.0,870.0,883.6,13959510.0,"Neutral on Cipla, target price Rs 840: Motilal Oswal","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 72908.31 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 10:14:44.000,895.0,905.0,870.0,883.6,13959510.0,Cipla share price falls 3% post Q4 earnings. Here’s what brokerages say,The drug major reported a 73% rise in consolidated net profit at ₹412 crore against ₹238 crore in the same quarter last year.,negative,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 10:18:00.000,895.0,905.0,870.0,883.6,13959510.0,Cipla Q4 PAT rises 68% YoY to Rs 413 cr,"On a consolidated basis, the drug major’s net profit surged 68.1% to Rs 413.38 crore on 6.6% rise in net sales to Rs 4584.88 crore in Q4 FY21 over Q4 FY20.",positive,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 10:22:00.000,895.0,905.0,870.0,883.6,13959510.0,Cipla dips 4% on lower than expected March quarter earnings,The company’s performance in Q4FY21 was weighed by moderate YoY growth in India Domestic Formulation (DF)/South Africa and decline in API sales for the quarter,negative,negative,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 10:37:27.000,895.0,905.0,870.0,883.6,13959510.0,"Top Stocks For Investors Today: L&T, Cipla, Hero MotoCorp and Others",Indian markets are expected to open in the green on Monday amid strong global cues.,neutral,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 10:46:09.000,895.0,905.0,870.0,883.6,13959510.0,"Cipla — While COVID Scope Continues, Watch Out For FY23","Just when it seemed that Covid tailwinds are waning for Cipla, the drug maker has repositioned itself for the opportunities emerging from the second wave of the pandemic",neutral,positive,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 11:26:00.000,895.0,905.0,870.0,883.6,13959510.0,Cipla stock slips 3% despite 73% rise in Q4 profit,"Cipla stock touched an intraday low of Rs 870, falling 3.77% on BSE",negative,negative,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 11:59:00.000,895.0,905.0,870.0,883.6,13959510.0,"Results Review For Larsen & Toubro, Dr. Reddy’s Labs, Cipla, Escorts","Results Review For Larsen & Toubro, Dr. Reddy’s Labs, Cipla, Escorts",neutral,neutral,-1.273743016759774,negative,-0.0958286358511863,neutral
2021-05-17 12:33:00.000,887.0,888.35,878.45,886.15,5112168.0,"Eli Lilly buckles under pressure, offers voluntary licence to Natco Pharma","Lily has issued voluntary licenses for Barcitinib to six Indian drug makers besides Natco, these include- Sun Pharma, Cipla, Dr Reddy’s, Lupin, Torrent Pharma and MSN Labs. Barcitinib, in combination with Remdesivir, received emergency approval last year from the USFDA for treatment of hospitalized …",positive,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-17 13:05:00.000,887.0,888.35,878.45,886.15,5112168.0,"Top stocks in focus: Hero MotoCorp, Cipla, Larsen & Toubro, IDBI Bank, Bharti Airtel",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-17 14:29:11.000,887.0,888.35,878.45,886.15,5112168.0,"Coronavirus Pandemic | Cipla To Expand Portfolio For COVID-19 Drugs Over Next Two Months, Says CFO",Swiss company Regeneron has signed with Cipla for exclusive distribution of its imported antibody cocktail in India.,neutral,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-17 15:22:12.000,887.0,888.35,878.45,886.15,5112168.0,Eli Lilly in pact with Natco Pharma for Baricitinib drug used to treat Covid 19,"It also has licence agreements with Cipla, Lupin, Sun Pharma, Dr. Reddy’s, MSN Laboratories and Torrent Pharma for the drug",positive,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-17 16:57:00.000,887.0,888.35,878.45,886.15,5112168.0,Cipla posts 68% yoy rise in Q4 PAT to Rs413cr; US biz reports revenue of $138M,"Consolidated revenue from operations increased by 5% to Rs4,606cr in the quarter under review against Rs4,376cr of Q4FY20.",positive,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-17 18:38:42.000,887.0,888.35,878.45,886.15,5112168.0,"Cipla - Inventory Write-Off Impacts Q4, Progress On Inhalation Assets Key Driver: Dolat Capital","Cipla - Inventory Write-Off Impacts Q4, Progress On Inhalation Assets Key Driver: Dolat Capital",neutral,neutral,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-17 22:19:07.000,887.0,888.35,878.45,886.15,5112168.0,Cipla stock corrects after a disappointing March quarter,"Despite US sales rising 17% on a year-on-year basis, Cipla’s revenues still grew just 5% year-on-year",neutral,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-18 00:59:00.000,887.0,888.35,878.45,886.15,5112168.0,"Analyst Corner: Maintain ‘buy’ on Cipla, raise TP to Rs 1,065",US on a steady growth path; sizeable launches lined up in FY23: Cipla continues to see strong traction for its gProventil (albuterol inhaler) launch in the US where it has garnered 13.2% volume share. 4Q US sales at $138 m declined 2% qoq on lack of meaningful launches.,positive,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-18 07:23:00.000,887.0,888.35,878.45,886.15,5112168.0,Analysts expect Cipla to return up to 30% from here on as India biz gains momentum,Kotak Securities said the expansion of the Covid portfolio would support near-term earnings while the continued rollout of respiratory franchisee in the US and strong execution of One India strategy will drive the company’s earnings growth over FY23-24.,positive,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-18 07:30:00.000,887.0,888.35,878.45,886.15,5112168.0,Nifty Pharma trades lower; Torrent Pharma dips ~1.5% ahead of earnings,Sun Pharma led the marginal gains (0.06%) followed by Cipla (0.02%).,negative,positive,-0.0958286358511863,neutral,1.7232640648758184,positive
2021-05-18 13:59:00.000,887.85,905.95,881.0,903.15,7233438.0,"Core portfolio of Cipla very strong, momentum intact: Umang Vohra","India will need a stockpile of Covid drugs to prepare for the next wave, says the Cipla Global CEO.",positive,neutral,1.7232640648758184,positive,2.152317880794702,positive
2021-05-19 07:52:00.000,887.85,905.95,881.0,903.15,7233438.0,"Sensex slips 291 pts amid weak global cues; pharma, PSB stocks rally","Coal India, Cipla, Sun Pharma, UPL, Nestle India, Indian Oil Corporation, Tech M, Axis Bank, and SBI Life were the top gainers of the day",negative,neutral,1.7232640648758184,positive,2.152317880794702,positive
2021-05-19 18:25:00.000,906.0,927.9,905.0,925.5,12359861.0,Nifty Pharma stocks outperform; Torrent Pharma leads gain on earnings,"Lupin, Cadila, Cipla and Sun Pharma also gained around 1.5% to lift the performance of the sector.",positive,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-19 19:08:00.000,906.0,927.9,905.0,925.5,12359861.0,"Cipla allots 26,338 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,29,86,788/- comprising of 80,64,93,394 equity shares of face value Rs.2/- each.",neutral,neutral,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 09:03:55.000,906.0,927.9,905.0,925.5,12359861.0,Cipla launches polymerase chain reaction test kit ‘ViraGen’ for Covid-19,ViraGen is a real-time detection kit approved by the Indian Council of Medical Research and is based on multiplex PCR technology.,neutral,neutral,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 09:08:00.000,906.0,927.9,905.0,925.5,12359861.0,Cipla launches RT-PCR test kit ‘ViraGen’ for COVID-19 in India,In partnership with Ubio Biotechnology Systems,neutral,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 09:18:00.000,906.0,927.9,905.0,925.5,12359861.0,"Markets close bearish; Sensex sheds 340 pts, Nifty 50 holds 14,920; Metal nosedives; M&M, Cipla top bulls","Except for PSU Bank and Realty, all other sectoral indices settled lower on Indian exchanges.",neutral,negative,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 10:30:00.000,906.0,927.9,905.0,925.5,12359861.0,Cipla launches COVID-19 real-time test kit ‘ViraGen’; to be sold from May 25,‘ViraGen’ is the third COVID-19 testing kit by Cipla as the pharma major already has partnerships for antibody detection kit and antigen test kits,neutral,neutral,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 10:33:19.000,906.0,927.9,905.0,925.5,12359861.0,Cipla Share Price Gains On Launching Polymerase Chain Reaction Test Kit,ViraGen is Cipla’s third offering in the Covid-19 testing segment.,neutral,neutral,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 11:03:00.000,906.0,927.9,905.0,925.5,12359861.0,Cipla launches RT-PCR test kit ‘ViraGen’ in India partnership with Ubio Biotech,"Umang Vohra, MD and Global CEO, Cipla, said, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19. Guided by our core purpose of ‘Caring for Life’, this partnership will enable us to reach out to more people across the country at a crucial time li…",positive,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 11:09:23.000,906.0,927.9,905.0,925.5,12359861.0,Cipla Launches RT-PCR Test Kit ‘ViraGen’ In India Partnership With Ubio Biotech,"“This launch will help address the current testing services and capacity issues while reaffirming the company’s ongoing expansion in the diagnostic space,” Cipla said in a regulatory filing.",neutral,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 11:15:00.000,906.0,927.9,905.0,925.5,12359861.0,"Cipla, Ubio Biotech launches RT-PCR test kit ‘ViraGen’ for Covid in India","Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit ‘ViraGen’ for Covid-19 in India, in partnership with Ubio Biotechnology Systems",neutral,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 11:23:08.000,906.0,927.9,905.0,925.5,12359861.0,"Cipla Q4 Review: Analysts See Covid-19 Products, U.S. Inhaler Pipeline Key Catalysts",Cipla shares are on a three-session gaining streak.,neutral,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 11:52:56.000,906.0,927.9,905.0,925.5,12359861.0,"Cipla Launches New Covid-19 RT-PCR Test Kit ‘Vira-Gen’, To be Sold From May 25","Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit ‘ViraGen’ for Covid-19 in India, in partnership with Ubio Biotechnology Systems.",neutral,positive,2.152317880794702,positive,-0.4247311827957038,neutral
2021-05-20 12:24:16.000,930.0,935.0,922.3,926.05,6711847.0,"Cipla launches RT-PCR test kit ‘ViraGen’ in India, partnership with Ubio Biotech",ViraGen is Cipla’s third offering in the COVID-19 testing segment.,positive,neutral,-0.4247311827957038,neutral,0.2148227712137486,neutral
2021-05-20 13:32:23.000,930.0,935.0,922.3,926.05,6711847.0,Cipla Ltd gains for third straight session,"Cipla Ltd is quoting at Rs 922.3, up 2.03% on the day as on 12:49 IST on the NSE. The stock is up 49.58% in last one year as compared to a 64.77% jump in NIFTY and a 47.14% jump in the Nifty Pharma index.",positive,positive,-0.4247311827957038,neutral,0.2148227712137486,neutral
2021-05-20 15:02:00.000,930.0,935.0,922.3,926.05,6711847.0,Cipla with Ubio Biotechnology launches ‘ViraGen’ a polymerase chain reaction (RT-PCR) test for Covid,Strengthens offerings & continues to be at the forefront of COVID care.,neutral,positive,-0.4247311827957038,neutral,0.2148227712137486,neutral
2021-05-24 07:44:00.000,931.0,945.5,926.15,933.0,6410818.0,"Nifty Pharma holds steady amid slowdown in Covid resurge, vaccination progress; Cadila, Dr Reddy’s, Cipla lead","The index has touched an intraday high and low of 14,171.40 and 14,016.65 respectively.",positive,negative,0.2148227712137486,neutral,-0.3884425051880995,neutral
2021-05-24 09:18:00.000,931.0,945.5,926.15,933.0,6410818.0,Cipla to distribute Antibody Cocktail (Casirivimab and Imdevimab) in India,Used in treatment of mild to moderate Covid-19 in adults and pediatric patients (12 years and older),neutral,neutral,0.2148227712137486,neutral,-0.3884425051880995,neutral
2021-05-24 11:03:38.000,931.0,945.5,926.15,933.0,6410818.0,"Roche’s Antibody Cocktail launched in India at Rs 59,750/dose; Cipla to market drug in country","Drug majors Roche India and Cipla on Monday announced launch of Roche’s Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk.“The first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now avail…",neutral,neutral,0.2148227712137486,neutral,-0.3884425051880995,neutral
2021-05-24 11:26:04.000,931.0,945.5,926.15,933.0,6410818.0,"COVID-19 Treatment: Roche, Cipla Launch Antibody Cocktail Casirivimab And Imdevimab In India","The price for each patient dose [a combined dose of 1200 mg (600 mg of Casirivimab and 600 mg of Imdevimab) will be Rs 59,750 inclusive of all taxes.",neutral,neutral,0.2148227712137486,neutral,-0.3884425051880995,neutral
2021-05-24 12:11:50.000,939.65,940.0,930.0,936.0,3684750.0,"Roche’s antibody cocktail launched in India at ₹59,750/dose",Cipla to market drug in country,neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 12:17:00.000,939.65,940.0,930.0,936.0,3684750.0,Why Natco Pharma share zoomed 20% today,"Presently six firms - BDR Pharma, Bharat Serums and Vaccines, Mylan, Sun Pharma, Cipla, and Life Care - are producing Amphotericin B",neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 13:01:13.000,939.65,940.0,930.0,936.0,3684750.0,"Roche’s Antibody Cocktail Launched in India at Rs 59,750/dose; Cipla to Market Drug in Country","The price for each patient dose [a combined dose of 1,200 mg (600 mg of Casirivimab and 600 mg of Imdevimab)] will be Rs 59,750 inclusive of all taxes.",neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 13:17:02.000,939.65,940.0,930.0,936.0,3684750.0,"Cipla Ltd spurts 0.28%, gains for five straight sessions","Cipla Ltd is quoting at Rs 929.5, up 0.28% on the day as on 12:49 IST on the NSE. The stock is up 48.08% in last one year as compared to a 68.3% gain in NIFTY and a 48.21% gain in the Nifty Pharma.",positive,positive,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 13:42:50.000,939.65,940.0,930.0,936.0,3684750.0,"Cipla, Roche launch covid-19 antibody cocktail at ₹59,750 per dose",An antibody cocktail is a mixture of two or more unique biological drugs that act like human antibodies in the immune system and help fight off infection,neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 13:54:00.000,939.65,940.0,930.0,936.0,3684750.0,Cipla to market Roche’s Antibody Cocktail in India,"Cipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint statement.",neutral,positive,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 15:05:00.000,939.65,940.0,930.0,936.0,3684750.0,"Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India",Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk of severe Covid.,neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-24 23:42:37.000,939.65,940.0,930.0,936.0,3684750.0,Cipla launches Roche’s Covid antibody cocktail in India for Rs 60k per dose,The antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate Covid-19 in adults and pediatric patients,neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-25 07:56:16.000,939.65,940.0,930.0,936.0,3684750.0,Cipla’s RT-PCR test kit ‘ViraGen’ to be sold from today,ViraGen is a real-time detection kit approved by the ICMR and is based on multiplex PCR technology,neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-25 08:08:03.000,939.65,940.0,930.0,936.0,3684750.0,"Stocks to Watch: Cadila, Cipla, DHFL, Panacea Biotec, Yes Bank",Lenders to bankrupt Dewan Housing Finance Ltd (DHFL) on Monday filed an appeal in the NCLAT challenging Mumbai bench of NCLT’s order that has asked them evaluate an offer by DHFL’s erstwhile promoter Kapil Wadhawan,neutral,positive,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-25 08:36:23.000,939.65,940.0,930.0,936.0,3684750.0,"Reliance Home, India Cements, Bharti Airtel, Cadila, Cipla, Panacea Biotec, Alembic Pharma stocks in focus","Nifty futures were trading 145 points or 0.95 per cent higher at 15,335 on Singaporean Exchange, suggesting a strong opening for BSE Sensex and Nifty 50",neutral,positive,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-25 08:50:41.000,939.65,940.0,930.0,936.0,3684750.0,Cipla’s Real-time Covid-19 Testing Kit ‘ViraGen’ to Make Market Debut Today,"A real-time Covid-19 testing kit, launched last week pharmaceutical major Cipla, will hit the markets today.",neutral,neutral,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-25 09:23:31.000,939.65,940.0,930.0,936.0,3684750.0,"Top Stocks to Watch Today: Cipla, Grasim Industries and Others",Indian benchmark indices are expected to open in green on Tuesday following gains in global peers.,neutral,positive,-0.3884425051880995,neutral,0.5207226354941528,neutral
2021-05-25 14:22:15.000,941.0,951.95,939.05,945.9,5426257.0,Buy Cipla; Target Of Rs 940: Dolat Capital Market,"Dolat Capital Market is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated May 15, 2021.",neutral,positive,0.5207226354941528,neutral,-0.2114164904862579,neutral
2021-05-25 20:36:00.000,941.0,951.95,939.05,945.9,5426257.0,Pfizer ready with 50 mn doses for India; Moderna jab likely in 2022: Report,"Moderna plans to launch its single-dose vaccine for the Indian market only in 2022, for which, they are in discussion with Cipla and other Indian companies, a source said",neutral,neutral,0.5207226354941528,neutral,-0.2114164904862579,neutral
2021-05-25 22:56:43.000,941.0,951.95,939.05,945.9,5426257.0,Moderna’s single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021,"New Delhi: Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including …",neutral,neutral,0.5207226354941528,neutral,-0.2114164904862579,neutral
2021-05-26 00:59:55.000,941.0,951.95,939.05,945.9,5426257.0,Moderna’s single-dose vaccine likely next year; Pfizer ready with 5cr doses for 2021,"Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said o…",neutral,positive,0.5207226354941528,neutral,-0.2114164904862579,neutral
2021-05-26 06:49:15.000,941.0,951.95,939.05,945.9,5426257.0,"Moderna to launch single-dose COVID-19 vaccine in India in 2022, Pfizer ready to offer 5 crore doses this year","Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said o…",positive,positive,0.5207226354941528,neutral,-0.2114164904862579,neutral
2021-05-26 07:45:00.000,941.0,951.95,939.05,945.9,5426257.0,Nifty Pharma gains momentum in trade; Sun Pharma and Cipla lead gains,"Lupin, Torrent Pharma, and DR Reddy’s were under pressure.",positive,neutral,0.5207226354941528,neutral,-0.2114164904862579,neutral
2021-05-26 16:12:06.000,946.0,948.75,934.05,944.0,6241671.0,Casirivimab-Imdevimab antibody cocktail is new weapon against Covid-19: Medanta Chairman Dr Naresh Trehan,"Mumbai, May 26: Pharma companies Roche India and Cipla on May 24 announced the availability of the first batch of the antibody cocktail (Casirivimab and Imdevimab) in India for the treatment of mild to moderate COVID-19 in patients who are at high risk. The Central Drugs Standard…",neutral,neutral,-0.2114164904862579,neutral,-0.6700701978302561,neutral
2021-05-27 10:00:00.000,946.0,948.75,934.05,944.0,6241671.0,India’s Zydus Cadila seeks human trial approval for COVID-19 antibody cocktail,"Regeneron and Roche’s antibody cocktail has also received emergency use approval in India, and will be distributed by drugmaker Cipla. The first batch of the cocktail became available in the country earlier this week.",positive,neutral,-0.2114164904862579,neutral,-0.6700701978302561,neutral
2021-05-27 10:58:13.000,946.0,948.75,934.05,944.0,6241671.0,"COVID-19 Vaccine | Pfizer Tells India Jab Suitable For Children, Can Be Stored At 2-8C: Report","The other American drug maker, Moderna, is in talks for the domestic production of its vaccine with Mumbai-based Cipla.",neutral,neutral,-0.2114164904862579,neutral,-0.6700701978302561,neutral
2021-05-27 14:26:00.000,940.2,947.35,931.0,933.9,2150301.0,"N+1 Capital makes first ever India investment, parks Rs 5 cr in Clensta","Clentsa recently entered a strategic tie-up with pharma brand Cipla for its first commercialised products, Waterless Bodybath and Waterless Shampoo",neutral,positive,-0.6700701978302561,neutral,1.353882378123827,positive
2021-05-28 14:28:57.000,940.2,947.35,931.0,933.9,2150301.0,Apollo Hospitals to offer antibody cocktail to treat mild Covid-19 cases,This treatment uses the combination of Casirivimab and Imdevimab -- popularly being called an ‘antibody cocktail’ -- now available in India.Roche India and Cipla had earlier announced its launch in the country,neutral,neutral,-0.6700701978302561,neutral,1.353882378123827,positive
2021-05-31 13:43:00.000,952.0,958.0,943.55,946.5,2888800.0,Yusuf Hamied,"Yusuf Hamied’s Assets: Cipla Ltd Yusuf Hamied’s Journey so far ... Yusuf Hamied was brought up in Mumbai and attended the Cathedral and John Connon School and Saint Xavier’s College. At the age of 18, he joined Cambridge and went on to obtain a PhD in chemistry in 1960 under the guidance …",neutral,neutral,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-05-31 20:21:13.000,952.0,958.0,943.55,946.5,2888800.0,Cipla to market Delhi start-up’s ‘waterless’ hygiene products,Start-up Clensta International is a pioneer in ‘waterless’ hygiene products,neutral,positive,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-05-31 21:51:00.000,952.0,958.0,943.55,946.5,2888800.0,"Close to commit over $1-bn to Moderna for COVID-19 booster vaccine; Provide price capping waiver, indemnity: Cipla to Govt","Commending the government for its efforts to increase the vaccine availability in the country for achieving effective protection against COVID-19, the Indian pharma giant has said its discussions with Moderna on the COVID-19 booster vaccine are nearing finalisation and for that, they are seeking the…",neutral,positive,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-05-31 21:55:38.000,952.0,958.0,943.55,946.5,2888800.0,Close to committing $1 bn to Moderna for COVID booster vaccine in India: Cipla,"Provide price capping waiver, indemnity, bridging trial waiver and basic customs duty exemption, Cipla further asks govt",neutral,neutral,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-05-31 22:20:20.000,952.0,958.0,943.55,946.5,2888800.0,Close to commit over $1-b to Moderna for booster vaccine: Cipla to Govt,"Need support of the government to make the program successful, said Cipla",neutral,positive,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-05-31 23:10:47.000,952.0,958.0,943.55,946.5,2888800.0,Close to Committing Over $1-bn to Moderna for Booster Vaccine; Provide Indemnity: Cipla to Govt,"Seeking fast-track approvals to bring Moderna’s single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that it is close to committing over USD 1-billi…",neutral,neutral,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-05-31 23:25:00.000,952.0,958.0,943.55,946.5,2888800.0,Cipla says close to committing $1 billion to Moderna for booster vaccine,The company has further requested for the government’s assurance that no price capping would apply for imported vaccines to be provided through private hospitals,neutral,neutral,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-06-01 07:52:16.000,952.0,958.0,943.55,946.5,2888800.0,"Cipla-Moderna deal ‘excellent news’, pray govt grants exemptions: Anand Mahindra",Cipla’s discussions with Moderna on Covid booster vaccine are nearing finalisation,positive,positive,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-06-01 08:19:09.000,952.0,958.0,943.55,946.5,2888800.0,"Stocks to Watch: ABFRL, Britannia, Cipla, Divi’s Labs, PNB Housing Finance","PNB Housing Finance’s board approved raising ₹4,000 crore in capital from the Carlyle Group and a handful of other investors through a preferential share issue.",neutral,positive,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-06-01 09:47:00.000,952.0,958.0,943.55,946.5,2888800.0,Cipla seeks clarity for exploring the possible roadmap for vaccine importation to India,The drug major submitted that to exchanges in response to media queries on vaccine distribution.,neutral,neutral,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-06-01 10:29:00.000,952.0,958.0,943.55,946.5,2888800.0,Cipla close to committing $1 billion advance for Moderna COVID-19 booster vaccine in India,"Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India",positive,positive,-0.5777310924369748,neutral,0.7237571979502254,neutral
2021-06-01 14:58:00.000,946.45,960.5,946.45,953.3,2443483.0,Anand Mahindra calls Cipla-Moderna COVID-19 vaccine deal ‘good news’; hopes for exemptions,Mahindra believes that a substantial supply of a variety of vaccines made around the world is,positive,neutral,0.7237571979502254,neutral,-0.5235602094240838,neutral
2021-06-01 17:02:00.000,946.45,960.5,946.45,953.3,2443483.0,"Seeking clarity, guidance from govt for Covid vaccine import: Cipla","Pharma major Cipla on Tuesday said it is seeking clarity and guidance from the government on the possible roadmap to import vaccine, while stressing that it has been at the forefront of Covid-19 care",neutral,neutral,0.7237571979502254,neutral,-0.5235602094240838,neutral
2021-06-01 17:22:45.000,946.45,960.5,946.45,953.3,2443483.0,"Seeking Clarity, Guidance from Govt for Covid-19 Vaccine Import: Cipla","Pharma major Cipla on Tuesday said it is seeking clarity and guidance from the government on the possible roadmap to import vaccine, while stressing that it has been at the forefront of COVID-19 care.",neutral,neutral,0.7237571979502254,neutral,-0.5235602094240838,neutral
2021-06-02 08:00:30.000,946.45,960.5,946.45,953.3,2443483.0,Dr Reddy’s to Cipla — experts recommend ‘buy’ on these pharma stocks,Experts have recommended investors to look at pharma stocks as there are still some shares in the sector that are available at attractive valuations,positive,neutral,0.7237571979502254,neutral,-0.5235602094240838,neutral
2021-06-07 11:23:00.000,951.75,951.75,937.55,939.0,2019936.0,"Nifty Pharma witness volatility post RBI Policy; Heavyweights Cipla, Dr Reddy's drag; Biocon shines","Heavyweight, Alkem Industries was the top loser performing at Rs3,139.05 per piece, 0.82% down.",neutral,negative,-1.3396375098502755,negative,1.510959778676319,positive
2021-06-08 11:54:39.000,939.8,955.0,931.85,954.0,2271513.0,"Covid propels India pharma sales in May; Glenmark, Cipla, Alkem outperform","Like the previous month, growth was led by acute segment, which was up 70% year-on-year. Sub-chronic segment grew 38%, while the chronic segment rose 28%",positive,positive,1.510959778676319,positive,0.5446166736489365,neutral
2021-06-09 15:15:00.000,960.95,975.0,960.0,974.6,4749926.0,"Markets in green led by pharma, PSU Bank stocks; Sensex near 52,400, Nifty 50 around 15,770; Cipla top gainer; Shree Cement, Bajaj Auto laggard","The upside in Indian equities today was led by broad-based buying with pharma, PSU Bank, Realty and Media stocks outperforming.",positive,positive,1.4204693272282611,positive,-0.5743589743589766,neutral
2021-06-10 11:22:00.000,960.95,975.0,960.0,974.6,4749926.0,"Buy Cipla, target price Rs 1090: ICICI Direct","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 78267.26 Crore) operating in Pharmaceuticals sector.",neutral,neutral,1.4204693272282611,positive,-0.5743589743589766,neutral
2021-06-10 17:54:00.000,975.0,982.3,965.5,969.4,3466001.0,"Nifty Pharma at fresh record highs with all stocks in green; Divis Lab, Cipla hit new 52-week high; Dr Reddy’s, Lupin, Cadila add to gains","India has reported 94,052 Daily New Cases in the last 24 hours. The country has recorded less than 1 lakh Daily New Cases for 3 continuous days now.",positive,neutral,-0.5743589743589766,neutral,0.3084198622391282,neutral
2021-06-15 09:50:00.000,975.0,978.85,967.15,968.25,1287318.0,Cipla’s Avenue Therapeutics gets USFDAs Complete Response Letter for IV tramadol,"The drug major’s subsidiary, Avenue Therapeutics Inc. has received a second Complete Response Letter (CRL) from the US drug regulator regarding its New Drug Application (NDA) seeking approval for IV tramadol.",neutral,positive,-0.6923076923076923,neutral,-1.3415892672858616,negative
2021-06-15 16:00:00.000,969.0,971.15,953.8,956.0,1679972.0,Cipla-led Avenue Therapeutics receives CRL from USFDA for IV Tramadol,"The FDA did not identify any Chemistry, Manufacturing and Controls issues in the CRL.",neutral,neutral,-1.3415892672858616,negative,-0.7329842931937173,neutral
2021-06-16 18:03:00.000,955.0,959.75,943.5,948.0,2425673.0,Cipla allots 1.03 lakh equity shares under ESOS,"Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,31,93,506/- comprising of 80,65,96,753 equity shares of face value Rs.2/- each.",neutral,neutral,-0.7329842931937173,neutral,1.4459224985540773,positive
2021-06-17 15:14:00.000,950.95,967.65,945.35,964.7,4975376.0,Cipla grants over 1.03 lakh equity shares under ESOP Scheme,"The issued, subscribed and paid-up share capital of the Company stands increased to Rs1,61,31,93,506/-.",neutral,positive,1.4459224985540773,positive,0.2139874739039618,neutral
2021-06-18 09:24:00.000,950.95,967.65,945.35,964.7,4975376.0,"Govt continues to monitor manufacturing, import, supplies and availability of drugs used for treatment of Mucormycosis","The existing five manufacturers of Liposomal Amphotericin B are Bharat Serums and Vaccines Limited, Cipla, Sun Pharma, BDR Pharmaceuticals and Lifecare Innovations.",neutral,neutral,1.4459224985540773,positive,0.2139874739039618,neutral
2021-06-22 07:35:00.000,956.2,960.9,949.15,955.0,2340904.0,"Nifty Pharma stocks make subdued gains; Divis Lab, Alkem Lab lift performance","Heavyweights Biocon, Cipla, and Sun Pharma were under pressure.",positive,negative,-0.125496758000423,neutral,0.4184100418410041,neutral
2021-06-23 11:28:00.000,956.0,966.0,954.2,960.0,1806361.0,Cipla receives USFDA approval for ANDA for Arformoterol Tartrate Inhalation Solution,Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana.,positive,neutral,0.4184100418410041,neutral,-0.5481311338484026,neutral
2021-06-23 11:37:00.000,956.0,966.0,954.2,960.0,1806361.0,Cipla receives USFDA nod for arformoterol tartrate inhalation solution,The solution had US sales of approximately $438 million for the 12-month period ending April 2021.,neutral,neutral,0.4184100418410041,neutral,-0.5481311338484026,neutral
2021-06-23 11:43:00.000,956.0,966.0,954.2,960.0,1806361.0,Cipla gets USFDA nod for inhalation product,"The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said in a regulatory filing.",neutral,positive,0.4184100418410041,neutral,-0.5481311338484026,neutral
2021-06-23 11:48:00.000,956.0,966.0,954.2,960.0,1806361.0,Cipla receives USFDA approval for Arformoterol Tartrate Inhalation Solution,Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana.,positive,neutral,0.4184100418410041,neutral,-0.5481311338484026,neutral
2021-06-23 12:03:26.000,957.8,958.7,944.0,952.55,1767222.0,Cipla Gets USFDA Nod For Inhalation Product,"The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said in a regulatory filing.",neutral,positive,-0.5481311338484026,neutral,0.7623554153522608,neutral
2021-06-23 12:28:08.000,957.8,958.7,944.0,952.55,1767222.0,Cipla receives USFDA nod for Arformoterol Tartrate Inhalation Solution,Arformoterol Tartrate Inhalation Solution is used to treat conditions like chronic bronchitis and emphysema,neutral,neutral,-0.5481311338484026,neutral,0.7623554153522608,neutral
2021-06-23 17:13:00.000,957.8,958.7,944.0,952.55,1767222.0,Cipla receives final USFDA nod for Arformoterol Tartrate Inhalation Solution,Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana.,neutral,neutral,-0.5481311338484026,neutral,0.7623554153522608,neutral
2021-06-23 22:37:06.000,957.8,958.7,944.0,952.55,1767222.0,IRM India Affiliate to work with Cipla to build a strong risk-aware ecosystem,IRM India Affiliate will focus on building risk awareness and a robust risk management ecosystem in collaboration with leading organisations across various other sectors,positive,neutral,-0.5481311338484026,neutral,0.7623554153522608,neutral
2021-06-24 07:30:00.000,957.8,958.7,944.0,952.55,1767222.0,"Nifty Pharma index under pressure: Lupin, Cipla top losers","Auro Pharma and Cadila were also under pressure 0.8% and 0.7% respectively. Dr. Reddy, Alkem Lab, and Torrent Pharma were also trading lower.",neutral,negative,-0.5481311338484026,neutral,0.7623554153522608,neutral
2021-06-24 09:43:00.000,957.8,958.7,944.0,952.55,1767222.0,"Stocks in news: Reliance Industries, Adani Ports, Tata Motors, Shyam Metalics and more","Stocks in news: Reliance Industries, Cipla, Dabur India, Adani Ports, Apollo Hospitals, Tata Motors, and more",neutral,neutral,-0.5481311338484026,neutral,0.7623554153522608,neutral
2021-06-28 08:45:00.000,962.0,971.35,957.1,964.0,1752894.0,Markets closed lower; Pharma stocks outperformed,"The Nifty Pharma index was among the top outperformers closing ~1.3% higher with stocks like Dr Reddys, Cipla, Biocon & Lupin adding fresh long positions.",negative,positive,0.2079002079002079,neutral,1.5560165975103737,positive
2021-06-28 10:21:46.000,962.0,971.35,957.1,964.0,1752894.0,"Sensex jumps to fresh high; Nifty crosses 15,900, IT, auto stocks under selling pressure","On the Nifty50 index, ONGC, Cipla, RIL, SBI and IndusInd Bank were the top gainers while HDFC Life TCS, Bajaj Auto, L&T and MAruti led the losses. Broader markets were also higher with the midcap and smallcap indices up 0.3 percent and 0.4 percent, respectively.",positive,positive,0.2079002079002079,neutral,1.5560165975103737,positive
2021-06-29 10:07:00.000,964.0,989.0,960.05,979.0,4291164.0,"Cipla, Dr Reddy’s, Sun Pharma, Torrent Pharma, Emcure join hands for the clinical trial of Molnupiravir to treat Covid",Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.,neutral,neutral,1.5560165975103737,positive,-2.1316266881677173,negative
2021-06-29 11:43:35.000,964.0,989.0,960.05,979.0,4291164.0,Cipla Seeks DCGI Nod To Import Moderna’s COVID-19 Vaccine,DCGI is likely to take up the application soon and may even grant permission to import the COVID-19 vaccine today.,neutral,neutral,1.5560165975103737,positive,-2.1316266881677173,negative
2021-06-29 12:47:43.000,992.2,997.0,969.15,971.05,7119039.0,Moderna seeks regulatory approval for its Covid vaccine in India: Report,"Cipla has applied for import and marketing authorisation of Moderna’s covid jabs, sources told PTI",positive,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 13:17:58.000,992.2,997.0,969.15,971.05,7119039.0,Moderna seeks approval for use of its COVID-19 vaccine in India; decision to be taken today,"India’s COVID-19 inoculation drive may soon be boosted by addition vaccines. According to reports, Moderna has sought approval for use of it’s COVID-19 vaccine in India. Sources say that a decision is expected by the end of the day. Reportedly, Cipla has applied for import, marketing authorisatio…",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 13:25:00.000,992.2,997.0,969.15,971.05,7119039.0,"Moderna seeks nod for Covid-19 vaccine in India, Cipla wants import permit, say sources","India’s drug regulator may soon grant restricted emergency use authorisation for Moderna’s COVID-19 vaccine, official sources said on Tuesday. Mumbai-based pharmaceutical firm Cipla, on behalf of the US pharma major, has requested for import and marketing authorisation of these jabs.",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 14:04:11.000,992.2,997.0,969.15,971.05,7119039.0,Cipla seeks nod to import Moderna COVID-19 vaccine in India,Moderna has also informed that the U.S. government has agreed to donate to India a certain number of doses of the Moderna vaccine through COVAX,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 15:13:30.000,992.2,997.0,969.15,971.05,7119039.0,Cipla seeks DCGI permission to import Moderna COVID-19 vaccine: Report,Cipla filed an application on Monday seeking permission for import of Moderna COVID-19 vaccine referring to DCGI notices dated April 15.,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 15:20:15.000,992.2,997.0,969.15,971.05,7119039.0,Cipla gets nod to import Moderna’s vaccine for emergency use in India: Report,Cipla filed an application on Monday seeking permission for import of Moderna COVID-19 vaccine,neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 15:30:15.000,992.2,997.0,969.15,971.05,7119039.0,Cipla Hits 52-week High As Company Seeks DCGI Nod To Import Moderna’s COVID Jab,"The firm submitted its application to the drugs regulator on June 28, CNBC TV-18 has reported.",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 15:46:04.000,992.2,997.0,969.15,971.05,7119039.0,"Vaccine no. 4 is almost here, Cipla gets nod to import Moderna jab","Pharmaceutical company Cipla has now got Drugs Controller General of India’s (DCGI) nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India, say sources",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 16:25:17.000,992.2,997.0,969.15,971.05,7119039.0,"DRL, Cipla, 3 more pharma firms tie-up for trial of oral covid drug","The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 16:35:49.000,992.2,997.0,969.15,971.05,7119039.0,Five Indian firms ink licensing deal with MSD for COVID-19 drug molnupiravir: Report,"MSD Pharmaceuticals Pvt Ltd, a wholly-owned subsidiary of Merck Sharp & Dohme (MSD), has signed non-exclusive voluntary licensing agreements with five established Indian generic manufacturers—Sun Pharmaceutical Industries, Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals and Hetero Labs—to …",positive,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 16:39:00.000,992.2,997.0,969.15,971.05,7119039.0,Cipla gets authorisation for restricted use in India of donated Moderna vaccines,"Foreign vaccine makers have been urging the government to provide indemnity for vaccines in India, which would mean that the government would be liable to pay for serious vaccine-related injuries instead of the company",neutral,negative,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 16:40:47.000,992.2,997.0,969.15,971.05,7119039.0,Cipla gets DCGI nod for import of Moderna’s COVID-19 vaccine,The Drugs Controller General of India (DCGI) gave nod to Cipla for import of Moderns’ COVID-19 vaccine. The Union Health Ministry on Tuesday said that new drug permission has been granted to Moderna which is the first internationally developed vaccine. However it said that Moderna has been given …,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 16:48:56.000,992.2,997.0,969.15,971.05,7119039.0,"Sun Pharma, Cipla And Others Partner To Conduct Trials Of COVID-19 Antiviral Drug Molnupiravir","As per the directive of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization, Dr.Reddy’s will conduct the clinical trial using its product, and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr. Red…",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 17:05:52.000,992.2,997.0,969.15,971.05,7119039.0,India approves Moderna’s vaccine for emergency use; Cipla to import jab,Cipla had filed an application on Monday seeking permission for import of Moderna’s vaccine.,neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 17:12:20.000,992.2,997.0,969.15,971.05,7119039.0,"After Moderna, India likely to close deal with Pfizer Covid vaccine: Govt","Last week Pfizer’s chief executive Albert Bourla said that the company was in the final stages to get approval for the coronavirus vaccine in India.On Tuesday, the DCGI granted approval to Cipla Ltd to import the COVID-19 vaccine developed by Moderna Inc",positive,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 17:30:00.000,992.2,997.0,969.15,971.05,7119039.0,Cipla may import Moderna’s COVID-19 vaccine; approval likely today,The pharma company had filed an application with DCGI seeking approval to import the vaccine on June 28,positive,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 17:30:00.000,992.2,997.0,969.15,971.05,7119039.0,Cipla gets DCGI nod to import Moderna COVID-19 vaccine,Cipla has been given approval for emergency use in the country,neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 17:43:00.000,992.2,997.0,969.15,971.05,7119039.0,"India gets fourth Covid Vaccine, Cipla granted emergency use authorisation for Moderna","New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use: Dr VK Paul, member-health, Niti Aayog",positive,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 17:49:00.000,992.2,997.0,969.15,971.05,7119039.0,Five Indian drugmakers to jointly start trial of Merck & Co’s Covid-19 drug,The drugmakers include Cipla and Dr Reddy’s Laboratories,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 21:10:18.000,992.2,997.0,969.15,971.05,7119039.0,What is Molnupiravir? All you need to know about oral anti-viral drug for treating COVID-19,"MSD Pharmaceuticals Pvt Ltd, a wholly-owned subsidiary of Merck Sharp & Dohme (MSD), has signed non-exclusive voluntary licensing agreements with five established Indian generic manufacturers—Sun Pharmaceutical Industries, Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals and Hetero Labs—to …",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 21:17:15.000,992.2,997.0,969.15,971.05,7119039.0,Cipla Gets DCGI Nod to Import Moderna’s Covid Jab for Emergency Use in India,"Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received the approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine for restricted emergency use in India.",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 21:40:00.000,992.2,997.0,969.15,971.05,7119039.0,Cipla gets DCGI nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India,"Moderna’s vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik.",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 21:49:34.000,992.2,997.0,969.15,971.05,7119039.0,Cipla Says Doesn’t Have Definitive Pact On Commercial Supplies Of Moderna Vaccine,"Cipla said it is supporting Moderna with the regulatory approval and importation of vaccines to be donated to India. The government of India has issued a registration certificate and a permission to import the COVID-19 Vaccine Moderna for restricted use in an emergency situation, in adults aged 18 y…",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 22:21:31.000,992.2,997.0,969.15,971.05,7119039.0,Moderna’s Covid vaccine gets nod for restricted use,"Cipla says it is part of US donation, only helping with regulatory norms",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 23:18:11.000,992.2,997.0,969.15,971.05,7119039.0,Cipla says supporting Moderna for COVID vaccine to be donated to India,Pharma major Cipla on Tuesday said it is supporting Moderna with the regulatory approval and import of COVID-19 vaccines to be donated to India and there is no agreement on commercial supplies at this stage.India’s drug regulator DCGI has granted permission to Cipla to import Moderna’s COV…,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-29 23:21:00.000,992.2,997.0,969.15,971.05,7119039.0,Supporting Moderna for Covid vax to be donated to India: Cipla,"Moderna’s vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik V.",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 00:10:02.000,992.2,997.0,969.15,971.05,7119039.0,"Moderna’s vaccine gets emergency use nod, India partner Cipla to import jabs",Moderna’s covid-19 vaccine is the first foreign jab to get approval under the government’s revised norms for accelerated regulatory clearance of covid-19 jabs,neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 00:29:58.000,992.2,997.0,969.15,971.05,7119039.0,Covid-19: Cipla gets India go-ahead to import Moderna vaccine,Permitted for restricted use; vaccine is the fourth to be available in India; talks with Pfizer and J&J continue,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 01:37:00.000,992.2,997.0,969.15,971.05,7119039.0,Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet,1st mRNA vax part of US-India pact; no commercial deal yet,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 01:54:00.000,992.2,997.0,969.15,971.05,7119039.0,"Cipla on Moderna vaccine says,",Cipla was responding to media queries on vaccine import.,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 07:35:47.000,992.2,997.0,969.15,971.05,7119039.0,"Stocks To Watch: Cipla, AstraZeneca, RIL, Bharti Airtel, CG Power, Sun Pharma, Dr Reddy’s, Ruchi Soya",Here are the stocks to watch in trade today...,neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 07:39:08.000,992.2,997.0,969.15,971.05,7119039.0,Government gives nod for Cipla to import Moderna’s COVID-19 vaccine,DCGI grants emergency use approval for ready-to-use injectable jab,neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 07:59:47.000,992.2,997.0,969.15,971.05,7119039.0,"Stocks to Watch: AstraZeneca India, Cipla, IRCTC, Sterling and Wilson","Indiabulls Housing Finance’s board has approved a proposal to raise over ₹7,000 crore through various means. This includes $275 million ( ₹2,043.43 crore) by issuing equity shares or other instruments",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 08:29:00.000,992.2,997.0,969.15,971.05,7119039.0,"Markets likely to consolidate; HDFC, Cipla, Dish TV in focus","Ircon International, Dish TV India, Prime Focus, Anant Raj and Sadbhav Engineering will announce their March quarter results today",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 08:30:00.000,992.2,997.0,969.15,971.05,7119039.0,Nifty Pharma trades marginally lower; Divis Lab lead gainer while Lupin drags,"Dr Reddy, Sun Pharma, Torrent Pharma, and Cipla were under pressure after joining hands-on Wednesday for the clinical trial of the investigational oral anti-viral drug Molnupiravir",positive,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 08:37:00.000,992.2,997.0,969.15,971.05,7119039.0,"Select pharma stocks, RIL, NBCC (India) in focus","Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries and Torrent Pharmaceuticals announced that the five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 08:55:47.000,992.2,997.0,969.15,971.05,7119039.0,"Cipla, HDFC among 4 technical stocks to buy; Nifty may go down to 15,450 if it falls below 15,670","According to options statistics and retracement levels, the Nifty / Sensex would find support at 15800/52800 and 15670/52300 levels.",negative,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 09:09:00.000,992.2,997.0,969.15,971.05,7119039.0,"Stocks to watch: Voda Idea, RIL, Cipla, Indiabulls Housing, pharma stocks",Vodafone Idea is likely to post a narrowing of losses in Q4FY21 even though subscriber losses and zero IUC regime may dent the top-line,neutral,negative,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 09:39:00.000,992.2,997.0,969.15,971.05,7119039.0,India’s drug regulator okays Cipla’s imports of Moderna COVID-19 vaccine,"Cipla will import vaccines that have been donated by the US company to India. “This will not be for a commercial supply. Cipla is facilitating the import of donated vaccines to give to the government,” said a person aware of the development.",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 09:52:00.000,992.2,997.0,969.15,971.05,7119039.0,Cipla hits new high on DCGI nod to import Moderna vaccine; up 4% in 2 days,"At this stage, there is no definitive agreement on commercial supplies, the company said in response to media queries on vaccine import",positive,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 10:15:15.000,992.2,997.0,969.15,971.05,7119039.0,"With Moderna Added to List, How Many Covid Vaccines India Have Till Now? All You Need to Know",India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country.,neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 10:16:12.000,992.2,997.0,969.15,971.05,7119039.0,"Sensex, Nifty open in green, tech stocks jump high","Indian shares rose on Wednesday, helped by automakers and information technology stocks, while drugmaker Cipla climbed after getting a regulatory nod to import partner Moderna`s COVID-19 vaccine.",positive,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 10:27:47.000,992.2,997.0,969.15,971.05,7119039.0,"Cipla Seeks Drug Regulator’s Nod to Import Moderna Vaccine, Sources Say May Get Approval Today","Cipla, a multinational pharmaceutical company headquartered in Mumbai, has sought Drugs Controller General of India nod for importing Moderna’s coronavirus vaccine, sources told CNBC-TV18.",neutral,neutral,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 10:38:31.000,992.2,997.0,969.15,971.05,7119039.0,"The daily dose: June 30, 2021","# India is set to get its first mRNA vaccine, albeit through a donation, from Moderna. And drugmaker Cipla will facilitate the through-pass. That said, it paves the way for more strategic partnerships",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 11:12:18.000,992.2,997.0,969.15,971.05,7119039.0,From efficacy to availability in India and dosage - Here’s all you need to know about Moderna’s COVID-19 vaccine,"On Tuesday, India approved a fourth COVID-19 vaccine, with Cipla receiving permission from the Drugs Controller General of India (DCGI) to import Moderna’s COVID-19 vaccine for restricted emergency use. With the permission, the vaccine by the US-based company could be imported and start getting u…",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 11:17:20.000,992.2,997.0,969.15,971.05,7119039.0,Cipla share price hits record high on DGCI nod to import Moderna vaccine to treat COVID-19; may rally 12% more,"Cipla share price hit a new record high of Rs 997.20 apiece in intraday on BSE on Wednesday, after the DCGI approved the firm to import Moderna, a Covid-19 vaccine, with emergency use authorisation in India.",positive,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 11:27:00.000,992.2,997.0,969.15,971.05,7119039.0,Five drug makers collaborate for clinical trial of Molnupiravir,"Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries & Torrent Pharmaceuticals will collaborate for the clinical trial of investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in India.",neutral,positive,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 11:36:39.000,992.2,997.0,969.15,971.05,7119039.0,Cipla records fresh highs on nod for Moderna’s Covid-19 vaccine,"Cipla was trading at ₹975.25 on the BSE, down ₹3.80 or 0.39 per cent",neutral,negative,-2.1316266881677173,negative,0.1841997544003228,neutral
2021-06-30 12:28:00.000,977.2,980.0,967.2,979.0,2277473.0,"Cipla, Dr Reddy’s Labs: Tech charts show up to 11% rally in pharma stocks","After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100",positive,positive,0.1841997544003228,neutral,-0.3870244945765715,neutral
2021-06-30 12:39:30.000,977.2,980.0,967.2,979.0,2277473.0,Coronavirus live updates | Curbs extended with more relaxations in Punjab till July 10,"The DCGI on Tuesday granted permission to Cipla to import Moderna’s COVID-19 vaccine, making it the fourth vaccine in the country to be given the emergency use authorisation.",positive,positive,0.1841997544003228,neutral,-0.3870244945765715,neutral
2021-06-30 14:03:04.000,977.2,980.0,967.2,979.0,2277473.0,"Cipla, Tata Coffee, Reliance Industries: Top Stocks for Investors on June 30",Indian stock markets are likely to open in green as Asian stocks showed positive momentum early Wednesday.,neutral,positive,0.1841997544003228,neutral,-0.3870244945765715,neutral
2021-06-30 17:21:00.000,977.2,980.0,967.2,979.0,2277473.0,"Torrent Pharma, Dr Reddy’s, Sun Pharma stocks rise, Cipla drops on partnering for the clinical trial of Molnupiravir","These five companies have signed a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India.",neutral,positive,0.1841997544003228,neutral,-0.3870244945765715,neutral
2021-06-30 17:30:00.000,977.2,980.0,967.2,979.0,2277473.0,"Stocks in news: IRCTC, Cipla, Ruchi Soya, RIL, IndusInd Bank and more","Stocks in news: IRCTC, Cipla, Ruchi Soya, Emami Realty and more",neutral,neutral,0.1841997544003228,neutral,-0.3870244945765715,neutral
2021-07-02 07:51:29.000,981.85,985.8,975.1,978.05,1414744.0,Cipla Seeks Growth For Biosimilar Arm Via Tie-Ups,"Cipla plans to launch biosimilars in South Africa, Australia and emerging markets in the next one year.",neutral,neutral,-0.3870244945765715,neutral,-0.4646175839885586,neutral
2021-07-05 09:48:00.000,979.3,983.85,973.1,974.75,1284050.0,Moderna vaccine to be available at select hospitals by Mid-July,"Last week, Indians drug regulator granted permission to Cipla to import donated doses of Moderna from the US. The vax doses, which are being imported by Cipla, will be given to the central government and will be available in select metros which have hospitals where the vaccine can be stored easily, …",neutral,positive,-0.4646175839885586,neutral,-0.6153846153846154,neutral
2021-07-06 12:54:00.000,968.0,968.95,961.0,965.5,1736136.0,Cipla may be Re-Rated for Probable Commercial JV with Moderna’mRNA COVID Vaccine,Cipla may be Re-Rated for Probable Commercial JV with Moderna’mRNA COVID Vaccine,neutral,neutral,-0.2582644628099174,neutral,-1.5018125323666496,negative
2021-07-08 06:35:00.000,965.5,968.0,944.8,951.0,1658951.0,"Nifty Pharma sinks 1% amid fragile markets; Sun Pharma, Cipla drag",Alkem Lab was the only company in the pharma sector to trade in the green.,negative,neutral,-1.5018125323666496,negative,0.8928571428571428,neutral
2021-07-08 13:36:24.000,952.0,965.6,949.95,960.5,1299433.0,Moderna covid vaccines to reach India this week,Cipla will be importing Moderna covid vaccines from the US.These doses will be given to the central government and will be available in selected hospitals of the country,positive,neutral,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-08 14:12:00.000,952.0,965.6,949.95,960.5,1299433.0,"Discussions still going on over indemnity to Moderna, says report","Earlier on June 29, Indian drug regulators granted permission to Cipla to import donated doses of Moderna from the US.",neutral,positive,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-08 15:35:00.000,952.0,965.6,949.95,960.5,1299433.0,Pharmaceutical Market records 14% yoy growth in June 2021: Ind-Ra report,"Cipla, Glenmark and Emcure significantly outperformed the market, with yoy growth of 19.9%, 38.8% and 24.9%, respectively.",positive,positive,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-09 00:08:34.000,952.0,965.6,949.95,960.5,1299433.0,Discussions still on over indemnity to Moderna: Sources,"Even as the US giant drug maker Moderna’s Covid-19 messenger RNA (mRNA) vaccine is expected to reach India this week, discussions are still going on over indemnity waiver, informed sources. Earlier on June 29, Indian drug regulators granted permission to Cipla to import donated doses of Moderna from…",neutral,positive,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-09 11:41:36.000,952.0,965.6,949.95,960.5,1299433.0,Street bets on Cipla’s respiratory drug portfolio to drive growth,"The strong growth in the domestic arena, led by focus on specialty and covid treatment drugs, has kept investor interest firm",positive,positive,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-09 22:32:26.000,952.0,965.6,949.95,960.5,1299433.0,Rubicon Research acquires Cipla’s Meditab Specialities Satara plant,"Acquisition of oral liquid, nasal inhalers facility may be completed in two months",neutral,neutral,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-09 22:52:00.000,952.0,965.6,949.95,960.5,1299433.0,"Rubicon Research acquires Cipla arm’s oral liquid, nasal product unit","Rubicon Research Private Ltd., a specialty pharmaceutical company backed by General Electric, had acquired Cipla Ltd.’s wholly owned subsidiary Meditab Specialities Ltd.’s oral liquid dosage and nasal",neutral,neutral,0.8928571428571428,neutral,-0.1041666666666666,neutral
2021-07-12 19:35:18.000,962.2,969.85,956.05,965.0,1316120.0,Cipla Q1 PAT May Dip 7.5% YoY To Rs 534.3 Cr: ICICI Direct,"Net Sales are expected to increase by 11 percent Y-o-Y (up 4.7 percent Q-o-Q) to Rs 4,822.4 crore, according to ICICI Direct.",neutral,positive,0.2909997921430008,neutral,1.461866611174691,positive
2021-07-13 11:37:54.000,962.2,969.85,956.05,965.0,1316120.0,Cipla Q1 PAT Seen Up 10.9% YoY To Rs 640.7 Cr: KRChoksey,"Net Sales are expected to increase by 18.5 percent Y-o-Y (up 11.8 percent Q-o-Q) to Rs 5,151.2 crore, according to KRChoksey.",neutral,positive,0.2909997921430008,neutral,1.461866611174691,positive
2021-07-13 17:51:34.000,961.1,978.4,961.1,975.15,1724477.0,‘No reply has come from them’: Niti Aayog’s Dr VK Paul over indemnity to Moderna,"India has last month approved the import of US pharmaceutical major Moderna’s mRNA technology-based COVID-19 vaccine. The Drugs Controller General of India (DCGI) has granted permission to Mumbai-based pharmaceutical firm Cipla to import Moderna’s COVID-19 vaccine, making it the fourth vaccine in…",neutral,positive,1.461866611174691,positive,-0.5617977528089888,neutral
2021-07-19 14:59:00.000,972.0,974.1,952.65,955.3,1516033.0,"Cipla board allots 45,704 equity shares under ESOP Scheme","The current market cap of the company is Rs78,820.63cr.",neutral,neutral,-1.7181069958847783,negative,-0.8193299238075382,neutral
2021-07-20 02:00:00.000,972.0,974.1,952.65,955.3,1516033.0,"Nifty Pharma joins bearish markets; Cadila, Cipla emerge top losers","Alkem Lab, Dr. Reddy’s, and Sun Pharma were also struggling.
Auro Pharma stock braved the bears to rise 1.2%.",neutral,positive,-1.7181069958847783,negative,-0.8193299238075382,neutral
2021-07-20 11:38:27.000,972.0,974.1,952.65,955.3,1516033.0,"When will India get Moderna’s COVID-19 jab? 7.5 million doses offered via COVAX, indemnity clause remains hurdle","At the end of June, India approved a fourth COVID-19 vaccine for emergency usage. But while Cipla has received permission from the Drugs Controller General of India (DCGI) to import the Moderna jab, it might be a while before the vaccine becomes available. According to recent reports, India has b…",neutral,positive,-1.7181069958847783,negative,-0.8193299238075382,neutral
2021-07-22 07:35:00.000,958.1,958.95,946.65,950.25,1778520.0,"Nifty Pharma stocks trade higher; Torrent Pharma, Alkem Lab, Sun Pharma stocks lead",Cipla continued to remain under selling pressure. Biocon was also in the red while Cadila was marginally lower.,positive,negative,-0.8193299238075382,neutral,-0.4201680672268907,neutral
2021-07-25 12:27:00.000,948.0,960.0,947.0,951.1,1302849.0,"Cipla recalls 7,228 bottles of overactive bladder treatment drug in America","As per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.",neutral,neutral,0.3270042194092851,neutral,-3.721784776902892,negative
2021-07-25 17:18:22.000,948.0,960.0,947.0,951.1,1302849.0,"Cipla recalls 7,228 bottles of overactive bladder treatment drug in US over manufacturing issues","Drug major Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market due to manufacturing issues.As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), the Mumbai-based company is re…",negative,negative,0.3270042194092851,neutral,-3.721784776902892,negative
2021-07-26 08:53:00.000,948.0,960.0,947.0,951.1,1302849.0,"Stocks to watch: RIL, ITC, Tata Motors, ICICI Bank, JSW Steel, YES Bank","Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets in the US market due to manufacturing issues",neutral,negative,0.3270042194092851,neutral,-3.721784776902892,negative
2021-07-27 15:07:43.000,921.6,921.6,886.65,894.0,5082282.0,19 Drug Cocktails Approved Pre-1988 Come Under Fresh Review,"Some popular brands facing fresh scrutiny include Piramal Enterprises’ Saridon, Abbott’s Phensedyl and Tixylix, Griffon’s Grilinctus, Cipla’s Cofdex, Nocold and Bromolin, Glenmark’s Ascoril C, Intas’ Despol and Reckitt Benckiser’s D-Cold",neutral,neutral,-2.994791666666669,negative,-1.492704198579977,negative
2021-07-27 18:21:00.000,921.6,921.6,886.65,894.0,5082282.0,"Nifty Pharma in a steep nosedive, index dips 430 pts as Dr Reddy’s slump 8% after Q1; Aurobindo, Cipla, Lupin drag too","Nifty Pharma index has slipped to at least nearly 435 points with an intraday low of 14,246.15.",negative,negative,-2.994791666666669,negative,-1.492704198579977,negative
2021-07-28 07:16:00.000,921.6,921.6,886.65,894.0,5082282.0,"Nifty Pharma under pressure on broad-based selloff; Dr Reddy’s extend loss after Q1; Cadila, Cipla drag too","The index is in focus after the government announced that the PLI scheme for Pharmaceuticals is estimated to have an export generation potential of Rs1,96,000cr over 6 years.",negative,neutral,-2.994791666666669,negative,-1.492704198579977,negative
2021-08-02 14:54:00.000,925.0,929.55,918.5,928.0,2009298.0,Cipla’s Umang Vohra: Ramped-up production by 5x for COVID-19 drugs like Remdesivir; Investment in ABCD Tech to add to digital channel transformation,"The company’s MD and Group CEO said that Cipla sustained strong EBITDA margins through the year, recording the highest ever margin of 22.5% in FY21.",positive,positive,0.3243243243243243,neutral,1.2444109249582578,positive
2021-08-05 06:45:00.000,944.2,953.0,932.0,945.4,4021800.0,Nifty Pharma edges higher amid market rally; Cipla gains over 1% ahead of quarterly results,Sun Pharma and Dr. Reddy are also trading higher. Biocon and Torrent Pharma dragged the most.,positive,positive,0.1270917178563791,neutral,-2.8753993610223643,negative
2021-08-05 07:41:06.000,944.2,953.0,932.0,945.4,4021800.0,"Stocks To Watch: Vodafone, Titan, HPCL, SBI Life, Dr. Reddy’s, RIL, Shipping Corp, Cipla, GAIL (India)",Here are the stocks to watch in trade today...,neutral,neutral,0.1270917178563791,neutral,-2.8753993610223643,negative
2021-08-05 08:04:55.000,944.2,953.0,932.0,945.4,4021800.0,"Stocks to Watch: Adani Green, HPCL, RIL, Maruti, PNB Housing, SBI, Voda Idea","Adani Power, Adani Transmission, Bajaj Consumer, Birla Corp., Cipla, Edelweiss, GAIL, Gujarat GAs, Indiabulls Housing, Jubilant Industries, Shree Dinesh Mills, Tata Chemicals, TTK Healthcare, among other companies will report their Q1 earnings today.",neutral,neutral,0.1270917178563791,neutral,-2.8753993610223643,negative
2021-08-05 08:16:11.000,944.2,953.0,932.0,945.4,4021800.0,"Markets may stay firm ahead of RBI policy; Vodafone, SBI Life, Cipla in focus","Some of the key companies which will announce June quarter results today are Adani Transmission, Cipla, GAIL (India), Adani Power, REC, Tata Chemicals, Thermax and Indiabulls Housing Finance.",positive,neutral,0.1270917178563791,neutral,-2.8753993610223643,negative
2021-08-05 08:18:00.000,944.2,953.0,932.0,945.4,4021800.0,"Market Ahead Podcast, August 5: Top factors that could guide markets today","Over 100 companies, including Adani Power, NCC, GAIL, Tata Chemicals, Cipla, Quess Corp, Indiabulls Housing Finance and Gujarat Gas are slated to post their results",neutral,neutral,0.1270917178563791,neutral,-2.8753993610223643,negative
2021-08-05 08:36:19.000,944.2,953.0,932.0,945.4,4021800.0,"RIL, SBI, Titan, Vodafone Idea, Adani Green, Devyani, Windlas, Exxaro, Krsnaa IPOs, Cipla stocks in focus","Nifty futures were trading 22 points or 0.14 per cent up at 16,282.50 on Singaporean Exchange, suggesting a gap-up start for BSE Sensex and Nifty 50 on Thursday",neutral,positive,0.1270917178563791,neutral,-2.8753993610223643,negative
2021-08-05 12:56:00.000,939.0,939.0,909.0,912.0,9582846.0,"Important results today: GAIL India, Cipla, Adani Power among others","Quess Corp, REC, Thermax, and TTK Healthcare are among the companies that will announce their June quarter results today.",neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 13:16:15.000,939.0,939.0,909.0,912.0,9582846.0,Cipla Ltd up for fifth session,"Cipla Ltd is quoting at Rs 945.5, up 0.62% on the day as on 12:49 IST on the NSE. The stock is up 29.33% in last one year as compared to a 45.6% spurt in NIFTY and a 28.2% spurt in the Nifty Pharma.",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 17:30:00.000,939.0,939.0,909.0,912.0,9582846.0,Cipla’s profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%,"Cipla registered a 27 per cent YoY jump in revenue from operations at Rs 5,504 crore during the June-end quarter. The pharma firm’s EBITA stood Rs 1,346 crore in Q1 of FY22, compared to Rs 1,039 crore in Q1 of last year",positive,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 20:19:00.000,939.0,939.0,909.0,912.0,9582846.0,Cipla’s Q1 PAT grows 24% to Rs 715 crore riding on domestic sales,"The company posted a 27% YoY increase in income from operations, at Rs 5,504 cr. Ebitda grew 28% to Rs 1,346 cr with a resulting Ebitda margin of 24.5%",positive,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 20:33:49.000,939.0,939.0,909.0,912.0,9582846.0,"Cipla Posts 24% YoY Net Profit Growth In Q1FY22 Led By Core Therapies, COVID Portfolio","India business that includes branded formulations, trade generics and consumer health grew by 68% YoY to Rs 2,710 crore driven by volume growth in core therapies and support from existing and new introduction in covid portfolio through the second wave. In addition, acute and respiratory nebulization…",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 20:57:57.000,939.0,939.0,909.0,912.0,9582846.0,Top headlines: Govt buries retro tax; Cipla Q1 net profit rises 24%,Business Standard brings you the top headlines on Thursday,positive,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 21:05:55.000,939.0,939.0,909.0,912.0,9582846.0,Cipla Q1 Results: Profit Jumps 73% On India Business,The Mumbai-based drugmaker’s net profit rose 73% sequentially to Rs 714.7 crore in the quarter ended June.,neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-05 21:29:13.000,939.0,939.0,909.0,912.0,9582846.0,Cipla Q1 Net Profit Up 25% To Rs 709.92 Crore,"The company had posted a net profit of Rs 566.04 crore in the corresponding period of the previous fiscal, Cipla said in a filing to BSE.",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 07:34:09.000,939.0,939.0,909.0,912.0,9582846.0,"Buzzing Stocks: Rate-sensitives, Cipla, RIL And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 07:50:00.000,939.0,939.0,909.0,912.0,9582846.0,Cipla consolidated net profit rises 23.67% in the June 2021 quarter,Sales rise 27.91% to Rs 5470.72 crore,positive,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 08:35:47.000,939.0,939.0,909.0,912.0,9582846.0,"Glenmark Life Sciences, RIL, Airtel, Vodafone Idea, SBI, HDFC Bank, Cipla, rate sensitive stocks in focus","Nifty futures were trading 14 points up at 16,324.50 on Singaporean Exchange, suggesting a positive start for BSE Sensex and Nifty 50 ahead of RBI MPC outcome on Friday.",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 08:50:00.000,939.0,939.0,909.0,912.0,9582846.0,"Stocks to watch: M&M, Glenmark Life Sciences, Cipla, Adani Power, Tata Chem","Stocks from the banking, real estate and auto sectors will be in focus amid the RBI policy outcome later today",neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 09:29:00.000,939.0,939.0,909.0,912.0,9582846.0,Cipla Q1 FY22 PAT spurts 25% to Rs 710 cr,"On a consolidated basis, Cipla’s net profit soared 25.41% to Rs 709.92 crore on a 26.64% jump in total revenue from operations to Rs 5,504.35 crore in Q1 June 2021 (Q1 FY22) over Q1 June 2020 (Q1 FY21).",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 09:31:59.000,939.0,939.0,909.0,912.0,9582846.0,"What Should Investors Do With Cipla Post Q1 Earnings: Buy, Sell Or Hold?","The company reported a 25.41 percent increase in its consolidated net profit to Rs 709.92 crore for the quarter ended June 30, 2021",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 11:37:00.000,939.0,939.0,909.0,912.0,9582846.0,"Results Review for Godrej Consumers, Cipla, GAIL, Gujarat Gas, Hindustan Petroleum","Results Review for Godrej Consumers, Cipla, GAIL, Gujarat Gas, Hindustan Petroleum",neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 11:38:07.000,939.0,939.0,909.0,912.0,9582846.0,Cipla: M&A Opportunity Could Be Near-term Trigger,"Cipla, with its leadership in inhalation, focus on green chemistry and potential deployment of cash savings for new growth drivers, warrants attention",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 11:48:35.000,939.0,939.0,909.0,912.0,9582846.0,Cipla’s domestic formulation biz drives Q1 show; outlook remains firm,"The company derived almost half of its revenues from the domestic market, benefitting from strong sales of covid-related products",positive,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 12:55:00.000,939.0,939.0,909.0,912.0,9582846.0,"Top stocks in focus: Cipla, Adani Group, Accelya Solutions, Quess Corp, Honeywell Automation",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 13:51:00.000,939.0,939.0,909.0,912.0,9582846.0,Cipla logs Q1 PAT of Rs715cr rising by 24% yoy on robust revenue,"Consolidated revenue from operations stood at Rs5,504cr in the quarter under review increasing by 27% yoy and 19% qoq.",positive,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 13:52:34.000,939.0,939.0,909.0,912.0,9582846.0,"Cipla Consolidated June 2021 Net Sales At Rs 5,504.35 Crore, Up 26.65% Y-o-Y",,neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 15:32:15.000,939.0,939.0,909.0,912.0,9582846.0,Moneycontrol Pro Panorama | RBI Gives Priority To Growth But Inflationary Pressures Stoke Concerns,"In today’s edition of Moneycontrol Pro Panorama: RBI Monetary Policy, reduction in global food prices, Herd Immunity Tracker, Nykaa IPO, Cipla, Godrej Consumer Products earnings and more",neutral,negative,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 16:01:45.000,939.0,939.0,909.0,912.0,9582846.0,"Cipla, Indiabulls Housing, Maruti Suzuki: Top Stocks for Investors on August 6","The Indian stock market is speculated to open flat on Friday, as the Reserve Bank of India prepares its bi-monthly monetary policy announcement.",neutral,neutral,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 17:30:00.000,939.0,939.0,909.0,912.0,9582846.0,Cipla share price tanks 4% post Q1 results; here’s what brokerages say,The company posted a net profit of Rs 709.92 crore in the April-June quarter of the current fiscal compared to Rs 566.04 in the same quarter of the previous fiscal,neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 17:30:00.000,939.0,939.0,909.0,912.0,9582846.0,"Stocks in news: Adani Power, Cipla, Maruti Suzuki, Future Retail, Escorts and more","On Thursday, the equity indices closed at record highs for the third consecutive session, despite profit-booking in the last hour of trade. Sensex ended 123 points higher at 54,492 and Nifty climbed 35 points to 16,294",neutral,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-06 20:05:00.000,939.0,939.0,909.0,912.0,9582846.0,"India growth, steady margins are key to near-term upsides for Cipla","Over the medium term, success of the new launches in the US would drive gains",positive,positive,-2.8753993610223643,negative,0.6468588970507594,neutral
2021-08-09 14:38:00.000,920.0,923.8,905.0,913.45,2548468.0,Cipla confident about earning trajectory over next couple of quarters: Umang Vohra,“We feel confident about the margin profile of the company and we are hoping to maintain that in the quarters going forward.”.,positive,positive,-0.7119565217391255,neutral,-0.4819805016978834,neutral
2021-08-09 19:15:31.000,920.0,923.8,905.0,913.45,2548468.0,"Cipla CFO Says Drug Maker To Outperform Domestic Market In FY22, Moderna Vaccine Import May Take Time","In an interview to Moneycontrol, Cipla’s Global Chief Financial Officer Kedar Upadhye expressed confidence that the company will outperform domestic formulation market and clock EBITDA margins of 22.5–23 percent for FY22.",neutral,positive,-0.7119565217391255,neutral,-0.4819805016978834,neutral
2021-08-10 11:23:27.000,920.0,923.8,905.0,913.45,2548468.0,Buy Cipla; Target Of Rs 1205: ICICI Direct,"ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1205 in its research report dated August 06, 2021.",neutral,positive,-0.7119565217391255,neutral,-0.4819805016978834,neutral
2021-08-10 16:45:00.000,912.9,914.0,891.05,908.5,2170550.0,"Nifty Pharma joins markets bull wagon; Alkem, Aurobindo led the pack",Cipla shed 0.29% being the top underperformer at Rs916 per piece.,neutral,neutral,-0.4819805016978834,neutral,-0.8333333333333357,neutral
2021-08-11 19:05:58.000,912.0,916.2,903.7,904.4,2123795.0,"Drug Companies See US Sales Plunging In Q1FY22 Amidst Pricing Pressure, Lack Of New Approvals","Strides Pharma, Cipla among the companies. Strides Pharma reports net loss of Rs 21.23 crore in the first quarter of FY22. MD & CEO says firm has not seen the kind of price erosion it has seen in Q1FY22.",neutral,neutral,-0.8333333333333357,neutral,-1.2748344370860876,negative
2021-08-12 09:46:00.000,912.0,916.2,903.7,904.4,2123795.0,Cipla gets final nod for generic ophthalmic emulsion,The drug major on Thursday announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for difluprednate ophthalmic emulsion 0.05% from the US drug regulator.,neutral,positive,-0.8333333333333357,neutral,-1.2748344370860876,negative
2021-08-12 09:54:00.000,912.0,916.2,903.7,904.4,2123795.0,Cipla receives final approval for Difluprednate Ophthalmic Emulsion,Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated generic therapeutic equivalent version of Novartis Pharmaceutical Corporation’s Durezol.,positive,neutral,-0.8333333333333357,neutral,-1.2748344370860876,negative
2021-08-12 13:16:00.000,906.0,910.95,892.35,894.45,2915865.0,Cipla gets USFDA nod for generic product,"According to IQVIA (IMS Health), Durezol had US sales of around USD 106 million for the 12-month period ending June 2021.",neutral,neutral,-1.2748344370860876,negative,-0.8370535714285714,neutral
2021-08-12 13:41:48.000,906.0,910.95,892.35,894.45,2915865.0,Cipla Gets USFDA Nod For Generic Product,"The company has received final approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Novartis Pharmaceutical Corporation″s Durezol, Cipla said in a statement.",neutral,positive,-1.2748344370860876,negative,-0.8370535714285714,neutral
2021-08-12 13:59:48.000,906.0,910.95,892.35,894.45,2915865.0,Cipla gets USFDA nod for generic product for Difluprednate Ophthalmic Emulsion,,neutral,neutral,-1.2748344370860876,negative,-0.8370535714285714,neutral
2021-08-12 18:11:00.000,906.0,910.95,892.35,894.45,2915865.0,Cipla gets USFDA final nod for Difluprednate Ophthalmic Emulsion,The product will be available for shipping soon.,neutral,neutral,-1.2748344370860876,negative,-0.8370535714285714,neutral
2021-08-16 14:31:05.000,891.0,906.3,889.9,903.0,3765023.0,Cipla Ltd drops for fifth straight session,"Cipla Ltd is quoting at Rs 893.4, down 0.11% on the day as on 13:19 IST on the NSE. The stock jumped 15.78% in last one year as compared to a 47.29% rally in NIFTY and a 20.08% spurt in the Nifty Pharma index.",neutral,positive,1.3468013468013469,positive,0.966451899577864,positive
2021-08-18 08:31:58.000,900.2,910.7,900.0,908.9,2317193.0,"F&O expiry: Nifty support at 16,500, Bank Nifty may hit 36,300; ICICI Bank, Cipla, others strong on charts","On Wednesday, against the backdrop of the weekly expiration of index options, the Nifty would find resistance between the 16650 and 16700 levels",neutral,neutral,0.966451899577864,positive,-2.079436681703155,negative
2021-08-18 10:21:00.000,900.2,910.7,900.0,908.9,2317193.0,"Cipla allots 8,668 equity shares under ESOP","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,33,02,250/- comprising of 80,66,51,125 equity shares of face value Rs.2/- each",neutral,neutral,0.966451899577864,positive,-2.079436681703155,negative
2021-08-24 07:42:00.000,903.0,919.55,897.65,916.95,2580445.0,"Nifty Pharma rallies 1.2%; Biocon, Cipla, Sun Pharma, Lupin lead the winning streaks","Cipla, Sun Pharma, Lupin, DR Reddy’s also advanced to lift the spirits after a gloomy morning.",positive,positive,1.5448504983388751,positive,-0.7524536532170095,neutral
2021-08-25 15:54:00.000,912.6,916.75,906.3,910.0,1519882.0,"Cipla, Kemwell Biopharma join hands to develop biosimilars","Under the terms of the agreement, the joint venture will leverage Cipla and Kemwells complementary strengths for end-to-end product development, clinical development, regulatory filings, manufacturing and commercialisation of biopharmceutical products.",positive,positive,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-25 17:16:59.000,912.6,916.75,906.3,910.0,1519882.0,"Cipla, Kemwell form JV for developing, commercialising biosimilars for global markets","Cipla, Kemwell form JV for developing, commercialising biosimilars for global markets",neutral,neutral,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-25 17:30:00.000,912.6,916.75,906.3,910.0,1519882.0,"Cipla, Kemwell Biopharma enter JV to develop biosimilars","The two companies will incorporate the JV for this purpose with an aim to enter the respiratory biosimilars space, Cipla said in a regulatory filing",positive,neutral,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-25 17:50:00.000,912.6,916.75,906.3,910.0,1519882.0,Cipla and Kemwell partner to enter into respiratory biosimilars space,"Under the terms of the agreement, the joint venture will leverage Cipla and Kemwell’s complementary strengths for end-to-end product development, clinical development, regulatory filings, manufacturing and commercialisation of biopharmaceutical",positive,positive,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-25 18:04:10.000,912.6,916.75,906.3,910.0,1519882.0,Cipla enters into JV agreement with Kemwell Biopharma,Powered by Capital Market - Live News,positive,neutral,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-25 19:21:44.000,912.6,916.75,906.3,910.0,1519882.0,Cipla Partners Kemwell To Foray Into Respiratory Biosimilars Space,Cipla’s respiratory drug prowess combined with Kemwell’s expertise in biologics will accelerate bringing these essential products to market.,neutral,positive,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-26 06:30:00.000,912.6,916.75,906.3,910.0,1519882.0,Cipla and Kemwell Biopharma execute JV agreement to develop biosimilars,Cipla’s respiratory prowess combined with Kemwell’s expertise in biologics will accelerate bringing these essential products to market.,positive,positive,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-26 08:33:16.000,912.6,916.75,906.3,910.0,1519882.0,"Stocks to Watch: Automobiles, Bharti Airtel, BoI, Cipla, FRL, sugar",Revenue Secretary Tarun Bajaj on Wednesday said that the government is open to discussing a change in GST rates on automobiles amid several remarks from automakers across the country to lower taxes,neutral,neutral,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-26 08:36:04.000,912.6,916.75,906.3,910.0,1519882.0,"Stocks to Watch Today: Airtel, Infosys, Bank of India, Chenplast Sanmar, Cipla and More","Indian markets, on Wednesday, opened in the green and touched all-time highs.",neutral,neutral,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-26 10:25:00.000,912.6,916.75,906.3,910.0,1519882.0,"Cipla, Kemwell Biopharma tieup for respiratory biosimilars","The drug major on Wednesday announced execution of a joint venture agreement with Kemwell Biopharma for developing, manufacturing and commercialising biosimilars.",neutral,positive,-0.2849002849002874,neutral,0.8973517181002458,neutral
2021-08-26 17:30:00.000,913.8,925.45,907.5,922.0,1877430.0,"Stocks in news: Bharti Airtel, Jindal Steel, ICICI Bank, Cipla and more","Stocks to watch out for: Bharti Airtel, Jindal Steel, Future Retail, Kaveri Seed and more",neutral,neutral,0.8973517181002458,neutral,0.974025974025974,positive
2021-08-30 07:15:26.000,924.0,936.5,920.45,933.0,2012896.0,"Hot Stocks | ‘Can Bet On Cipla, BPCL For Short Term’","“The immediate supports for Nifty are placed around 16,600 and 16,500 while the levels to watch on the upside will be 16,800 and then 17,000,” said Ruchit Jain of Angel Broking.",neutral,neutral,0.974025974025974,positive,1.497326203208556,positive
2021-08-30 07:28:28.000,924.0,936.5,920.45,933.0,2012896.0,"Stocks To Watch: Bharti Airtel, Cipla, M&M, Nazara Technologies, Burger King, IDBI Bank, Max Healthcare",Here are the stocks to watch in trade today...,neutral,neutral,0.974025974025974,positive,1.497326203208556,positive
2021-08-30 08:05:00.000,924.0,936.5,920.45,933.0,2012896.0,"Nifty Pharma picks speed to advance 2%; Divis Lab, Biocon, Sun Pharma lift performance",Dr Reddy’s Laboratories (up 1.73%) and Torrent Pharmaceuticals (up 1.564%) were also bullish. Lupin and Cipla advanced over 1.2%.,positive,positive,0.974025974025974,positive,1.497326203208556,positive
2021-09-02 08:44:00.000,927.0,960.0,923.4,954.8,3680539.0,"Nifty Pharma skyrockets 1.5% on broad-based buying; Cipla, Aurobindo, Dr Reddy’s in the fast lane","The index has touched an intraday high and low of 14,500.40 and 14,364.00 respectively.",neutral,negative,2.9989212513484307,positive,-1.579332705783916,negative
2021-09-02 13:19:00.000,956.1,963.0,930.65,941.0,3105921.0,Cipla partners with IIT Delhi backed startup Clensta for distribution of waterless technology products,"Cipla will run an intensive marketing drive to educate the right buyers such as hospitals, pharmacies, defense forces and various institutions, the company said in a statement.",neutral,neutral,-1.579332705783916,negative,0.4969075434794028,neutral
2021-09-07 17:13:22.000,948.0,953.15,940.0,953.15,1597284.0,"Cipla Wants Modi Govt to Hike Prices of Asthma Drugs, Cites 300% Increase in Production Cost","New Delhi: Drug major Cipla has asked the Narendra Modi government at the Centre to allow price hike of asthma and other respiratory drugs, citing a 300 per cent increase in production cost, News18 has learnt.",neutral,positive,0.543248945147677,neutral,-0.0420543552541636,neutral
2021-09-07 21:44:33.000,948.0,953.15,940.0,953.15,1597284.0,"Cipla Seeks Price Hike For Certain Respiratory Medications, Writes To NPPA","Cipla spokesperson confirmed the development, and said the products impacted are a “small subset” of the overall basket of respiratory products.",neutral,neutral,0.543248945147677,neutral,-0.0420543552541636,neutral
2021-09-08 08:38:34.000,948.0,953.15,940.0,953.15,1597284.0,"Stocks to Watch Today: Vodafone Idea, IRCTC, TVS Motor, Cipla, Wipro and More",Indian markets on Wednesday can open on a positive note- thanks to positive global cues.,neutral,positive,0.543248945147677,neutral,-0.0420543552541636,neutral
2021-09-15 22:33:00.000,954.5,964.8,950.2,954.0,3567648.0,"Cipla allots 2,499 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,33,07,248/- comprising of 80,66,53,624 equity shares of face value Rs.2/- each",neutral,neutral,-0.0523834468308014,neutral,-0.6458333333333381,neutral
2021-09-20 15:25:00.000,935.0,959.0,933.0,955.0,2434169.0,Cipla acquires 5% stake of Swasth Digital Health Foundation to leverage digital technologies,The investment is being made with an aim to leverage digital technologies and build healthcare tech infrastructure.,positive,positive,2.13903743315508,positive,1.3021790496193204,positive
2021-09-28 10:11:41.000,960.5,977.0,950.8,977.0,1540091.0,"Sensex opens flat; HCL Tech, Infosys, Cipla among top losers","Indian share markets opened flat on Tuesday. The BSE Sensex fell 78 points in opening deals, while the Nifty50 was down 13 points",neutral,negative,1.717855283706403,positive,2.11231324059763,positive
2021-09-30 22:57:56.000,980.0,991.9,973.1,984.05,1944315.0,Cipla’s shares echo investors’ bet on sustained core growth,"The Cipla stock trades at about 27 times FY22 earnings estimates, leaving little room for further upside",positive,positive,0.4132653061224443,neutral,-2.951318458417852,negative
2021-10-01 11:11:00.000,980.0,991.9,973.1,984.05,1944315.0,Cipla eyes acquisitions after Covid windfall,"Founded in 1935 by Hamieds grandfather in then-colonial Bombay, Cipla made its name globally by pioneering the sale of cheap, generic HIV drugs across Africa at the turn of the millennium. Since then the Hamied family has sought to build Cipla into a major global pharmaceutical player, with a curren…",neutral,neutral,0.4132653061224443,neutral,-2.951318458417852,negative
2021-10-01 14:56:00.000,980.0,991.9,973.1,984.05,1944315.0,"Cipla eyes acquisitions in India, US after Covid-led windfall","With a funding frenzy currently underway in India, Cipla may struggle to find attractive targets",neutral,negative,0.4132653061224443,neutral,-2.951318458417852,negative
2021-10-01 19:17:55.000,980.0,991.9,973.1,984.05,1944315.0,Storied Indian Drugmaker Eyes Acquisitions After Covid Windfall,"With an arsenal of Covid treatments, Cipla’s cash and cash equivalents swelled 33% to $660 million from March to June.",neutral,positive,0.4132653061224443,neutral,-2.951318458417852,negative
2021-10-04 09:19:00.000,986.0,996.95,954.9,956.9,4091811.0,Eli Lilly to transfer rights of key diabetes products to Cipla,"Under the deal, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two Lilly Diabetes products subject to all regulatory approvals.",neutral,neutral,-2.951318458417852,negative,-2.838427947598249,negative
2021-10-04 09:25:00.000,986.0,996.95,954.9,956.9,4091811.0,Cipla to sell two diabetes products of Eli Lilly in India,"As a part of this agreement, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two Lilly Diabetes products - Humalog & Trulicity& trade; to Cipla, subject to all regulatory approvals.",neutral,neutral,-2.951318458417852,negative,-2.838427947598249,negative
2021-10-04 09:54:00.000,986.0,996.95,954.9,956.9,4091811.0,"Cipla to sell Lilly’s Trulicity, Humalog diabetes treatments in India",This will allow Cipla to expand access to the drugs in the country with the second-highest number of diabetic people in the world. India has more than 70 million adults with diabetes.,neutral,positive,-2.951318458417852,negative,-2.838427947598249,negative
2021-10-04 09:56:00.000,986.0,996.95,954.9,956.9,4091811.0,"Cipla to sell Eli Lilly’s insulin products Humalog, Trulicity in India","Only 3 firms - Novo Nordisk, Sanofi, and Eli Lilly - supply insulin to patients in the US. These three companies, commonly called the ‘Big Three’, control over 90 per cent of the global insulin market",neutral,neutral,-2.951318458417852,negative,-2.838427947598249,negative
2021-10-04 10:12:18.000,986.0,996.95,954.9,956.9,4091811.0,"Eli Lilly, Cipla enter into strategic partnership in India","Eli Lilly, Cipla enter into strategic partnership in India",positive,positive,-2.951318458417852,negative,-2.838427947598249,negative
2021-10-04 11:38:19.000,986.0,996.95,954.9,956.9,4091811.0,Eli Lilly To Transfer Rights Of Two Diabetes Products To Cipla,"As a part of the agreement, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two diabetes products – Humalog and Trulicity to Cipla, subject to all regulatory approvals, the company said in a statement.",neutral,neutral,-2.951318458417852,negative,-2.838427947598249,negative
2021-10-04 14:02:16.000,961.8,961.9,928.45,934.5,4976625.0,Cipla To Sell Eli Lilly’s Diabetic Drugs In India,Lilly said that the existing operating model for its other products would remain unaltered. The idea is to leverage Cipla’s strong local footprint.,neutral,positive,-2.838427947598249,negative,-2.3248356581689915,negative
2021-10-04 17:30:00.000,961.8,961.9,928.45,934.5,4976625.0,"Cipla to sell Eli Lilly’s Trulicity, Humalog diabetes treatments in India","Lilly will transfer its rights in India to sell, promote and distribute its Trulicity and Humalog products, while continuing to maintain its existing operating model for the remaining portfolio of its products",neutral,neutral,-2.838427947598249,negative,-2.3248356581689915,negative
2021-10-05 07:13:51.000,961.8,961.9,928.45,934.5,4976625.0,"Biocon, Cipla and ZEEL are among stocks in the news",Initial indicators from stock markets globally indicate a fall in stocks pushed by surging raw-material prices and fears of inflation,neutral,negative,-2.838427947598249,negative,-2.3248356581689915,negative
2021-10-06 17:39:06.000,920.0,922.25,898.0,915.8,7001756.0,Cipla Q2 PAT Seen Up 20.3% YoY To Rs 793.4 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 4 percent Y-o-Y (down 5.5 percent Q-o-Q) to Rs 5,169.7 crore, according to Prabhudas Lilladher.",neutral,positive,-0.4565217391304397,neutral,-0.6554712892741013,neutral
2021-10-11 06:20:00.000,922.8,923.15,910.0,914.3,1446086.0,Eli Lilly lays off 120 employees in India after Cipla sale,The sales team was informed of the decision at a virtual town hall organised last week in conjunction with the media announcement of the deal with Cipla.,negative,positive,-0.9211096662332032,negative,0.3229337712096382,neutral
2021-10-11 12:03:00.000,913.5,924.7,907.85,916.45,1162127.0,22 Nifty stocks still trade at discount to historical valuations. Worth a look?,"Pharma names such as Sun Pharma, Dr Reddy’s Labs and Cipla, refiner IOC and utilities Power Grid and NTPC are trading at up to 26 per cent discounts to their 10-year averages.",neutral,neutral,0.3229337712096382,neutral,-0.922258992025172,negative
2021-10-26 07:15:15.000,908.9,914.15,900.0,906.0,1402006.0,"Cipla Q2 Results Preview: Topline Likely To Increase 4%, Bottomline 6%, Say Experts","Investors would look at the outlook for limited competition pipeline in the US, decision on Avenue Therapeutics and update on inhaler products for the US",neutral,neutral,-0.3190670040708523,neutral,0.4634931021320682,neutral
2021-10-26 07:56:18.000,908.9,914.15,900.0,906.0,1402006.0,"Stocks to Watch: Axis Bank, Bajaj Finance, BPCL, Airtel","Axis Bank, Kotak Mahindra Bank, Bajaj Finance, ABB India, Cipla, Ambuja Cements, Canara Bank, Central Bank of India, Dr Lal PathLabs, Mahanagar Gas, Persistent Systems, Torrent Pharmaceuticals, among others, will release their September quarter earnings today",neutral,neutral,-0.3190670040708523,neutral,0.4634931021320682,neutral
2021-10-26 08:18:55.000,908.9,914.15,900.0,906.0,1402006.0,"Stock markets likely to consolidate; telcos, Eicher Motors, Axis Bank in focus","Among key companies, Bajaj Finance, Kotak Mahindra Bank, Axis Bank, Ambuja Cement, Cipla, Torrent Pharma, Canara Bank, Dr Lal Pathlabs, Nippon Life India Asset Management and Central Bank of India will announce their September quarter results today",positive,neutral,-0.3190670040708523,neutral,0.4634931021320682,neutral
2021-10-26 16:51:00.000,916.95,926.9,902.45,921.2,5082024.0,"Key earnings today: Axis Bank, Kotak Bank, Bajaj Finance, Cipla, Ambuja Cement in focus",From banking and financial sector giants to cement and pharmaceuticals - companies are set to announce their quarterly results.,neutral,neutral,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-26 17:30:00.000,916.95,926.9,902.45,921.2,5082024.0,"Cipla Q2 results: Net profit rises 7% to Rs 711 cr, revenue up 10%","The company’s revenue from operations grew 10 per cent to Rs 5,520 crore, while EBITDA rose 4 per cent to Rs 1,226 crore.",positive,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-26 18:51:24.000,916.95,926.9,902.45,921.2,5082024.0,"Cipla Q2 Result | Profit Rises 7% YoY To Rs 711 Crore, Revenue Up 10% At Rs 5,520 Crore",Revenues were aided by brisk business in the domestic and US formulations space for the company as well as in other parts of the world.,neutral,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-26 20:23:00.000,916.95,926.9,902.45,921.2,5082024.0,"Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth","Sequentially, however, the company has posted muted growth-revenue growth of 0.3%, and a PAT decline of 0.5%. Ebitda dipped sequentially too, by 9%",positive,negative,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-26 20:33:40.000,916.95,926.9,902.45,921.2,5082024.0,"Cipla Q2 Results: Profit Dips But Meets Estimates, Revenue Flat Sequentially",Cipla’s Q2 revenue flat sequentially as contribution from Covid portfolio declines.,neutral,negative,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 07:40:56.000,916.95,926.9,902.45,921.2,5082024.0,"Buzzing Stocks: Cipla, Torrent Pharma, Axis Bank, And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 08:04:00.000,916.95,926.9,902.45,921.2,5082024.0,Cipla standalone net profit rises 4.93% in the September 2021 quarter,Sales rise 3.98% to Rs 3858.82 crore,positive,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 08:07:00.000,916.95,926.9,902.45,921.2,5082024.0,Cipla consolidated net profit rises 6.90% in the September 2021 quarter,Sales rise 10.32% to Rs 5485.84 crore,positive,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 08:24:00.000,916.95,926.9,902.45,921.2,5082024.0,Cipla Q2 PAT rises 7% YoY to Rs 711 crore,"The drug major’s consolidated net profit grew 7% year on year to Rs 711 crore on a 10% rise in total revenue from operations to Rs 5,520 crore in Q2 FY22 over Q2 FY21.",positive,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 08:31:48.000,916.95,926.9,902.45,921.2,5082024.0,"Cipla Q2 Review - In-Line, Next Set Of Key Launches In The U.S. In H2 FY23: Dolat Capital","Cipla Q2 Review - In-Line, Next Set Of Key Launches In The U.S. In H2 FY23: Dolat Capital",neutral,neutral,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 08:33:00.000,916.95,926.9,902.45,921.2,5082024.0,"Stocks to Watch: Bajaj Auto, Axis Bank, ITC, Maruti, L&T, SBI Life, Cipla","The broader markets may swing to the global cues, while individual stocks are likely to react to corporate earnings and company specific developments in trade today",neutral,neutral,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 08:44:00.000,916.95,926.9,902.45,921.2,5082024.0,"Axis Bank, Bajaj Finance, Cipla to react to September quarterly results","Larsen & Toubro, ITC, IndusInd Bank, Bajaj Auto, Titan Company, Lupin, Maruti Suzuki India, SBI Life Insurance Company, Zee Entertainment Enterprises, Adani Enterprises, Adani Ports and Special Economic Zone, United Spirits among others will",positive,neutral,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 10:36:43.000,916.95,926.9,902.45,921.2,5082024.0,Cipla - Steady Q2; Strong Respiratory Pipeline: ICICI Securities,Cipla - Steady Q2; Strong Respiratory Pipeline: ICICI Securities,neutral,neutral,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 10:42:10.000,916.95,926.9,902.45,921.2,5082024.0,Cipla: Focus Shifts To FY23 Launches,"In the US market, while the Albuterol opportunity is stabilising for Cipla, traction for Arformoterol and the high-value product launch calendar in H2 FY23 is a key watch",neutral,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 11:28:56.000,916.95,926.9,902.45,921.2,5082024.0,Cipla’s decent Q2 performance provides confidence on forward prospects,The India business growth of 16% year-on-year provided the positive impetus despite a decline in sales of covid-19 drugs,positive,positive,0.4634931021320682,neutral,-3.5125758889852534,negative
2021-10-27 13:10:00.000,922.4,928.55,886.3,890.0,2218996.0,"Top stocks in focus: Zee Entertainment Enterprises, Bajaj Finance, Cipla, Axis Bank, Kotak Bank",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 13:31:33.000,922.4,928.55,886.3,890.0,2218996.0,"Cipla Ltd spurts 1.43%, gains for third straight session","Cipla Ltd is quoting at Rs 920.5, up 1.43% on the day as on 12:54 IST on the NSE. The stock is up 20.29% in last one year as compared to a 56.03% spurt in NIFTY and a 25.04% spurt in the Nifty Pharma index.",positive,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 15:18:11.000,922.4,928.55,886.3,890.0,2218996.0,"Cipla Standalone September 2021 Net Sales At Rs 3,935.03 Crore, Up 3.34% Y-o-Y",,neutral,neutral,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 15:27:00.000,922.4,928.55,886.3,890.0,2218996.0,"Cipla’s ‘core’ growth offsets weak show in US, Covid portfolio","Contributing over 40% to total revenues, domestic market sales grew 16% on a high base of Covid-led drug sales. Sustained growth in the company’s core therapies such as respiratory and urology compensated for the normalising contribution of the Covid portfolio.",positive,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 15:57:00.000,922.4,928.55,886.3,890.0,2218996.0,Cipla consolidated PAT up 6.9% yoy in Q2 on higher top line and steady raw material costs,"The pharma company reported 9.56% growth in total revenues for the Sep-21 quarter on a consolidated basis at Rs5,519.80cr.",positive,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 16:31:31.000,922.4,928.55,886.3,890.0,2218996.0,Buy Cipla: Target Of Rs 1150: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated October 26, 2021.",neutral,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 16:34:00.000,922.4,928.55,886.3,890.0,2218996.0,Should You Cheer for Cipla After its Second Quarter Earnings?,Should You Cheer for Cipla After its Second Quarter Earnings?,neutral,neutral,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 17:30:00.000,922.4,928.55,886.3,890.0,2218996.0,"Stocks in news: Cipla, Bajaj Finance, ITC, Axis Bank, Titan, Torrent Pharma and more","Benchmark indices closed higher for the second straight session on Tuesday, buoyed by shares of Reliance Industries, Kotak Bank and Bajaj Finance amid a largely positive trend in global markets.",neutral,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 17:57:00.000,922.4,928.55,886.3,890.0,2218996.0,"Nifty Pharma tops 200 pts on broad-based buying; Lupin, Cipla in focus; Divis Lab, Sun Pharma top bulls","Nifty Pharma index has gained to more than 14,200-level on broad-based buying as major companies have lined up to announce their Q2 financial performance.",neutral,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-27 18:17:00.000,922.4,928.55,886.3,890.0,2218996.0,"Cipla withdraws demerger plan of India based US business and Consumer business, to examine more efficient option",Cipla had also received requisite approvals from The National Stock Exchange of India Limited and BSE Limited for filing the Scheme with National Company Law Tribunal.,positive,positive,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-28 08:33:53.000,922.4,928.55,886.3,890.0,2218996.0,"Cipla Standalone September 2021 Net Sales At Rs 3,935.03 Crore, Up 3.34% Y-o-Y",,neutral,neutral,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-28 10:04:57.000,922.4,928.55,886.3,890.0,2218996.0,Talking Point: Cipla’s CFO On Q2 Report Card & H2 Growth Outlook,Talking Point: Cipla’s CFO On Q2 Report Card & H2 Growth Outlook,neutral,neutral,-3.5125758889852534,negative,1.9036954087346023,positive
2021-10-28 16:00:00.000,893.0,917.0,885.25,910.0,2781317.0,"What should you do with Maruti, Cipla and Axis Bank? Devang Mehta answers",“The Street probably will give Maruti a bounce back because it has underperformed but it is a difficult call to take right now. I would say it is not the best to buy at this point. ”,neutral,positive,1.9036954087346023,positive,-0.8778625954198424,neutral
2021-11-01 08:26:00.000,917.0,918.55,902.2,908.95,982675.0,Cipla expects sales of branded generics to cross $1 billion this fiscal,"Cipla’s branded generics business reported sales of around ₹6,000 crore in FY21. The drug maker’s India business, which consists of prescription, trade generics and consumer health divisions, generated sales of ₹5,126 crore in the first half of this fiscal year, compared with ₹3,698 crore in H1FY21,…",neutral,neutral,-0.8778625954198424,neutral,-0.8241758241758242,neutral
2021-11-03 09:05:00.000,909.55,914.7,903.7,912.1,1270686.0,Cipla update on acquisition of Avenue Therapeutics,InvaGen receives termination notice from Avenue Therapeutics,neutral,neutral,0.2803584189984133,neutral,-0.1807921985427028,neutral
2021-11-03 13:20:37.000,912.65,914.25,908.85,911.0,94535.0,Cipla Unit Gets Notice From US Firm For Termination Of Acquisition Deal,"In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around Rs 1,560 crore).",neutral,positive,-0.1807921985427028,neutral,-0.6372896127240071,neutral
2021-11-03 13:44:00.000,912.65,914.25,908.85,911.0,94535.0,Cipla unit gets notice from US firm for termination of acquisition deal,"“Since the second stage closing could not be completed as per the agreed timelines, in the terms of the SPMA, InvaGen has received a notice of termination from Avenue,” the Mumbai-based drug major said in a regulatory filing.",neutral,negative,-0.1807921985427028,neutral,-0.6372896127240071,neutral
2021-11-03 15:40:00.000,912.65,914.25,908.85,911.0,94535.0,Cipla trades flat after subsidiary receives termination of SPMA notice from Avenue,"InvaGen Pharmaceuticals Inc., USA had entered into a Stock Purchase and Merger Agreement for the acquisition of Avenue Therapeutics Inc.",neutral,neutral,-0.1807921985427028,neutral,-0.6372896127240071,neutral
2021-11-03 19:21:28.000,912.65,914.25,908.85,911.0,94535.0,Cipla unit gets notice from US firm for termination of 2018 acquisition deal,Cipla unit gets notice from US firm for termination of 2018 acquisition deal,neutral,neutral,-0.1807921985427028,neutral,-0.6372896127240071,neutral
2021-11-10 12:02:00.000,912.45,912.45,896.0,906.0,1178254.0,Cipla gains on resolving funding dispute with US-based Pulmatrix,"The funding tussle with Pulmatrix Inc was regarding the development of Pulmazole, an asthma medication that is currently under development.",positive,neutral,-0.7068880486602055,neutral,0.461133069828727,neutral
2021-11-10 15:40:00.000,912.45,912.45,896.0,906.0,1178254.0,Cipla arm and Pulmatrix complete amendment to agreement for development and commercialization of Pulmazole; Stock up 1%,CipTec will continue to reimburse Pulmatrix for 50% of all third-party costs for the development of Pulmazole.,positive,neutral,-0.7068880486602055,neutral,0.461133069828727,neutral
2021-11-11 17:30:00.000,910.8,917.0,905.0,915.0,933947.0,"Taking Stock: Sensex, Nifty End Lower Amid Volatility; Private Banks, Metals Drag","Asian Paints, UPL, Divis Labs, Infosys and Cipla were among the major Nifty gainers. Losers included Axis Bank, Bajaj Finance, ONGC, Tata Motors and Bajaj Finserv",neutral,neutral,0.461133069828727,neutral,2.349726775956284,positive
2021-11-15 20:04:06.000,943.15,943.9,919.0,923.0,1908820.0,Cipla gets inducted into S&P Dow Jones Sustainability Index for Emerging Markets,Powered by Capital Market - Live News,neutral,neutral,-2.1364576154376267,negative,-2.088418768646596,negative
2021-11-16 07:48:43.000,943.15,943.9,919.0,923.0,1908820.0,"Stocks To Watch: Macrotech, Cipla, Phoenix Mills, Jindal Steel, Escorts",Here are the stocks to watch in trade today...,neutral,neutral,-2.1364576154376267,negative,-2.088418768646596,negative
2021-11-16 09:03:00.000,943.15,943.9,919.0,923.0,1908820.0,Cipla to be added to Dow Jones Sustainability Index for emerging markets,The emerging markets index for the year comprises of 108 companies from 12 emerging economies.,neutral,neutral,-2.1364576154376267,negative,-2.088418768646596,negative
2021-11-16 17:11:00.000,921.75,921.75,901.0,902.5,1992579.0,Cipla enters in S&P Dow Jones Sustainability Index for the Emerging Markets in 2021,"The Company significantly improved performance in parameters like a strategy to improve access to drugs or products, human capital development, tax strategy and climate strategy compared to last year.",neutral,positive,-2.088418768646596,negative,-1.4249420081740836,negative
2021-11-17 07:30:00.000,921.75,921.75,901.0,902.5,1992579.0,"Cipla launches Spirofy, India’s first pneumotach based portable wireless Spirometer","With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India.",neutral,positive,-2.088418768646596,negative,-1.4249420081740836,negative
2021-11-17 09:14:00.000,921.75,921.75,901.0,902.5,1992579.0,Cipla launches Spirofy for early diagnosis for COPD,"The drug major announced the launch of Spirofy, India’s first pneumotach based portable, wireless Spirometer.",neutral,positive,-2.088418768646596,negative,-1.4249420081740836,negative
2021-11-17 09:58:00.000,921.75,921.75,901.0,902.5,1992579.0,Cipla launches portable spirometer to diagnose COPD diseases,"With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India. This is a part of the Companys ‘LungAttack’ campaign that endeavors to drive awareness about COPD and encourage early d…",neutral,positive,-2.088418768646596,negative,-1.4249420081740836,negative
2021-11-17 12:05:14.000,905.3,907.0,891.0,892.4,1006758.0,"Cipla launches Spirofy for early diagnosis for COPD, Asthma","Cipla launches India’s first portable wireless spirometer for early diagnosis of COPD, Asthma",neutral,neutral,-1.4249420081740836,negative,0.16237402015678,neutral
2021-11-17 13:25:09.000,905.3,907.0,891.0,892.4,1006758.0,"Cipla introduces portable wireless spirometer for diagnosis of COPD, asthma","With the introduction of Spirofy, the company aims to help doctors to improve the lives of patients.",neutral,positive,-1.4249420081740836,negative,0.16237402015678,neutral
2021-11-18 19:35:00.000,905.3,907.0,891.0,892.4,1006758.0,"Cipla scales up offerings, investments as it eyes global lung specialty leadership","Drugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become the number one company in lung specialty.",neutral,positive,-1.4249420081740836,negative,0.16237402015678,neutral
2021-11-23 08:56:00.000,891.7,918.55,890.0,907.0,1818111.0,"Buy Cipla, target price Rs 935: Yes Securities","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 72227.77 Crore) operating in Pharmaceuticals sector.",neutral,neutral,1.7158237075249474,positive,-1.9758507135016463,negative
2021-11-26 13:59:00.000,892.0,976.05,890.65,962.95,14454351.0,"BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy’s rally up to 8%",The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.,positive,neutral,7.954035874439468,positive,-1.2320328542094456,negative
2021-11-26 18:05:00.000,892.0,976.05,890.65,962.95,14454351.0,"Friday’s Bull! Nifty Pharma soars 2.5% as new Covid variant takes focus; Cipla surges 8%; Dr Reddy’s, Pfizer, Alkem, Divis Lab, Cadila drive",Pharma and healthcare stocks were in demand due to their nature of being frontrunners in tackling the virus and leading to recovery.,positive,negative,7.954035874439468,positive,-1.2320328542094456,negative
2021-11-26 18:54:00.000,892.0,976.05,890.65,962.95,14454351.0,"Pharma stocks rally on buzz about new Covid variant, travel stocks sink","Huge gains for Cipla, Alkem Labs and Dr Lal Path, even as IndiGo, Chalet Hotels and IHC tank",positive,positive,7.954035874439468,positive,-1.2320328542094456,negative
2021-11-29 07:02:25.000,974.0,998.0,956.0,962.0,8282045.0,"Trade Spotlight | What Should Investors Do With Indiabulls Housing Finance, Cipla, Meghmani Organics & BEML Now?","Here’s what Mehul Kothari of Anand Rathi Shares & Stock Brokers, recommends investors should do with these stocks when the market resumes trading today.",neutral,neutral,-1.2320328542094456,negative,0.8497409326424917,neutral
2021-11-29 11:06:00.000,974.0,998.0,956.0,962.0,8282045.0,Bears maintain grip on market: What’s dragging indices lower?,"In the 50-share pack Nifty, Reliance Industries was the biggest gainer, up 2.38 per cent. Cipla, IndusInd Bank, Dr Reddys Labs, HCL Tech, Bharti Airtel, Hindalco Industries and Tata Steel were among other gainers.",negative,positive,-1.2320328542094456,negative,0.8497409326424917,neutral
2021-12-01 12:11:00.000,937.95,937.95,917.5,920.8,2737350.0,"Glenmark, Alembic, Cipla: Pharma stocks on a booster dose this December","Select pharma stocks look good on the technical charts and may jump up to 15 per cent in December. On the fundamental side, fears of Omicron variant spreading may also keep them in news and buzzing",positive,positive,-1.8284556746095304,negative,-1.9247311827956963,negative
2021-12-01 17:01:00.000,937.95,937.95,917.5,920.8,2737350.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Cipla, Divis Labs, UltraTech Cem., Dr. Reddys and Sun Pharma were among the top losers on NSE in today’s trade.",neutral,negative,-1.8284556746095304,negative,-1.9247311827956963,negative
2021-12-02 08:09:18.000,937.95,937.95,917.5,920.8,2737350.0,"Stocks to Watch: Airtel, Nykaa, Bajaj Auto, HUL, Raymond","Anand Rathi IPO will open for subscription today. On Wednesday, IndusInd Bank and Axis Bank were the top gainers on Sensex, while Dr Reddy’s and Ultra Cement were top drags. On the Nifty, IndusInd Bank and JSW Steel gained the most, while Cipla, Ultra Cement along with Dr Reddy’s dragged.",neutral,positive,-1.8284556746095304,negative,-1.9247311827956963,negative
2021-12-02 16:25:00.000,930.0,930.0,908.3,912.1,2369539.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Cipla, ICICI Bank, Axis Bank, UltraTech Cem. and Tata Consumer were among the top losers on NSE in today’s trade.",neutral,negative,-1.9247311827956963,negative,-2.272975631078578,negative
2021-12-03 16:24:08.000,930.0,930.0,908.3,912.1,2369539.0,Upskilling start-up Vani.Coach eyeing $2mn fund raise,"The B2B firm started operation about six-months back and counts companies such as L&T, Lupin, CEAT, Cipla, Reckitt Benckiser and Kotak Mahindra Bank as its clients.",positive,neutral,-1.9247311827956963,negative,-2.272975631078578,negative
2021-12-07 10:29:00.000,898.3,898.3,884.0,889.9,2468944.0,Stock market update: Stocks that hit 52-week lows on NSE,"SBI Life, Cipla, Asian Paints, Divis Labs and Dr. Reddys were among the top losers on NSE.",neutral,negative,-0.9350996326394276,negative,0.4357541899441315,neutral
2021-12-07 12:54:00.000,895.0,902.0,890.3,898.9,1657842.0,Cipla corrects over 8% in five sessions,"Cipla fell 0.72% to Rs 889.45, extending losses for the fifth trading session.",neutral,negative,0.4357541899441315,neutral,-0.6111111111111112,neutral
2021-12-07 13:50:19.000,895.0,902.0,890.3,898.9,1657842.0,Cipla Ltd eases for fifth straight session,"Cipla Ltd is quoting at Rs 888.75, down 0.69% on the day as on 13:24 IST on the NSE. The stock jumped 16.02% in last one year as compared to a 28.35% rally in NIFTY and a 6.52% spurt in the Nifty Pharma index.",neutral,positive,0.4357541899441315,neutral,-0.6111111111111112,neutral
2021-12-07 16:48:51.000,895.0,902.0,890.3,898.9,1657842.0,"Taking Stock | Sensex Zooms 887 Points, Nifty Above 17,150; All Eyes On RBI Policy Outcome","Hindalco Industries, Tata Steel, Axis Bank, ICICI Bank and Tata Motors were among the top Nifty gainers. Losers included Cipla, Britannia Industries, Divis Labs, IOC and Asian Paints",neutral,neutral,0.4357541899441315,neutral,-0.6111111111111112,neutral
2021-12-07 16:51:00.000,895.0,902.0,890.3,898.9,1657842.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Cipla, Britannia, Divis Labs, Indian Oil Corp. and Asian Paints were among the top losers on NSE in today’s trade.",neutral,negative,0.4357541899441315,neutral,-0.6111111111111112,neutral
2021-12-09 14:36:00.000,895.0,901.0,891.0,893.3,946384.0,"Sun, Cipla, Gland Pharma should do well in FY23: Nithya Balasubramanian","“Sun Pharma shifted focus from generics to speciality, which seems to be doing well. Relatively they have a portfolio that is immune from price erosion.”",positive,positive,-0.1899441340782173,neutral,-0.4915102770330753,neutral
2021-12-10 15:41:00.000,895.0,901.0,891.0,893.3,946384.0,"Communication fitness firm vani.coach to skill corp execs, eyes $15 mn ARR","Pune-based firm counts Lupin, L&T, Asian Paints, Reckitt and Cipla among clients; has raised a pre-seed round of $150,000, and is now in talks with some venture capitalists for a seed round",neutral,positive,-0.1899441340782173,neutral,-0.4915102770330753,neutral
2021-12-14 09:42:00.000,893.5,907.85,891.0,896.2,2646710.0,"Buy Cipla, target price Rs 1140: Emkay Global","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 72715.79 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.302182428651376,neutral,-0.133898683329619,neutral
2021-12-15 16:32:00.000,903.5,903.5,878.25,882.0,2270325.0,Cipla informs about dissolution of step-down wholly-owned subsidiary; Stock trades flat,"Inyanga Trading 386, a wholly-owned subsidiary of Cipla Medpro South Africa has been dissolved with effect from December 10, 2021.",neutral,neutral,-2.3796347537354734,negative,-2.947845804988662,negative
2021-12-15 18:44:00.000,903.5,903.5,878.25,882.0,2270325.0,Cipla to acquire 33% stake in Clean Max Auriga Power,"Clean Max Auriga Power LLP is a special purpose vehicle engaged in the business of production, supply, and distribution of solar, wind and other renewable energy.",neutral,neutral,-2.3796347537354734,negative,-2.947845804988662,negative
2021-12-15 19:44:00.000,903.5,903.5,878.25,882.0,2270325.0,Drug major Cipla to acquire 33% stake in Clean Max Auriga Power,"Post-acquisition, Clean Max Auriga Power LLP will become an associate of Cipla",neutral,neutral,-2.3796347537354734,negative,-2.947845804988662,negative
2021-12-16 09:29:07.000,903.5,903.5,878.25,882.0,2270325.0,Stocks that will see action on December 16,"Buzzing Stocks: Sun Pharma, Adani Transmission, Wipro, Lemon Tree, Sigachi Ind, Isgec, Cipla, Alan Scott, Vakrangee, Nxtdigital",neutral,neutral,-2.3796347537354734,negative,-2.947845804988662,negative
2021-12-16 12:50:00.000,882.0,884.5,850.0,856.0,2814475.0,"Top stocks in focus: Adani Ports, Vakrangee, Wipro, Cipla, Sun Pharma",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.947845804988662,negative,3.2928240740740797,positive
2021-12-16 17:20:33.000,882.0,884.5,850.0,856.0,2814475.0,Gainers & Losers: 10 Stocks That Moved The Most On December 16,"Bajaj Finance, Infosys, BPCL, Titan Company and Reliance Industries were among the top Nifty gainers. Losers included Hindalco Industries, Cipla, Maruti Suzuki, ICICI Bank and Hero MotoCorp.",neutral,neutral,-2.947845804988662,negative,3.2928240740740797,positive
2021-12-16 17:26:00.000,882.0,884.5,850.0,856.0,2814475.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Hindalco, Cipla, Maruti Suzuki, ICICI Bank and Hero MotoCorp were among the top losers on NSE in today’s trade.",neutral,negative,-2.947845804988662,negative,3.2928240740740797,positive
2021-12-16 17:30:00.000,882.0,884.5,850.0,856.0,2814475.0,"Taking Stock | Market Gains For Second Day; Sensex Surges 777 Points; Nifty Reclaims 17,400","Adani Ports, HDFC, Power Grid Corp, Tata Steel and Sun Pharma were among the major Nifty gainers. The losers included ICICI Bank, Cipla and Axis Bank",neutral,neutral,-2.947845804988662,negative,3.2928240740740797,positive
2021-12-16 17:30:00.000,882.0,884.5,850.0,856.0,2814475.0,"Stocks in news: ICICI Bank, Tata Steel, TVS Motor, Cipla and more","Stocks in news: ICICI Bank, PNB, Tata Steel, TVS Motor, Cipla, Prestige Estates and more",neutral,neutral,-2.947845804988662,negative,3.2928240740740797,positive
2021-12-16 17:38:00.000,882.0,884.5,850.0,856.0,2814475.0,Cipla acquires 33% stake in Clean Max Auriga Power LLP; Stock tumbles 1%,"Clean Max Auriga Power LLP is a special purpose vehicle engaged in the business of production, supply and distribution of solar and wind or other renewable energy generation plant.",neutral,neutral,-2.947845804988662,negative,3.2928240740740797,positive
2021-12-19 13:49:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla receives USFDA nod to market Lanreotide injection in American market,"The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (USFDA). The FDA approval is based on new drug application (NDA), it added.",neutral,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-19 16:21:23.000,864.0,898.45,861.1,892.45,8073756.0,Cipla gets USFDA nod to market Lanreotide injection in US market,Cipla gets USFDA nod to market Lanreotide injection in US market,neutral,neutral,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-19 17:30:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla gets USFDA approval to market Lanreotide injection in US market,The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (USFDA),positive,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 01:16:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla receives USFDA nod to market Lanreotide injection in US market,"Drug major Cipla on Sunday said it has received approval from the US health regulator to market the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors, in the American market.",neutral,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 05:30:00.000,864.0,898.45,861.1,892.45,8073756.0,Here’s Why Cipla is Rising in a Weak Mkt on Monday; Top Gainer on Nifty,Here’s Why Cipla is Rising in a Weak Mkt on Monday; Top Gainer on Nifty,neutral,neutral,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 08:15:00.000,864.0,898.45,861.1,892.45,8073756.0,"Stocks to Watch: Airtel, ICICI, Hindalco, Shriram Properties, ONGC, Cipla",Consumer Durable stocks are also likely to be in focus on Monday after the company have hiked prices for the third time this year,neutral,neutral,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 08:55:57.000,864.0,898.45,861.1,892.45,8073756.0,Stocks that will see action today (Dec 20),"Buzzing stocks: Trigyn, Zomato, ITC, CIpla, Brookfield REIT, Dish TV, Deep Industries, Mastek, ISMT, Jindal Poly, Aditya Ispat",neutral,neutral,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 08:59:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla gets USFDA nod for Lanreotide injection,"Cipla and its subsidiary Cipla USA Inc., have received the final approval for Lanreotide injection from the United States Food and Drug Administration (USFDA).",neutral,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 08:59:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla and subsidiary secure USFDA nod on Lanreotide Injection,"Cipla and its subsidiary Cipla USA Inc., has announced that it has received the final approval for its Lanreotide Injection from the United States Food and Drug Administration (USFDA).",neutral,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 09:35:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla receives USFDA final approval for Lanreotide Injection,"Lanreotide Injection is supplied in 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL singledose pre-filled syringes. It is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs).",positive,neutral,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 09:56:31.000,864.0,898.45,861.1,892.45,8073756.0,Cipla Shares Gain 2% On Final FDA Approval For Lanreotide Injection,"Foreign research firm Nomura has kept a ‘buy’ call on the stock with a target at Rs 1,051 per share",neutral,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 10:23:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla gains 3% on USFDA’s final approval for Lanreotide injection,ICICI Securities remains positive on Cipla’s calibrated approach of focusing more on branded products and core therapies across the world,positive,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 10:50:00.000,864.0,898.45,861.1,892.45,8073756.0,Cipla gains 3% on USFDA nod to market Lanreotide,"“This approval is a significant step for our US business and is in line with our aspiration to continue growth in our complex product pipeline and address unmet patient needs,” reports quoted Cipla MD and Global CEO Umang Vohra as saying.",positive,positive,3.2928240740740797,positive,-0.5370328932647074,neutral
2021-12-20 12:43:00.000,893.8,897.4,882.05,889.0,2290594.0,Cipla stocks climb over 2% after receiving final nod for Lanreotide Injection,"Umang Vohra, MD and Global CEO, Cipla Limited said, “We are pleased to receive the final approval for Lanreotide injection from the USFDA.",positive,positive,-0.5370328932647074,neutral,-0.0112485939257618,neutral
2021-12-20 17:30:00.000,893.8,897.4,882.05,889.0,2290594.0,"Stocks in news: Zomato, ITC, ICICI Bank, Bharti Airtel and more","Stocks in news: RBL Bank, Indiabulls Real Estate, Cipla, Zomato, NHPC, Shriram Properties, ITC , ICICI Bank, Bharti Airtel and more",neutral,neutral,-0.5370328932647074,neutral,-0.0112485939257618,neutral
2021-12-20 17:55:00.000,893.8,897.4,882.05,889.0,2290594.0,Market Movers: Why Cipla shined and retail investor honeymoon is over?,Ciplas shares surged nearly 4 per cent on a day when the Nifty50 slumped over 2 per cent as investors looked for defensive stocks to hide amid the carnage.,neutral,positive,-0.5370328932647074,neutral,-0.0112485939257618,neutral
2021-12-20 19:34:00.000,893.8,897.4,882.05,889.0,2290594.0,"Cipla stock rises on strong launch pipeline, FDA approval for injection","Margin gains and steady growth in the Indian market to support the stock, say analysts.",positive,positive,-0.5370328932647074,neutral,-0.0112485939257618,neutral
2021-12-21 01:04:02.000,893.8,897.4,882.05,889.0,2290594.0,An unexpected American booster for Cipla,"The product approval that was not earlier anticipated brings an element of positive surprise for investors, said analysts. Looking at the size of the product, one can expect significant earnings upgrades",neutral,positive,-0.5370328932647074,neutral,-0.0112485939257618,neutral
2021-12-21 07:24:20.000,893.8,897.4,882.05,889.0,2290594.0,"Trade Spotlight | What Should You Do With Future Retail, Cipla, Bajaj Finance, And SBI Now?","Here’s what Karan Pai of GEPL Capital, recommends investors should do with these stocks when the market resumes trading today.",neutral,neutral,-0.5370328932647074,neutral,-0.0112485939257618,neutral
2021-12-21 16:35:00.000,889.0,893.85,880.95,888.9,1269580.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Power Grid, Axis Bank, Bajaj Finance, Cipla and SBI were among the top losers on NSE in today’s trade.",neutral,negative,-0.0112485939257618,neutral,1.844170403587449,positive
2021-12-27 07:20:33.000,912.9,933.15,910.15,928.4,4592774.0,"Hot Stocks | Here’s Why You Should Bet On Cipla, Coforge In Near Term",Traders are advised to stick to the stock centric approach because the real action lies there and we expect it to continue in coming session as well.,neutral,neutral,1.6978858582539162,positive,-0.010729613733908,neutral
2021-12-27 08:24:33.000,912.9,933.15,910.15,928.4,4592774.0,Cipla - Lanreotide Approval From U.S. FDA Makes Way For An Expanding Market Opportunity: Nirmal Bang,Cipla - Lanreotide Approval From U.S. FDA Makes Way For An Expanding Market Opportunity: Nirmal Bang,neutral,neutral,1.6978858582539162,positive,-0.010729613733908,neutral
2021-12-27 08:50:00.000,912.9,933.15,910.15,928.4,4592774.0,"Markets closed higher, Pharma stocks outperformed","Nifty Pharma index closed ~1.5 % higher as stocks like Cipla, Dr Reddys and Sun Pharma were among the top outperformers closing around intraday highs along with an addition of fresh long positions.",positive,positive,1.6978858582539162,positive,-0.010729613733908,neutral
2021-12-27 15:00:00.000,932.0,936.3,923.05,931.9,1903048.0,"Markets trade lower on broad-based selloff; Sensex down over 360 points, Nifty 50 erases 16,900; RBL Bank, IndusInd Bank top bears","Cipla, Divis Labs and Power Grid Corporation were among the major gainers on the Nifty, while the losers were IndusInd Bank, Bajaj Finance, Bajaj Finserv, Tata Consumer Products and Axis Bank.",negative,positive,-0.010729613733908,neutral,-0.4051172707889077,neutral
2021-12-27 17:42:00.000,932.0,936.3,923.05,931.9,1903048.0,"Nifty Pharma leads market revival; Index surges over 1%; Lupin, Cipla among top gainers","Laurus Labs, Torrent Pharma, Natco Pharma, and Glenmark Pharma outperformed. Pfizer was under pressure.",positive,positive,-0.010729613733908,neutral,-0.4051172707889077,neutral
2021-12-28 08:02:00.000,932.0,936.3,923.05,931.9,1903048.0,Cipla receives EUA for oral antiviral drug to treat mild to moderate Covid-19,"After getting DGCI Emergency Use Authorisation permission, Cipla plans to launch Molnupiravir under the brand name Cipmolnu.",neutral,neutral,-0.010729613733908,neutral,-0.4051172707889077,neutral
2021-12-28 11:29:00.000,932.0,936.3,923.05,931.9,1903048.0,"Add Cipla, target price Rs 1004: ICICI Securities","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 75418.08 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.010729613733908,neutral,-0.4051172707889077,neutral
2021-12-28 13:45:00.000,938.0,947.6,933.25,934.2,2681688.0,Cipla receives EUA for oral antiviral drug to treat mild-to-moderate Covid,"Cipla will soon make Cipmolnu 200 mg capsules, which will be available at all leading pharmacies and Covid treatment centres across the country",neutral,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 14:30:17.000,938.0,947.6,933.25,934.2,2681688.0,Cipla Gets EUA From DCGI To Market Molnupiravir For COVID-19 Treatment,The Mumbai-based firm said it plans to launch Molnupiravir under the brand name Cipmolnu.,neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 15:15:29.000,938.0,947.6,933.25,934.2,2681688.0,Cipla gets EUA from DCGI; to market Molnupiravir for mild-to-moderate COVID-19 treatment,Cipla gets EUA from DCGI; to market Molnupiravir for mild-to-moderate COVID-19 treatment,neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 15:19:00.000,938.0,947.6,933.25,934.2,2681688.0,Cipla gets EUA nod from DCGA to launch Molnupiravir in India,The pharmaceutical major has been granted the Emergency Use Authorisation (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in the country.,neutral,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 15:31:08.000,938.0,947.6,933.25,934.2,2681688.0,CIPLA receives Emergency Use Authorisation,Powered by Capital Market - Live News,neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 16:02:05.000,938.0,947.6,933.25,934.2,2681688.0,"After Cipla, Sun Pharma gets DCGI nod to launch Merck’s Covid drug in India",Molnupiravir is developed by US-based biotechnology company Ridgeback in collaboration with US Pharma giant Merck.,neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 16:41:03.000,938.0,947.6,933.25,934.2,2681688.0,"Torrent, Cipla, Sun announce branded versions of molnupiravir in India","Torrent to sell the anti-viral drug under brand name Molnutor, Cipla under brand Cipmolnu and Sun Pharmaceuticals under brand Molxvir",neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 16:53:00.000,938.0,947.6,933.25,934.2,2681688.0,Companies race to make COVID antiviral drug molnupiravir available in pharmacies,Drug maker Cipla said it will soon make molnupiravir capsules available at all leading pharmacies and Covid treatment centers across the country. The Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation(EUA) permission for the launch of molnupiravir in the country.,neutral,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 17:00:00.000,938.0,947.6,933.25,934.2,2681688.0,Cipla to launch Molnupiravir under Cipmolnu brand name for COVID-19 treatment,"“This launch is yet another step in our endeavour to enable access to all treatments in COVID care. We continue to be guided by the power of science to address the unmet needs of patients across the globe and bring care closer to the patients,” Cipla MD and Global CEO Umang Vohra said in a statement…",neutral,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 17:14:29.000,938.0,947.6,933.25,934.2,2681688.0,"Drug Majors, Sun Pharma, Cipla and Torrent Pharmaceuticals Get DCGI Nod to Market Molnupiravir for Covid-19 Treatment",he DCGI has approved molnupiravir for treatment of adult patients with COVID-19 and who have high risk of progression of the disease including hospitalisation or death.,neutral,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-28 18:11:00.000,938.0,947.6,933.25,934.2,2681688.0,Pharma players to launch anti-Covid pill shortly after DCGI approval,"Homegrown pharma majors Sun Pharma, Cipla, Hetero, Torrent announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with Covid across India shortly.",neutral,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-29 05:30:00.000,938.0,947.6,933.25,934.2,2681688.0,"13 Indian Drugmakers to Manufacture Anti-Covid Pill: Sun Pharma, Cipla & More","13 Indian Drugmakers to Manufacture Anti-Covid Pill: Sun Pharma, Cipla & More",neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-29 08:53:09.000,938.0,947.6,933.25,934.2,2681688.0,Stocks that will see action today,"Buzzing Stocks: Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Cipla, Torrent Pharmaceuticals, Strides Pharma Science, Aurobindo Pharma, Natco Pharma, Mishtann Food",neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-29 09:40:00.000,938.0,947.6,933.25,934.2,2681688.0,5 pharma and auto ancillary stocks to bet on now: Daljeet Singh Kohli,"‘Within pharma, one has to be choosey. Look at stocks which are more inclined towards the domestic market like Cipla and Sun Pharma. Secondly, healthcare as a theme will also work next year. So hospitals and diagnostics will be the stocks in focus. We added Max recently.’",neutral,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-29 10:02:00.000,938.0,947.6,933.25,934.2,2681688.0,"Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high","Sun Pharma, Cipla, Natco, Dr Reddy’s, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI",positive,neutral,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-29 10:23:00.000,938.0,947.6,933.25,934.2,2681688.0,Pharma stocks gain as DGCI approves emergency use of COVID pill Molnupiravir,"Shares of Strides Pharma were up 2.3 per cent while those of Cipla gained 1.4 per cent. Dr Reddys scrip registered a gain of close to a per cent while Aurobindo Pharma and Natco Pharma were up 0.9 and 1.3 per cent, respectively.",positive,positive,-0.4051172707889077,neutral,1.6862326574172846,positive
2021-12-29 13:31:40.000,937.0,955.0,936.1,952.8,1725616.0,Cipla Ltd rises for third consecutive session,"Cipla Ltd is quoting at Rs 942.95, up 1.03% on the day as on 12:54 IST on the NSE. The stock is up 14.46% in last one year as compared to a 23.22% spurt in NIFTY and a 9.34% spurt in the Nifty Pharma index.",positive,positive,1.6862326574172846,positive,-1.1465968586387485,negative
2021-12-30 08:26:31.000,937.0,955.0,936.1,952.8,1725616.0,"Approved by India, Full Treatment of Anti-Viral Drug Molnupiravir May Cost Up to Rs 3,000: Report","Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr. Reddy’s, Natco, Mylan, Hetero, Optimus will be manufacturing Molnupiravir.",neutral,neutral,1.6862326574172846,positive,-1.1465968586387485,negative
2021-12-30 14:28:00.000,955.0,957.25,942.0,944.05,2034694.0,"Sun, Cipla and Gland remain top pharma picks in 2022: Nithya Balasubramanian","“In terms of the sector, I would say it is back to basics. I would not recommend a pure Covid play at all.“",positive,neutral,-1.1465968586387485,negative,-1.6155430019534296,negative
2021-12-31 15:03:14.000,955.0,957.25,942.0,944.05,2034694.0,Brinton Pharma to launch generic version of anti-Covid pill Molnupiravir next week,"Strides Pharma, Dr Reddy’s, Sun Pharma, Cipla, Hetero, Torrent and Optimus also have plans to roll out their generic versions of the drug",positive,neutral,-1.1465968586387485,negative,-1.6155430019534296,negative
2021-12-31 16:30:00.000,955.0,957.25,942.0,944.05,2034694.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"NTPC, Cipla, Tech Mahindra, Power Grid and Infosys were among the top losers on NSE in today’s trade.",neutral,negative,-1.1465968586387485,negative,-1.6155430019534296,negative
2022-01-03 06:38:00.000,947.05,947.9,925.8,931.75,2007523.0,Nifty Pharma stocks under pressure despite upbeat markets; Cipla emerges top loser,Strides Pharma and Natco Pharma led the gains to lend support to the sector.,negative,positive,-1.6155430019534296,negative,-1.3280708304442952,negative
2022-01-03 11:00:00.000,947.05,947.9,925.8,931.75,2007523.0,Stock market update: Stocks that hit 52-week lows on NSE,"Cipla, Dr. Reddys, Divis Labs, Titan Company and IndusInd Bank were among the top losers on NSE.",neutral,negative,-1.6155430019534296,negative,-1.3280708304442952,negative
2022-01-03 16:35:00.000,937.45,937.45,920.25,925.0,1232831.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Cipla, Dr. Reddys, M&M, Divis Labs and Tech Mahindra were among the top losers on NSE in today’s trade.",neutral,negative,-1.3280708304442952,negative,0.1726929303831648,neutral
2022-01-06 08:49:26.000,928.55,935.95,919.3,921.4,1380507.0,"TCS, SBI Life, Cipla And More - Top Stock Picks For January: KRChoksey","TCS, SBI Life, Cipla And More - Top Stock Picks For January: KRChoksey",neutral,neutral,-0.7700177696408355,neutral,-1.133419689119171,negative
2022-01-06 11:50:35.000,928.55,935.95,919.3,921.4,1380507.0,Super Six Chart Picks By KRChoksey For An Upside Up To 40%,"SBI Life Insurance, Godrej Consumer Products, UPL, Cipla, Bajaj Auto and Tata Consultancy Services are among the top chart picks of KRChoksey for an upside of up to 40 percent.",neutral,neutral,-0.7700177696408355,neutral,-1.133419689119171,negative
2022-01-07 10:04:00.000,926.4,926.65,913.35,915.9,1542286.0,Stock market update: Stocks that hit 52-week lows on NSE,"HDFC, Eicher Motors, Cipla, Dr. Reddys and Bajaj Finance were among the top losers on NSE.",neutral,negative,-1.133419689119171,negative,0.1366493577480186,neutral
2022-01-07 11:30:05.000,926.4,926.65,913.35,915.9,1542286.0,"India to become global hub for COVID-19 antiviral generic drug production as omicron looms, says Fitch","Big pharmaceutical companies like Cipla, Sun Pharma and Dr. Reddy’s are set to release anti COVID-19 pill molnupiravir in the coming weeks following Indian drug regulator’s emergency approval, Fitch Solutions said.",neutral,neutral,-1.133419689119171,negative,0.1366493577480186,neutral
2022-01-09 18:45:06.000,914.75,917.85,908.65,916.0,1632582.0,"IICT, Cipla Foundation to upskill PG students from the north east",The Indian Institute of Chemical Technology (IICT) here and Cipla Foundation (CF) have signed an agreement to conduct an ’orientation-cum-training programme for M. Sc. (Chemistry) students from the no,neutral,positive,0.1366493577480186,neutral,-0.3814713896457765,neutral
2022-01-10 11:53:53.000,914.75,917.85,908.65,916.0,1632582.0,"Ipca, Ajanta, Sun, Torrent report strong sales growth during December: IPM data","The companies that derived large contributions from covid treatment drug sales during 2020 – Cadila Healthcare Ltd, Cipla Ltd , Glenmark Pharmaceuticals Ltd – saw a soft sales growth on a high base of last year",positive,positive,0.1366493577480186,neutral,-0.3814713896457765,neutral
2022-01-12 10:40:00.000,918.4,918.4,901.2,907.2,2088007.0,Stock market update: Stocks that hit 52-week lows on NSE,"Titan Company, Cipla, Divis Labs, TCS and Tech Mahindra were among the top losers on NSE.",neutral,negative,-1.219512195121944,negative,1.419956140350882,positive
2022-01-12 14:12:00.000,912.0,929.15,908.7,924.95,2734319.0,"Buy Cipla, target price Rs 1140: Emkay Global","Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 73115.08 Crore) operating in Pharmaceuticals sector.",neutral,neutral,1.419956140350882,positive,-0.5507262026888299,neutral
2022-01-12 17:06:00.000,912.0,929.15,908.7,924.95,2734319.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Titan Company, TCS, Shree Cements, Britannia and Cipla were among the top losers on NSE in today’s trade.",neutral,negative,1.419956140350882,positive,-0.5507262026888299,neutral
2022-01-13 01:07:00.000,912.0,929.15,908.7,924.95,2734319.0,InvaGen to continue to hold shares in Avenue Therapeutics: Cipla,"In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to $215 million",neutral,positive,1.419956140350882,positive,-0.5507262026888299,neutral
2022-01-13 09:31:08.000,912.0,929.15,908.7,924.95,2734319.0,Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award,Powered by Capital Market - Live News,neutral,neutral,1.419956140350882,positive,-0.5507262026888299,neutral
2022-01-13 10:08:00.000,912.0,929.15,908.7,924.95,2734319.0,Cipla announces termination of stock purchase and merger agreement with Avenue Therapeutics,"However, the ‘Stockholders Agreement’ dated 12 November 2018 between InvaGen, Avenue and other stockholders remains in force; and InvaGen will continue to hold shares in Avenue.",neutral,neutral,1.419956140350882,positive,-0.5507262026888299,neutral
2022-01-13 10:54:00.000,912.0,929.15,908.7,924.95,2734319.0,Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as,The company has been selected from a list of 50 reputed companies nominated for this award.,positive,neutral,1.419956140350882,positive,-0.5507262026888299,neutral
2022-01-13 12:26:33.000,926.05,933.0,916.3,920.95,2317106.0,"Antibody Cocktail Therapy: Dr Jaideep Gogtay, Global Chief Medical Officer, Cipla Ltd, explains how it works","Monoclonal antibody therapy, also known as cocktail therapy, has emerged as one of the effective and reliable treatment options against COVID-19. The therapy that aims to reduce viral loads and lessen symptom severity, according to health experts, can also help cut down the hospitalisation risk by 7…",neutral,positive,-0.5507262026888299,neutral,-0.628003494975972,neutral
2022-01-13 15:09:12.000,926.05,933.0,916.3,920.95,2317106.0,Cipla Q3 PAT May Dip 6.4% YoY To Rs 700.3 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 7.6 percent Y-o-Y (up 0.7 percent Q-o-Q) to Rs 5,560.6 crore, according to Prabhudas Lilladher.",neutral,positive,-0.5507262026888299,neutral,-0.628003494975972,neutral
2022-01-13 16:10:00.000,926.05,933.0,916.3,920.95,2317106.0,"Nifty Pharma advances 120 pts amid volatility; Sun Pharma emerges top bull; Cipla, Gland Pharma, Lupin add to winnings",Sun Pharma performed as top gainer surging by 3% after hitting 52-week high Rs861.50 per piece.,positive,positive,-0.5507262026888299,neutral,-0.628003494975972,neutral
2022-01-13 17:30:00.000,926.05,933.0,916.3,920.95,2317106.0,"Taking Stock | Sensex Up 329 Points, Nifty Reclaims 17,000 As IT, Oil & Gas, Realty Gain","Power Grid Corporation, IOC, ONGC, ITC and Cipla were among the top Nifty gainers. JSW Steel, Divis Labs, Bharti Airtel, Sun Pharma and UltraTech Cement were the top losers.",neutral,negative,-0.5507262026888299,neutral,-0.628003494975972,neutral
2022-01-13 19:51:17.000,926.05,933.0,916.3,920.95,2317106.0,"IICT, Cipla Foundation to upskill PG students from NE",Orientation-cum-training programme for M. Sc. (Chemistry) students,neutral,neutral,-0.5507262026888299,neutral,-0.628003494975972,neutral
2022-01-17 16:15:00.000,910.2,914.6,898.45,901.6,1827422.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"HCL Tech, HDFC Bank, Britannia, Axis Bank and Cipla were among the top losers on NSE in today’s trade.",neutral,negative,-0.9448472863107034,negative,-0.5610799400033282,neutral
2022-01-24 00:55:15.000,871.5,895.0,867.45,892.0,4981324.0,"Unfolding this week: IMF outlook, earnings, Padma awards","The IMF will release its updated economic outlook amid Omicron spread. Q3 earnings for two major companies, Cipla and Maruti Suzuki, are also due this week.",neutral,neutral,2.352266207687894,positive,1.1610949068880438,positive
2022-01-24 18:37:00.000,891.4,909.0,881.1,901.75,2315188.0,"Market movers: Monday mayhem eludes Sharda Cropchem, Cipla shares",Sharda stock jumped after the company on Friday reported a two-fold jump in consolidated net profits,neutral,positive,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 07:41:26.000,891.4,909.0,881.1,901.75,2315188.0,"Trade Spotlight | What Should You Do With Sharda Cropchem, Bandhan Bank, Lupin, Cipla, Global Education?","Here’s what Malay Thakkar of GEPL Capital, suggests investors possessing these stocks when the market resumes trading today",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 07:45:23.000,891.4,909.0,881.1,901.75,2315188.0,Cipla Q3 Results Preview | Decline In Domestic Business Likely To Impact Profitability,A growth of 2-3 percent is seen in revenue but profit is expected to decline 7-12 percent on-year.,neutral,negative,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 07:55:47.000,891.4,909.0,881.1,901.75,2315188.0,"Stocks to Watch: Maruti, Axis Bank, Vodafone Idea, IEX, Deepak Nitrite","Shares of companies like Maruti Suzuki India, Cipla, ICRA, Federal Bank, Pidilite, Raymond, RPG Life Sciences, Allsec Technologies, Star Cement, Torrent Pharma, United Spirits, and Finolex Industries will be in focus as they announce their December quarter earnings today",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 08:03:00.000,891.4,909.0,881.1,901.75,2315188.0,"Stocks in the news: Axis Bank, Maruti, Voda Idea, SBI Cards and IEX","Maruti Suzuki, Pidilite Industries, SRF, Cipla, United Spirits, Macrotech Developers, Torrent Pharma, APL Apollo Tubes and Federal Bank are among the companies that will announce their December quarter results today.",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 08:04:00.000,891.4,909.0,881.1,901.75,2315188.0,"Stocks to Watch: Axis Bank, Airtel, SBI Cards, Voda Idea, IEX, Burger King","Cipla, Federal Bank, Finolex Industries, Indiabulls Real Estate, ICRA, Macrotech Developers, Maruti Suzuki, Pidilite, SRF, Torrent Pharma and United Spirits to announce results today.",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 08:04:00.000,891.4,909.0,881.1,901.75,2315188.0,"Stocks to Watch: Axis Bank, Airtel, SBI Cards, Voda Idea, IEX, Burger King","Cipla, Federal Bank, Finolex Industries, Indiabulls Real Estate, ICRA, Macrotech Developers, Maruti Suzuki, Pidilite, SRF, Torrent Pharma and United Spirits to announce results today.",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 17:30:00.000,891.4,909.0,881.1,901.75,2315188.0,"Stocks that will see action on January 25, 2022","Buzzing stocks: Maruti Suzuki, Tube Investments, Aditya Birla Sun Life AMC, Star Housing Fin, CarTrade Tech, Cipla, Ashoka Buildcon, Emkay Global, Federal Bank, ICRA, Macrotech, Max India, Pidilite, RPG Life, Skipper, SRF, Star Cement, Goa Carbon",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 17:30:00.000,891.4,909.0,881.1,901.75,2315188.0,Cipla Q3 results: Consolidated PAT falls marginally to Rs 729 cr,"Meanwhile, consolidated revenue from sale of products rose nearly 6 per cent to Rs 5,443 crore versus Rs 5,154 crore a year ago",neutral,positive,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 17:30:00.000,891.4,909.0,881.1,901.75,2315188.0,"Stocks in news: Vodafone Idea, Axis Bank, Maruti Suzuki, Pidilite and more","Stocks in news: Shriram Transport Finance, Vodafone Idea, Hero MotoCorp, Axis Bank, Maruti Suzuki, Sensex, Nifty, Pidilite, SRF, Cipla, United Spirits, Macrotech Developers and more",neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 17:53:37.000,891.4,909.0,881.1,901.75,2315188.0,"Cipla Q3 Results | Profit Falls 2.6% YoY To Rs 729 Crore, Revenue Grows To Rs 5,479 Crore",A lower contribution from COVID-related drugs dented the performance in the domestic market but a healthy growth in overseas markets provided the much-needed cushion.,neutral,positive,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 18:04:00.000,891.4,909.0,881.1,901.75,2315188.0,"Cipla Q3 results: Net profit slips marginally to Rs 729 crore, beats estimates","Total revenue from operations was at Rs 5,478.86 crore against ET NOW poll of Rs 5,420 crore.",negative,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 19:01:21.000,891.4,909.0,881.1,901.75,2315188.0,Cipla Q3 Results: Profit Falls 3% But Beats Estimates,The Mumbai-based drugmaker’s net profit fell 3% year-on-year to Rs 728.6 crore in the quarter ended December.,neutral,negative,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 20:08:00.000,891.4,909.0,881.1,901.75,2315188.0,Cipla Q3 PAT dips 2.6% at Rs 729 crore,"Drug major Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021.",neutral,negative,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 20:16:59.000,891.4,909.0,881.1,901.75,2315188.0,"Cipla Q3 PAT dips 2.6% at Rs 729 cr, total revenue up 6%","Cipla Q3 PAT dips 2.6% at Rs 729 cr, total revenue up 6%",positive,positive,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 21:10:08.000,891.4,909.0,881.1,901.75,2315188.0,Cipla Q3 PAT dips 2.6 per cent at Rs 729 crore,The Mumbai-based company had posted a consolidated profit after tax (PAT) of Rs 748 crore in the October-December quarter of 2020-21 fiscal.,neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-25 21:11:52.000,891.4,909.0,881.1,901.75,2315188.0,"Cipla Consolidated December 2021 Net Sales At Rs 5,478.86 Crore, Up 6% Y-o-Y",,neutral,neutral,1.1610949068880438,positive,2.8357380688124256,positive
2022-01-26 11:57:43.000,901.0,931.5,887.0,926.55,7839095.0,"Cipla’s Q3 performance better than expected on strong show in India, US",The domestic sales that contributed 46% to overall revenues remain a key growth driver for Cipla’s performance,positive,positive,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 14:31:27.000,901.0,931.5,887.0,926.55,7839095.0,"Cipla, Torrent Pharma, APL Apollo Tubes, Shriram Transport, Federal Bank & More Q3 Reviews: HDFC Securities","Cipla, Torrent Pharma, APL Apollo Tubes, Shriram Transport, Federal Bank & More Q3 Reviews: HDFC Securities",neutral,neutral,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 15:10:00.000,901.0,931.5,887.0,926.55,7839095.0,"Results Review For Cipla, Torrent Pharma, Shriram Transport Finance Company","Results Review For Cipla, Torrent Pharma, Shriram Transport Finance Company",neutral,neutral,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 15:10:00.000,901.0,931.5,887.0,926.55,7839095.0,"Results Review For Cipla, Torrent Pharma, Shriram Transport Finance Company","Results Review For Cipla, Torrent Pharma, Shriram Transport Finance Company",neutral,neutral,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 17:57:00.000,901.0,931.5,887.0,926.55,7839095.0,Naina Lal Kidwai resigns from Cipla board,"Drug major Cipla on Wednesday said Naina Lal Kidwai has resigned as independent director on its board, with effect from March 31, 2022. In a letter shared by the Mumbai-based drug firm, the veteran banker noted that she has put in her papers to fulfil several other responsibilities and professional …",neutral,neutral,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 18:11:00.000,901.0,931.5,887.0,926.55,7839095.0,Naina Lal Kidwai resigns from Cipla board,The veteran banker noted that she has put in her papers to fulfil several other responsibilities and professional commitments,neutral,neutral,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 19:53:00.000,901.0,931.5,887.0,926.55,7839095.0,Multiple triggers across key markets may support Cipla’s recent rally,"In addition to the Q3 show, new launches offer upsides from current levels",positive,positive,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-26 19:53:00.000,901.0,931.5,887.0,926.55,7839095.0,Multiple triggers across key markets may support Cipla’s recent rally,"In addition to the Q3 show, new launches offer upsides from current levels",positive,positive,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-27 08:17:00.000,901.0,931.5,887.0,926.55,7839095.0,Cipla consolidated net profit declines 2.61% in the December 2021 quarter,Sales rise 5.60% to Rs 5442.86 crore,negative,positive,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-27 08:28:00.000,901.0,931.5,887.0,926.55,7839095.0,"Stocks to Watch: Axis Bank, Brightcom, Cipla, Federal Bank, Pidilite, IT","BHEL, Birlasoft, Canara Bank, Fino Payments Banks, LIC Housing Finance, MayMyIndia, McDowell Holdings, PNB, RBL Bank and Wockhardt to announce results today.",neutral,neutral,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-27 08:53:00.000,901.0,931.5,887.0,926.55,7839095.0,"Wipro, Cipla, United Spirits to be watched","Wipro: The IT major completed the acquisition of additional 13.3% equity stake in Encore Theme. Consequently, the company’s holding in Encore Theme increased from 83.4% to 96.7%.",neutral,positive,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-27 09:23:00.000,901.0,931.5,887.0,926.55,7839095.0,Cipla Q3 PAT falls 2.6% YoY to Rs 729 cr,Cipla reported a 2.6% decline in consolidated net profit to Rs 729 crore in Q3 FY22 from Rs 748 crore posted in Q3 FY21.,neutral,negative,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-27 09:53:00.000,901.0,931.5,887.0,926.55,7839095.0,"What Should Investors Do With Cipla Post Q3 Earnings; Buy, Sell Or Hold?","Consolidated revenues stood at Rs 5,479 crore, up 6 percent compared to Rs 5,169 crore reported in the corresponding quarter of the previous year.",neutral,positive,2.8357380688124256,positive,0.4371053909664959,neutral
2022-01-27 13:31:04.000,926.55,942.0,917.45,930.6,2422400.0,"Cipla Ltd spurts 2.22%, rises for third straight session","Cipla Ltd is quoting at Rs 925.8, up 2.22% on the day as on 12:54 IST on the NSE. The stock is up 9.97% in last one year as compared to a 22.48% gain in NIFTY and a 3.38% gain in the Nifty Pharma index.",positive,positive,0.4371053909664959,neutral,0.6389776357827476,neutral
2022-01-27 15:26:00.000,926.55,942.0,917.45,930.6,2422400.0,Cipla Q3 PAT slips 2.6% yoy to Rs729cr; Stock up 1%,"The total revenues from operations of the company increased 6% yoy at Rs5,479cr in Q3FY22.",positive,positive,0.4371053909664959,neutral,0.6389776357827476,neutral
2022-01-27 17:30:00.000,926.55,942.0,917.45,930.6,2422400.0,"Stocks in news: Cipla, Maruti Suzuki, Vedanta, Raymond and more","Stocks in news: Indus Towers, Punjab National Bank, Canara Bank, Bharat Petroleum, Maruti Suzuki , Vedanta, Raymond, Indiabulls Real Estate, Cipla and more",neutral,neutral,0.4371053909664959,neutral,0.6389776357827476,neutral
2022-01-28 06:33:00.000,926.55,942.0,917.45,930.6,2422400.0,"Demand for Covid drugs down, says Cipla Global CFO","The third wave has been fuelled by the Omicron variant, which is highly infectious yet milder, causing flu-like symptoms such as fever, body pain and sore throat - requiring mostly over-the-counter medications such as paracetamol and multivitamin pills.",neutral,neutral,0.4371053909664959,neutral,0.6389776357827476,neutral
2022-01-28 12:33:40.000,926.55,942.0,917.45,930.6,2422400.0,"Cipla Consolidated December 2021 Net Sales At Rs 5,478.86 Crore, Up 6% Y-o-Y",,neutral,neutral,0.4371053909664959,neutral,0.6389776357827476,neutral
2022-01-31 11:09:00.000,939.0,950.0,930.65,945.0,2004203.0,Cipla seeing a lot of volume growth in tier I to VI towns: MD,“India’s growth has very strong base numbers. Our Covid portfolio actually de-grew by almost 16%. So the base portfolio has clearly taken it forward.”,neutral,positive,0.6389776357827476,neutral,-0.4219409282700421,neutral
2022-01-31 13:04:51.000,948.0,959.0,938.8,944.0,2028597.0,"Cipla Ltd spurts 1.34%, gains for fifth straight session","Cipla Ltd is quoting at Rs 944.7, up 1.34% on the day as on 12:49 IST on the NSE. The stock is up 17.15% in last one year as compared to a 21.74% jump in NIFTY and a 8.64% jump in the Nifty Pharma.",positive,positive,-0.4219409282700421,neutral,0.4865150713908009,neutral
2022-02-02 20:49:52.000,953.0,957.0,944.55,950.2,1113802.0,Accumulate Cipla; Target Of Rs 998: KR Choksey,"KR Choksey recommended accumulate rating on Cipla with a target price of Rs 998 in its research report dated January 28, 2022.",neutral,positive,-0.2938090241343079,neutral,-0.5045992115637271,neutral
2022-02-04 20:02:00.000,951.25,957.75,940.0,946.45,1426912.0,Drugmaker Cipla to buy 32.49% stake in AMP Energy Green Eleven,"AMP Energy Green Eleven was incorporated on November 21, 2020, and is engaged in the business of generating and supplying electrical power generated using solar energy",neutral,neutral,-0.5045992115637271,neutral,-1.6856901289368045,negative
2022-02-04 20:06:00.000,951.25,957.75,940.0,946.45,1426912.0,Cipla to buy 32.49 per cent stake in solar power firm,"The acquisition is in line with the commitment to enhance the share of renewable power sources in its operation and to comply with regulatory requirements for being a captive user under Indian electricity laws, it added.",neutral,positive,-0.5045992115637271,neutral,-1.6856901289368045,negative
2022-02-07 13:15:00.000,933.3,951.0,931.1,950.2,1810858.0,Cipla to acquire 32.49% stake in AMP Energy Green Eleven for Rs 7.50 cr,"Cipla entered into share subscription & shareholder’s agreement (SSHA) along with a power purchase agreement to acquire up to 32.49% stake on a fully diluted basis in AMP Energy Green Eleven, for setting up captive solar power project in",neutral,positive,1.8107789563913097,positive,1.27775450356096,positive
2022-02-15 07:52:38.000,916.55,938.8,912.3,920.9,8093398.0,"Stocks to Watch: RIL, Future Retail, Vedanta, ONGC, Cipla, Adani Enterprises","BHEL, Indiabulls Housing Finance, Punjab National Bank, SAIL and Tata Power Company are under the F&O ban for 15 February. Securities in the ban period under the F&O segment include companies in which the security has crossed 95% of the market-wide position limit",neutral,neutral,0.4746058589275024,neutral,-0.6396588486140725,neutral
2022-02-15 08:15:11.000,916.55,938.8,912.3,920.9,8093398.0,"Stocks to Watch Today: RIL, Future Retail, Cipla, and Others","Stocks to watch: Shares of firms like RIL, Future Retail, Dr Reddy’s Labs, Adani Wilmar will be in focus in Tuesday’s trade Today’s biggest stock Gainers Market News at news18.com",neutral,neutral,0.4746058589275024,neutral,-0.6396588486140725,neutral
2022-02-15 09:28:36.000,916.55,938.8,912.3,920.9,8093398.0,Cipla falls as 2.5% shares change hands in block deal,"The stock dropped 3.64% to hit a low of Rs 920 on BSE. At 9.20am, the scrip was trading at Rs 921, down 3% from its previous close.",neutral,negative,0.4746058589275024,neutral,-0.6396588486140725,neutral
2022-02-15 09:44:00.000,916.55,938.8,912.3,920.9,8093398.0,Cipla slips 5% as 2.5% equity changes hands on the BSE,"According to the disclosure made by the company, Y K Hamied, Chairman, and MK Hamied, Vice Chairman, sold 2,01,69,756 shares, representing 2.5 per cent of the total capital",neutral,neutral,0.4746058589275024,neutral,-0.6396588486140725,neutral
2022-02-15 10:19:40.000,916.55,938.8,912.3,920.9,8093398.0,"Stock Market LIVE: Sensex up 200 pts, Nifty eyes 17K; IT stocks gain, Cipla hit","Share market LIVE updates: Indian equities were higher on Tuesday, with gains largely led by IT stocks. Global peers, however, remained on the edge over rising Russia-Ukraine tensions. At 10am, Sensex was up 125.30 points at 56531.14, and Nifty rose 23.50 points to 16866.30",positive,positive,0.4746058589275024,neutral,-0.6396588486140725,neutral
2022-02-15 11:54:28.000,916.55,938.8,912.3,920.9,8093398.0,Cipla clarifies on promoter stake sale; for personal and philanthropic purposes,"The sale will bring in about ₹1,800 crore",neutral,neutral,0.4746058589275024,neutral,-0.6396588486140725,neutral
2022-02-15 12:24:47.000,938.0,940.25,920.1,932.0,2463320.0,Cipla shares tank over 3 per cent as promoters sell 2.5 per cent stake in block deal,"Cipla was trading at ₹925.40 on the BSE, down ₹29.85 or 3.12 per cen",neutral,negative,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-15 14:21:00.000,938.0,940.25,920.1,932.0,2463320.0,"Cipla – Volatile Range, Big Players and Distribution Phase!","Cipla – Volatile Range, Big Players and Distribution Phase!",neutral,neutral,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-15 14:53:00.000,938.0,940.25,920.1,932.0,2463320.0,Two Cipla promoters sell 20 mn shares; promoter group now holds 34.23%,"Chairman Y K Hamied and Vice Chairman MK Hamied, who are non-executive directors and promoters, have sold 2,01,69,756 shares on Tuesday",neutral,neutral,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-15 17:30:00.000,938.0,940.25,920.1,932.0,2463320.0,"Stocks in news: Reliance Industries, Cipla, Adani Enterprises, Future Retail and more","Stocks in news: Reliance Industries, Coal India, Cipla, Jet Airways, Adani Enterprises, Future Retail and more",neutral,neutral,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-15 17:30:00.000,938.0,940.25,920.1,932.0,2463320.0,Why Cipla stock fell 5% in early trade,Cipla stock fell 4.73% to Rs 910.05 against the previous close of Rs 955.25 on BSE.,negative,negative,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-15 21:51:45.000,938.0,940.25,920.1,932.0,2463320.0,Cipla promoters sell 2.5 per cent stake for personal and philanthropic purposes,"Deal worth ₹1,800 crore",neutral,neutral,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-16 05:30:00.000,938.0,940.25,920.1,932.0,2463320.0,"Stocks in Focus on Feb 16: Vedant Fashions, Cipla, Burger King & More","Stocks in Focus on Feb 16: Vedant Fashions, Cipla, Burger King & More",neutral,neutral,-0.6396588486140725,neutral,-0.7381258023106523,neutral
2022-02-16 20:12:00.000,934.8,955.5,925.7,927.9,2841548.0,"Cipla allots 3,086 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,36,28,072/- comprising of 80,68,14,036 equity shares of face value Rs.2/- each.",neutral,neutral,-0.7381258023106523,neutral,-1.9892183288409755,negative
2022-02-17 22:10:59.000,927.5,929.85,903.05,909.05,3641615.0,"ESG and corporate performance of a company are linked: Geena Malhotra, Cipla | The Financial Express","As the world evolves into a more complex and hyper-connected place, the sustainability challenges the world is facing are evolving even faster.",neutral,neutral,-1.9892183288409755,negative,0.2103864466836427,neutral
2022-02-18 16:10:00.000,927.5,929.85,903.05,909.05,3641615.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"ONGC, Cipla, Divis Labs, UltraTech Cem. and Shree Cements were among the top losers on NSE in today’s trade.",neutral,negative,-1.9892183288409755,negative,0.2103864466836427,neutral
2022-02-22 18:14:00.000,915.25,921.3,910.25,915.25,1398235.0,"India Inc’s governance score improves marginally in 2021, shows IiAS study","20 companies were in the ‘Leadership’ category, against 11 in 2020 and six in 2019. These included Airtel, Cipla, HDFC Life, Marico and Tata Motors among others",positive,neutral,0.0,neutral,-0.5334518781951495,neutral
2022-02-24 19:24:00.000,903.0,926.7,890.95,925.35,2821372.0,Cipla to conduct study on Paxlovid,"In its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cipla will carry study on 44 participants and soon share data with the regulatory authority,” a government official said.",neutral,positive,2.475083056478408,positive,0.7227868050649521,neutral
2022-02-28 20:04:00.000,920.05,929.95,911.0,926.7,1532096.0,India’s equity market capitalisation drops to six-month low in February,"The 10 most active securities during Feb 2022 were Reliance Industries, HDFC, Cipla, Tata Power, Adani Wilmar, Vodafone Idea Ltd, Tata Consultancy Services (TCS), Adani Power, Tata Motors and Infosys",negative,neutral,0.7227868050649521,neutral,1.3280649764021537,positive
2022-03-02 17:30:00.000,925.0,945.0,919.55,934.3,2620394.0,Fair-value stocks: 25 Nifty firms trading at discount to historical valuations,"Some of the stocks in the list included Axis Bank, Bharat Petroleum Corporation, Bharti Airtel, Cipla, Coal India and Grasim Industries.",neutral,neutral,1.0054054054054005,positive,0.3283100107642577,neutral
2022-03-08 08:09:00.000,938.0,977.0,935.4,974.25,5825486.0,"Sensex leaps 1,163 pts from the day’s low, ends 581 pts up; Nifty tops 16K","CLOSING BELL: The winners included Indian Oil Corporation, Sun Pharma, Tata Consumer Products, TCS, Cipla, Shree Cement, NTPC, Tech M, Dr Reddy’s Labs, Wipro, Ultratech Cement, and Infosys",neutral,neutral,3.8646055437100215,positive,1.077819607034196,positive
2022-03-09 13:31:28.000,982.05,992.9,975.0,985.0,4141009.0,"Cipla Ltd spurts 1.05%, gains for third straight session","Cipla Ltd is quoting at Rs 979.75, up 1.05% on the day as on 12:54 IST on the NSE. The stock is up 20.6% in last one year as compared to a 7.32% gain in NIFTY and a 6.35% gain in the Nifty Pharma index.",positive,positive,0.3003920370653272,neutral,6.029972059944111,positive
2022-03-11 05:30:00.000,984.25,1053.75,981.35,1043.6,11101285.0,"Nifty50 Top Gainer: Cipla Surges 6%, Hits Record High; Nifty Pharma Outperforms","Nifty50 Top Gainer: Cipla Surges 6%, Hits Record High; Nifty Pharma Outperforms",neutral,neutral,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-11 11:04:00.000,984.25,1053.75,981.35,1043.6,11101285.0,Cipla hits record high; rises 8% in five days,"Cipla added 2.24% to Rs 1,008.95, extending its winning run to fifth consecutive trading session.",positive,positive,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-11 11:37:00.000,984.25,1053.75,981.35,1043.6,11101285.0,"Cipla gains 3%, hits record high; trades higher for 5th straight day","Analysts at ICICI Securities have maintained a ‘buy’ rating on the stock with target price of Rs 1,100 on the stock",positive,positive,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-11 13:16:58.000,984.25,1053.75,981.35,1043.6,11101285.0,Cipla Ltd jumps around 5%,"Cipla Ltd is quoting at Rs 1037.1, up 5.07% on the day as on 12:49 IST on the NSE. The stock is up 28.68% in last one year as compared to a 10.75% spurt in NIFTY and a 9.93% spurt in the Nifty Pharma.",positive,positive,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-11 15:04:34.000,984.25,1053.75,981.35,1043.6,11101285.0,"D-Street Buzz: Pharma stocks outperform; Sun Pharma, Cipla hit fresh highs","Cipla, Laurus Labs and Sun Pharma which gained over 3 percent each followed by Torrent Pharma, Dr Reddy’s Labs and Aurobindo Pharma.",positive,positive,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-11 17:30:00.000,984.25,1053.75,981.35,1043.6,11101285.0,"Nifty Pharma surges over 1.5% amid volatile trade; Sun Pharma, Dr Reddy’s, Cipla lead gains","Laurus Labs and Granules India rose 4.27% each to lif the performance of the Index. Cipla rose 3.33% at Rs1,019.90 per piece. Abbot India and Strides Pharma were the top losers in the sector.",positive,positive,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-11 20:09:00.000,984.25,1053.75,981.35,1043.6,11101285.0,"Pharma stocks surge on positive cues from Nifty healthcare, Cipla up 6%","Outlook for Indian drug exporters turned positive on prospects of firm exports amid the ongoing geo-political scenario, said analysts",positive,positive,6.029972059944111,positive,0.2488038277511874,neutral
2022-03-15 10:24:00.000,1045.0,1083.0,1045.0,1070.0,7938922.0,Cipla hits fresh all-time high in a volatile market; rallies 12% in 1 week,"Going forward, significant momentum in Cipla will likely continue due to US gains on the back of peptide portfolio unlocking and possible approvals and launches of gRevlimid, gAdvair and gAbraxane",positive,positive,2.392344497607656,positive,-2.163416898792939,negative
2022-03-17 17:11:00.000,1056.0,1066.4,1045.7,1046.7,3703793.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Infosys, Cipla, Indian Oil Corp., HCL Tech and Coal India Ltd were among the top losers on NSE in today’s trade.",neutral,negative,-0.8806818181818138,neutral,-1.55459823937066,negative
2022-03-17 17:30:00.000,1056.0,1066.4,1045.7,1046.7,3703793.0,Broker’s call: Cipla (Buy),Axis Securities,neutral,neutral,-0.8806818181818138,neutral,-1.55459823937066,negative
2022-03-23 08:01:00.000,1044.9,1044.9,1011.25,1015.05,2774541.0,"Sensex falls 305 pts, Nifty gives up 17,250; Paytm slides 4%, HDFC 2%","CLOSING BELL: HDFC, Bharti Airtel, Cipla, Britannia, Sun Pharma, Maruti, and Bajaj Auto were the major drags today",neutral,neutral,-2.8567327016939545,negative,1.4792899408284024,positive
2022-03-23 12:48:32.000,1014.0,1040.1,1001.75,1029.0,3340936.0,"Analysts initiate coverage on 5 stocks with buy rating, expect 14-39 percent returns","Brokerages see opportunities in companies including Star Health, Data Patterns, Cipla, Aditya Birla Capital and KPIT Technologies",positive,positive,1.4792899408284024,positive,-1.577470240975511,negative
2022-03-23 17:30:00.000,1014.0,1040.1,1001.75,1029.0,3340936.0,"Nifty Pharma stocks continue to rally; Dr. Reddy’s, Strides Pharma emerge top gainers","Alkem Lab, Pfizer, and Divis Lab were also among the top gainers. Cipla, Granules India, and Lupin were trading in the red.",positive,positive,1.4792899408284024,positive,-1.577470240975511,negative
2022-03-24 11:50:00.000,1014.0,1040.1,1001.75,1029.0,3340936.0,"Sensex gyrates 690 pts, ends 89 pts down; metal, pharma rally, banks slide","CLOSING BELL: Dr Reddy’s Labs (up nearly 5 per cent) was the top Nifty gainer today, followed by Coal India, Hindalco, Cipla, NTPC, JSW Steel, Tech M, and RIL",negative,positive,1.4792899408284024,positive,-1.577470240975511,negative
2022-03-24 14:44:00.000,1033.3,1033.3,1006.0,1017.0,1675452.0,"Why Nithya Balasubramanian is betting on Sun Pharma & Cipla, avoiding 2 others","“When it comes to pharma we are not seeing secular growth. While India can be a secular growth story, we believe the US would not be and therefore one can bet on specific names from a long-term perspective – something like a Cipla or a Sun. Cipla because of its complex generic portfolio and Sun beca…",neutral,neutral,-1.577470240975511,negative,-0.2984344422700542,neutral
2022-03-25 08:10:00.000,1033.3,1033.3,1006.0,1017.0,1675452.0,"Sensex ends choppy day 234 pts down; Nifty holds 17,150; IT, FMCG weigh","CLOSING BELL: Titan Company, Tech M, Maruti Suzuki, Cipla, IOC, Nestle India, Hero MotoCorp, Eicher Motors, L&T, TCS, Wipro, and Tata Steel were the top laggards",negative,neutral,-1.577470240975511,negative,-0.2984344422700542,neutral
2022-03-28 08:33:00.000,1022.0,1044.25,1008.9,1018.95,3843677.0,"ET Businesswoman of the Year 2021: Samina Hamied - The woman who carries forward a storied legacy, seeking profit, but never at the cost of values","“I am humbled and honoured to receive the ETs Businesswoman of the Year Award. This recognition belongs to each and every one of our 25,000 employees who stand with Cipla, putting patients interests before their own and upholding our purpose of Caring for Life,” Hamied, executive vice-chairperson, C…",neutral,neutral,-0.2984344422700542,neutral,1.9309939227602475,positive
2022-03-28 13:18:00.000,1020.2,1041.0,1020.2,1039.9,3192227.0,ET Awards: Serum CEO Poonawalla voted Biz Leader of the Year while Infosys declared top company,"Freshworks founder and CEO Girish Mathrubootham walked away with the coveted Entrepreneur of the Year award, while Cipla’s executive vice-chairperson Samina Hamied was voted Businesswoman of the Year in a strong field of achievers.",neutral,neutral,1.9309939227602475,positive,-1.4381591562799616,negative
2022-03-29 15:28:00.000,1043.0,1054.8,1025.2,1028.0,3080966.0,BS Awards for Corporate Excellence 2021: Samina Hamied lauds team effort,"Cipla, which has seen a generational change in its leadership, draws 40 per cent of its revenues from India and 21 per cent from the US market.",neutral,neutral,-1.4381591562799616,negative,-1.004854368932041,negative
2022-03-31 08:09:00.000,1030.0,1035.0,1013.6,1019.65,1970455.0,"RIL, HDFC Bk drag Sensex 115pts, Nifty holds 17,450; indices up 19% in FY22","CLOSING BELL: Hindalco tumbled 5 per cent, followed by Divis Labs, Apollo Hospitals, RIL, Wipro, Eicher Motors, Dr Reddy’s Labs, and Cipla",positive,negative,-1.004854368932041,negative,-0.4252199413489758,neutral
2022-04-01 12:14:06.000,1023.0,1025.9,1006.0,1018.65,1284321.0,Buy Cipla: target of Rs 1150: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated March 31, 2022.",neutral,positive,-0.4252199413489758,neutral,0.9332023575638508,positive
2022-04-13 08:15:00.000,1031.0,1033.8,1012.2,1017.35,1888583.0,"Sensex slips for 3rd day, ends 237 pts down; HDFC duo top drags, ITC up 2%","CLOSING BELL: HDFC, HDFC Bank, Maruti Suzuki, Dr Reddy’s Labs, Tata Motors, PowerGrid, Asian Paints, Bajaj Finserv, Kotak Bank, Titan, Cipla, and Eicher Motors were the top laggards on the Nifty index",neutral,neutral,-1.3239573229873889,negative,1.2935274444225828,positive
2022-04-20 06:08:00.000,1001.9,1015.0,990.05,1009.15,1794420.0,Cost pressure likely to weigh on pharma companies’ margins in Q4,"Among Indian firms, Edelweiss feels that Cipla (respiratory) and Sun Pharma (specialty) are better placed to tide the price erosion",neutral,positive,0.7236251122866554,neutral,-1.7764873775896812,negative
2022-04-22 16:05:00.000,998.0,998.55,959.0,969.0,2448379.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Hindalco, HUL, Cipla, SBI and IndusInd Bank were among the top losers on NSE in today’s trade.",neutral,negative,-2.905811623246493,negative,-0.1410510918399355,neutral
2022-05-01 00:17:00.000,979.0,989.75,971.8,979.7,1765725.0,"Pills to wellness, Cipla is seeking a new identity","One of the major successes of Hamied was building a strong US business, despite Cipla being a late entrant. Hamied said this was made possible by pursuing selective yet complex generic portfolios. Cipla entered US in a big way with the strategic acquisitions of two generic companies, InvaGen Pharma …",neutral,positive,0.0715015321756941,neutral,-2.1278772378516577,negative
2022-05-09 17:56:00.000,930.0,939.6,918.55,923.45,1659710.0,"Q4FY22 Preview: Cipla: Revenue seen at Rs52,586 million, adjusted PAT at Rs5,891 million",Company likely to post healthy growth in profitability on a year-on-year basis,neutral,positive,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 07:56:57.000,930.0,939.6,918.55,923.45,1659710.0,"Stocks to Watch: Banks, IT, GNFC, SRF, PVR, UPL, CBI, Vedant Fashions","Stocks to Watch Today: Asian Paints, Cipla, Gujarat Gas and Vodafone Idea will be in focus ahead of the Q4 results on Tuesday, May 10, 2022.",neutral,neutral,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 08:03:21.000,930.0,939.6,918.55,923.45,1659710.0,"Stocks to Watch: RIL, Asian Paints, HCL Tech, JSW Group, NTPC, Adani Ports","Asian Paints, Cipla, Vodafone Idea, Gujarat Gas, Ajanta Pharma, Cera Sanitaryware, Chalet, Electrosteel Castings, Kansai Nerolac Paints, Max Financial Services, Mahanagar Gas, Reliance Capital, Torrent Power are among the companies due to announce quarterly results today",neutral,neutral,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 08:11:40.000,930.0,939.6,918.55,923.45,1659710.0,"Stocks To Watch Today: Asian Paints, Cipla, PVR, Torrent Power, Vodafone Idea",Here are the stocks to watch going into trade today..,neutral,neutral,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 09:19:00.000,930.0,939.6,918.55,923.45,1659710.0,Cipla launches ‘RT-Direct’ multiplex COVID-19 RT PCR test kit in India,Cipla will be responsible for the distribution of RT Direct kits in India and has commenced supply of the same.,neutral,neutral,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 09:27:09.000,930.0,939.6,918.55,923.45,1659710.0,"Stocks that will see action on May 10, 2022","Buzzing stocks: HCL Tech, Vodafone Idea, Asian Paints, Cipla, Gujarat Gas, Chemplast Sanmar, MRF, SRF, Sutlej Textiles, Suraj Ind",neutral,neutral,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 10:47:00.000,930.0,939.6,918.55,923.45,1659710.0,Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit,"With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding its diagnostics offerings, it said in a regulatory filing.",positive,positive,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 10:57:35.000,930.0,939.6,918.55,923.45,1659710.0,Cipla launches real-time RT-PCR test kit for Covid-19,Cipla says RT-Direct multiplex COVID-19 RT PCR test kit is much more advanced than other RT PCR tests,neutral,positive,-0.7043010752688124,neutral,2.850877192982456,positive
2022-05-10 12:14:00.000,912.0,942.6,904.25,938.0,5272398.0,Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit,"The kit is validated by the Indian Council of Medical Research (ICMR) and much more advanced than other RT PCR tests, the drug firm said",neutral,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 12:14:41.000,912.0,942.6,904.25,938.0,5272398.0,Cipla Results Preview | Consolidated net profit may rise 47% on India ops,The company will report its March quarter numbers later today,positive,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 14:47:00.000,912.0,942.6,904.25,938.0,5272398.0,Cipla launches ‘RT Direct’ Multiplex real time PCR kit for Covid-19,RNA extraction free kit to deliver results in just 45 Minutes.,neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 17:30:00.000,912.0,942.6,904.25,938.0,5272398.0,"Cipla Q4 net profit declines 12% to Rs 362 cr, revenue rises 14%",The company said its board has approved a dividend of Rs 5 per equity share of face value Rs 2 per share for the year 2021-22.,negative,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 17:30:00.000,912.0,942.6,904.25,938.0,5272398.0,Cipla launches real-time RT-PCR test kit for COVID-19,"The RT Direct test protocol does not require any RNA extraction process, which makes it faster and helps deliver results in 45 minutes, the company added.",neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 18:57:14.000,912.0,942.6,904.25,938.0,5272398.0,"Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates","The decline during the quarter was due to an increase in employee costs, other expenses and a rise in inventory.",negative,negative,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 19:25:00.000,912.0,942.6,904.25,938.0,5272398.0,Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact,"For the full fiscal, Cipla has posted a 4.7% jump in net profit to Rs 2,517 crore, revenue and Ebitda rose 13.6% and 6.4% respectively",negative,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 19:28:00.000,912.0,942.6,904.25,938.0,5272398.0,"Cipla Q4 Results: Profit falls 12.4% YoY to Rs 362 cr, misses estimates","​The total revenue from operations was Rs 5,260.33 crore, up 14.19 per cent from Rs 4,606.45 crore the company reported in the year-ago quarter.",negative,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-10 20:22:52.000,912.0,942.6,904.25,938.0,5272398.0,Cipla Q4 net profit declines 12% to Rs 362 crore | The Financial Express,The Mumbai-based company had posted a PAT (Profit After Tax) of Rs 413 crore in the January-March quarter of 2020-21 fiscal.,negative,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 07:38:46.000,912.0,942.6,904.25,938.0,5272398.0,"Stocks to Watch Today: Vodafone Idea, Wipro, Cipla, Adani Ports, PNB and Others","Stocks to watch today: Shares of firms like Vodafone Idea, Wipro, Cipla, Adani Ports, PNB, and others will be in focus in Wednesday’s trade",neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 07:41:00.000,912.0,942.6,904.25,938.0,5272398.0,"Stocks to Watch: SBI, Cipla, Voda Idea, Gujarat Gas, Zensar, MGL, Welspun","Stocks to Watch Today: The primary market too is likely to be abuzz with activity with three IPOs namely - Delhivery, Prudent Corporate Advisory Services IPO and Venus Pipes IPO open for subscription.",neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 07:59:27.000,912.0,942.6,904.25,938.0,5272398.0,"Stocks to Watch: Adani Ports, PNB, Bajaj Finance, Cipla, Vodafone Idea, SBI","Adani Ports, Punjab National Bank, Indian Bank, Petronet LNG, Kalyan Jewellers India, NCC, Relaxo Footwears, Sagar Cements, SKF India, Century Enka, Cholamandalam Financial Holdings are among the companies scheduled to announce their March quarter earnings today",neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 08:36:00.000,912.0,942.6,904.25,938.0,5272398.0,"Wipro, Cipla, Vodafone Idea to be watched","Wipro: Wipro announced that it has extended its strategic agreement with Crit Agricole CIB, the corporate and investment bank division of Crit Agricole Group, to fuel Crit Agricole CIB’s next stage of growth.",neutral,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 08:46:39.000,912.0,942.6,904.25,938.0,5272398.0,Cipla Q4 Review - Higher Opex Drags Profitability: Motilal Oswal,Cipla Q4 Review - Higher Opex Drags Profitability: Motilal Oswal,neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 09:30:07.000,912.0,942.6,904.25,938.0,5272398.0,"As Cipla falls after earnings, should you buy or sell stock?","Cipla on May 10 reported a consolidated profit after tax (PAT) of Rs 362 crore for the quarter ended March, a decline of 12 percent from a year ago. The company had registered a PAT of Rs 729 crore in the previous quarter.",neutral,negative,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 09:39:50.000,912.0,942.6,904.25,938.0,5272398.0,"Cipla Q4 Review - Another Quarter Of Strong India, U.S. Growth: Prabhudas Lilladher","Cipla Q4 Review - Another Quarter Of Strong India, U.S. Growth: Prabhudas Lilladher",neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 10:25:00.000,912.0,942.6,904.25,938.0,5272398.0,Cipla skids 4% on Jan-Mar earnings miss,"The total revenue from operations was Rs 5,260.33 crore, up 14.19 per cent from Rs 4,606.45 crore the company reported in the year-ago quarter.",negative,positive,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 10:29:00.000,912.0,942.6,904.25,938.0,5272398.0,Cipla skids after Q4 PAT declines 12% YoY,"Cipla fell 0.90% to Rs 917.90 after the company’s consolidated net profit fell 12.4% to Rs 362 crore on 14.2% increase in total revenue from operations to Rs 5,260 crore in Q4 March 2022 over Q4 March 2021.",negative,negative,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 10:45:28.000,912.0,942.6,904.25,938.0,5272398.0,Cipla Shares Decline Even As Analysts Reiterate ‘Buy’ Calls After Q4 Results,Here’s what brokerages have to say about Cipla’s fourth-quarter performance.,neutral,neutral,2.850877192982456,positive,-1.5989304812834275,negative
2022-05-11 13:05:34.000,935.0,937.0,915.5,920.05,2240330.0,"Cipla Q4 Review - Strong Traction In One-India, U.S. Business: Axis Securities","Cipla Q4 Review - Strong Traction In One-India, U.S. Business: Axis Securities",neutral,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-11 15:56:16.000,935.0,937.0,915.5,920.05,2240330.0,"Sensex Ends 277pts Lower, Nifty Below 16,200; Indiabulls Housing Tanks 21%, Ruchi Soya Down 10%","On the other hand, Asian Paints, HUL, Infosys, RIL, L&T, IndusInd Bank, Cipla and Britannia were the top laggards, down up to 2 per cent.",neutral,negative,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-11 17:30:00.000,935.0,937.0,915.5,920.05,2240330.0,"Stocks in news: Cipla, Vodafone Idea, Adani Ports, PNB and more","Stocks in news: Cipla, Vodafone Idea, Adani Ports, PNB, Asian Paints and more",neutral,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-11 21:29:55.000,935.0,937.0,915.5,920.05,2240330.0,Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO,Focus on getting plants audited to ensure product launches go as planned,neutral,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-11 23:46:00.000,935.0,937.0,915.5,920.05,2240330.0,Cipla will use Covid-19 bulk drugs inventory when demand rises,"The Covid-19 portfolio contributed 5-6 per cent of Cipla’s turnover during peak Covid waves, the firm said",neutral,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-12 00:48:00.000,935.0,937.0,915.5,920.05,2240330.0,"Drug companies may take a hit, too","One of India’s leading drug maker Cipla said it took a charge of around Rs 40 crore in Q4FY22 on its forex line, on account of receivables from Sri Lanka.",negative,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-12 06:01:00.000,935.0,937.0,915.5,920.05,2240330.0,Cipla looks to invest more in mRNA tech; holds discussions with firms,"Speaking to Business Standard, Samina Hamied, executive vice chairperson, Cipla, says one must invest in research and development (R&D) to feed the commercial growth engines",neutral,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-12 06:28:00.000,935.0,937.0,915.5,920.05,2240330.0,Analysts lower targets on Cipla,"They were also disappointed with the margin guidance of 21-22% for the ongoing financial year. Shares of Cipla ended up 1.2% to close at ₹937.50 on Wednesday, recovering from early losses. CLSA, Jefferies and Edelweiss maintained a buy rating, Credit Suisse retained an outperform, and Morgan Stanley…",negative,positive,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-12 11:49:46.000,935.0,937.0,915.5,920.05,2240330.0,Cipla: Targets for US complex generics on track,Cipla is looking at launching inhalation product Advair in the second half of FY23,neutral,neutral,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-12 11:58:53.000,935.0,937.0,915.5,920.05,2240330.0,Buy Cipla: target of Rs 1150: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated May 10, 2022.",neutral,positive,-1.5989304812834275,negative,0.94145655232117,positive
2022-05-12 12:58:05.000,924.1,940.1,922.2,932.8,1731431.0,Buy Cipla; target of Rs 1085: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Cipla recommended buy rating on the stock with a target price of Rs 1085 in its research report dated May 11, 2022.",neutral,positive,0.94145655232117,positive,0.4373413962529095,neutral
2022-05-12 14:33:00.000,924.1,940.1,922.2,932.8,1731431.0,Neutral Cipla; target of Rs 880: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 880 in its research report dated May 11, 2022.",neutral,positive,0.94145655232117,positive,0.4373413962529095,neutral
2022-05-12 16:07:01.000,924.1,940.1,922.2,932.8,1731431.0,Buy Cipla; target of Rs 1095: ICICI Direct,"ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1095 in its research report dated May 11, 2022.",neutral,positive,0.94145655232117,positive,0.4373413962529095,neutral
2022-05-18 14:16:00.000,940.0,953.95,934.4,936.2,1195786.0,Cipla’s Umang Vohra on new growth frontier in a post Covid world,“Being a good innovator in the generic world is one part of our business. It is the bulk of our business and needs to do that but we have opened up to the fact that MRNA is going to be a very significant part of how the world is going to innovate in future. We believe that some of the other therapi…,neutral,neutral,-0.4042553191489313,neutral,2.736842105263158,positive
2022-05-19 06:03:00.000,940.0,953.95,934.4,936.2,1195786.0,"Rejuvenating Cipla: After global expansion, acquisitions on cards","Having consolidated its presence across geographies, the pharma major is looking at acquisitions",neutral,neutral,-0.4042553191489313,neutral,2.736842105263158,positive
2022-05-19 06:04:00.000,940.0,953.95,934.4,936.2,1195786.0,"Caring for patients runs in our DNA, say Cipla’s Samina Hamied, Umang Vohra","‘Cipla has so many capabilities that for anything we need to do, we say we can do it’",neutral,neutral,-0.4042553191489313,neutral,2.736842105263158,positive
2022-05-20 08:47:00.000,950.0,982.6,939.0,976.0,2592457.0,"Sensex soars 1,534 pts; Nifty tops 16,250; Dr Reddy’s surges 8%, RIL 6%","CLOSING BELL: Dr Reddy’s Labs, JSW Steel, Nestle India, Tata Motors, Tata Steel, Cipla, Adani Ports, L&T, RIL, Axis Bank, and SBI led from the front, rallying over 3.5 per cent each",positive,positive,2.736842105263158,positive,-0.9092766653044522,negative
2022-05-24 09:09:00.000,977.0,977.7,961.75,971.95,1621081.0,Neutral on pharma; near-term negative on steel stocks: Siddhartha Khemka,"“Our overall view on the pharma sector remains neutral right now. Some of the larger companies are trading at an attractive valuation. For example, the likes of Sun Pharma, Cipla are doing well but I think the entire space will take some more time to come out of the woods.”",negative,positive,-0.5168884339815716,neutral,-0.0411353352529799,neutral
2022-06-02 09:05:00.000,977.5,1006.85,977.5,985.0,2637999.0,"Cipla, Greaves Cotton, RIL will be watched","Cipla: The drug major announced the commercial operation of additional capacity of captive renewable energy power plant in Maharashtra & Karnataka. In Jan′21, Cipla had commissioned 30 MWp solar project at Tuljapur, and now further added 16 MWp of",neutral,positive,0.7672634271099744,neutral,-2.823089742942269,negative
2022-06-02 09:16:06.000,977.5,1006.85,977.5,985.0,2637999.0,Cipla commission additional capacity of captive renewable energy power plant,"In Jan′21, Cipla had commissioned 30 MWp solar project at Tuljapur, and now further added 16 MWp of solar capacity for supplying the renewable energy for its manufacturing units/ facilities in Maharashtra. These projects have been commissioned in",neutral,positive,0.7672634271099744,neutral,-2.823089742942269,negative
2022-06-02 09:45:40.000,977.5,1006.85,977.5,985.0,2637999.0,"Bharti Airtel, Cipla, Tech Mahindra And More - Top Stock Picks For June By Axis Securities","Bharti Airtel, Cipla, Tech Mahindra And More - Top Stock Picks For June By Axis Securities",neutral,neutral,0.7672634271099744,neutral,-2.823089742942269,negative
2022-06-02 17:30:00.000,990.05,998.75,957.15,962.1,1054540.0,"Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka",Indian multinational pharmaceutical company Cipla Limited on Thursday announced the commercial operation of additional capacity of captive renewable energy power plant in Maharashtra and Karnataka.,neutral,positive,-2.823089742942269,negative,1.5661584889952604,positive
2022-06-10 12:50:37.000,960.0,971.6,960.0,966.15,774028.0,Marico To Cipla: What Morgan Stanley Makes Of These Stocks Amid Volatility,Morgan Stanley hosted its ‘Virtual India Summit’ on June 7-9 in Mumbai.,neutral,neutral,0.6406249999999977,neutral,0.1675392670157091,neutral
2022-06-13 14:21:55.000,955.0,970.8,950.8,968.05,1568974.0,"Stock Market Update: Sensex Falls Above 1,730 points, Nifty Below 15,700; 10 Updates","Stock Market Today: Sensex Falls Above 1,450 points, Nifty Below 15,850; Key Updates, Stock Market LIVE Updates: Cipla, Sun Pharma, SBI Life Insurance and Power Grid Corporation, Latest Share Market News at news18.com",neutral,neutral,1.3664921465968538,positive,0.1450777202072515,neutral
2022-06-14 17:04:05.000,965.0,974.9,964.0,966.4,1108899.0,Cipla and DNDi launch 4-in-1 antiretroviral treatment for young children in South Africa,The drug major received South African Health Products Regulatory Authority (SAHPRA) approval to launch 4-in-1 fixed-dose combination of four antiretroviral (ARV) treatments for infants and young children with HIV in South Africa.,neutral,neutral,0.1450777202072515,neutral,-2.8432377049180326,negative
2022-06-14 17:30:00.000,965.0,974.9,964.0,966.4,1108899.0,"Cipla, DNDi launch antiretroviral treatment for young children with HIV in South Africa","According to Cipla, this new formulation does not require refrigeration, has a sweet taste and is easy to administer to infants and children of different weights and ages.",neutral,neutral,0.1450777202072515,neutral,-2.8432377049180326,negative
2022-06-14 18:24:00.000,965.0,974.9,964.0,966.4,1108899.0,"Cipla, DNDi launch 4-in-1 antiretroviral treatment for children with HIV","South African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and ‘4-in-1’ fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine, lopinavir, and ritonavir that is specifically designed for infants and young children …",neutral,positive,0.1450777202072515,neutral,-2.8432377049180326,negative
2022-06-14 18:31:15.000,965.0,974.9,964.0,966.4,1108899.0,Cipla receives South African health authority’s approval for ‘4-in-1’ paediatric ARV formulation,Used to treat infants and young children with HIV,positive,neutral,0.1450777202072515,neutral,-2.8432377049180326,negative
2022-06-15 08:50:00.000,965.0,974.9,964.0,966.4,1108899.0,Stocks that will see action today (June 15),"Buzzing stocks: Engineers India, NLC, Bharti Airtel, Asian Paints, Cipla, Sukhjit Starch & Chemicals Ltd, PNB Housing, GR Infraprojects, Spandana Sphoorty",neutral,neutral,0.1450777202072515,neutral,-2.8432377049180326,negative
2022-06-15 09:08:29.000,965.0,974.9,964.0,966.4,1108899.0,"Stocks to watch: SBI, IDBI Bank, Hero Moto, Bajaj Electricals, NTPC, Cipla","Stocks to watch today: SBI and IDBI Bank have raised their interest rates on retail term deposits, subject to different tenors; LIC hiked stake in Hero MotoCorp to 11.2 per cent from 9.1 per cent.",neutral,positive,0.1450777202072515,neutral,-2.8432377049180326,negative
2022-06-17 23:37:08.000,932.2,944.55,910.8,918.0,2711504.0,Cipla to acquire 21% stake in diagnostic company Achira Labs for Rs 25 cr,"The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing",neutral,positive,-1.5232782664664284,negative,1.1369226564635122,positive
2022-06-17 23:58:18.000,932.2,944.55,910.8,918.0,2711504.0,Cipla To Acquire 21% Stake In Achira Labs For Rs 25 Crore,"The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing.",neutral,positive,-1.5232782664664284,negative,1.1369226564635122,positive
2022-06-20 05:30:00.000,914.75,928.15,902.0,925.15,939366.0,"Some Pharma Companies in Focus: Cipla, Aster DM, Aurobindo & More","Some Pharma Companies in Focus: Cipla, Aster DM, Aurobindo & More",neutral,neutral,1.1369226564635122,positive,0.949196418940778,positive
2022-06-20 07:35:16.000,914.75,928.15,902.0,925.15,939366.0,"Stocks to Watch Today: Wipro, Cipla, Aurobindo Pharma, Nazara Tech, and Others","Stocks to watch today: Shares of firms like Wipro, Cipla, Aurobindo Pharma, Nazara Tech, and others will be in focus in Monday’s trade",neutral,neutral,1.1369226564635122,positive,0.949196418940778,positive
2022-06-20 07:56:47.000,914.75,928.15,902.0,925.15,939366.0,"Stocks to Watch: ICICI Bank, Axis Bank, Coal India, Cipla, Dilip Buildcon","Indiabulls Housing Finance, RBL Bank, and Delta Corp remain under the NSE F&O ban for 20 June. Securities in the ban period include companies in which the security has crossed 95% of the market-wide position limit",neutral,neutral,1.1369226564635122,positive,0.949196418940778,positive
2022-06-20 08:10:15.000,914.75,928.15,902.0,925.15,939366.0,"Stocks To Watch Today: Adani Wilmar, Axis Bank, Cipla, Delhivery, ICICI Bank, Yes Bank",Here are the stocks to watch going into trade today.,neutral,neutral,1.1369226564635122,positive,0.949196418940778,positive
2022-06-20 08:40:22.000,914.75,928.15,902.0,925.15,939366.0,"Stocks that will see action on June 20, 2022","Buzzing stocks: Nazara Tech, Wipro, Aurobindo Pharma, Cipla, Alkem Lab, Sadbhav Infra, NTPC, Max Ventures, Star Housing Fin, Muthoot Capital, Vadilal Ind, Balkrishna Paper, Indian Hume Pipes, NTPC, Engineers India",neutral,neutral,1.1369226564635122,positive,0.949196418940778,positive
2022-06-20 17:30:00.000,927.1,944.45,927.1,935.9,521071.0,"Stocks in news: Adani Wilmar, Nazara Technologies, Cipla and more","Stocks in news: Adani Wilmar, Nazara Technologies, Cipla, Zydus Wellness, Canara Bank and more",neutral,neutral,0.949196418940778,positive,-1.6004296455424252,negative
2022-06-27 21:33:00.000,935.0,947.8,921.85,947.3,930065.0,Cipla buys additional stake in digital health company GoApptiv,"Post completion of the deal, Ciplas total stake in GoApptiv will increase to 22.02% on a fully diluted basis. The investment will be made in equity shares and compulsorily convertible preference shares and is likely to be completed within 30 days or such other date mutually agreed between the partie…",neutral,neutral,1.3155080213903694,positive,1.381996691745376,positive
2022-06-27 23:03:07.000,935.0,947.8,921.85,947.3,930065.0,Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%,"Pharma company Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent, the company said on Monday.",positive,positive,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 06:44:47.000,935.0,947.8,921.85,947.3,930065.0,"Stocks To Watch Today: Aurobindo Pharma, Cipla, IDFC First, Star Health, Mahindra",Here are the stocks to watch in today’s trade,neutral,neutral,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 07:27:23.000,935.0,947.8,921.85,947.3,930065.0,Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22%,"The investment will be made in equity shares and Compulsorily Convertible Preference Shares and is likely to be completed within 30 days or such other date mutually agreed between the parties, Cipla said in a regulatory filing.",positive,neutral,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 07:28:00.000,935.0,947.8,921.85,947.3,930065.0,"Stocks in the news: RIL, JSW Steel, ICICI Bank, Cipla and Bank of Baroda",Pharma firm Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent.,neutral,positive,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 07:40:02.000,935.0,947.8,921.85,947.3,930065.0,"Stocks to Watch: Tata Consumer, Cipla, Bank of Baroda","Indian indices on Friday closed higher, posting gains for the third straight day, with technology and metal stocks leading the gains, as easing oil prices tempered inflation fears.",neutral,positive,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 07:58:49.000,935.0,947.8,921.85,947.3,930065.0,"Stocks to Watch Today: GMR Infrastructure, JSW Steel, ICICI Bank, Cipla, and Others","Stocks to watch today: Shares of firms like GMR Infrastructure, JSW Steel, ICICI Bank, Cipla, and others will be in focus in Monday’s trade",neutral,neutral,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 08:05:05.000,935.0,947.8,921.85,947.3,930065.0,"Stocks to watch: Bajaj Auto, TVS Motor, Tata Steel, Cipla, JSW Steel, FRL","Stocks to watch today: Bajaj Auto approved buyback of shares worth up to Rs 2,500 crore; Moody’s upgraded Tata Steel’s outlook to ‘positive’ from ‘stable’",neutral,positive,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 08:42:42.000,935.0,947.8,921.85,947.3,930065.0,Stocks that will see action today (June 28),"Buzzing stocks: Cipla, Bank of Baroda, Manappuram Fin, Star Health, Paras Defence, Nova Iron, Brigade Enterprises, Sterling Tools, Indian Card Clothing, Sakthi Sugars, Intellect Design and Gillanders Arbuthnot",neutral,neutral,1.3155080213903694,positive,1.381996691745376,positive
2022-06-28 17:30:00.000,937.05,961.9,922.9,950.0,2454134.0,"Stocks in news: RIL, Cipla, ICICI Bank, JSW Steel and more","Stocks in news: RIL, ICICI Bank, Cipla, Bank of Baroda, Star Health, TTK Prestige, JSW Steel and more",neutral,neutral,1.381996691745376,positive,-3.1779661016949152,negative
2022-06-29 12:17:00.000,944.0,944.0,911.4,914.0,2429470.0,Bullish on these 7 pharma and capital goods stocks now: Pankaj Pandey,"“Within the pharma sector, Sun Pharma and Cipla are looking attractive to us. Among capital goods, besides L&T, we are bullish on AI Engineering, LD Equipments and Ador Welding. The bearing companies are also looking attractive to us. Within that Timken and SKF are the ones which are looking good.”",neutral,positive,-3.1779661016949152,negative,4.0386303775241394,positive
2022-06-29 14:31:00.000,944.0,944.0,911.4,914.0,2429470.0,Nithya Balasubramanian on why Cipla will outperform its peers and market post FY23,"“In trade generics, Cipla traditionally has been a market leader and I believe that in the next three-four years, trade generics will continue to grow faster than the market and given that they are market leaders with established equity in the system and distribution muscle, I expect Cipla to grow f…",positive,positive,-3.1779661016949152,negative,4.0386303775241394,positive
2022-06-30 12:18:00.000,911.2,956.05,911.2,948.0,1788788.0,"ITC, Sun Pharma: 5 defensive stocks that may gain up to 25%. You own any?","Pharma stocks like Torrent Pharmaceuticals, Sun Pharmaceutical Industries, and Cipla can easily run up to 18 per cent",positive,neutral,4.0386303775241394,positive,-1.46622909167902,negative
2022-07-04 11:15:00.000,944.6,950.0,928.5,930.75,1002236.0,Stock market update: Stocks that hit 52-week lows on NSE,"JSW Steel, ONGC, Hindalco, Tata Steel and Cipla were among the top losers on NSE.",neutral,negative,-1.46622909167902,negative,0.320855614973262,neutral
2022-07-05 07:56:30.000,935.0,949.65,930.25,938.0,1528709.0,"Stocks to Watch Today: Cipla, RIL, PNB, Reliance Power, Metals, Restaurants","Stocks to Watch Today: Shares of metal companies are also to be in focus as copper prices fell to 17-month lows amid new COVID restrictions in China, slowing global manufacturing activity and a jump i",neutral,neutral,0.320855614973262,neutral,0.952127659574473,positive
2022-07-05 08:36:35.000,935.0,949.65,930.25,938.0,1528709.0,"Stocks that will see action on July 5, 2022","Buzzing stocks: TCS, Tata Steel Long Products, LIC, MMTC, NMDC, Cipla, Kirloskar Ferrous, Kotak Mahindra Bank, IndusInd Bank, Emami, Muthoot Fin, PTC India Financial, PTC India",neutral,neutral,0.320855614973262,neutral,0.952127659574473,positive
2022-07-05 08:47:03.000,935.0,949.65,930.25,938.0,1528709.0,"Stocks To Watch Today: Cipla, IndusInd Bank, Kotak Mahindra Bank, Tata Steel, TCS, Vedanta",Here are the stocks to watch in today’s trade.,neutral,neutral,0.320855614973262,neutral,0.952127659574473,positive
2022-07-05 12:04:05.000,940.0,950.0,933.15,948.95,1389452.0,Cipla’s Indore plant gets two USFDA observations,The US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) at the drug major’s Indore plant from 27 June 2022 to 1 July 2022.,neutral,neutral,0.952127659574473,positive,-1.5415373283527096,negative
2022-07-05 17:30:00.000,940.0,950.0,933.15,948.95,1389452.0,"Stocks in news: TCS, Vedanta, Tata Power, Cipla and more","Stocks in news: Kotak Mahindra Bank, TCS, Vedanta, Tata Power, Cipla and more",neutral,neutral,0.952127659574473,positive,-1.5415373283527096,negative
2022-07-14 21:21:00.000,963.0,968.0,951.5,965.5,1043668.0,Cipla | Endura Mass: Cipla to acquire nutritional supplement brand Endura Mass,Endura and all other associated trademarks would be part of the acquisition. CHL will initiate the distribution and marketing of the Endura Mass pending the closure of the proposed acquisition.,neutral,neutral,0.2596053997923156,neutral,-0.5969227602531729,neutral
2022-07-15 07:34:58.000,963.0,968.0,951.5,965.5,1043668.0,"Stocks to Watch Today: Tata Elxsi, ACC, Cipla, Adani Group Stocks and Others","Stocks to watch today: Shares of firms like Tata Elxsi, ACC, Cipla, Adani Group Stocks, and others will be in focus in Friday’s trade",neutral,neutral,0.2596053997923156,neutral,-0.5969227602531729,neutral
2022-07-15 08:50:07.000,963.0,968.0,951.5,965.5,1043668.0,Cipla forays into nutritional wellness space; buys Endura Mass brand,"The drug major said its wholly-owned subsidiary, Cipla Health, has signed definitive agreements for acquisition of Endura Mass from Medinnbelle Herbalcare.",neutral,positive,0.2596053997923156,neutral,-0.5969227602531729,neutral
2022-07-15 08:57:42.000,963.0,968.0,951.5,965.5,1043668.0,"Stocks that will see action on July 15, 2022","Buzzing stocks: L&T Technologies, LIC, Cipla, Syngene International, AB Money, Federal Bank, Mahindra Holidays, Mukand, SecureKloud Tech, Kesoram, Oberoi Realty",neutral,neutral,0.2596053997923156,neutral,-0.5969227602531729,neutral
2022-07-15 09:16:05.000,963.0,968.0,951.5,965.5,1043668.0,"ACC, Tata Elxsi, Angel One, Cipla in focus","ACC: ACC reported 60% fall in consolidated net profit to Rs 227 crore despite a 15% rise in net sales to Rs 4,393 crore in Q2 June 2022 as compared with Q2 June 2021.",neutral,negative,0.2596053997923156,neutral,-0.5969227602531729,neutral
2022-07-27 20:41:37.000,977.0,978.95,964.2,968.4,1042505.0,Board of large-cap pharma company Cipla fixes record date for 250% dividend,"A large-cap pharmaceutical firm with a market valuation of ₹78,617.21 Cr is Cipla.",neutral,neutral,-0.8802456499488253,neutral,0.544315497586521,neutral
2022-07-28 07:53:00.000,977.0,978.95,964.2,968.4,1042505.0,"Q1 FY23 Preview: Cipla: Revenue seen at Rs53,720 million; PAT at Rs5,770 million",Company’s performance will be impacted by intense competition in generic drugs markets in US and India,neutral,negative,-0.8802456499488253,neutral,0.544315497586521,neutral
2022-07-28 08:45:36.000,977.0,978.95,964.2,968.4,1042505.0,Cipla Fixes Record Date For 250% Dividend Payout; Key Details For Investors,Pharmaceutical firm Cipla’s board of directors has proposed a final dividend. Know key details here,neutral,neutral,-0.8802456499488253,neutral,0.544315497586521,neutral
2022-07-28 15:15:25.000,973.7,983.95,953.0,979.0,2938290.0,"Cipla Q1 revenue may be muted on high base, low Covid drug sales: Analysts","Cipla Q1 results preview: Analysts attribute the likely dull performance due to the high base of last year, and the reduction in revenue contribution from Covid-19 therapies in the recent quarter.",negative,negative,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-28 16:00:00.000,973.7,983.95,953.0,979.0,2938290.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Shree Cements, Bharti Airtel, UltraTech Cem., Cipla and Bajaj Auto were among the top losers on NSE in today’s trade.",neutral,negative,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-28 16:56:37.000,973.7,983.95,953.0,979.0,2938290.0,"Taking Stock: Market gains nearly 2% on positive cues; IT, metal shine","Bajaj Finance, Bajaj Finserv, Kotak Mahindra Bank, IndusInd Bank and SBI Life Insurance were among the top Nifty gainers. The losers included Shree Cements, Bharti Airtel, UltraTech Cement, Cipla and Bajaj Auto",positive,neutral,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 07:30:39.000,973.7,983.95,953.0,979.0,2938290.0,"Stocks to Watch: Vedanta, PNB, Dr Reddy’s, TVS Motors, M&M Financials","DLF, Cipla, Sun Pharma, Ashok Leyland, HDFC, IOC, and GMR Infra will be in focus as they declare their June quarter earnings today.",neutral,neutral,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 07:54:22.000,973.7,983.95,953.0,979.0,2938290.0,"Stocks to watch: HDFC, Sun Pharma, Dr Reddy’s, STFC, TVS Motor, SpiceJet","Stocks to watch today: HDFC, Sun Pharma, and Cipla will report their June quarter results on Friday, July 29; Dr Reddy’s saw 108 per cent YoY rise in consolidated net profit to Rs 1,187.6 crore in Q1.",neutral,positive,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 16:30:26.000,973.7,983.95,953.0,979.0,2938290.0,Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%,The Mumbai-based company had reported a net profit of Rs 710 crore in the April-June quarter of the last fisca,negative,positive,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 16:40:24.000,973.7,983.95,953.0,979.0,2938290.0,Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%,Cipla Q1 Result: The company’s performance in the domestic market was subdued on a high base of last year but the overseas markets witnessed healthy growth,negative,positive,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 17:50:06.000,973.7,983.95,953.0,979.0,2938290.0,Cipla consolidated net profit declines 3.96% in the June 2022 quarter,Sales decline 2.79% to Rs 5317.87 crore,negative,negative,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 20:57:11.000,973.7,983.95,953.0,979.0,2938290.0,Cipla Q1 Results: Profit Falls But Beats Estimates,Cipla’s profits falls but beats estimates.,neutral,positive,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 21:28:50.000,973.7,983.95,953.0,979.0,2938290.0,Cipla looking at products to treat monkey pox,"Opthalmology, dermatology and women’s health categories to drive future growth",neutral,positive,0.544315497586521,neutral,1.5151515151515151,positive
2022-07-29 22:06:47.000,973.7,983.95,953.0,979.0,2938290.0,"Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales",Domestic revenue dips 8.4% as Covid-19 share of branded prescription business normalises; North American business up 10% to $155 million,negative,positive,0.544315497586521,neutral,1.5151515151515151,positive
2022-08-01 08:36:50.000,990.0,1031.0,988.3,1005.0,4613609.0,"Stocks to Watch: YES Bank, Cipla, Bank of Baroda, Zomato, HDFC, ITC, NTPC","Stocks to Watch today: ITC, UPL, Zomato, Arvind, Bajaj Consumer Care, among others will release their Q1 earnings today.",neutral,neutral,1.5151515151515151,positive,-0.1145817765157153,neutral
2022-08-04 23:31:23.000,1040.0,1045.95,1032.0,1035.8,1551172.0,"Sun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1",Pricing pressure continues to remain a key headwind for the growth of pharma companies in the US market,positive,negative,-0.4038461538461582,neutral,-0.5259602393360399,neutral
2022-08-05 10:00:00.000,1040.0,1045.95,1032.0,1035.8,1551172.0,Can pharma sustain the rally? Chakri Lokapriya answers,"“There is a move towards more complex generics which are higher margin and are subject to less price erosion in the US and also in the advanced markets. The US has traditionally been stronger pricing wise versus Europe. Against this whole backdrop, Lupin and Cipla because of the move towards comple…",positive,neutral,-0.4038461538461582,neutral,-0.5259602393360399,neutral
2022-08-05 17:13:31.000,1040.0,1045.95,1032.0,1035.8,1551172.0,7 stocks to turn ex-dividend next week on Monday: Check if you own any,"On Monday of next week, the following stocks will begin trading ex-dividend: D. B. Corp Limited, ICICI Bank, Castrol India Limited, Honeywell Automation India Limited, Alkem Laboratories Limited, Cipla Ltd, and Chennai Petroleum Corporation Limited.",neutral,neutral,-0.4038461538461582,neutral,-0.5259602393360399,neutral
2022-08-07 13:17:00.000,1036.2,1039.5,1024.1,1030.75,764604.0,Cipla betting big on digitisation and emerging segments,"The drug firm has embarked on the digital transformation of the value chain across functions, including finance, R&D, manufacturing, supply chain, HR, customer outreach and stakeholder engagement, she added.",neutral,neutral,-0.5259602393360399,neutral,0.1931340833373569,neutral
2022-08-07 13:51:11.000,1036.2,1039.5,1024.1,1030.75,764604.0,Cipla Betting Big On Digitisation And Emerging Segments,Cipla is betting big on digitisation and segments like biosimilars and mRNA-aided medications to drive its next phase of growth.,neutral,positive,-0.5259602393360399,neutral,0.1931340833373569,neutral
2022-08-07 23:53:41.000,1036.2,1039.5,1024.1,1030.75,764604.0,Cipla betting big on digitisation and emerging segments like mRNA,Drug major Cipla is betting big on digitisation and emerging segments like biosimilars and mRNA aided medications to drive its next phase of growth,neutral,positive,-0.5259602393360399,neutral,0.1931340833373569,neutral
2022-08-17 06:20:46.000,1039.75,1042.95,1024.2,1027.0,1100114.0,"Stocks to Watch Today | Cipla, SBI Card, Bharat Gears, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.226256311613369,negative,0.4375303840544483,neutral
2022-08-17 06:39:05.000,1039.75,1042.95,1024.2,1027.0,1100114.0,"Stocks To Watch: Avenue Supermarts, Cipla, Techno Electric, Bajaj Hindusthan",Stocks to watch before going into trade today.,neutral,neutral,-1.226256311613369,negative,0.4375303840544483,neutral
2022-08-17 07:13:00.000,1039.75,1042.95,1024.2,1027.0,1100114.0,"Stocks in the news: NTPC, Cipla, SAIL, Mahanagar Gas and Future Group stocks","State-owned power giant NTPC floated a tender to raise Rs 5,000 crore term loan from financial institutions. As per the document, the bids can be submitted till 1100 hours on August 31.",neutral,positive,-1.226256311613369,negative,0.4375303840544483,neutral
2022-08-17 07:50:00.000,1039.75,1042.95,1024.2,1027.0,1100114.0,"Stocks to Watch: Cipla, NTPC, Adani group, SBI Cards, Hind Zinc, Nxtdigital","Stocks to Watch: ICICI Securities, Axis Capital and Citigroup Global Markets are among the 5 investment bankers selected to manage the sale of the government’s 29.53% residual stake in Hindustan Zinc",neutral,neutral,-1.226256311613369,negative,0.4375303840544483,neutral
2022-08-17 07:52:26.000,1039.75,1042.95,1024.2,1027.0,1100114.0,"Stocks to Watch Today: NTPC, Cipla, SAIL, Tata Chemicals, and Others","Stocks to watch today: Shares of firms like NTPC, Cipla, SAIL, Tata Chemicals, and others will be in focus in Friday’s trade",neutral,neutral,-1.226256311613369,negative,0.4375303840544483,neutral
2022-08-17 10:50:05.000,1039.75,1042.95,1024.2,1027.0,1100114.0,Cipla board appoints Ashish Adukia as global CFO,The pharma major on Tuesday announced that its board has approved the appointment of Ashish Adukia as the global chief financial officer (CFO) and key managerial personnel of the company with effect from 16 August 2022.,neutral,neutral,-1.226256311613369,negative,0.4375303840544483,neutral
2022-08-17 17:30:00.000,1028.5,1034.05,1007.35,1033.0,1199746.0,"Stocks in news: HDFC AMC, Ansal Housing, Bajaj Hindusthan, Cipla and more","Stocks in news: HDFC Asset Management Company, Ansal Housing, Bajaj Hindusthan, Cipla, Bajaj Electricals, Future Lifestyle Fashions and more",neutral,neutral,0.4375303840544483,neutral,-0.0048588503959918,neutral
2022-08-19 08:22:12.000,1029.05,1036.6,1020.1,1029.0,652980.0,Cipla - Enhanced Effort Required To Improve Return Ratios Going Forward: Motilal Oswal,Cipla - Enhanced Effort Required To Improve Return Ratios Going Forward: Motilal Oswal,neutral,neutral,-0.0048588503959918,neutral,0.4921259842519685,neutral
2022-08-21 11:25:00.000,1016.0,1029.85,1015.5,1021.0,990163.0,"Glenmark, Strides Pharma, Cipla recall products in the US","The USFDA noted in its report that the company, a subsidiary of Mumbai-based drug firm, is recalling the affected lot due to “blister package issues.” The lot was produced at Glenmark’s Pithampur (Madhya Pradesh) based manufacturing facility. The USFDA stated that Glenmark initiated the Class II nat…",negative,negative,0.4921259842519685,neutral,3.039002177786581,positive
2022-08-21 12:33:04.000,1016.0,1029.85,1015.5,1021.0,990163.0,"Glenmark, Strides Pharma And Cipla Recall Products In U.S.","Glenmark, Strides Pharma and Cipla are recalling products in the world’s largest market for medicines due to manufacturing issues.",neutral,negative,0.4921259842519685,neutral,3.039002177786581,positive
2022-08-26 21:34:05.000,1030.9,1035.7,1018.5,1022.5,1262722.0,"Acquisitions, always on cards, says Cipla MD","In FY22, Cipla’s research-spend increased 21% over the previous fiscal, Vohra told shareholders",neutral,positive,-0.8148220001940141,neutral,1.7000000000000002,positive
2022-08-29 01:00:00.000,1000.0,1024.0,991.3,1017.0,1299186.0,"Stocks To Watch Today: Cipla, Reliance Industries, RITES, Syngene, UltraTech Cement",Stocks to watch before going into trade today.,neutral,neutral,1.7000000000000002,positive,1.5365733922435043,positive
2022-08-29 08:07:50.000,1000.0,1024.0,991.3,1017.0,1299186.0,"Stocks to watch: RIL, Britannia, NHPC, Cipla, InterGlobe Aviation, RITES","Stocks to watch today: Reliance Industries will hold their 45th Annual General Meeting on Monday, August 29; Tons of biscuits were destroyed after a major fire broke out at Britannia’s Pantnagar plant",neutral,negative,1.7000000000000002,positive,1.5365733922435043,positive
2022-08-29 08:30:46.000,1000.0,1024.0,991.3,1017.0,1299186.0,"Stocks that will see action on August 29, 2022","Buzzing stocks: Reliance, Tata Steel, Glenmark Pharma, Cipla, Aster DM Healthcare, Syngene, UltraTech Cement, Adani Total, GMR Power, RITES, NHPC, Jubilant Pharmova",neutral,neutral,1.7000000000000002,positive,1.5365733922435043,positive
2022-08-29 08:34:50.000,1000.0,1024.0,991.3,1017.0,1299186.0,"Stocks to Watch Today: RIL, Ultratech, NTPC, Cipla, IndiGo, and Others","Stocks to watch today: Shares of firms like RIL, Ultratech, NTPC, Cipla, IndiGo, and others will be in focus in Friday’s trade",neutral,neutral,1.7000000000000002,positive,1.5365733922435043,positive
2022-08-29 17:30:00.000,1018.5,1042.2,1016.1,1034.15,1569386.0,"Stocks in news: Reliance Industries, NTPC, Cipla, RITES and more","Stocks in news: Reliance Industries, NTPC, Cipla, RITES, UltraTech Cement, Allcargo Logistics, Strides Pharma Science and more",neutral,neutral,1.5365733922435043,positive,-0.1949317738791423,neutral
2022-09-01 07:01:24.000,1026.0,1044.25,1019.4,1024.0,1520305.0,"Stocks to Watch Today | Tata Motors, Zee Entertainment, Cipla and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-0.1949317738791423,neutral,-0.78125,neutral
2022-09-05 15:35:17.000,1025.0,1042.0,1024.9,1040.9,1366984.0,"Dalal Street defies global mood; Sensex soars 443 pts, Nifty top 17,650","CLOSING BELL: ITC, Sun Pharma, RIL, Tata Steel, NTPC, HCL Tech, L&T, and ICICI bank were the top Sensex gainers, while Hindalco, JSW Steel, Grasim, and Cipla were additional top gainers on the Nifty50",neutral,neutral,1.5512195121951309,positive,1.6395028292305505,positive
2022-09-06 00:06:00.000,1025.0,1042.0,1024.9,1040.9,1366984.0,"Cipla, JB Chemicals, Torrent lead Rs 4,500-crore race for Medley Pharma","Set up in 1969 by Sami Khatib as Medley Laboratories, the Mumbai-based privately held company, now called Medley Pharmaceuticals, ranks among the top 40 pharmaceutical companies in India, as per research firm ORG IMS.",neutral,neutral,1.5512195121951309,positive,1.6395028292305505,positive
2022-09-07 08:13:00.000,1033.85,1061.85,1033.0,1050.8,2465093.0,Cipla bags USFDA approval for generic version of Revlimid; stock surges ~2%,Cipla’s Lenalidomide Capsules are an AB-rated generic version of Bristol Myers Squibb’s (Celgene) Revlimid (Lenalidomide) Capsules.,positive,neutral,1.6395028292305505,positive,-0.4440245630609396,neutral
2022-09-07 14:39:23.000,1058.5,1059.75,1044.0,1053.8,1751915.0,Cipla gets USFDA nod for cancer drug,"The company has received the final approval from the US Food and Drug Administration (USFDA) for the product in strengths of 5 mg, 10 mg, 15 mg and 25 mg, Cipla said in a regulatory filing.",neutral,positive,-0.4440245630609396,neutral,-0.4716981132075472,neutral
2022-09-07 14:47:09.000,1058.5,1059.75,1044.0,1053.8,1751915.0,Cipla closes in on 52-week high on getting USFDA nod for cancer drug,"According to external data that Cipla provided, Revlimid (Lenalidomide) capsules had US sales of approximately $2.58 billion for the 12-month period ending June 2022",neutral,neutral,-0.4440245630609396,neutral,-0.4716981132075472,neutral
2022-09-07 19:10:36.000,1058.5,1059.75,1044.0,1053.8,1751915.0,Cipla set to ship its version of BMS drug Revlimid in the US,Lenalidomide is a prescription drug indicated for several blood-related malignancies in adults,neutral,neutral,-0.4440245630609396,neutral,-0.4716981132075472,neutral
2022-09-09 13:06:47.000,1060.0,1065.95,1055.0,1055.0,1091119.0,"Cipla Ltd spurts 0.6%, up for fifth straight session","Cipla Ltd is quoting at Rs 1062.35, up 0.6% on the day as on 12:44 IST on the NSE. The stock is up 11.77% in last one year as compared to a 2.9% jump in NIFTY and a 11.35% jump in the Nifty Metal.",positive,positive,-0.4716981132075472,neutral,0.6236416895020445,neutral
2022-09-12 11:10:57.000,1058.3,1068.5,1057.1,1064.9,932812.0,Buy Cipla; target of Rs 1225: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1225 in its research report dated September 09, 2022.",neutral,positive,0.6236416895020445,neutral,0.0898727590937084,neutral
2022-09-13 17:06:00.000,1040.0,1068.0,1040.0,1059.55,993895.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Shree Cements, Cipla, Eicher Motors, BPCL and TCS were among the top losers on NSE in today’s trade.",neutral,negative,1.879807692307688,positive,-2.547169811320755,negative
2022-09-14 11:50:22.000,1040.0,1068.0,1040.0,1059.55,993895.0,"Cipla allots 5,683 equity shares under ESOS","Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,40,03,206 comprising of 80,70,01,603 equity shares of face value Rs 2 each.",neutral,neutral,1.879807692307688,positive,-2.547169811320755,negative
2022-09-15 15:45:59.000,1038.5,1060.0,1034.0,1043.9,2844460.0,"Sensex down 413pts, Nifty holds 17,850; Ceat soars 20%, MRF 7%; IT stks dip","CLOSING BELL: IT, pharma, and select metal stocks reeled under pressure today with Hindalco, Infosys, Cipla, Tech M, Tata Steel, Divis Labs, and Apollo Hospitals leading the list of Nifty losers",neutral,positive,0.519980741454029,neutral,-1.0105847981225111,negative
2022-09-16 10:03:34.000,1038.5,1060.0,1034.0,1043.9,2844460.0,"This Indian pharma stock is Jefferies’ top pick, target price raised","The brokerage has maintained its Buy rating on Cipla shares with a target price of ₹1,223 apiece (from ₹1,144)",positive,positive,0.519980741454029,neutral,-1.0105847981225111,negative
2022-09-16 13:14:29.000,1038.5,1060.0,1034.0,1043.9,2844460.0,Why Cipla Is Jefferies’ ‘Top Pick’ Among India Pharma Stocks,"Shares of Cipla gained after Jefferies initiated coverage with a ‘buy’, while terming the company as “Top Pick in Indian Pharma”.",neutral,positive,0.519980741454029,neutral,-1.0105847981225111,negative
2022-09-20 11:12:30.000,1041.5,1097.55,1039.5,1095.0,2489443.0,"U.S. FDA Flags Operational, Procedural Lapses At Cipla’s Goa Unit",The U.S. FDA inspected Cipla’s formulation-making facility in Goa from Aug. 16-26.,neutral,neutral,5.13682189150264,positive,-3.077272727272719,negative
2022-09-20 23:05:47.000,1100.0,1101.85,1064.25,1066.15,2263990.0,Growth forecast in US market set to drive gains for Cipla stock,"Street remains bullish on India prospects, regulatory headwinds for Goa site continue",positive,positive,-3.077272727272719,negative,0.0801017763746792,neutral
2022-09-21 08:40:12.000,1100.0,1101.85,1064.25,1066.15,2263990.0,"Stocks to Watch Today: Central Bank, Cipla, Yes Bank, GAIL, SpiceJet, and Others","Stocks to watch today: Shares of firms like Central Bank, Cipla, Yes Bank, GAIL, SpiceJet, and others will be in focus in Wednesday’s trade",neutral,neutral,-3.077272727272719,negative,0.0801017763746792,neutral
2022-09-23 08:29:35.000,1067.25,1093.0,1063.25,1071.45,3261467.0,"Stocks To Watch Today: Hero MotoCorp, Cipla, Mahindra Finance, Tata Steel, TVS Motor",A look at the stocks to watch before start of trading.,neutral,neutral,0.3935347856640941,neutral,-0.0609927747020822,neutral
2022-09-23 08:52:28.000,1067.25,1093.0,1063.25,1071.45,3261467.0,"Stocks that will see action on September 23, 2022","BUuzzing stocks: Cipla, Trident, M&M, Kirloskar Engines, Swaraj Engines, M&M Financial, Bombay Dyeing, Hero MotoCorp, Shilpa Medicare, Zydus Life, Udaipur Cement, Aster DM, Century Textiles",neutral,neutral,0.3935347856640941,neutral,-0.0609927747020822,neutral
2022-09-23 09:31:04.000,1067.25,1093.0,1063.25,1071.45,3261467.0,Cipla’s Indore plant gets EIR from USFDA,"The drug major on Thursday announced that it has received the Establishment Inspection Report (EIR) from the US drug regulator for its Indore plant, indicating closure of the inspection.",neutral,negative,0.3935347856640941,neutral,-0.0609927747020822,neutral
2022-09-23 17:30:00.000,1067.25,1093.0,1063.25,1071.45,3261467.0,"Stocks in news: Tata Steel, Reliance Industries, M&M, Bharti Airtel and more","Shares to watch out for today: Tata Steel, Reliance Industries, M&M, Bharti Airtel, Cipla, Lupin, Century Textiles and more",neutral,neutral,0.3935347856640941,neutral,-0.0609927747020822,neutral
2022-09-25 12:03:00.000,1065.7,1081.2,1050.85,1065.05,1217174.0,"Rupee could further fall to 81-82; Asian Paints, Cipla, HCL top buys for October series: Manoj Vayalar","We believe that the Nifty50 has been in the 17,000-17,800 range for a while, and Friday’s closing below 17,500 triggered fresh selling.The Nifty50 might be heading towards 17,100-17,000 levels. As we are now in the monthly expiry week, positioning of October Nifty futures would be the key indicator…",neutral,neutral,-0.0609927747020822,neutral,2.8992950184415665,positive
2022-09-28 06:57:59.000,1101.0,1117.7,1087.65,1094.0,3438092.0,Buy or sell: Vaishali Parekh recommends 2 stocks to buy today — Sept 28,Buy or sell stocks for today: Vaishali Parekh of Prabhudas Lilladher has recommended two stocks to buy today — Cipla and Tata Coffee,positive,positive,-0.6357856494096277,neutral,1.7672981690972738,positive
2022-09-29 05:59:00.000,1100.55,1121.65,1088.1,1120.0,2090083.0,Investors seek safety in a stable pharma amid recession fears,"Stocks such as Divi’s Laboratories, Ipca, Dr Reddy’s, Cipla, and Alkem Laboratories have gained between 2% and 4% in the past week. The sector was in a consolidation phase in the past year due to a decline in business growth post-Covid, and valuations dropped about a fifth.",positive,positive,1.7672981690972738,positive,-0.4242018307657959,neutral
2022-10-03 12:51:18.000,1138.85,1147.5,1133.0,1145.0,1907033.0,"Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs","Shares of Glenmark Pharma, Granules India, Divi’s Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday’s intra-day trade",positive,positive,0.5400184396540451,neutral,-1.338664812239229,negative
2022-10-11 16:24:00.000,1111.6,1118.05,1099.2,1108.0,1230117.0,"India facilities of Cipla, Dr Reddy’s Labs, Mondelez join WEF’s Global Lighthouse Network","The World Economic Forum on Tuesday announced the addition of 11 factories and industrial sites, including three from India, to its Global Lighthouse Network. From India, the additions are pharma major Cipla’s Indore facility, Dr Reddy’s Laboratories’ Hyderabad facility and the Mondelez facility in …",neutral,positive,-0.3238575026988043,neutral,-0.4871887405268937,neutral
2022-10-11 18:50:08.000,1111.6,1118.05,1099.2,1108.0,1230117.0,Cipla’s Indore OSD plant joins World Economic Forum’s Lighthouse Network,"The Global Lighthouse Network is an exclusive community of manufacturing leaders from across sectors who depict an accelerated adoption of 4IR technologies to transform factories, value chains and business models for resilience, growth and",neutral,neutral,-0.3238575026988043,neutral,-0.4871887405268937,neutral
2022-10-11 20:17:00.000,1111.6,1118.05,1099.2,1108.0,1230117.0,"WEF recognises DRL’s Bachupally plant, Cipla’s Indore OSD unit as part of Global Lighthouse Network","A press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0 or 4IR) technologies to drive impact in productivity, workforce engagement, sustainability and supply chain resilience",neutral,positive,-0.3238575026988043,neutral,-0.4871887405268937,neutral
2022-10-12 00:11:22.000,1111.6,1118.05,1099.2,1108.0,1230117.0,"India facilities of Cipla, Dr Reddy’s Labs, join Global Lighthouse Network","The World Economic Forum on Tuesday announced the addition of 11 factories and industrial sites, including three from India, to its Global Lighthouse Network.",neutral,positive,-0.3238575026988043,neutral,-0.4871887405268937,neutral
2022-10-12 08:33:47.000,1111.6,1118.05,1099.2,1108.0,1230117.0,Stocks that will see action on October 12,"Buzzing stocks: Infosys, HCL Tech, Wipro, Suzlon, SW Solar, Cipla, Marksans Pharma, Brigade Enterprises, L&T Finance Holdings, Genesys International, Kirloskar Electric, Fino Payments, IndusInd Bank, Inox Leisure",neutral,neutral,-0.3238575026988043,neutral,-0.4871887405268937,neutral
2022-10-12 16:26:00.000,1108.4,1127.85,1101.1,1103.0,1437846.0,Cipla’s Indore plant joins World Economic Forum’s Lighthouse Network,"Demonstrates advanced technologies to drive productivity, workforce engagement, sustainability, and resilience across 22 sites in parallel.",neutral,neutral,-0.4871887405268937,neutral,-0.8698771410635655,neutral
2022-10-14 15:56:00.000,1115.1,1120.0,1105.4,1105.4,1129790.0,Diwali picks: Jayesh Bhanushali on 8 stocks he is betting on,"“Among largecaps, Bhanushali has 5 top bets. These are ICICI Bank, SBI, Cipla, Reliance Industries and Ashok Leyland. Among midcaps, there are 3 chemical stocks – Deepak Fertiliser, Deepak Nitrite and JB Chemicals. Aptus Home Value is the smallcap in the portfolio where the brokerage is seeing a…",neutral,neutral,-0.8698771410635655,neutral,0.2797833935017968,neutral
2022-10-14 17:30:00.000,1115.1,1120.0,1105.4,1105.4,1129790.0,"Britannia, ICICI Bank, Ajanta Pharma, La Opala among Nirmal Bang’s top 12 Diwali picks","From the large cap space, the brokerage recommended players such as Britannia Industries (Target price: Rs 4,600), Cipla (Rs 1,268), Hero MotoCorp (Rs 3,161), ICICI Bank (Rs 1,079) and UltraTech Cement (Rs 8,581).",neutral,neutral,-0.8698771410635655,neutral,0.2797833935017968,neutral
2022-10-18 11:08:00.000,1113.7,1130.2,1110.3,1129.5,958438.0,cipla: Cipla bets on digitisation to raise the bar on productivity,"The firm’s spending on digital could reach almost ₹100 crores in some years, said Umang Vohra, managing director and global CEO of Cipla. “In our digital journey, on a zero to 10 scale, we are probably at three or four. We have so much to do,” he told ET.",positive,positive,1.4186944419502518,positive,-0.7512152010605391,neutral
2022-10-23 11:14:00.000,1145.6,1150.0,1141.55,1146.15,127828.0,"Dr Reddy’s, Cipla, Aurobindo units recall products in US market","As per the enforcement report by the US Food and Drug Administration (USFDA), the US-based unit of Dr Reddy’s Laboratories is recalling 2,838 ampules of vitamin K deficiency treatment drug Phytonadione Injectable Emulsion. According to the USFDA, Dr Reddy’s Laboratories is recalling the affected lot…",negative,neutral,0.0480097765363287,neutral,0.7018308631211817,neutral
2022-10-23 11:58:25.000,1145.6,1150.0,1141.55,1146.15,127828.0,"Dr. Reddy’s, Cipla, Aurobindo units recall products in U.S. market","According to the USFDA, Dr. Reddy’s Laboratories is recalling the affected lot of vitamin K deficiency treatment drug due to ‘failed stability specifications’",neutral,negative,0.0480097765363287,neutral,0.7018308631211817,neutral
2022-10-23 11:59:50.000,1145.6,1150.0,1141.55,1146.15,127828.0,"Dr Reddy’s, Cipla, Aurobindo Units Recall Products In U.S. Market","According to the USFDA, Dr Reddy’s Laboratories is recalling the affected lot due to “failed stability specifications.”",neutral,negative,0.0480097765363287,neutral,0.7018308631211817,neutral
2022-10-23 12:08:51.000,1145.6,1150.0,1141.55,1146.15,127828.0,"Dr Reddy’s, Cipla, and Aurobindo units recall products in US market","Leading drug firms Dr Reddy’s Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration",negative,negative,0.0480097765363287,neutral,0.7018308631211817,neutral
2022-10-23 17:30:00.000,1145.6,1150.0,1141.55,1146.15,127828.0,"With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy’s looking at?","There is also muted demand for the much-hyped anti-viral drug Molnupiravir, which at least 13 firms are manufacturing including Sun Pharma, Cipla, Dr. Reddy’s, and Aurobindo Pharma, among others.",neutral,negative,0.0480097765363287,neutral,0.7018308631211817,neutral
2022-10-24 09:58:00.000,1145.6,1150.0,1141.55,1146.15,127828.0,"Nifty may retest 18,000 in near term; Cipla, Canara Bank top stocks for muhurat trading: Akhilesh Jat",Benchmark index Nifty50 closed positive for the sixth consecutive session and continued with its higher-high and higher-low formation.,neutral,positive,0.0480097765363287,neutral,0.7018308631211817,neutral
2022-11-01 09:00:00.000,1167.5,1185.25,1163.6,1173.0,1489565.0,"Cipla Stocks | Trent Stocks: ETMarkets Smart Talk: Cipla, Trent, VIP among 12 top buy ideas for next 12 months: Yuvraj A Thakker","“We are very bullish on the Indian domestic theme like banks, capital goods & infra, auto, midcap cement, pharma, and steel. We also believe that some IT stocks like Wipro are giving a good opportunity for long-term investors to grab considering a 15-20% correction from here is possible as the US i…",positive,positive,0.4710920770877944,neutral,-1.2866942183971632,negative
2022-11-03 15:54:00.000,1167.85,1175.25,1141.0,1146.05,1710590.0,Why Nithya Balasubramanian is gung-ho on Sun Pharma & Cipla,"“One gets different types of exposure with Sun Pharma and Cipla. For Sun, the capital allocation into US specialty is now bearing fruit. At the same time, Cipla started pivoting towards more complex generics. Everybody else has been working on complex generics as well but at least now it seems like …",neutral,neutral,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-03 17:44:02.000,1167.85,1175.25,1141.0,1146.05,1710590.0,Cipla Q2 preview | Consolidated net profit likely to rise 9% YoY,"In the year-ago quarter, Cipla benefitted from the surge in sales of COVID-19-related drugs",positive,positive,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 05:00:00.000,1167.85,1175.25,1141.0,1146.05,1710590.0,"Titan, Cipla, Marico, TVS Motor, Escorts Kubota, Minda Corp Q2 Results Today — Earning Estimates","September quarter earning estimates for Titan, Cipla, Marico, TVS Motor, Escorts Kubota, Minda Corp and others.",neutral,neutral,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 09:01:25.000,1167.85,1175.25,1141.0,1146.05,1710590.0,"Stocks that will see action on November 04, 2022","Stocks to watch: Titan, CIpla, Wipro, Amrutanjan, Chochin Shipyard, Indigo, Shipping Corp, Chemplast Sanmar, City Union Bank, Dreamfolks Services, Escorts Kubota, GAIL India, Go Fashion (India), Godrej Agro, Marico, Puravankara, TTK Prestiege, TVS Motor Company and Wockhardt",neutral,neutral,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 14:07:00.000,1167.85,1175.25,1141.0,1146.05,1710590.0,"Cipla beats estimate, net profit rises 10.9% on-year in Q2","The drugmaker reported a 5.6 percent on-year rise in consolidated revenue from operations to Rs 5,828.4 crore",positive,positive,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 15:30:31.000,1167.85,1175.25,1141.0,1146.05,1710590.0,"Cipla Q2 net profit up 12% at Rs 797 crore, revenue rises to Rs 5,829 crore","Shares of the company were trading 0.5 per cent up at Rs 1,154.10 apiece on the BSE",positive,positive,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 16:07:00.000,1167.85,1175.25,1141.0,1146.05,1710590.0,Cipla Q2 Net Profit Rises 12% To Rs 797 Crore,"Cipla’s total revenue from operations rose to Rs 5,829 crore for the September quarter from Rs 5,520 crore in the year-ago period",neutral,positive,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 16:44:25.000,1167.85,1175.25,1141.0,1146.05,1710590.0,Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate,The company is de-risking key product Abraxane in case the Goa plant FDA issue is not cleared immediately,positive,neutral,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 17:30:00.000,1167.85,1175.25,1141.0,1146.05,1710590.0,"Cipla’s profit up 11% YoY to Rs 789 crore in Sept quarter; EBITDA at Rs 1,303 cr",This increase in consolidated net profit could be attributed to the rising demand for its drugs and inhalers and a boost in its new ventures.,positive,positive,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-04 17:30:00.000,1167.85,1175.25,1141.0,1146.05,1710590.0,"Q2 result previews: Titan, Cipla, GAIL, Britannia, Marico & IndiGo",Titan Company and Britannia Industries are seen clocking double-digit growth in Q2 profits. Cipla and Marico may report low single-digit growth in profit,neutral,positive,-1.8666780836580004,negative,-1.4527528138905736,negative
2022-11-07 06:37:12.000,1146.1,1152.0,1116.5,1129.45,2000258.0,"Stocks To Watch: TVS Motor Company, Bhagiradha Chemicals & Industries, Cipla, Birlasoft",Stocks to watch before going into trade.,neutral,neutral,-1.4527528138905736,negative,-1.060380334764693,negative
2022-11-07 08:18:39.000,1146.1,1152.0,1116.5,1129.45,2000258.0,"Stocks to Watch Today: Titan, Coal India, Cipla, Paytm, Tata Motors, and Others","Stocks to watch today: Shares of firms like Titan, Coal India, Cipla, Paytm, Tata Motors, and others will be in focus in Monday’s trade",neutral,neutral,-1.4527528138905736,negative,-1.060380334764693,negative
2022-11-07 17:30:00.000,1146.1,1152.0,1116.5,1129.45,2000258.0,"Stocks in news: Reliance Industries, SBI, Tata Motors, Titan and more","Stocks to watch out for today: Reliance Industries, SBI, Tata Motors, Titan, Cipla, TVS, DCB Bank and more",neutral,neutral,-1.4527528138905736,negative,-1.060380334764693,negative
2022-11-09 15:13:38.000,1130.0,1152.0,1119.0,1125.0,2027401.0,Buy Cipla; target of Rs 1350: ICICI Direct,"ICICI Direct is bullish on Cipla recommended buy rating on the stock with a target price of Rs 1350 in its research report dated November 07, 2022.",neutral,positive,-0.4424778761061947,neutral,-0.6637168141592921,neutral
2022-11-09 16:11:14.000,1130.0,1152.0,1119.0,1125.0,2027401.0,Buy Cipla; target of Rs 1360: Sharekhan,"Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1360 in its research report dated November 04, 2022.",neutral,positive,-0.4424778761061947,neutral,-0.6637168141592921,neutral
2022-11-09 17:16:38.000,1130.0,1152.0,1119.0,1125.0,2027401.0,Neutral Cipla; target of Rs 1180: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 1180 in its research report dated November 04, 2022.",neutral,positive,-0.4424778761061947,neutral,-0.6637168141592921,neutral
2022-11-09 17:30:00.000,1130.0,1152.0,1119.0,1125.0,2027401.0,"SBI, ITC, Adani Ent: These 11 bluest of blue chips hit all-time high since October; which stock to buy now?","Adani Enterprises, Britannia Industries, State Bank Of India, Bharti Airtel, Cipla, Eicher Motors, Mahindra & Mahindra, Titan Company, Axis Bank, ICICI Bank and Nestle India are among the 11 Nifty companies which have scaled their all-time high amid the ongoing result season",positive,neutral,-0.4424778761061947,neutral,-0.6637168141592921,neutral
2022-11-11 15:11:57.000,1130.0,1143.85,1116.65,1122.5,1507435.0,Buy Cipla; target of Rs 1300: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated November 06, 2022.",neutral,positive,-0.6637168141592921,neutral,0.4001778568252557,neutral
2022-11-13 10:11:00.000,1124.5,1133.6,1118.2,1129.0,1499638.0,"India is a huge price sensitive market; there is tremendous opportunity: Umang Vohra, Cipla","“In the last 10 or 15 years, most consumption happened in the US. We are now at a stage where a lot of the emerging markets now have high consumption sectors. So India is one, China is the other. The Philippines, Vietnam, Indonesia and Africa will emerge as new places where healthcare will shift. D…",neutral,neutral,0.4001778568252557,neutral,-1.0661262610687816,negative
2022-11-14 14:30:48.000,1134.95,1134.95,1110.85,1122.85,1260853.0,Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers,"The suit is expected to impact Natco Pharma, Dr Reddy’s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021",negative,neutral,-1.0661262610687816,negative,0.1338150675766091,neutral
2022-11-24 14:36:38.000,1093.05,1107.0,1078.5,1104.8,1449105.0,USFDA designates Cipla’s Goa plant as ‘Official Action Indicated’,"According to USFDA definition, OAI means “objectionable conditions were found and regulatory administrative sanctions by FDA are indicated” during inspections",neutral,neutral,1.0749736974520836,positive,0.0909090909090909,neutral
2022-11-24 16:49:22.000,1093.05,1107.0,1078.5,1104.8,1449105.0,U.S. FDA Designates Cipla’s Goa Plant As ‘Official Action Indicated’,It states that an FDA inspection revealed significant objectionable conditions or practices and action must be taken to address the issues.,neutral,neutral,1.0749736974520836,positive,0.0909090909090909,neutral
2022-11-24 20:02:47.000,1093.05,1107.0,1078.5,1104.8,1449105.0,U.S. FDA designates Cipla’s Goa plant as ‘Official Action Indicated’,New Delhi,neutral,neutral,1.0749736974520836,positive,0.0909090909090909,neutral
2022-11-28 00:01:00.000,1100.0,1110.0,1094.1,1101.0,671213.0,Medley-Cipla deal talks called off over valuation issues,This is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due to market volatility and valuation mismatch. Hyderabad-based Aurobindo Pharma had also scrapped the demerger and sale of its injectables arm Eugia Pharma Specialities to Blackstone e…,neutral,neutral,0.0909090909090909,neutral,1.464737793851722,positive
2022-11-29 09:50:28.000,1106.0,1125.85,1105.0,1122.2,1898513.0,Cipla gains on launching US FDA-approved prostate cancer treatment drug,"Cipla rose 1.10% to Rs 1113.40 after the company announced the launch of Leuprolide Acetate Injection Depot 22.5mg, the approval for which was granted by the US FDA based on an NDA submitted under the 505(b)(2) regulatory pathway.",positive,positive,1.464737793851722,positive,1.9399723498193815,positive
2022-11-29 17:30:00.000,1121.15,1149.0,1120.0,1142.9,2678156.0,"Share Market News Live: Sensex hits all-time high, Nifty tops 18,650; HUL, Nestle, Cipla among top gainers","Stock Market News Live: Sensex and Nifty touched record highs in early deals today, extending their gains for the sixth straight session. Asian stocks rebounded as South Korea’s KOSPI moved 0.35 per cent higher, the Shanghai Composite index rose 1.63 per cent higher and Hong Kong’s Hang Seng Index j…",neutral,positive,1.9399723498193815,positive,-1.7467248908296942,negative
2022-11-30 07:25:00.000,1121.15,1149.0,1120.0,1142.9,2678156.0,"Stocks in the news: Wipro, Britannia, Cipla, IDFC, Biocon and Gland Pharma","BNP Paribas Arbitrage offloaded over 18,00,164 lakh shares at an average price of Rs 405 apiece of IT major Wipro for Rs 72.9 crore through an open market transaction.",neutral,neutral,1.9399723498193815,positive,-1.7467248908296942,negative
2022-11-30 17:30:00.000,1145.0,1145.2,1117.0,1125.0,1358853.0,"Stocks in news: Wipro, Britannia Industries, Cipla, Biocon and more","Stocks to watch out for today: Wipro, Britannia Industries, Cipla, Biocon, Gland Pharma, Kilpest India and more",neutral,neutral,-1.7467248908296942,negative,-0.4355942750466788,neutral
2022-12-14 17:34:56.000,1111.2,1118.1,1099.35,1102.15,709250.0,Raw material price ‘very challenging’ for pharma firms: Cipla’s Hamied,"Companies will have to manage work to match India’s National List of Essential Medicines but it will be worth the endeavour, she says",negative,neutral,-0.8144348452123789,neutral,-0.5427346529234741,neutral
2022-12-15 12:08:28.000,1096.3,1108.0,1086.1,1090.35,1308440.0,Hold Cipla; target of Rs 1210: Sharekhan,"Sharekhan recommended Hold rating on Cipla with a target price of Rs 1210 in its research report dated December 14, 2022.",neutral,positive,-0.5427346529234741,neutral,0.3485119457055241,neutral
2022-12-16 07:59:32.000,1096.3,1108.0,1086.1,1090.35,1308440.0,Cipla - Efforts Towards Building A Sustainable Growth Thrust: Motilal Oswal,Cipla is expanding its product offerings (own and in-licensing).,neutral,positive,-0.5427346529234741,neutral,0.3485119457055241,neutral
2022-12-16 11:09:10.000,1096.3,1108.0,1086.1,1090.35,1308440.0,Neutral Cipla; target of Rs 1180: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 1180 in its research report dated December 15, 2022.",neutral,positive,-0.5427346529234741,neutral,0.3485119457055241,neutral
2022-12-16 17:19:00.000,1096.3,1108.0,1086.1,1090.35,1308440.0,Broker’s call: Cipla (Neutral),Motilal OSwal,neutral,neutral,-0.5427346529234741,neutral,0.3485119457055241,neutral
2022-12-16 17:30:00.000,1096.3,1108.0,1086.1,1090.35,1308440.0,"Ambuja Cements, Just Dial, Indian Hotels & Cipla: Here’s what analysts said on these 4 stocks","Just Dial has ramped up its sales force, making employee expenses front-ended and leading to lower margins. This will improve as the workforce matures, Nuvama said",neutral,negative,-0.5427346529234741,neutral,0.3485119457055241,neutral
2022-12-21 15:37:21.000,1135.0,1147.35,1117.05,1122.0,2059170.0,"Healthcare Stocks Surge on Renewed Covid Fears; Dr Lal PathLabs, Cipla Rise Up to 6%",Healthcare Stocks Rise: Shares of healthcare service providers jumped on Wednesday amid renewed fears of Covid outbreaks,neutral,positive,-1.145374449339207,negative,0.3746654772524572,neutral
2022-12-22 06:47:05.000,1135.0,1147.35,1117.05,1122.0,2059170.0,"Hot Stocks | Bet on Cipla, UTI AMC, Abbott India for double-digit healthy return in short term. Here’s why",Cipla has given a breakout of downward slopping trend line with volume confirmation indicating positive strength of the stock.,positive,positive,-1.145374449339207,negative,0.3746654772524572,neutral
2022-12-26 00:53:00.000,1127.0,1135.0,1094.0,1097.3,1275759.0,India Inc to hire more women this new year in diversity push,"Leading organisations including Cognizant, Larsen & Toubro, HDFC Bank, ITC, KPMG, Axis Bank, Schneider Electric, Cipla and Procter & Gamble are doubling down on efforts to improve gender diversity in the workplace.",positive,neutral,-2.6353149955634465,negative,0.3564736529409159,neutral
2022-12-26 06:01:13.000,1127.0,1135.0,1094.0,1097.3,1275759.0,"SBI, Titan to Cipla — 6 day trading stocks to buy today","Day trading guide: Nifty on the weekly timeframe formed a long negative candle, which indicates sharp downside momentum in the market, say experts",positive,negative,-2.6353149955634465,negative,0.3564736529409159,neutral
2022-12-26 17:30:00.000,1094.05,1104.9,1090.1,1097.95,1202392.0,"Tata Steel, ITC, Cipla and Ashok Leyland: Trading strategies by Axis Securities",Ashok Leyland on the weekly time frame has decisively broken below the “Head and Shoulder” pattern. Neckline for the same was placed at Rs 142 level,neutral,neutral,0.3564736529409159,neutral,-0.7312614259597806,neutral
2022-12-27 11:56:00.000,1094.05,1104.9,1090.1,1097.95,1202392.0,Cipla’s higher automation spends to continue for 3 more years: CTO Geena Malhotra,"The company, however, did not disclose the financial details of its automation spends. The journey on automation has its roots in a decision Cipla took in 2020, where it started with reimagining technology and making it more cost-effective, Malhotra said, adding that it wanted to align closely with …",positive,neutral,0.3564736529409159,neutral,-0.7312614259597806,neutral
2022-12-27 12:30:12.000,1094.0,1103.15,1084.1,1086.0,870766.0,Cipla’s higher automation spends to continue for 3 more yrs: CTO Malhotra,"Cipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said.",positive,positive,-0.7312614259597806,neutral,0.0,neutral
2022-12-28 13:50:06.000,1086.0,1098.0,1070.0,1086.0,1622200.0,Cipla Ltd down for fifth straight session,"Cipla Ltd is quoting at Rs 1085.15, down 0.98% on the day as on 13:19 IST on the NSE. The stock jumped 15.99% in last one year as compared to a 5.28% rally in NIFTY and a 10.07% fall in the Nifty Metal index.",negative,negative,0.0,neutral,-1.6393442622950862,negative
2022-12-29 22:34:00.000,1094.95,1095.0,1073.5,1077.0,1181575.0,Cipla invests in Ethris for mRNA-based inhalation therapies,"The investment will facilitate a long-term strategic partnership between Cipla and Ethris for the development of messenger RNA (mRNA)-based therapies and fast-track Ciplas participation in the mRNA space, enabling it to provide access to cutting-edge solutions developed by Ethris for the developing …",neutral,positive,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 05:00:00.000,1094.95,1095.0,1073.5,1077.0,1181575.0,"Stocks To Watch: Reliance Industries, Eicher, Cipla, Tata Power, Kalpataru Power",Stocks to watch before going into trade today,neutral,neutral,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 07:29:23.000,1094.95,1095.0,1073.5,1077.0,1181575.0,"Stocks to Watch: Elin Electronics, RIL, Eicher, Cipla, Tata Power, Dish TV","Despite negative global cues, mostly due to a surge in Covid cases in China, Indian indices ended higher on Thursday. Markets gained momentum in the second half of Thursday with Sensex rising above the 61,100 mark and Nifty 50 slightly shy of the 18,200 mark.",neutral,positive,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 08:17:24.000,1094.95,1095.0,1073.5,1077.0,1181575.0,"Stocks to Watch: Elin Electronics, Cipla, Eicher Motors, RIL, Banks, Pharma","Stocks to Watch: Elin Electronics to debut today, the stock is likely to list on a quiet note.",neutral,neutral,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 09:04:13.000,1094.95,1095.0,1073.5,1077.0,1181575.0,"Cipla EU to invest 15 million euros in Ethris, collaborates for mRNA-based therapies","The drug major said its wholly-owned UK subsidiary, Cipla (EU), has signed definitive agreements for equity investment of 15 million euros in Ethris GmbH (“Ethris”).",neutral,positive,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 09:10:36.000,1094.95,1095.0,1073.5,1077.0,1181575.0,"Stocks to Watch Today: Cipla, Eicher Motors, Elin Electronics, Lotus, RIL, and Others","Stocks to watch: Shares of firms like Cipla, Eicher Motors, Elin Electronics, Lotus, RIL, and others will be in focus in Friday’s trade.",neutral,neutral,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 17:30:00.000,1094.95,1095.0,1073.5,1077.0,1181575.0,"Stocks in news: Lotus Chocolate, Cipla, Eicher Motors, SBI Cards and more","Stocks to watch out for today: Lotus Chocolate, Cipla, Eicher Motors, SBI Cards, Welspun Enterprises, Indo US-Biotech and more",neutral,neutral,-1.6393442622950862,negative,-0.5322841934737329,neutral
2022-12-30 20:36:54.000,1094.95,1095.0,1073.5,1077.0,1181575.0,Cipla invests in Germany’s Ethris for mRNA-based therapies,The investment marks a strategic move for Cipla in the mRNA space,neutral,positive,-1.6393442622950862,negative,-0.5322841934737329,neutral
2023-01-04 07:30:37.000,1078.95,1081.95,1063.95,1065.0,1368953.0,"India-Australia FTA: Cipla, Lupin, Sun And Other Top Drugmakers to Go Down Under in Bid to Push Up Exports","Starting on February 6, the business delegation is scheduled to meet government officials, drug procurement agencies, the pharmacy guild and the local regulatory agency of Australia",neutral,neutral,-1.2929236757959168,negative,1.3953488372093024,positive
2023-01-05 14:42:00.000,1088.35,1093.1,1073.5,1077.15,823513.0,Sun Pharma Stocks | Cipla Stocks: Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla,"“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near term, there are multiple assets waiting to play out. For Cipla this year, we are hoping to see generic Advair, generic Abraxane which is most likely in the price …",neutral,neutral,-1.0290807185188422,negative,0.6055003466604996,neutral
2023-01-11 10:39:22.000,1078.7,1083.95,1043.0,1048.6,2167666.0,"Stock Market LIVE: Sensex jumps 150 pts, Nifty 50 pts; IT, Metal gain","Share Market LIVE Update: Stock markets are trading in the green on Wednesday as Sensex is hovering the 60,300 mark and Nifty above 17,950. Airtel and Cipla are down, while Hindalco, TCS and Infosys gain. Metal and IT remain strong; Pharma and FMCG indices drag.",positive,neutral,-2.790395846852705,negative,0.7836246200607904,neutral
2023-01-16 07:45:25.000,1070.5,1074.7,1051.0,1060.5,824531.0,Why Cipla Is Still A Growth Bet After Outpacing Nifty Pharma In 2022,One of the core reasons for Cipla’s outperformance was its strategy and focus on the domestic market.,neutral,positive,-0.9341429238673516,negative,0.5739555890101747,neutral
2023-01-17 14:09:28.000,1068.9,1072.0,1059.35,1065.0,1298681.0,"Cipla Q3 PAT seen up 33.1% YoY to Rs 9,699 cr: Nirmal Bang","Net Sales are expected to increase by 16 percent Y-o-Y (up 8.3 percent Q-o-Q) to Rs 63,138 crore, according to Nirmal Bang.",positive,positive,-0.3648610721302358,neutral,-0.0047014574518057,neutral
2023-01-18 10:45:00.000,1068.9,1072.0,1059.35,1065.0,1298681.0,Cipla launches diagnostic device for multiple health conditions,The company said with the device the company has expanded its product offerings for diagnostics laboratories and aims to bridge the current gap in the diagnostic ecosystem in India by providing reliable and accurate tests at affordable prices. Cippoint will allow healthcare professionals to get test…,neutral,positive,-0.3648610721302358,neutral,-0.0047014574518057,neutral
2023-01-18 11:11:25.000,1068.9,1072.0,1059.35,1065.0,1298681.0,This device diagnoses multiple diseases within 15 minutes,"Cipla has launched a product touted to diagnose various health conditions including diabetes, infectious disease, and thyroid function",neutral,neutral,-0.3648610721302358,neutral,-0.0047014574518057,neutral
2023-01-18 11:55:23.000,1068.9,1072.0,1059.35,1065.0,1298681.0,"Cipla launches diagnostic device, says it will provide results in minutes","Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility",neutral,neutral,-0.3648610721302358,neutral,-0.0047014574518057,neutral
2023-01-18 17:30:00.000,1063.5,1069.6,1058.55,1063.45,376437.0,"Cipla expands diagnostics portfolio, launches point-of-care testing device","Another addition to its product offerings for diagnostics laboratories, Cipla’s device named Cippoint, offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers.",positive,neutral,-0.0047014574518057,neutral,-1.1246485473289598,negative
2023-01-22 11:43:00.000,1053.4,1064.25,1050.7,1063.75,748361.0,"Q3 results this week: Axis Bank, Maruti Suzuki, Tata Motors, Bajaj Finance, NTPC and more","Tata Motors, Bajaj Auto, DLF, Cipla, Dr Reddy’s Laboratories, Torrent Pharmaceuticals, Patanjali Foods, Tata Elxsi, Solar Industries India, and Indian Bank, are slated to come out with Q3 earnings on Jan 25.",neutral,neutral,0.9825327510916944,positive,-0.3098591549295732,neutral
2023-01-24 16:36:38.000,1064.9,1068.25,1020.0,1039.0,2225877.0,Cipla Q3 preview | Consolidated net profit likely to rise 22% YoY,Cipla’s generic version of Revlimid may reinforce sales in the US and improve the EBITDA margin on a yearly basis,positive,positive,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 05:00:00.000,1064.9,1068.25,1020.0,1039.0,2225877.0,"Tata Motors, Bajaj Auto, Cipla, Dr Reddy’s, Patanjali Foods Q3 Results Today — Earning Estimates","Tata Motors, Bajaj Auto, Cipla, Dr Reddy’s and Patanjali Foods are among the companies that will declare their results today.",neutral,neutral,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 07:56:30.000,1064.9,1068.25,1020.0,1039.0,2225877.0,"Stocks to Watch: Maruti, TVS Motor, Coffee Day, Indus Towers, SBI Card, IOC","Stocks to Watch: Bajaj Auto, Cipla, Dr.Reddy’s, Tata Elxsi and Tata Motors are some of the prominent companies to announce Q3 results on Wednesday.",neutral,neutral,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 08:50:42.000,1064.9,1068.25,1020.0,1039.0,2225877.0,"Stocks that will see action on January 25, 2023","Buzzing stocks: Tata Motors, Tata Elxsi, Tata Steel Long Products, Bajaj Auto, atteries, Arvind, Bajaj Auto, Blue Dart, Cipla, Ceat, Dr Reddy’s Lab, DLF, Embassy Office Parks REIT, Equitas Holdings, Go Fashion, Indian Bank, Jindal Saw, Patanjali Foods, Sundaram Clayton, Torrent Pharmaceuticals, Reli…",neutral,neutral,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 14:40:25.000,1064.9,1068.25,1020.0,1039.0,2225877.0,"Cipla Q3 Result | Profit rises 10% YoY to Rs 801 crore, revenue up 6%",,positive,neutral,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 15:15:45.000,1064.9,1068.25,1020.0,1039.0,2225877.0,Cipla Q3 net profit rises 7% to Rs 808 cr on accout of robust sales,"Drug major Cipla on Wednesday reported a 7 per cent increase in its consolidated net profit to Rs 808 crore for the third quarter ended December 2022, aided by robust sales.",positive,positive,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 15:31:45.000,1064.9,1068.25,1020.0,1039.0,2225877.0,Cipla Q3 PAT rises 10% YoY to Rs 801 cr,"The pharma major’s consolidated net profit rose 9.93% to Rs 800.96 crore on 6.05% increase in total revenue from operations to Rs 5,810.09 crore in Q3 FY23 over Q3 FY22.",positive,positive,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 16:39:56.000,1064.9,1068.25,1020.0,1039.0,2225877.0,"Cipla Q3 Results: Profit Rises, But Misses Estimates",The drug maker’s net profit rose to Rs 801 crore year-on-year.,neutral,positive,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 16:55:00.000,1064.9,1068.25,1020.0,1039.0,2225877.0,Cipla Q3 Results: Profit rises 10% YoY to Rs 801 crore but misses estimates; stock hits 4-month low,"The dismal numbers from the drugmaker weighed on the stock, which extended the days losses and hit an over 4-month low of Rs 1,021. The shares were trading 3.2% lower on the National Stock Exchange at Rs 1,028.45.",positive,negative,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 17:30:00.000,1064.9,1068.25,1020.0,1039.0,2225877.0,Cipla Q3 net profit rises 7% to Rs 808 crore,The Mumbai-based drug maker Cipla had reported a net profit of Rs 757 crore in the October-December period of the last fiscal,positive,neutral,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 17:44:51.000,1064.9,1068.25,1020.0,1039.0,2225877.0,"Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US","Cipla Q3 earning : Revenue up 6% to Rs 5,810 cr; firm expects US FDA audit at Goa unit",positive,positive,-2.432153253826659,negative,2.609333007573911,positive
2023-01-25 23:00:34.000,1064.9,1068.25,1020.0,1039.0,2225877.0,Cipla Q3 net profit rises 10%,"The company saw record contributions from the US market and in spite of a decent India performance, some weakness in the Africa business pulled down the overall show.",positive,positive,-2.432153253826659,negative,2.609333007573911,positive
2023-01-27 08:31:59.000,1023.25,1072.95,1023.25,1049.95,2940604.0,"Cipla Q3 profit up 10%, brokerages remain positive","Macquarie has kept ‘Outperform’ rating on Cipla with a target at Rs 1,235 per share",positive,neutral,2.609333007573911,positive,-1.9394512771996213,negative
2023-01-27 10:34:00.000,1023.25,1072.95,1023.25,1049.95,2940604.0,"Hot Stocks: Brokerages on Bajaj Auto, Dr Reddy’s Laboratories, Tata Motors and Cipla post Q3 results","EBITDA margin improved by 176 bps YoY to 24.2% despite soft Revlimid sales, mainly driven by an improvement in the mix. The net profit grew by 9.9% YoY to Rs8bn mainly on the back of a strong operational performance, which was partially offset by a higher tax rate on account of DTA reversal.",neutral,positive,2.609333007573911,positive,-1.9394512771996213,negative
2023-01-27 12:49:11.000,1023.25,1072.95,1023.25,1049.95,2940604.0,Cipla: Sharp improvement in margins not likely to sustain,"While the respiratory portfolio remains a significant part of the US portfolio, the peptides portfolio is a key watch in the near to medium term.",positive,neutral,2.609333007573911,positive,-1.9394512771996213,negative
2023-01-27 22:50:50.000,1023.25,1072.95,1023.25,1049.95,2940604.0,"Hold Cipla, target of Rs 1158: Sharekhan","Sharekhan recommended Hold rating on Cipla with a target price of Rs 1158 in its research report dated January 25, 2023.",neutral,positive,2.609333007573911,positive,-1.9394512771996213,negative
2023-01-29 09:11:00.000,1057.0,1057.0,1028.5,1036.5,2111382.0,"What to buy as Sensex dives below 59,500? Dilip Bhat answers","“Pharma is certainly one of the spaces that one should look at because that is one of the space which has not done anything at all. They have only gone down. I think one should definitely look into some of the frontline pharma stocks like Sun Pharma, Lupin, Cipla. I will also be a little more comfor…",neutral,neutral,-1.9394512771996213,negative,-2.205177372962608,negative
2023-01-29 19:45:34.000,1057.0,1057.0,1028.5,1036.5,2111382.0,Buy Cipla; target of Rs 1280: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1280 in its research report dated January 26, 2023.",neutral,positive,-1.9394512771996213,negative,-2.205177372962608,negative
2023-01-30 17:30:00.000,1043.0,1043.0,1007.5,1020.0,2702451.0,Taking Stock | Market ends flat amid high volatility; all eyes on inflation data,"Hindalco Industries, Sun Pharma, BPCL, UltraTech Cement and HDFC Bank gained the most among the Nifty pack, while losers included Bharti Airtel, Cipla, Divis Labs, Apollo Hospitals and HUL",neutral,positive,-2.205177372962608,negative,1.3738959764474974,positive
2023-01-31 16:42:00.000,1019.0,1035.9,1015.1,1033.0,1595339.0,I-T dept conducts survey action against Cipla,"As part of a survey, the Income Tax Department only covers the business premises of a company and does not raid the residences and other locations of its promoters or directors.",neutral,neutral,1.3738959764474974,positive,-0.1072020270928671,neutral
2023-01-31 17:30:00.000,1019.0,1035.9,1015.1,1033.0,1595339.0,"Taking Stock | Investors cautious ahead of inflation data; Sensex, Nifty end lower","Divis Labs, Reliance Industries, BPCL, Axis Bank and Tata Motors were among the top Nifty losers, while gainers included SBI Life Insurance, UltraTech Cement, Larsen and Toubro, HCL Technologies and Cipla",neutral,neutral,1.3738959764474974,positive,-0.1072020270928671,neutral
2023-01-31 23:00:33.000,1019.0,1035.9,1015.1,1033.0,1595339.0,Income tax department conducts survey action against drug major Cipla,"The Income Tax Department has carried out a survey action against drug major Cipla, sources said on Tuesday.",neutral,neutral,1.3738959764474974,positive,-0.1072020270928671,neutral
2023-02-09 15:38:33.000,1021.0,1036.85,1015.05,1033.0,1105623.0,"Sensex rises 142 pts in fag-end, Nifty near 17,900; broader indices fall","CLOSING BELL: Adani Enterprises, Adani Ports, Hero MotoCorp, Cipla, JSW Steel, Bharti Airtel, Sun Pharma, UPL, Ultratech Cement, HDFC, Bajaj Auto, and Tata Motors fell over half a per cent to 11%",positive,neutral,1.1753183153770812,positive,-1.529922779922782,negative
2023-02-15 19:31:51.000,1031.75,1038.0,1028.35,1032.8,666965.0,"Framework to assess, nudge generic drug makers to expand access to products",Indian companies Cipla and Sun Pharma among five companies to be assessed by Access to Medicine Foundation,positive,neutral,0.1017688393506134,neutral,-0.6904876871076863,neutral
2023-02-20 08:29:25.000,998.0,998.0,955.25,963.0,5803719.0,"Stocks to watch: HUL, United Breweries, Motherson, Sun Pharma, Paytm, Cipla","Stocks to watch: Samvardhana Motherson announced it is buying SAS Autosystemtechnik (SAS), which manufactures auto cockpit modules, from French company Faurecia for Rs 4,790 crore",neutral,neutral,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 09:04:10.000,998.0,998.0,955.25,963.0,5803719.0,"HUL, Cipla, Surya Roshni in spotlight","Hindustan Unilever: The FMCG major has signed an agreement for the sale of its atta and salt business carried out under the brands ‘Annapurna’ and ‘Captain Cook.’ The brands were sold at Rs 60.4 crore to Uma Global Foods , and Uma Consumer",neutral,positive,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 09:10:55.000,998.0,998.0,955.25,963.0,5803719.0,"Stocks that will see action on February 20, 2023","Stocks to watch: Infosys, Hindustan Unilever, Info Edge, Lumax Auto, Dilip Buildcon, Cipla, Kirloskar Ferrous, Crisil, Powergrid, KEC International, RITES, Imagicaaworld, Bharat Forge, NINtec Systems, Zee Learn, HG Infra, Prince Pipes",neutral,neutral,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 09:50:06.000,998.0,998.0,955.25,963.0,5803719.0,"Indices edge lower, breadth negative, Cipla drops over 5%","The domestic equity barometers were trading with tiny losses in early trade. The Nifty traded below the 17,950 mark. FMCG, bank and financial services stocks edged higher while pharma, healthcare and metal shares declined.",neutral,positive,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 10:08:36.000,998.0,998.0,955.25,963.0,5803719.0,"Stocks to Watch Today: Motherson, Sun Pharma, HUL, Dilip Buildcon, Cipla, Zydus and Others","Stocks to Watch Today: Motherson, Sun Pharma, HUL, Dilip Buildcon, Cipla, Zydus and Others",neutral,neutral,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 10:40:45.000,998.0,998.0,955.25,963.0,5803719.0,Cipla Shares Fall Nearly 7% After Pithampur Unit Gets 8 Observations from USFDA,Cipla Shares Fall Nearly 7% After Pithampur Unit Gets 8 Observations from USFDA,neutral,neutral,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 11:25:43.000,998.0,998.0,955.25,963.0,5803719.0,Why Cipla share price is falling today — explained,Cipla share price today dipped to the tune of 7 percent in early morning deals,negative,negative,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 11:29:00.000,998.0,998.0,955.25,963.0,5803719.0,Cipla stocks dive to 7-month low; here’s why bears are ruling the counter,"If they are minor in nature, then it is unlikely to hurt sales from the unit. However, if the regulator found major deviations from good manufacturing practices norms, then the resolution process could be longer and delay product launches from the facility.",negative,negative,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 11:32:50.000,998.0,998.0,955.25,963.0,5803719.0,Cipla dips 7% after Pithampur unit receives 8 USFDA observations,The company said it will work closely with the USFDA and is committed to address these comprehensively within stipulated time.,neutral,positive,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 11:50:14.000,998.0,998.0,955.25,963.0,5803719.0,Volumes jump at Cipla Ltd counter,"Cipla Ltd saw volume of 1.4 lakh shares by 10:47 IST on BSE, a 6.63 fold spurt over two-week average daily volume of 21095 shares",positive,positive,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 11:50:27.000,998.0,998.0,955.25,963.0,5803719.0,"Stocks In Focus | Cipla, HUL, Kotak Mahindra Bank & More | BQ Prime","Stocks In Focus | Cipla, HUL, Kotak Mahindra Bank & More | BQ Prime #StocksInFocus | #Cipla slumps in trade after Pithampur unit receives eight U.S. FDA observations. #HUL gains after selling atta and salt businesses.",neutral,positive,-3.5070140280561124,negative,0.1237368529593777,neutral
2023-02-20 12:04:04.000,969.8,979.1,963.5,971.0,2035008.0,Cipla slides as Pithampur unit gets 8 USFDA observations,"Cipla tumbled 5.96% to Rs 964.65 after the drug major said that the US drug regulator has issued Form 483, with eight observations after inspecting its Pithampur manufacturing facility in Madhya Pradesh.",neutral,negative,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 12:29:56.000,969.8,979.1,963.5,971.0,2035008.0,Cipla Shares Decline After U.S.FDA Issues Eight Observations At Pithampur Plant,The USFDA conducted a current Good Manufacturing Practices inspection at Cipla’s Pithampur manufacturing unit earlier this month.,neutral,neutral,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 16:04:05.000,969.8,979.1,963.5,971.0,2035008.0,"Sensex drops 311 pts, Nifty settles below 17,850, Cipla tumbles over 6%","The headline equity indices ended a volatile session with modest losses on Monday. The Nifty closed a tad below the 17,850 mark after hitting the day’s high of 18,004.35 in morning trade. IT and auto stocks edged higher. On the other hand, oil &",negative,positive,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 16:16:25.000,969.8,979.1,963.5,971.0,2035008.0,Shilpa Medicare Ltd leads losers in ‘A’ group,"Cipla Ltd, Adani Enterprises Ltd, Data Patterns (India) Ltd and TCNS Clothing Co. Ltd are among the other losers in the BSE’s ‘A’ group today, 20 February 2023.",positive,negative,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 17:30:00.000,969.8,979.1,963.5,971.0,2035008.0,"Sensex drops 311 pts, Nifty below 17,850; Adani Enterprises, Cipla, Shilpa Medicare down up to 8%","The 30-share BSE Sensex fell 311 points, or 0.51 per cent, to settle at 60,692; while the broader NSE Nifty index moved 100 points, or 0.56 per cent, down to close at 17,845. Most Asian shares, however, traded on a positive note.",neutral,negative,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 17:30:00.000,969.8,979.1,963.5,971.0,2035008.0,Cipla shares dive 6% after Pithampur unit gets observations from US drug regulator,"Cipla share price: The stock was last seen trading lower than 5-day, 20-, 50-, 100- and 200-day moving averages. The counter’s 14-day relative strength index (RSI) came at 28.40. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company’s stock has a price…",neutral,negative,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 17:30:00.000,969.8,979.1,963.5,971.0,2035008.0,"Stocks in news: Adani Wilmar, Adani Power, HUL, Marico, Cipla and more","Stocks to watch out for today: RITES, HUL,Marico, Adani Wilmar, Adani Power, Prince Pipes , Cipla and more",neutral,neutral,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-20 18:24:52.000,969.8,979.1,963.5,971.0,2035008.0,Cipla shares fall over 6% after its unit gets 8 observations from USFDA,Shares of Cipla on Monday ended over 6 per cent lower after the company received ‘Form 483’ with eight observations for its Pithampur-based manufacturing facility.,negative,neutral,0.1237368529593777,neutral,-0.1655286571487712,neutral
2023-02-24 11:32:09.000,961.1,966.0,955.0,966.0,1584501.0,Hold Cipla; target of Rs 1080: Sharekhan,"Sharekhan recommended Hold rating on Cipla with a target price of Rs 1080 in its research report dated February 20, 2023.",neutral,positive,0.509832483612525,neutral,-1.4291632145816142,negative
2023-02-24 13:48:52.000,961.1,966.0,955.0,966.0,1584501.0,Cipla: Plant observation may trigger delays in launches,All eyes on gAdvair opportunity which may shrink,negative,neutral,0.509832483612525,neutral,-1.4291632145816142,negative
2023-02-28 09:54:47.000,945.9,945.9,903.1,905.75,5376103.0,Contamination risk among 8 observations US FDA issued to Cipla’s Pithampur unit; stock falls,The US FDA’s current Good Manufacturing Practices (cGMP) inspection at the said unit was conducted between February 6 and February 17.,neutral,neutral,-4.244634739401626,negative,-0.8702357347433332,neutral
2023-02-28 16:08:46.000,907.8,910.25,896.0,899.9,3491516.0,"Cipla falls 4%, nears 52-week low on concerns of product launch delay in US","In the past seven trading days, the stock has dipped 11% after the United States Food and Drug Administration issued Form 483 with 8 observations for the company’s Pithampur manufacturing facilities",negative,negative,-0.8702357347433332,neutral,-1.657519818171744,negative
2023-02-28 17:37:10.000,907.8,910.25,896.0,899.9,3491516.0,"U.S. Drug Regulator Flags Quality, Procedural Lapses At Cipla Facility",Cipla got eight observations after U.S. FDA conducted a current good manufacturing practices inspection at its Pithampur facility.,neutral,neutral,-0.8702357347433332,neutral,-1.657519818171744,negative
2023-03-01 13:44:26.000,901.95,903.0,884.5,887.0,1883464.0,Buy Cipla; target of Rs 1070: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated March 01, 2023.",neutral,positive,-1.657519818171744,negative,-1.3748597081930416,negative
2023-03-01 13:48:11.000,901.95,903.0,884.5,887.0,1883464.0,Cipla - Regulatory Set Back; U.S. Scale Up Gets Delayed: Prabhudas Lilladher,FDA recently highlighted eight observations in the 483 letters issued to Cipla’s Pithampur (Indore) unit.,neutral,neutral,-1.657519818171744,negative,-1.3748597081930416,negative
2023-03-01 14:47:43.000,901.95,903.0,884.5,887.0,1883464.0,Neutral Cipla; target of Rs 990: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 990 in its research report dated February 28, 2023.",neutral,positive,-1.657519818171744,negative,-1.3748597081930416,negative
2023-03-01 15:45:30.000,901.95,903.0,884.5,887.0,1883464.0,"Cipla - Pithampur Facility Form 483 Observations, Expect Official Action Indicated Status: Systematix",The company had received eight observations for which we have received the Form 483.,neutral,neutral,-1.657519818171744,negative,-1.3748597081930416,negative
2023-03-03 08:00:00.000,891.0,892.0,877.0,878.75,1887330.0,"TMS Ep381: SC on Adani-Hindenburg, employment data, Cipla stocks, and more",What next in the Adani-Hindenburg saga? What do India’s employment numbers imply? What do USFDA observations mean for Cipla? What is the New START Treaty?,neutral,neutral,-1.3748597081930416,negative,-0.5649717514124294,neutral
2023-03-06 17:30:00.000,885.0,885.55,869.05,880.0,4085088.0,"Ambuja Cements, Cipla, Punjab National Bank: What should be your strategy amid market volatility","In the case of Ambuja Cements, the stock has reclaimed its 20-day SMA. The RSI is gaining momentum, which suggests that the upside momentum is likely to continue on the counter.",neutral,positive,-0.5649717514124294,neutral,-0.6450152766776106,neutral
2023-03-08 09:44:12.000,883.7,883.8,871.1,878.0,2924440.0,"Jefferies cuts target, lowers EPS outlook for Cipla; flags delay in FDA approvals","Cipla’s largest Indian facilities including Goa and Indore are under the regulatory scanner, which could impact new launches in the medium term. It estimates the value of India business at Rs 680 per share.",negative,neutral,-0.6450152766776106,neutral,0.5984611000284981,neutral
2023-03-09 17:30:00.000,879.15,884.6,871.3,881.6,1713599.0,‘Don’t self-edit’: Cipla top executive’s advice for women entrepreneurs,"Samina Hamied, Executive Vice Chairperson, Cipla, speaks to Business Today about her vision and plans for the pharma company and her journey as an entrepreneur",neutral,neutral,0.2786782687823517,neutral,-0.5948334466349422,neutral
2023-03-09 17:30:00.000,879.15,884.6,871.3,881.6,1713599.0,"Grasim, M&M, Cipla, Phoenix Mills, Mahanagar Gas: Should you buy, hold or sell?","Mahanagar Gas announced acquisition of UEPL for Rs 531 crore. UEPL is implementing CGD network in Ratnagiri, Latur & Osmanabad in Maharashtra and Chitradurga & Devengere in Karnataka.",neutral,positive,0.2786782687823517,neutral,-0.5948334466349422,neutral
2023-03-14 10:59:43.000,873.0,883.7,853.85,873.0,2442088.0,Income Tax department investigates Cipla for potential tax violations,The department had carried out a survey action against the company on January 31.,neutral,neutral,0.0,neutral,0.4571428571428572,neutral
2023-03-14 12:29:05.000,875.0,883.4,872.6,879.0,1281592.0,Income Tax Department Investigates Drug Major Cipla for Alleged Tax Violations; Details,"The income tax department is investigating drugmaker Cipla over potential tax violations and tax avoidance, people familiar with the matter told CNBC-TV18.",neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 13:13:44.000,875.0,883.4,872.6,879.0,1281592.0,Cipla shares hit 52-week low on reports of I-T probe into tax violations,"The company’s shares hit a fresh 52-week low after alleged wrongful Tax claims and deductions worth Rs 1,700 crore.",negative,negative,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 14:27:00.000,875.0,883.4,872.6,879.0,1281592.0,"Nifty Pharma index hits 2-year low; Cipla, Divis, Laurus Labs at 52-wk lows","Analysts said the pace of US FDA inspections has again picked-up in the last few months post Covid, and they have seen increased incidents with 483 observations and adverse outcomes",negative,positive,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 14:42:17.000,875.0,883.4,872.6,879.0,1281592.0,"TMS Ep381: SC on Adani-Hindenburg, employment data, Cipla stocks, and more",What next in the Adani-Hindenburg saga? What do India’s employment numbers imply? What do USFDA observations mean for Cipla? What is the New START Treaty?,neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 17:30:00.000,875.0,883.4,872.6,879.0,1281592.0,Income Tax Dept investigates Cipla on potential tax violations: Report,I-T dept investigates Cipla: Primary investigation has alleged wrong claims worth Rs 400 crore that were made under the section.,neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 17:30:00.000,875.0,883.4,872.6,879.0,1281592.0,Cipla shares hit 52-week low as I-T dept probes potential tax violations,"Shares of Cipla fell to a fresh 52-week low of Rs 853.5, falling up to 2.47 per cent on BSE. At 2:15 pm, Cipla shares were trading 0.03 per cent higher at Rs 875.40 against the previous close of Rs 875.15.",negative,negative,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 17:30:00.000,875.0,883.4,872.6,879.0,1281592.0,"Taking Stock | After 8 days, market goes green; Sensex up 449 points, Nifty above 17,400","Adani Enterprises, Hindalco Industries, UPL, SBI and Axis Bank were among the top Nifty gainers. Britannia Industries, Power Grid Corporation, Cipla, BPCL and SBI Life Insurance lost the most",positive,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 18:50:04.000,875.0,883.4,872.6,879.0,1281592.0,"Cipla to divest its 51.18% stake in Cipla Quality Chemical Industries, Uganda",Powered by Capital Market - Live News,neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-14 23:37:34.000,875.0,883.4,872.6,879.0,1281592.0,Cipla inks pact with Africa Capitalworks to sell 51% stake in Uganda unit,Drug major Cipla on Tuesday said it has inked a pact with Africa Capitalworks to sell a 51.18 per cent stake in Uganda-based Cipla Quality Chemical Industries Ltd.,neutral,positive,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-15 05:00:00.000,875.0,883.4,872.6,879.0,1281592.0,"Stocks To Watch: Reliance Industries, Cipla, PNC Infratech, Maruti Suzuki, GMR Airports, TVS",Stocks to watch before going into trade today.,neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-15 07:00:14.000,875.0,883.4,872.6,879.0,1281592.0,"Buzzing Stocks: Cipla, RailTel Corporation, LIC Housing Finance, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-15 07:15:24.000,875.0,883.4,872.6,879.0,1281592.0,"Stocks to watch: Cipla, Axis Bank, PNC Infratech, RailTel, Glenmark Pharma","Stocks to watch today: From Cipla to Axis Bank, here are top stocks to watch out in Wednesday’s trading session",neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-15 08:20:06.000,875.0,883.4,872.6,879.0,1281592.0,"Stocks to Watch: Cipla, LIC, NBCC, Welspun, HPCL, Axis Bank, RailTel, and Others","Stocks to watch: Shares of firms like Cipla, LIC, NBCC, Welspun, HPCL, Axis Bank, RailTel, and others will be in focus on Wednesday’s trade.",neutral,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-15 09:50:10.000,875.0,883.4,872.6,879.0,1281592.0,Cipla to divest 51.18% stake in Uganda-based subsidiary,"Cipla and its wholly owned subsidiaries, Cipla (EU), UK, and Meditab Holdings, Mauritius, have entered into a share purchase agreement with Africa Capitalworks SSA 3 for sale of 51.18% stake held in Cipla Quality Chemical Industries (CQCIL), Uganda.",neutral,positive,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-15 11:29:14.000,875.0,883.4,872.6,879.0,1281592.0,Cipla shares gain as co to sell majority stake in Uganda subsidiary,"With the stake sale, CQCIL will cease to be a subsidiary of Cipla.",positive,neutral,0.4571428571428572,neutral,0.340522133938706,neutral
2023-03-16 09:25:49.000,881.0,890.0,876.75,884.0,2020717.0,"Stocks that will see action on March 15, 2023","Buzzing stocks: Reliance, Cipla, NBCC, RailTel Corp, PNC Infratech, Xpro India, Industrial Investment Trust, HCC",neutral,neutral,0.340522133938706,neutral,-1.6171747337578208,negative
2023-03-17 17:30:00.000,887.35,888.4,870.0,873.0,2202291.0,"Taking Stock | A happy Friday for market; Sensex zooms 900 points, Nifty closes in on 17,600","Adani Enterprises, Adani Ports, SBI, Bharti Airtel and SBI Life Insurance were among the top Nifty gainers, while losers included Tech Mahindra, UltraTech Cement, Cipla, Divis Labs and Asian Paints",neutral,neutral,-1.6171747337578208,negative,-0.8065900120130375,neutral
2023-03-27 10:22:00.000,881.05,891.35,876.05,890.0,3983023.0,We may see 25-30% upside in consumer durable stocks when demand comes back: Sandip Sabharwal,"Pharma is a sector which has flattered to deceive, so there are very few companies which have done well consistently and some of the companies which were doing well like Cipla etc. suddenly the performance slipped. So it is a difficult sector to participate especially given the price pressures all a…",positive,negative,1.0158333806253954,positive,-0.2803319129849742,neutral
2023-03-28 17:30:00.000,893.95,896.6,885.35,888.5,3046983.0,Sun Pharma vs Cipla vs Auro Pharma: How should you trade these healthcare stocks,Sun Pharma has made a decent correction from the ‘double top’ level of Rs 1080 to Rs 940 and has been consolidating around these levels for quite some time.,neutral,negative,-0.6096537837686722,neutral,1.3163816381638216,positive
2023-03-29 17:30:00.000,893.95,896.6,885.35,888.5,3046983.0,How India has become a growing market for anti-flu drug Oseltamivir,"The market for anti-flu drug Oseltamivir in India has grown over 3x in the past three years, with Cipla, Hetero and Macleods being the biggest gainers",positive,positive,-0.6096537837686722,neutral,1.3163816381638216,positive
2023-03-30 14:54:25.000,888.8,902.7,886.7,900.5,2317460.0,"MPP inks pact with Aurobindo, Cipla and Viatris on ViiV Healthcare’s long-acting HIV prevention medicine","The Medicines Patent Pool (MPP) has signed sublicence agreements with Aurobindo, Cipla and Viatris (through its subsidiary Mylan) to manufacture generic versions of cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis",positive,positive,1.3163816381638216,positive,-2.071428571428574,negative
2023-03-30 18:53:00.000,888.8,902.7,886.7,900.5,2317460.0,"Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV’s HIV preventive therapy","Through the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic versions of cabotegravir LA for PrEP, in 90 countries, subject to required regulatory approvals. Aurobindo and Viatris will manufacture in India; Cipla will manufacture…",positive,positive,1.3163816381638216,positive,-2.071428571428574,negative
2023-03-30 20:34:36.000,888.8,902.7,886.7,900.5,2317460.0,"Aurobindo, Cipla, Viatris to make generic of ViiV’s HIV prevention drug","Aurobindo and Viatris will manufacture in India, while Cipla will manufacture in India and has plans to manufacture in South Africa as well, MPP said.",neutral,neutral,1.3163816381638216,positive,-2.071428571428574,negative
2023-04-10 13:39:06.000,905.0,908.15,902.0,907.05,1777448.0,Cipla signs pact with Novartis Pharma AG for diabetes drug Galvus,Drugmaker Cipla has signed a perpetual license agreement with Novartis Pharma AG (Switzerland) to manufacture,positive,positive,0.2265193370165696,neutral,1.1881188118811832,positive
2023-04-10 20:58:31.000,905.0,908.15,902.0,907.05,1777448.0,"Cipla inks licensing pact with Novartis to manufacture, mkt diabetes drug","Drug major Cipla on Monday said it has inked a licensing pact with Novartis Pharma AG to manufacture and market Galvus range, used in the treatment of type 2 diabetes, from January 1, 2026.",positive,positive,0.2265193370165696,neutral,1.1881188118811832,positive
2023-04-11 05:00:00.000,905.0,908.15,902.0,907.05,1777448.0,"Stocks To Watch: Bank of Baroda, Cipla, SBI, IRB Infrastructure Developers, Vedanta, Delta Corp",Stocks to watch before going into trade today.,neutral,neutral,0.2265193370165696,neutral,1.1881188118811832,positive
2023-04-11 07:52:16.000,905.0,908.15,902.0,907.05,1777448.0,"Stocks to watch: JSW Steel, Cipla, Zydus Life, Kaveri Seed, Kalpataru Power","Stocks to watch today: From Cipla to Zydus Lifesciences, here are top stocks to watch in Tuesday’s trading session",neutral,neutral,0.2265193370165696,neutral,1.1881188118811832,positive
2023-04-11 07:57:35.000,905.0,908.15,902.0,907.05,1777448.0,"Stocks to Watch: Titan, Cipla, State Bank of India, Bajaj Finserv, L&T, and Others","Stocks to watch: Shares of firms like Titan, Cipla, State Bank of India, Bajaj Finserv, L&T, and others will be in focus on Tuesday’s trade.",neutral,neutral,0.2265193370165696,neutral,1.1881188118811832,positive
2023-04-11 09:16:00.000,905.0,908.15,902.0,907.05,1777448.0,"Cipla, Novartis AG ink agreement on diabetes therapy Galvus",During the interim period Cipla would continue to market and distribute Galvus-branded products,positive,neutral,0.2265193370165696,neutral,1.1881188118811832,positive
2023-04-11 17:30:00.000,909.0,920.9,908.2,919.8,3448453.0,"JSW Steel, SBI, Vedanta, Paytm and other stocks to watch out for today","Stocks to watch out for today: JSW Steel, SBI, Vedanta, Kalpataru Power Transmission, Zydus Lifesciences, Cipla, Paytm and more",neutral,neutral,1.1881188118811832,positive,-0.7809957696062406,neutral
2023-04-12 10:40:16.000,909.0,920.9,908.2,919.8,3448453.0,"Cipla shares edge higher on large exchange volumes, hopes of better sales",Cipla has been in the news recently after it signed a perpetual license agreement with Novartis Pharma AG to manufacture and market the Galvus range for the treatment of type 2 diabetes on April 10.,positive,neutral,1.1881188118811832,positive,-0.7809957696062406,neutral
2023-04-12 12:29:56.000,921.9,923.05,912.3,914.7,1066791.0,"Improved sentiment, hopes of better sales fuel gains in pharma stocks; Divi’s Lab spurts 8%","Multiple counters in the pharmaceutical space, including Divi’s Laboratories, Cipla, Sun Pharmaceuticals, Lupin, and Natco Pharma also witnessed large deals on April 12.",positive,positive,-0.7809957696062406,neutral,-0.8743169398907104,neutral
2023-04-12 17:30:00.000,921.9,923.05,912.3,914.7,1066791.0,"Sensex rises over 100 points, Nifty tops 17,750; Divi’s Lab, Adani Enterprises & Cipla jump up to 5%","The 30-share BSE Sensex climbed 125 points or 0.21 per cent to trade at 60,283, while the broader NSE Nifty moved 51 points or 0.29 per cent higher to trade at 17,773. Mid- and small-cap shares were up as Nifty Midcap 100 rose 0.21 per cent and small-cap gained 0.24 per cent.",positive,positive,-0.7809957696062406,neutral,-0.8743169398907104,neutral
2023-04-12 17:30:00.000,921.9,923.05,912.3,914.7,1066791.0,"Taking Stock | Sensex slips 398 points, Nifty below 17,000; PSU bank, metal, realty worst hit","Bajaj Finserv, Bajaj Finance, Adani Enterprises, Tata Steel and Hindalco Industries were among the biggest Nifty losers. Cipla, Kotak Mahindra Bank, Dr Reddy’s Laboratories, Infosys and Apollo Hospitals gained the most",negative,positive,-0.7809957696062406,neutral,-0.8743169398907104,neutral
2023-04-17 14:16:36.000,905.0,925.5,897.0,925.1,1949463.0,"Cipla Q4 PAT seen up 58% YoY to Rs 6,485 cr: Nirmal Bang","Net Sales are expected to increase by 9.5 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs 57,594 crore, according to Nirmal Bang.",positive,positive,2.220994475138124,positive,-1.42016307576004,negative
2023-04-17 17:30:00.000,905.0,925.5,897.0,925.1,1949463.0,"Taking Stock | Sensex up 127 points, Nifty closes in on 17,000 amid high volatility","Grasim Industries, Reliance Industries, Cipla, Sun Pharma and SBI were among the top Nifty gainers, while losers were Adani Ports, Power Grid Corp, SBI Life Insurance, M&M and Tata Motors",positive,neutral,2.220994475138124,positive,-1.42016307576004,negative
2023-04-26 08:20:10.000,911.85,914.2,900.05,913.0,1399523.0,"Stocks to Watch: Cipla, Bajaj Auto, Adani Ports, Maruti Suzuki, AU SFB, and Others","Stocks to watch: Shares of firms like Cipla, Bajaj Auto, Adani Ports, Maruti Suzuki, AU SFB, and others will be in focus on Wednesday’s trade.",neutral,neutral,0.126117234194218,neutral,0.6584723441615451,neutral
2023-04-26 08:45:06.000,911.85,914.2,900.05,913.0,1399523.0,"Stocks to watch on April 26, 2023","Buzzing stocks of Maruti Suzuki, Bajaj Finance, HDFC Life, L&T Tech, Oracle Financial SBI Life, Nippon India, Cipla, KPI Energy, Amines and Plasticisers",neutral,neutral,0.126117234194218,neutral,0.6584723441615451,neutral
2023-04-26 17:30:00.000,911.2,917.3,903.0,917.2,2456310.0,"Tata Consumer, Cipla, Rallis India, Bajaj Finance among stocks to watch out for today","Stocks to watch out for today: Tata Consumer, Cipla, Rallis India, Bajaj Finance, Maruti, UCO Bank and more",neutral,neutral,0.6584723441615451,neutral,-1.077433748707621,negative
2023-05-03 15:35:06.000,920.65,935.4,920.65,932.5,3391926.0,"Infosys, Tata Steel, Cipla, Titan, Ambuja Cements, Godrej Consumer Products, NTPC stocks in focus | The Financial Express","The SGX Nifty hints that the domestic indices Nifty 50 and Sensex will snap their winning streak today. Infosys, Tata Steel, and Cipla are some of the stocks in focus on Wednesday.",neutral,positive,1.2871340900450794,positive,-1.390374331550802,negative
2023-05-08 18:23:42.000,935.0,943.0,929.1,940.0,2656401.0,IRM India Affiliate partners with Reliance Jio to drive Enterprise Risk Management in telecom sector | The Financial Express,"IRM has recently entered into knowledge partnerships with organisations, including Cipla, UltraTech, IHCL, NIMSME (Ministry of MSME) and AICTE (Ministry of Education), among others.",neutral,positive,0.53475935828877,neutral,0.2755696873343956,neutral
2023-05-10 05:42:00.000,943.5,946.7,933.2,946.1,1616829.0,Mankind Pharma rallies 32% on day 1,"At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2…",positive,neutral,0.2755696873343956,neutral,-0.3645200486026779,neutral
2023-05-11 16:42:26.000,948.85,953.0,913.0,931.5,3843562.0,"Cipla Q4 preview: Robust domestic traction, gRevlimid sales likely to give earnings a big boost",Cipla Q4 preview: The company is expected to double its consolidated net profit to Rs 723.4 crore from Rs 362.07 crore in the year-ago quarter. It is also seen as the biggest beneficiary of a strong flu season in India,positive,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 05:25:31.000,948.85,953.0,913.0,931.5,3843562.0,"Stocks To Watch: Tata Motors, HAL, Cipla, HPCL, Eicher Motors, Polycab, Manappuram Finance, Indraprastha Gas",Here are the stocks to watch before going into trade today.,neutral,neutral,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 08:52:26.000,948.85,953.0,913.0,931.5,3843562.0,"Stocks to Watch: Tata Motors, HPCL, ONGC, Mankind, Eicher Motors, Cipla, and Others","Stocks to watch: Shares of firms like Tata Motors, HPCL, ONGC, Mankind, Eicher Motors, Cipla, and others will be in focus on Friday’s trade.",neutral,neutral,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 15:08:31.000,948.85,953.0,913.0,931.5,3843562.0,"Cipla’s Q4 net profit surges 45% on year to Rs 525.65 crore, lags estimate","Cipla’s Q4 revenue was largely in-line with the Street’s expectations of Rs 5,744.42 crore.",positive,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 15:15:14.000,948.85,953.0,913.0,931.5,3843562.0,"Cipla Q4 Results: Profit Rises 45%, But Misses Estimates","Cipla’s Q4 revenue rose 9% to Rs 5,739 crore against an estimated Rs 5,776 crore.",neutral,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 15:24:00.000,948.85,953.0,913.0,931.5,3843562.0,"Cipla Q4 Results: Profit jumps 45% YoY to Rs 526 crore, revenue rises 9%",The Board has also recommended the payment of a final dividend of Rs 8.50 per equity share for the financial year ended March 2023.,positive,neutral,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 16:02:12.000,948.85,953.0,913.0,931.5,3843562.0,"Cipla posts Q4FY23 profit at Rs 370.70 crore, misses estimates; revenue at Rs 5739.30 crore | The Financial Express","Cipla clocked revenue from operations at Rs 5739.30 crore, up 9.1 per cent from Rs 5260.33 crore in the fourth quarter of FY22.",negative,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 16:22:22.000,948.85,953.0,913.0,931.5,3843562.0,Cipla’s Q4 net profit up 45% at Rs 526 cr on account of robust sales,"Drug major Cipla on Friday said its consolidated net profit increased by 45 per cent to Rs 526 crore for the fourth quarter ended March 31, 2023, driven by robust sales across the domestic business and US market.",positive,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 17:30:00.000,948.85,953.0,913.0,931.5,3843562.0,"Wipro, Cipla, Hindustan Aeronautics: What should be your trading strategy?","Hindustan Aeronautics registered a breakout from a potential Volatility Contraction pattern, which is a bullish sign for the short-to-medium term trend.",neutral,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-12 21:08:59.000,948.85,953.0,913.0,931.5,3843562.0,Cipla’s Q4 profit grows 45% to ₹536 crore,"Drugmaker Cipla posted a 45 per cent growth in profit after tax for the quarter ended March 31, 2023, at ₹536 crore, compared with ₹362 crore in the corresponding period of the previous year",positive,positive,-1.8285292722769693,negative,-2.127659574468085,negative
2023-05-15 08:40:04.000,940.0,940.0,896.85,920.0,5477921.0,Cipla reports 45% jump in Q4 net profit; what should investors do now?,"Cipla Q4: Motilal Oswal expect 12.3% earnings CAGR over FY23-25, led by 9%/11% sales CAGR in DF/NA segments and marginal improvement in profitability.",positive,positive,-2.127659574468085,negative,-0.8141039465171399,neutral
2023-05-15 15:56:05.000,927.4,942.65,918.4,919.85,2960822.0,"Taking Stock: Market at 5-month high with Nifty around 18,400; Sensex gains 318 points","Hero MotoCorp, Tata Motors, ITC, Tech Mahindra and HUL were among the top gainers on the Nifty, while losers were Adani Enterprises, Cipla, BPCL, Divis Labs and Grasim Industries.",positive,positive,-0.8141039465171399,neutral,-0.3027190658954611,neutral
2023-05-15 17:30:00.000,927.4,942.65,918.4,919.85,2960822.0,Cipla shares fall 4% post Q4 earnings; what should investors do?,Cipla stock slipped 3.98% to Rs 897.7 against the previous close of Rs 934.90 on BSE. The large cap share has lost 1.38 % in one year and fallen 13.34% since the beginning of this year.,negative,negative,-0.8141039465171399,neutral,-0.3027190658954611,neutral
2023-05-15 20:39:43.000,927.4,942.65,918.4,919.85,2960822.0,Broker’s call: Cipla (Add),Broker’s call: Cipla (Add),neutral,neutral,-0.8141039465171399,neutral,-0.3027190658954611,neutral
2023-05-17 14:55:01.000,929.0,929.65,911.55,916.0,1878980.0,Cipla builds on its diabetes portfolio with Galvus agreement,"Cipla had inked a perpetual license agreement with Novartis, as part of its strategy to grow the One India franchise towards a higher share of chronic therapies. Galvus and its combination brands had clocked sales of ₹270 crore, upto March 2023, and would strengthen the company’s diabetes portfolio.",neutral,positive,-1.3993541442411197,negative,0.0,neutral
2023-05-17 17:31:27.000,929.0,929.65,911.55,916.0,1878980.0,Buy Cipla; target of Rs 1167: KR Choksey,"KR Choksey is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1167 in its research report dated May 17, 2023.",neutral,positive,-1.3993541442411197,negative,0.0,neutral
2023-05-24 22:10:03.000,941.45,947.0,935.0,945.5,2175370.0,Hold Cipla; target of Rs 1030: Sharekhan,"Sharekhan recommended Hold rating on Cipla with a target price of Rs 1030 in its research report dated May 23, 2023.",neutral,positive,0.4301874767645605,neutral,0.4334496246960591,neutral
2023-05-25 15:00:00.000,945.9,952.75,940.5,950.0,1128551.0,Cipla vows to crack diabetes segment with licensed branded portfolio,"“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and global CEO of Cipla in an interview to ET.",neutral,neutral,0.4334496246960591,neutral,0.2678571428571381,neutral
2023-06-01 08:51:57.000,950.0,966.5,946.75,964.4,1130895.0,"Stocks To Watch on 1 June, 2023: Cipla, Adani Ports, Adani Green Energy, HDFC Life Insurance, Cipla, Coal India, Vedanta | The Financial Express",The SGX Nifty hinted at a muted start for benchmark equity indices BSE Sensex and NSE Nifty 50. Here’s a look at the key stocks to watch on Thursday.,neutral,negative,1.515789473684208,positive,-0.093177347551504,neutral
2023-06-01 09:37:11.000,950.0,966.5,946.75,964.4,1130895.0,Cipla share price falls; will complete stake sale in subsidiary by July 31,"The share touched a 52-week high of Rs 1,185.20 on November 1, 2022 and a 52-week low of Rs 852 and March 22, 2023",negative,negative,1.515789473684208,positive,-0.093177347551504,neutral
2023-06-06 17:30:00.000,972.95,977.9,958.5,962.5,1612893.0,"Tata Motors, Bharti Airtel, HDFC Life: Stocks that saw upgrades in FY24 earnings estimates; should you buy these shares?","Companies that reported less-than-expected earnings included ONGC, Infosys, Coal India, Maruti Suzuki, Bajaj Finserv, Tata Steel, UPL, Dr Reddy’s Labs and Cipla, among others.",positive,negative,-1.074053137365748,negative,0.0984557985283496,neutral
2023-06-07 17:17:00.000,964.9,969.85,963.0,965.85,1477474.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Cipla, Kotak Bank, Bajaj Finance, M&M and Maruti Suzuki were among the top losers on NSE in today’s trade.",neutral,negative,0.0984557985283496,neutral,0.2070393374741201,neutral
2023-06-12 15:51:26.000,963.0,983.85,957.0,982.0,2156820.0,"Taking Stock: Sensex gains 99 points, Nifty at 18,600 led by IT, realty, oil & gas","Top gainers on the Nifty were BPCL, HCL Technologies, Infosys, NTPC and Adani Enterprises, while losers were Power Grid Corporation, Larsen & Toubro, Cipla, Maruti Suzuki and Titan Company",positive,neutral,1.9730010384215992,positive,-0.2547121752419766,neutral
2023-06-12 17:07:00.000,963.0,983.85,957.0,982.0,2156820.0,Stock market update: Stocks that hit 52-week lows on NSE in today’s trade,"Power Grid, L&T, Cipla, Titan Company and Maruti Suzuki were among the top losers on NSE in today’s trade.",neutral,negative,1.9730010384215992,positive,-0.2547121752419766,neutral
2023-06-14 06:03:00.000,981.5,981.9,972.6,979.0,1826800.0,Stock to buy today: Cipla (₹981.4),Cipla’s share price was largely moving within the range of ₹958-975 over the past week,positive,neutral,-0.2547121752419766,neutral,1.644686593003715,positive
2023-06-21 15:55:46.000,1003.1,1007.0,990.1,998.5,2847692.0,"Sensex Ends Off Record High, Rises 195 pts; Nifty Above 18,850; Blue Dart Up 7% - News18","Stock Market Today: JSW Steel, Hindalco, Divi’s, Cipla drop 1 per cent each on Nifty",neutral,neutral,-0.4585784069384929,neutral,-0.9650482524126296,negative
2023-06-28 12:26:00.000,1007.0,1018.5,1004.05,1013.05,1647425.0,Have we missed the bulk of the comeback rally in pharma stocks? Nithya Balasubramanian answers,"“Sun, Cipla, Lupin being market leaders, should be able to do well. Most of these companies have actually added on the Street last year. While all those costs are in the P&L, we are expecting that this year, we will see their productivity improve.”",negative,positive,0.600794438927503,neutral,0.2574512327953285,neutral
2023-07-03 20:25:24.000,1007.95,1016.0,996.5,1015.0,1105345.0,"Delhi HC restrains Cipla Health from using marks Gluco-C, Gluco-D","In a move that is brings relief to Zydus Wellness, the Delhi High Court has restrained Cipla Health from using brands Gluco-C and Gluco-D",neutral,positive,0.6994394563222337,neutral,-0.7128810226155359,neutral
2023-07-04 08:48:00.000,1007.95,1016.0,996.5,1015.0,1105345.0,HC restrains Cipla from using ‘Gluco-C’ or ‘Gluco-D’ trademarks,"​​Zydus Wellness Products, which manufactures and sells energy drink GLUCON-C and GLUCON-D, had alleged that Cipla Health’s Gluco-C and Gluco-D were deceptively similar to its registered trademarks.",neutral,neutral,0.6994394563222337,neutral,-0.7128810226155359,neutral
2023-07-04 13:42:06.000,1017.0,1018.8,1005.4,1009.75,744060.0,Delhi HC restrains Cipla from using Gluco-C or Gluco-D trademarks,"Zydus argued that Cipla started branding its Glucose product under Gluco C ++ and Gluco D ++, in order to create confusion in the minds of customers",neutral,negative,-0.7128810226155359,neutral,0.7905138339920948,neutral
2023-07-04 16:05:56.000,1017.0,1018.8,1005.4,1009.75,744060.0,"Sensex soars 274 pts, Nifty near 19,400 as Bajaj Fin leaps 7%, Hero Moto 5%","Closing Bell on July 4, 2023: The rally was led by Bajaj Finance, Bajaj Finserv, Hero Moto, Tech M, TCS, Wipro, Sun Pharma, Kotak Bank, Infosys, Cipla, HCL Tech, SBI, HDFC twins, and ICICI Bank",neutral,neutral,-0.7128810226155359,neutral,0.7905138339920948,neutral
2023-07-07 10:36:00.000,1009.45,1028.75,998.05,1022.95,1907661.0,US unit of India’s Cipla recalls six batches of bronchospasm inhaler,"Indian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container defect. The recall was made after leakage was observed through the inhaler valve of one single inhaler. All six batches, produced using the same lot of valves in …",negative,negative,1.3373619297637327,positive,-0.5078125000000044,neutral
2023-07-07 13:50:48.000,1009.45,1028.75,998.05,1022.95,1907661.0,Cipla recalls six batches of bronchospasm treatment inhalation aerosol in US,"The company’s wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level, Cipla Ltd said in a regulatory filing.",neutral,negative,1.3373619297637327,positive,-0.5078125000000044,neutral
2023-07-07 14:27:58.000,1009.45,1028.75,998.05,1022.95,1907661.0,Cipla initiates voluntary recall of six batches of inhaler in the US,The inhaler aerosol is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm.,negative,neutral,1.3373619297637327,positive,-0.5078125000000044,neutral
2023-07-12 12:24:45.000,1027.85,1036.0,1018.05,1022.0,1417650.0,Cipla Q1 PAT seen up 15.6% YoY to Rs 793.7 cr: Nirmal Bang,"Net Sales are expected to increase by 14.8 percent Y-o-Y (up 7.5 percent Q-o-Q) to Rs 6.171.7 crore, according to Nirmal Bang.",positive,positive,-0.5691491949214291,neutral,0.7649953710471089,neutral
2023-07-14 11:34:51.000,1026.15,1034.8,1019.35,1034.0,785902.0,Cipla Q1 PAT seen up 6.1% YoY to Rs. 552.3 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 5.1 percent Y-o-Y (up 1.3 percent Q-o-Q) to Rs. 6,555.2 crore, according to Prabhudas Lilladher.",positive,positive,0.7649953710471089,neutral,-0.4053271569195179,neutral
2023-07-20 15:51:26.000,1048.9,1062.0,1045.05,1049.0,871707.0,"Taking Stock: Nifty inches closer to 20,000, Sensex up 474 pts; IT underperform","Top gainers on the Nifty included ITC, Kotak Mahindra Bank, Dr Reddy’s Laboratories, ICICI Bank and Cipla.",positive,neutral,0.0095337973114604,neutral,-0.0047666714333337,neutral
2023-07-25 17:08:15.000,1060.0,1082.05,1042.15,1079.0,1851615.0,"Cipla Q1 Preview: Steady earnings expected, strong India growth to offset subdued US sales",Most brokerages see Cipla as the frontrunner of growth within the domestic market in Q1 which will help offset the adverse impact of a moderation in US sales.,positive,positive,1.7924528301886793,positive,5.201793721973094,positive
2023-07-26 17:24:53.000,1115.0,1219.4,1108.55,1173.0,14531958.0,"Cipla Q1 Results: Profit Jumps 45%, Beats Estimates","Revenue rose 18% to Rs 6,329 crore, while Ebitda margin was at 23.6% versus 21.3%.",neutral,positive,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-26 20:42:46.000,1115.0,1219.4,1108.55,1173.0,14531958.0,"Cipla posts healthy 45 % growth in Q1 net profit, buoyed by critical markets","Cipla posts 45% net profit growth in Q1 FY24; US, India, South Africa markets show healthy growth. Revenue up 18% to ₹6,329 crore. US business posts highest ever quarterly revenue at $222 million. One-India business grows 12%, driven by branded prescription, trade generics and consumer health. Compa…",positive,positive,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-26 21:25:10.000,1115.0,1219.4,1108.55,1173.0,14531958.0,Cipla Q1 net profit jumps 45% to ₹995 crore,"Cipla posts 45% net profit growth in Q1 FY24; US, India, South Africa markets show healthy growth. Revenue up 18% to ₹6,329 crore. US business posts highest ever quarterly revenue at $222 million. One-India business grows 12%, driven by branded prescription, trade generics and consumer health. Compa…",positive,positive,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-27 06:30:39.000,1115.0,1219.4,1108.55,1173.0,14531958.0,Cipla raises margin guidance for FY24 to 23% on strong Q1,"“A good quarter gone by gives us the confidence to raise margin guidance,” said Umang Vohra, chief executive officer, Cipla.",positive,positive,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-27 09:37:21.000,1115.0,1219.4,1108.55,1173.0,14531958.0,"Cipla zooms 9% on stronger-than-expected Q1; brokerages cheer, raise targets","Cipla’s management also guided for a strong growth outlook across segments for the upcoming quarters, which lifted sentiment for the drugmaker.",positive,positive,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-27 10:19:00.000,1115.0,1219.4,1108.55,1173.0,14531958.0,"DRL, Cipla can outperform in the near term: Hemang Jani","I think maybe because of this news you might see some action in the RBL Bank but I do not really think that there is a case for too much of development in terms of banks, etc.",positive,neutral,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-27 11:29:56.000,1115.0,1219.4,1108.55,1173.0,14531958.0,"Stocks In Focus: Colgate, HDFC AMC, Cipla, Dr. Reddy’s and More | BQ Prime","Stocks In Focus: Colgate, HDFC AMC, Cipla, Dr. Reddy’s and More | BQ Prime Blue Ocean Strategic Advisors’ Ashish Maheshwari shares insight on #Colgate, #HDFCAMC, #Cipla and other top stocks to watch for in trade today.",neutral,neutral,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-27 11:34:41.000,1115.0,1219.4,1108.55,1173.0,14531958.0,Cipla Q1 Results Review - Strong Revival In Outlook For The North America Segment: Motilal Oswal,Ebitda and profit after tax at all-time high levels on quarterly basis.,neutral,positive,5.201793721973094,positive,0.4737718212471684,neutral
2023-07-27 15:25:47.000,1171.45,1190.4,1155.7,1177.0,4436305.0,"Cipla Shares Rally 9% After Q1 Results; Should You Buy, Sell or Hold The Pharma Stock? - News18",Drug major Cipla posted a 45.1% rise in its consolidated net profit in Q1FY24 at Rs 995.7 crore; Should you invest?,neutral,positive,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-27 15:58:31.000,1171.45,1190.4,1155.7,1177.0,4436305.0,"Moneycontrol Pro Panorama | Cipla, Dr Reddy’s deliver a pep pill for pharma stocks","In today’s edition of Moneycontrol Pro Panorama: New Delhi needs strategic approach towards China, Colgate brings cheers to investors, Manipur situation should be resolved soon, a safety net for the gig workers, and more",neutral,positive,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-27 17:30:00.000,1171.45,1190.4,1155.7,1177.0,4436305.0,Cipla raises margin guidance for FY24 to 23%,"Pharma major has also set aside a substantial capital expenditure budget of Rs 10,000-15,000 crore for the fiscal year",positive,neutral,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-27 17:30:00.000,1171.45,1190.4,1155.7,1177.0,4436305.0,Report says Cipla’s promoters in talks to sell stake to PE firms; pharma co says ‘unaware’,"Cipla’s market capitalisation is over $10 billion, a 25 per cent stake sale would require a large investment of over $2.5 billion.",neutral,neutral,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-27 18:23:04.000,1171.45,1190.4,1155.7,1177.0,4436305.0,"Share Market Highlights 27 July 2023: Sensex falls 440 points, Nifty tests 19,650 on July contracts expiry; Cipla spurts nearly 10%","Sensex, Nifty updates on 26 July 2023: Domestic markets close red amid volatility on July contracts expiry; Pharma and Healthcare stocks lead gainers. At 3.30 pm, the Sensex ended at 66,266.82, down by 440.38 points, while Nifty fell 118.40 points to reach 19,659.90.",neutral,positive,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-27 18:52:00.000,1171.45,1190.4,1155.7,1177.0,4436305.0,Cipla clarifies on reports of promoters looking to sell part stake,"“The Company will make appropriate disclosure in compliance with the Listing Regulations as and when any such requirement arises,” the company said in a filing. The clarification came regarding reports that Cipla promoters are looking to sell a part stake in the promoter shareholding to private equi…",neutral,neutral,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-27 20:33:32.000,1171.45,1190.4,1155.7,1177.0,4436305.0,Cipla stock jumps amid talk of promoter stake sale,Cipla denies reports of stake sale by promoters; shares up 10% on BSE. Company not aware of any event requiring disclosure under Listing Regulations. Promoters hold 33% stake; succession-planning attributed to Dr YK Hamied being over 80 years.,positive,neutral,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-28 08:32:00.000,1171.45,1190.4,1155.7,1177.0,4436305.0,"Big Movers on D-Street: What should investors do with Cipla, RVNL and M&M?","In the short-term period, the stock has formed a strong price volume breakout pattern. The texture of the pattern suggests breakout action will continue in the near term if the stock succeeds to trade above the 1130 level.",neutral,positive,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-28 08:54:57.000,1171.45,1190.4,1155.7,1177.0,4436305.0,"Stocks to Watch: RailTel, Indian Hotels, Cipla, Airtel, Indian Oil, Marico, and Others - News18","Stocks to watch: Shares of firms like RailTel, Indian Hotels, Cipla, Airtel, Indian Oil, Marico, and others will be in focus on Friday’s trade.",neutral,neutral,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-28 10:43:32.000,1171.45,1190.4,1155.7,1177.0,4436305.0,Cipla and Dr. Reddy Q1FY24 results highlight tailwinds for pharma sector,"The main positive takeaway for the pharma sector after the Q1 results is related to the ease of operating environment in the US, indicated by both Cipla and Dr Reddy’s",positive,positive,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-07-28 12:52:34.000,1171.45,1190.4,1155.7,1177.0,4436305.0,"Stocks In Focus: M&M, ACC, Cipla, Lupin, DRL and More","Stocks In Focus: M&M, ACC, Cipla, Lupin, DRL and More",neutral,neutral,0.4737718212471684,neutral,-0.406160094770685,neutral
2023-08-04 06:50:00.000,1171.0,1238.7,1171.0,1206.95,8356629.0,Blackstone sets its sights on buying out Hamieds from Cipla,"Non-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn making it the largest PE buyout in the country",neutral,positive,3.0700256191289537,positive,2.301255230125523,positive
2023-08-04 10:28:00.000,1171.0,1238.7,1171.0,1206.95,8356629.0,"Cipla’s impending ‘takeover’ by Blackstone should sadden all of us, says Jairam Ramesh","Senior Congress leader Jairam Ramesh expressed his sadness over the potential acquisition of Cipla, India’s oldest pharmaceutical company, by the world’s largest private equity fund, Blackstone. Ramesh stated that the company is an essential part of India’s political, economic, and social history, p…",positive,negative,3.0700256191289537,positive,2.301255230125523,positive
2023-08-04 10:41:25.000,1171.0,1238.7,1171.0,1206.95,8356629.0,Cipla’s impending ‘takeover’ by Blackstone should sadden all of us: Jairam Ramesh,"The Congress general secretary shared a media report on Twitter which claimed that Blackstone, the world’s largest private equity fund, is set to submit a non-binding bid as early as next week to acquire the entire 33.47 per cent promoter stake in Cipla.",positive,neutral,3.0700256191289537,positive,2.301255230125523,positive
2023-08-04 10:50:35.000,1171.0,1238.7,1171.0,1206.95,8356629.0,Cipla surges to record high on talk of Blackstone eyeing to buy out promoter’s stake,"In the event that Blackstone proceeds with the move, it would lead to an open offer for an extra 26 percent of the company’s shares.",positive,neutral,3.0700256191289537,positive,2.301255230125523,positive
2023-08-04 20:31:42.000,1171.0,1238.7,1171.0,1206.95,8356629.0,Concerns arise over Cipla legacy of affordable drugs amid reports of ‘impending takeover’,"As suitors reportedly emerge to buy-out Cipla promoter’s stake in the company, industry-insiders point to the drugmaker’s reputation in supplying affordable medicines across the world, and the need to keep that legacy.",neutral,positive,3.0700256191289537,positive,2.301255230125523,positive
2023-08-06 12:48:00.000,1195.0,1228.5,1174.2,1222.5,2451439.0,Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the West,"Cipla has been closely associated with India’s struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big pharma in the West, Yusuf Hamied was a pirate; for poor patients in India and African countries, he was a do-gooder; for Cipla, he was a sharp businessman who w…",neutral,neutral,2.301255230125523,positive,3.510204081632653,positive
2023-08-08 15:53:42.000,1270.0,1271.65,1252.25,1265.05,2097848.0,"Taking Stock: Sensex, Nifty end lower as investors turn cautious in data-heavy week","Adani Enterprises, Power Grid Corporation, Hindalco Industries, M&M and Divis Labs were top losers on the Nifty. Gainers included Hero MotoCorp, SBI Life Insurance, Cipla, Tech Mahindra and Wipro",negative,negative,-0.3897637795275626,neutral,-0.7898894154818324,neutral
2023-08-09 10:42:00.000,1270.0,1271.65,1252.25,1265.05,2097848.0,Is the comeback in pharma here to stay? Should you buy expensive capital goods stocks?,"“The next few quarters may certainly be very good for pharma companies. But these are no longer the secular growth stories which we have pursued back in the 2000 or 2010 era, when companies like Sun Pharma, Lupin, Dr. Reddy, Cipla were easily growing at 20% plus,” says Dipan Mehta.",neutral,positive,-0.3897637795275626,neutral,-0.7898894154818324,neutral
2023-08-09 11:30:19.000,1270.0,1271.65,1252.25,1265.05,2097848.0,"As Cipla’s stock runs up, deal pricing key for Blackstone","Blackstone interested in acquiring Cipla’s 33.47% stake, but stock surge in past month has made deal more expensive. Open offers in past for R Systems & Mphasis had lukewarm response.",positive,positive,-0.3897637795275626,neutral,-0.7898894154818324,neutral
2023-08-10 19:15:44.000,1258.3,1258.8,1245.0,1248.25,1281224.0,Cipla doyen Hamied labels sale reports as “speculative”,YK Hamied labels reports of promoter family selling stake in Cipla to PE players as “speculation”; shareholders urge him to not sell company.,neutral,neutral,-0.7986966542160021,neutral,-1.4837625979843188,negative
2023-08-17 09:05:10.000,1235.0,1245.85,1226.05,1245.0,1851396.0,Cipla rolls out knowledge platform for health care practitioners,"Cipla has launched CiplaMed 2.0, a knowledge platform for healthcare professionals. It offers digital engagement, access to medical info, 19 specialities, scientific articles, webinars, podcasts, expert talks, patient education resources and tailored content. It has 12,000 users and leverages advanc…",neutral,neutral,0.8097165991902834,neutral,-0.4116222760290483,neutral
2023-08-17 09:30:13.000,1235.0,1245.85,1226.05,1245.0,1851396.0,Cipla shares fall after FDA suspends license of Patalganga unit for 10 days,Cipla said that it wasn’t in agreement with the FDA rulings and will appeal against the order to the state government.,negative,neutral,0.8097165991902834,neutral,-0.4116222760290483,neutral
2023-08-17 17:05:32.000,1239.0,1257.0,1231.0,1233.9,1290667.0,‘Cipla Patalganga unit licence suspended for 10 days in December 2023’,Drugmaker Cipla said the Konkan Division of the Food and Drugs Administration had ordered a suspension of the FDA licence to its manufacturing unit at Patalganga (Unit II) for 10 days in December 2023,neutral,negative,-0.4116222760290483,neutral,-0.3192048163562201,neutral
2023-08-23 06:47:00.000,1252.05,1259.9,1225.05,1233.6,2533321.0,"Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PE","Torrent Pharma is reportedly vying to acquire the Hamied family’s stake in Cipla, which could become the largest pharmaceutical deal since 2014. If successful, the deal could create India’s second-largest drugmaker by revenue. Other potential buyers include Blackstone and Baring PE Asia-EQT. Torrent…",neutral,positive,-1.4735833233497102,negative,-1.3722474093264283,negative
2023-08-23 10:01:14.000,1252.05,1259.9,1225.05,1233.6,2533321.0,Torrent Pharma In Race To Buy Hamied Family Stake in Cipla; Details - News18,Torrent Pharma has entered into the race to acquire the Hamied family’s stake in Cipla,neutral,neutral,-1.4735833233497102,negative,-1.3722474093264283,negative
2023-08-23 17:30:00.000,1235.2,1239.65,1217.0,1218.25,846532.0,Torrent Pharma joins race to acquire stake of Cipla promoters: Report,"A successful deal will take Torrent Pharma to the second-largest company by revenues in India. In domestic formulation business, it will overtake market leader Sun Pharma.",neutral,positive,-1.3722474093264283,negative,-0.4885258015517916,neutral
2023-08-23 17:30:00.000,1235.2,1239.65,1217.0,1218.25,846532.0,"Is Pharma back on growth track? Here’s why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma","Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.",neutral,positive,-1.3722474093264283,negative,-0.4885258015517916,neutral
2023-08-23 20:10:59.000,1235.2,1239.65,1217.0,1218.25,846532.0,Deal street abuzz on Torrent Pharma’s possible interest in Cipla promoter stake,"Torrent Pharma shows interest in Cipla; PE players keen on buying promoter stake. If successful, it would change dynamics of domestic pharma industry. Torrent has pulled off several domestic acquisitions, incl. Elder Pharma & Unichem. Last year, bought Curatio Healthcare for Rs ₹2000 crore. Reports …",neutral,positive,-1.3722474093264283,negative,-0.4885258015517916,neutral
2023-08-24 10:26:10.000,1235.2,1239.65,1217.0,1218.25,846532.0,How A Potential Acquisition Of Cipla Would Impact Torrent Pharma,"While an official confirmation is awaited, at least two analysts said the deal may be too big for Torrent Pharma.",neutral,neutral,-1.3722474093264283,negative,-0.4885258015517916,neutral
2023-08-25 09:51:24.000,1217.95,1219.9,1205.0,1212.0,885677.0,Responsible manufacturing critical to keep AMR in check: Study,"Pharmaceutical companies must prioritize responsible manufacturing to combat AMR and limit environmental impact. A handful of companies are taking promising action, such as Abbott, Centrient, Sandoz, Shionogi, Aurobindo, Cipla, Viatris and Sun Pharma.",neutral,neutral,-0.4885258015517916,neutral,1.7285478547854825,positive
2023-09-04 21:35:57.000,1255.0,1266.0,1235.1,1239.5,2168899.0,Cipla To Acquire South Africa’s Actor Pharma For $48.6 Million,"Actor Pharma is the fifth largest privately owned, over-the-counter player in the South African private market.",neutral,neutral,-1.235059760956175,negative,0.8305581190065328,neutral
2023-09-05 05:00:00.000,1255.0,1266.0,1235.1,1239.5,2168899.0,"Stocks To Watch: Hero MotoCorp, Cipla, M&M, Yes Bank, RVNL, Tata Power, Oil India, Bombay Dyeing, BHEL",Here are the stocks to watch before going into trade today.,neutral,neutral,-1.235059760956175,negative,0.8305581190065328,neutral
2023-09-05 08:59:33.000,1255.0,1266.0,1235.1,1239.5,2168899.0,"Stocks to Watch: Hero MotoCorp, Cipla, SBI, Yes Bank, BHEL, RVNL, Dabur, and Others - News18","Stocks to watch: Shares of firms like Hero MotoCorp, Cipla, SBI, Yes Bank, BHEL, RVNL, Dabur, and others will be in focus on Tuesday’s trade.",neutral,neutral,-1.235059760956175,negative,0.8305581190065328,neutral
2023-09-06 00:03:26.000,1246.15,1267.0,1242.6,1256.5,2719272.0,Cipla Acquires South Africa’s Actor Pharma,Cipla Acquires South Africa’s Actor Pharma,neutral,neutral,0.8305581190065328,neutral,-0.8737092930897538,neutral
2023-09-11 08:56:56.000,1244.6,1252.75,1236.5,1247.9,1157778.0,"Torrent Pharma - Visualising A Deal With Cipla; Key Positives, Negatives: Yes Securities Analysis","Upfront, deal would require large capital outlay to buy out promoter stake followed by an open offer.",neutral,neutral,0.2651454282500548,neutral,-0.8774389999599379,neutral
